UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON,

Washington, D.C. 20549

_______________________
FORM

Form 20-F


o
¨REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

 OR

OR
xANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2011

OR

For the fiscal year ended December 31, 2009

OR
o
£
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to _______________


OR

OR
o
£
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of event requiring this shell company report. . . . . . . . . . .


Commission file number 000-20181

_______________________

SAPIENS INTERNATIONAL CORPORATION N.V.

(Exact name of Registrant as specified in its charter)


NETHERLANDS ANTILLES

Curaçao

(Jurisdiction of incorporation or organization)


Landhuis Joonchi

Kaya Richard J. Beaujon z/n

P.O. Box 837

Curaçao Netherlands Antilles

(Address

 (Address of principal executive offices)

Roni Giladi, Chief Financial Officer

Tel: +972-8-938-2721

Fax:+972-8-938-2880

Fax+972-8-938-2730

Rabin Science Park

PO Box 4011

Nes Ziona 74140 Israel

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

Title of Class:Name of each exchange on which registered:
Common Shares, par value € 0.01 per shareNASDAQ Capital Market

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:None

 

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report

As of December 31, 20092011, the issuer had 21,591,08839,680,630 Common Shares, par value € 0.01 per share, outstanding.

Indicate by check mark if the registrant is well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes¨      Nox

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Yes¨      Nox

Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the proceedingpreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yesx      No¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yesx

     No¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act.

o Large Accelerated Filero Accelerated Filerx Non-Accelerated Filer

£ Large Accelerated Filer      £ Accelerated Filer      xNon-Accelerated Filer


Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

x U.S. GAAP    
o International Financial Reporting Standards as issued
     by the International Accounting tandards Board
o Other

£ U.S. GAAP        £International Financial Reporting Standards as issued     £Other

by the International Accounting Standards Board

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow:

Item 17¨      Item 18¨

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes¨       Nox£


TABLE OF CONTENTS

  Page
Introduction 1
PART I 1
Item 1.1
Item 2.1
Item 3.2
Item 4.1012
Item 4A.1928
Item 5.1928
Item 6.3141
Item 7.3853
40
Financial Information56
Item 9.4157
44
Additional Information60
Item 11.5882
Item 12.5983
 59
83
Item 13.5983
Item 14.  5983
Item 15T.15.5983
60
[Reserved]84
Item 16A.6084
Item 16B.6084
Item 16C.6085
Item 16D.6185
Item 16E.6185
Item 16F.6185
61
 62
16G.Corporate Governance6279
62
63
 64
PART III87
Item 17.Financial Statements87
Item 18.Financial Statements87
Item 19.Exhibits88
Signature90


Definitions

In this annual report, unless the context otherwise requires:

References to “Sapiens,” the “Company,” the "Registrant," “us,” “we” and “our” refer to Sapiens International Corporation N.V.,, a Netherlands AntillesCuraçao company, and its consolidated subsidiaries.

References to “our shares,” “Common Shares” and similar expressions refer to the Registrant’s Common Shares, par value € 0.01 per share.

References to “dollars”, “US dollars” or “$” are to United States Dollars.

References to “NIS” are to New Israeli Shekels, the Israeli currency.

Cautionary Statement Regarding Forward-Looking Statements

Certain matters discussed in this annual report are forward-looking statements that are based on our beliefs and assumptions as well as information currently available to us. Such forward-looking statements may be identified by the use of the words “anticipate,” “believe,” “estimate,” “expect,” “may,” “will,” “plan” and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those described herein. Please read the risks discussed in Item 3 – “Key Information” under the caption “Risk Factors” and cautionary statements appearing elsewhere in this annual report in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements.

We undertake no obligation publicly to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed in this annual report might not occur.

Item 1.    Identity of Directors, Senior Management and Advisers

Not applicable.

Item 2.    Offer Statistics and Expected Timetable

Not applicable.

IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS
Not applicable.
OFFER STATISTICS AND EXPECTED TIMETABLE
Not applicable.

KEY INFORMATION

Item 3.    Key Information

A. Selected Financial Data.

The following tables summarize certain selected consolidated financial data for the periods and as of the dates indicated. We derived the statement of operations financial data for the years ended December 31, 2007, 20082009, 2010 and 20092011 and the balance sheet data as of December 31, 20082010 and 20092011 from our audited consolidated financial statements included elsewhere in this annual report. The selected consolidated statement of operations financial data for the years ended December 31, 20052007 and 20062008 and the balance sheet data as of December 31, 2005, 20062007, 2008 and 20072009 are derived from our audited financial statements not included in this annual report. Certain financial data for previous years set forth below was reclassified to conform to later years' presentation. You should read the selected consolidated financial data together with our audited consolidated finan cialfinancial statements included elsewhere in this annual report and with Item 5, “Operating and Financial Review and Prospects.” Our consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”).

Selected Financial Data: Year Ended December 31, 
  2005  2006  2007  2008  2009 
  (In thousands, except share and per share data) 
Revenues:               
Products
 $13,295  $10,423  $5,632  $4,137  $3,123 
Consulting and other services
  26,109   33,888   36,763   39,397   42,572 
Total revenues  39,404   44,311   42,395   43,534   45,695 
                     
Cost of revenues:                    
Products
  8,809   6,302   3,277   2,482   1,874 
Consulting and other services
  16,037   22,499   22,306   23,975   24,697 
Total cost of revenues  24,846   28,801   25,583   26,457   26,571 
Gross profit  14,558   15,510   16,812   17,077   19,124 
Operating Expenses:                    
Research and development, net
  2,723   2,451   3,502   3,884   2,735 
Selling, marketing, general and administrative
  16,245   13,558   12,513   10,708   11,048 
Restructuring costs
  1,113   758   -   -     
Total operating expenses
  20,081   16,767   16,015   14,592   13,783 
Operating  income (loss)  (5,523)  (1,257)  797   2,485   5,341 
Financial expenses, net  1,788   2,230   2,798   2,236   880 
Other expenses (income), net  (12)  -   109   (32)  - 
Income (loss) before taxes on income  (7,299)  (3,487)  (2,110)  281   4,461 
Taxes on income  1,798   325   338   584   260 
                     
Net income (loss)  (9,097)  (3,812)  (2,448)  (303)  4,201 
                     
Attributable to non-controlling interest  (2)  (13)  (96)  (41)  - 
                     
Net income (loss) attributable to Sapiens  (9,099)  (3,825)  (2,544)  (344)  4,201 
                     
Basic net earnings (loss) per share attributable to Sapiens' shareholders $(0.76) $(0.29) $(0.14) $(0.02) $0.19 
Diluted net earnings (loss) per share attributable to Sapiens' shareholders $(0.76) $(0.29) $(0.14) $(0.02) $0.19 
Weighted average number of shares used in computing basic net earnings (loss) per share  11,982   13,395   18,218   21,550   21,591 
Weighted average number of shares used in computing diluted net earnings (loss) per share  11,982   13,395   18,218   21,550   21,592 
2

  At December 31, 
Balance Sheet Data: 2005  2006  2007  2008  2009 
  (In thousands) 
    
Cash and cash equivalents $6,699  $3,108  $13,125  $7,938  $11,172 
Working capital (deficit)  (10,636)  (12,616)  (567)  (4,506)  925 
Total assets  51,866   45,619   52,532   45,177   45,774 
Long-term debt and other long-term liabilities  15,603   13,157   7,467   1,432   972 
Capital stock  110,645   113,683   132,310   132,562   132,821 
Total shareholders’ equity  3,632   4,007   21,943   21,876   26,415 

 Year Ended December 31, 
Selected Financial Data:  2007  2008  2009  2010  2011 
  (In thousands, except share and per share data) 
                
Revenues  42,395   43,534   45,695   52,235   69,927 
Cost of revenues  25,583   26,457   26,571   29,921   40,067 
Gross profit  16,812   17,077   19,124   22,314   29,860 
Operating Expenses:                    
Research and development, net  3,502   3,884   2,735   3,293   5,008 
Selling, marketing, general and administrative  12,513   10,708   11,048   12,310   18,113 
Acquisition-related  and restructuring costs  -   -   -   -   1,115 
Total operating expenses  16,015   14,592   13,783   15,603   24,236 
Operating income  797   2,485   5,341   6,711   5,624 
Financial income (expenses), net  (2,798)  (2,236)  (880)  (364)  104 
Other expenses (income), net  109   (32)  -       - 
Income (loss) before taxes on income  (2,110)  281   4,461   6,347   5,728 
Taxes on income (benefit)  338   584   260   177   (230)
                     
Net income (loss)  (2,448)  (303)  4,201   6,170   5,958 
                     
Attributable to non-controlling interest  96   41   -   18   61 
                     
Net income (loss) attributable to Sapiens  (2,544)  (344)  4,201   6,152   5,897 
                     
Basic net earnings (loss) per share attributable to Sapiens' shareholders $(0.14) $(0.02) $0.19  $0.28  $0.21 
Diluted net earnings (loss) per share attributable to Sapiens' shareholders $(0.14) $(0.02) $0.19  $0.28  $0.19 
Weighted average number of shares used in computing basic net earnings (loss) per share  18,218   21,532   21,573   21,583   28,460 
Weighted average number of shares used in computing diluted net earnings (loss) per share  18,218   21,532   21,574   22,181   30,764 

  At December 31, 
Balance Sheet Data: 2007  2008  2009  2010  2011 
  (In thousands) 
    
Cash and cash equivalents $13,125  $7,938  $11,172  $16,182  $21,460 
Working capital (deficit)  (567)  (4,506)  925   4,868   7,736 
Total assets  55,307   47,867   48,731   58,719   153,468 
Accrued severance pay(1)  3,544   3,826   3,895   4,446   10,711 
Other long-term liabilities  6,698   296   34   299   617 
Capital stock  132,310   132,562   132,821   133,418   208,464 
Total  equity  21,943   21,876   26,415   34,118   110,247 
(1)Accrued severance pay relates to accrued severance obligations mainly to our Israeli employees as required under Israeli labor law.  We are legally required to pay severance upon certain circumstances, primarily upon termination of employment by our company, retirement or death of the respective employee.  Our liability for all of our Israeli employees is fully provided for by monthly deposits with insurance policies and by an accrual.

B.     Capitalization and Indebtedness.

Not applicable.

C.    Reasons for the Offer and Use of Proceeds.

Not applicable.

D.     Risk Factors.

We operate globally in a dynamic and rapidly changing environment that involves numerous risks and uncertainties. The following section lists some, but not all, of those risks and uncertainties that may have a material adverse effect on our business, financial position, results of operations or cash flows.

Risks Relating to Our Business, Our Industry and our Financing Activities

We may incur future losses and be unable to achieve long-term profitability
We incurred net losses of approximately $2.5 million and $0.3 million for the years ended December 31, 2007 and December 31, 2008, respectively and in 2009, for the first time in 10 years, recorded net income of $4.2 million.  We cannot predict whether we will remain profitable on a sustained basis. Due to the possible decline in orders from existing customers, especially because of the current worldwide economic slowdown, we have no assurance that our revenues in the short to medium term will significantly increase, if at all, and they may decrease. At the same time, expenses may increase in the foreseeable future as we maintain our research and development and sales and marketing activities. Our research and development, sales and marketing efforts may prove more costly than we currently anticipate, and we may not succeed in the long term i n increasing our revenues sufficiently to offset the expenses of those efforts. We must continue to increase our revenues in the future in order to achieve and maintain our profitability. If we fail to do so and our revenues fail to increase at a greater rate than our expenses, we may incur future losses and may be unable to achieve long-term profitability.
The current economic slowdown has adversely affected and may continue to adversely affect our results and financial condition.
The crisis of the financial and credit markets worldwide which took place beginning in 2008 led to an economic slowdown worldwide.  This has impacted the insurance and financial sectors in which in excess of 50% of our customers operate. The slowdown has resulted in a reduction in demand in some or all of our major markets and downward pressure on pricing in many markets, which has adversely affected our business, results of operations and financial condition by negatively impacting our ability to maintain or increase revenues. Also, significant changes and volatility in the equity, credit and foreign exchange markets, and in the competitive landscape, make it increasingly difficult for us to predict our revenues and earnings into the future. A continuation or worsening of unfavorable economic conditions could have an adverse impact on our fi nancial results and financial condition.
3

Implementing our strategy of focusing on the market for software solutions in the insurance industry has taken longer than anticipated, and we may not succeed in gaining acceptance in that market.
Our goal is to rise to a position of global leadership in delivering strategic business software solutions to the insurance industry. Achieving this goal requires us, among other things, to design appropriate software solutions, maintain sufficient sales and marketing resources, recruit, train and hire sufficient professional services personnel and face intense competition. We have experienced delays in penetration of the insurance industry, and expect that additional time will be required to achieve our goal. Our future efforts to gain acceptance for our solutions may still not succeed, which could have a material adverse affect on our results.
Our working capital may once again decrease and we may need to raise capital again.
At December 31, 2009, we had positive working capital of $0.9 million.  Despite our positive cash flow from operations generated in 2008 and 2009, our overall positive cash flow in 2009 and the $20 million (excluding finders’ fees and out of pocket expenses) of capital that we were able to raise from investors in 2007, there is no assurance that we will not need to raise additional capital in the future. There is no assurance that we will be able to obtain additional financing, or if we do, that it will be on favorable terms.  In addition, if we issue capital stock to investors in order to raise cash, our existing shareholders will experience dilution.

The software solutions market that we address is expected to continue to evolve, rapidly, and if we are not able to accurately predict and rapidly respond to market developments or customer needs, our competitive position will be impaired.

The market for our solutions is characterized by rapidly changing business conditions and customer requirements, yetincluding requirements based on regulations to which our customers are subject. Nevertheless, estimates of itsthe market's expected growth resulting from the changing conditions and requirements are inherently uncertain and are subject to many risks and assumptions. Many of our customers operate in markets characterized by rapidly changing technologies and business plans, which makes it difficult for us to predict their demands. The introduction of solutions embodying new technology and the emergence of new customer requirements can render existing technology obsolete and unmarketable. We are particularly susceptible to those changes since our software is used in a wide array of operating environments, which are constantly evolving.  We may need to rapidly develop and introduce additional software and enhancements to our existing solutions to satisfy our current customers and maintain o urour competitive position in the marketplace. We may also need to modify our software so that it can operate with new or enhanced software that may be introduced by other software vendors.vendors, it can be used in different environments or it can comply with regulatory requirements to which our customers are subject. The failure to anticipate changes in technology, partner and customer requirements and successfully develop, enhance or modify our software solutions, or the failure to do so on a timely basis, could limit our revenue growth and competitive position.  We

Our development cycles are lengthy, we may not have experienced in the past, and anticipate experiencing in the future, delays in the timing of the introductionresources available to complete development of new solutions and market acceptanceenhancements and modifications of those solutions.  Furthermore, substantial expendituresour current solutions and we may incur significant expenses before we generate revenues, if any, from new solutions or such enhancements or modifications.

Because our solutions are required forcomplex and require rigorous testing, development cycles can be lengthy, taking us up to two years to develop and introduce new, enhanced or modified products. Moreover, development projects can be technically challenging and expensive. The nature of these development cycles may cause us to experience delays between the time we incur expenses associated with research and development and the introduction of new, enhanced or modified products.time we generate revenues, if any, from such expenses. There can be no assurance that we will have sufficient resources to make such investments especially in light of the current worldwide financial and economic situation, or that these investments will bring the full advantages or any advantage as planned.  To support our software development, enhancement or modification, we may also find it necessary to license or acquire new technologies, which may not be available to us on acceptable terms, if at all.  In addition, there can be no assurance that we will not encounter technical or other difficulties that could delay introduction of new technologies or enhancements in the future. Various sectors of our market are served by competitors who may respond more effectively to market developments and customer needs.  Our failure, for technological or other reasons, to timely develop and market products incorporating new technologies, or the development of the market for our solutions in a manner that we do not expect, could have a material adverse effect on our business prospects and competitive position, and, consequently, on our results of operations, financial condition and cash flows.

If existing customers do not make subsequent purchases from us and continue using our solutions and services or if our relationships with our largest customers are impaired, our revenue could be negatively affected

Our existing customers are a key asset, of ours, and we depend on repeat product and service revenues from our base of customers. Our relationships with two largeFive of our customers represent 33% of our revenues (which include customers of our U.S. subsidiary – Texas Farm Bureau Insurance Companies and Occidental Fire & Casualty; a large customer of our subsidiary in the United Kingdom – Liverpool Victoria Friendly Services ("Liverpool Victoria"); one large customer of our subsidiary in Japan and one large customer of our subsidiary in Israel – Menora Mivtachim Insurance Ltd. (“Menora”), are the sources of a large portion of the revenues of those respective subsidiaries. During 2009, revenuesnewly-acquired businesses from sales to the American customers specified above constituted 33.9% of the total revenues of the U.S. subsidiary (5.8% of our consolidated revenues); revenues from sales to the British custo mer specified above constituted 32.1% of the total revenues of the U.K. subsidiary (8.7% of our consolidated revenues); revenues from sales to the Japanese customer specified above constituted 44.4% of the total revenues of our Japanese subsidiary (9.7% of our consolidated revenues); and revenues from sales to the Israeli customer specified above constituted 71.9% of the total revenues of the Israeli subsidiary (23.5% of our consolidated revenues)August 21, 2011 when we acquired these businesses, as described below). There can be no assurance that our existing customers will enter into new project contracts with us or that they will continue using our enabling technologies. IfA significant decline in our revenue stream from existing customers were to decline significantly, it would have a materialan adverse impacteffect on our operating results. In light

Our sales cycle is variable, depends upon many factors outside our control, and could cause us to expend significant time and resources prior to earning associated revenues.

The typical sales cycle for our solutions and services is lengthy and unpredictable, requires pre-purchase evaluation by a significant number of employees in our customers’ organizations, and often involves a significant operational decision by our customers. Our sales efforts involve educating our customers and industry analysts and consultants about the worldwide financialuse and economic situation,benefits of our products, including the technical capabilities of our products and the potential cost savings achievable by organizations deploying our solutions. Customers typically undertake a significant evaluation process, which frequently involves not only our products, but also those of our competitors and can result in a lengthy sales cycle. Our sales cycle for new customers is typically six to eighteen months and can extend even longer in some cases. We spend substantial time, effort and money in our sales efforts without any assurance that our efforts will produce any sales.

As part of our business strategy, we have seen a delaymade and reduction in investments bymay continue to make acquisitions, which, if not successfully integrated into our customers in the solutions thatbusiness, could harm our results of operations and financial condition and, if we offer. If this trend continues, itissue securities or need to obtain debt financing to complete such acquisitions, could negatively impact our capital structure.

In August 2011, we acquiredIDIT I.D.I. Technologies Ltd. (“IDIT”) and FIS Software Ltd. (“FIS”).In April 2010 we acquired Harcase Software Limited ("Harcase"). We have commenced the integration of IDIT and FIS into our current business, including adding their solutions to our product line and integrating their employees, including developers, technical support providers and sales and marketing personnel into our business. We expect that this process will continue through 2012, but there is no assurance that we will be able to successfully integrate the businesses of IDIT and FIS into our business and achieve anticipated synergies.

As part of our growth strategy, we may consider acquiring other products and businesses to grow our revenues and increase our customer base. We face the risk that businesses we may acquire in the future may ultimately fail to further our strategies. In addition, we may not be able to successfully integrate acquired technologies and achieve expected synergies or take advantage of the increase in our customer base. Further, we may not be able to retain the key employees that may be necessary to operate the businesses we acquired and may acquire and we may not be able to timely attract new skilled employees and management to replace them.

We may also compete with others to acquire businesses or other technologies, and such competition may result in decreased availability of, or increased prices for, suitable acquisition candidates. In addition, for various commercial and economic considerations, we may not be able to consummate acquisitions that we have identified as crucial to the implementation of our strategy. Furthermore, attempted acquisitions may divert management, operational and financial results.

4

We compete against companiesresources from the conduct of our core business, and we may not complete any attempted acquisition.

In addition, for some of our recent acquisitions, we have used capital stock, thereby diluting our shareholders and if we use capital stock in connection with significantly greater resources thansuch acquisitions, our own.

existing shareholders may experience further dilution. If we use cash or debt financing, our financial liquidity will be reduced, the holders of our debt would have claims on our assets ahead of holders of our Common Shares and our business operations may be restricted by the terms of any debt. An acquisition may involve accounting charges and/or amortization of significant amounts of intangible assets, which would adversely affect our ability to achieve and maintain profitability.

The market for software solutions and related services is highly competitive.

The market for software solutions and related services and for business solutions for the insurance and financial services industry in particular, is highly competitive. Our principalMany of our smaller competitors generally have significantlybeen acquired by larger competitors, which provides such smaller competitors with greater resources than we do.and potentially a larger client base for which they can develop solutions. Our customers or potential customers could prefer suppliers that are larger than us, andare better known in the market or that have not experienced lossesa greater global reach. In addition, we and some of our competitors have developed systems to allow customers to outsource their core systems to external providers (known as BPO). We are seeking to partner with BPO providers, but there can be no assurance that such as ours. There is no guarantee that our customers, present and future,BPO providers will be confident in our financial stability going forward. Price reductions or declines in demand foradopt our solutions rather than those of our competitors. Determinations by current and services, whether as apotential customers to use BPO providers that do not use our solutions may result of competition, technological change, economic downturn, changes in the levelloss of application development, reengineering or maintenance performed internally bysuch customers and limit our customers or potential customers would have a material adverse effect on our results of operations, financial position and cash flows.

ability to gain new customers.

Our business involves long-term, large projects, some of which are fixed-price projects that involve uncertainties, such as estimated project costs and profit margins.

Our business is characterized by relatively large projects or engagements that can have a significant impact on our total revenue and cost of revenue from quarter to quarter. A high percentage of our expenses, particularly employee compensation, isare relatively fixed. Therefore, a variation in the timing of the initiation, progress or completion of projects or engagements especially at or near the end of any quarter, can cause significant variations in operating results from quarter to quarter. Some of our solutions are sold as fixed-price projects with delivery requirements spanning more than one year. As our projects can be highly complex, we may not be able to accurately estimate our actual costs of completing a fixed-project. If our actual cost-to-completion of these projects differs significantly from the estimated costs, we could experience a loss on the related contracts, which would have a material adverse effect on our results of operatio ns,operations, financial position and cash flow. Similarly, delays in executing client contracts may affect our revenue and cause our operating results to vary widely. Some of ourOur solutions may be priced in excess of $1.0 million and are delivered over periods of time ranging from several months to a few years. Payment terms are generally based on periodic payments or on the achievement of milestones. Any delays in payment or in the achievement of milestones may have a material adverse impacteffect on our results of operations, financial position or cash flows. The sales cycle for

Failure to meet customer expectations with respect to the implementation and use of our solutions is longcould result in negative publicity, reduced sales and variable, typically ranging between nine months to eighteen months from initial contact with the potential client to the signingdiversion of a contract. Occasionally, sales require substantially more time. This variability may adversely affect our operating results in any particular quarter.

Defects in our technologyresources, all of which would harm our business, results of operations, financial condition and divert resources.
growth prospects.

We provide our customers with upfront estimates regarding the duration, budget and costs associated with the implementation of our products. Implementation of our solutions is complex and meeting the anticipated duration, budget and costs often depend on factors beyond our control. We may not meet the upfront estimates and expectations of our customers for the implementation of products as a result of our product capabilities or service engagements by us, our system integrator partners or our customers' IT employees.

The quality of our products,solutions, enhancements and new versions is critical to our success. Since our software solutions are complex, they may contain errors that can be detected at any point in their life cycle. Any errors or defects in our technology could result in:

delayed or lost revenue;
failure to attract new customers or achieve market acceptance;
claims against us;
diversion of development resources;
increased service, warranty and insurance costs; and
negative publicity resulting in damage to our reputation.

While we continually test our productssoftware for errors or defects and work with customers to identify and correct them, errors in our technology may be found in the future. Testing for errors or defects is complicated because it is difficult to simulate the breadth of operating systems, user applications and computing environments that our customers use and because our software itself is becoming increasingly complex itself.  Thecomplex.

If we fail to meet upfront estimates and the expectations of our customers for the implementation of our products we could lose customers and be subject to negative publicity regarding us and our solutions, which could adversely affect our ability to attract new customers and sell additional products and services to existing customers.

In addition, errors or defects in our technology could result in delayed or lost revenue, claims against us, diversion of development resources and increased service, warranty and insurance costs. In addition, time-consuming implementations may also increase the number of services personnel we must allocate to each customer, thereby increasing our costs we may incur in addressing technology errors could be substantial and could impairadversely affecting our business, results of operations.

5

operations and financial condition.

Our business involves business-critical solutions which expose us to potential liability claims.

Our products focus on organizations’ business-critical applications, including those related to core business solutions for the insurance industry, and we provide re-engineering and re-development services for customers’ specialized needs.  

Since our customers rely on our softwaresolutions to operate, monitor and improve the performance of their critical software applications,business processes, they are sensitive to potential disruptions that may be caused by the use of, or any defects in, our software. As a result, we may be subject to claims for damages related to software errors in the future. Liability claims could require us to spend significant time and money in litigation or to pay significant damages. Regardless of whether we prevail, diversion of key employees’ time and attention from our business, incurrence of substantial expenses and potential damage to our reputation might result. While the terms of our sales contracts typically limit our exposure to potential liability claims and we carry errors and omissions insurance against such claims, there can be no assurance that such insurance will continue to be available on acceptable terms, if at all, or that such insurance will provide us with adequate protection against any such claims. A significant liability claim against us could have a material adverse effect on our results of operations and financial position.

Although we apply measures to protect our intellectual property rights and our source code, there can be no assurance that the measures that we employ to do so will be successful.

In accordance with industry practice, since we have no registered patents, we rely on a combination of contractual provisions and intellectual property law to protect our proprietary technology. We believe that due to the dynamic nature of the computer and software industries, copyright protection is less significant than factors such as the knowledge and experience of our management and personnel, the frequency of product enhancements and the timeliness and quality of our support services. We seek to protect the source code of our products as trade secret information and as unpublished copyright works. We also rely on security and copy protection features in our proprietary software. We distribute our products under software license agreements that grant customers a personal, non-transferable license to use our products and contain terms an dand conditions prohibiting the unauthorized reproduction or transfer of our products. In addition, we attempt to protect trade secrets and other proprietary information through non-disclosure agreements with employees, consultants and distributors. Although we intend to protect our rights vigorously, there can be no assurance that these measures will be successful. Our failure to protect our rights, or the improper use of our products by others without licensing them from us, could have a material adverse effect on our results of operations and financial condition.

Our Sapiens eMerge™ solution is proprietary to us and if we need to hire programmers, maintenance and professional services providers, we would incur training costs and delays due to training.
Our Sapiens eMerge™ solution was designed by us and its use requires special knowledge and training.  

If our current employees leave the Company or if a new projectproducts experience data security breaches, and there is undertaken by the Company and we need to hire new programmers or people to provide maintenance and professional servicesunauthorized access to our customers' data, we may lose current or future customers and our reputation and business may be harmed.

Our products are used by our customers to manage and store proprietary information and sensitive or confidential data relating to their businesses. Although we would havemaintain security features in our products, our security measures may not detect or prevent hacker interceptions, break-ins, security breaches, the introduction of viruses or malicious code, and other disruptions that may jeopardize the security of information stored in and transmitted by our products. A party that is able to traincircumvent our security measures in our products could misappropriate our or our customers' proprietary or confidential information, cause interruption in their operations, damage or misuse their computer systems, and misuse any information that they misappropriate. If any compromise of the new employeessecurity of our products were to occur, we may lose customers and consultants in Sapiens eMerge™.  As a result, we would incur training costsour reputation, business, financial condition and would have to delay implementation of projects and services until such individuals were adequately trained.  In addition, once these individuals are initially trained, they would still be inexperienced with Sapiens eMerge™ and would take additional time to develop efficiency and proficiency with Sapiens eMerge™.  As a result of these costs and delays, there could be a negative impact on our results of operations our financial condition, our cash flows and our relationships with our customers.

Some of our potential customers are reluctant to purchase proprietary solutions.
Some customers of information technology solutions are reluctant to purchase solutions that are not off-the-shelf or widely used by a broad customer base. Since our Sapiens eMerge™ solution and our Sapiens INSIGHT™ suite of solutions are proprietary to us and require special knowledge and training, we have faced reluctance by potential customers to purchase such proprietary solutions. Such reluctance could have a negative impact on our results of operations and our financial condition.
6

be harmed.

Our future results could be adversely affected by an impairment of the value of certain intangible assets.

Theassets and goodwill.

As a result of our acquisitions of IDIT and FIS, our intangible assets and goodwill increased significantly. Our assets as of December 31, 20092011 include, among other things, goodwill amounting to approximately $8.6$67 million, capitalized software development costs, net, amounting to approximately $13.5$17 million, long-term deferred income taxescustomer relationship amounting to approximately $1.8$8 million, developed technology and short-term deferred income taxesin process R&D amounting to approximately $1.5$5 million. The applicable accounting standards require that (a) goodwill be tested for impairment at least annually, and written down when impaired;impaired and (b) capitalized software, customer relationship and developed technology costs be assessed for recoverability on a regular basis, to determine whether the amortization of the asset over its remaining life can be recovered through undiscounted future operating cash flows from the specific software product sold, in accordance with ASC 985 "Software"; and (c) certain identifiable intangible assets such as deferred taxes b e reviewed for impairment in certain circumstances."Software." If our goodwill, capitalized software development costs, customer relationship or deferred tax assets,developed technology were deemed to be impaired in whole or in part due to us not achieving its goals,adverse changes in the income we receive from our products, we could be required to reduce or write off such assets, thus having to recognize additional expense in our statements of operations and to reduce our shareholders’ equity.


As part

Weakened global economic conditions may adversely affect the financial services industry generally and the insurance industry in specific, including the rate of information technology spending, which could cause our customers to defer or forego purchases of our products or services.

Our business strategy, wedepends on the overall demand for information technology from, and on the economic health of, our current and prospective customers. In addition, the purchase of our products is discretionary and involves a significant commitment of capital and other resources. Economies throughout the world currently face a number of economic challenges, including threatened sovereign defaults, credit downgrades, restricted credit for businesses and consumers and potentially falling demand for a variety of products and services. Notwithstanding the recent recovery in some of the financial markets, many companies are still cutting back expenditures or delaying plans to add additional personnel or systems. Our customers have and may make acquisitions thatsuffer from reduced operating budgets, which could disruptcause them to defer or forego purchases of our products or services. Continued challenging economic conditions in many of our markets, or a reduction in information technology spending even if economic conditions improve, could adversely impact our business, and harm our results of operations and financial condition.

As partcondition in a number of ways, including longer sales cycles, lower prices for our products and services, material default rates among our customers, reduced sales of our growth strategy, we may consider acquiring complementary technologies, products and businesses.  If we use capital stock in connection with such acquisitions, our existing shareholders may experience dilution.  If we use cashservices and lower or debt financing, our financial liquidity will be reduced, the holders of our debt would have claims on our assets ahead of holders of our Common Shares and our business operations may be restricted by the terms of any debt.  An acquisition may involve nonrecurring charges or amortization of significant amounts of intangible assets, which would adversely affect our ability to achieve and maintain profitability. Attempted acquisitions may divert management, operational and financial resources from the conduct of our core business, and we may not complete any attempted acquisition.
no growth.

Risks Relating to Our International Operations Particularly in Israel

Our international operations involve inherent risks, such as foreign currency fluctuations and compliance with various regulatory and tax regimes.

Most of our revenues are derived from international operations that are conducted in local currencies as well as dollars. Changes in the value of such local currencies or the dollar relative to such local currencies may affect our financial position and results of operations. Gains and losses on translations to dollars of assets and liabilities may contribute to fluctuations in our financial position and results of operations. In certain locations, we engage in currency-hedging transactions intended to reduce the effect of fluctuations in foreign currency exchange rates on our financial position and results of operations. However, there can be no assurance that any such hedging transaction will materially reduce the effect of fluctuation in foreign currency exchange rates on such results. In addition, if for any reason exchange or price cont rolscontrols or other restrictions on the conversion of foreign currencies were imposed, our financial position and results of operations could be adversely affected.

Other potential risks that may impact our international business activities include longer accounts receivable payment cycles, the burdens of complying with a wide variety of foreign laws and changes in regulatory requirements, although such factors have not had a material adverse effect on our financial position or results of operations to date.

7

We face currency exchange risks, as changes in exchange rates between the US dollar and other currencies, especially the NIS, may negatively impact our costs.


earnings.

Exchange rate fluctuations between the US dollar and other currencies which we and our subsidiaries use, especially the NIS, may negatively affect our earnings. A significant portion of our expenses, including research and development, personnel and facilities-related expenses, are incurred in Israel, in NIS. (On April 1st, 2010, the exchange rate between the NIS and the US dollar was NIS 3.697 per 1 US dollar.) Consequently, we are particularly exposed to the risk of appreciation of the NIS vis-à-visin relation to the US dollar. This appreciation would cause, and in 2008 did cause an increase in our expenses as recorded in our US dollar denominated financial statements even if the expenses denominated in local currencies remains unchanged. Accordingly, In addition, our level of revenues and profits may be ad verselyadversely affected by exchange rate fluctuations.


The depreciation of the NIS vis-à-visin relation to the US dollarU.S. Dollar in 2009 was not significant,2011 and the exchange rate fluctuations between the U.S. dollarDollar and other currencies which we and our subsidiaries use, did not cause any significant change in our foreign currency transaction differences, compared to $0.3 million in 2008. A material  portion of our revenues in 2009 were, and will continue to be in future years, denominated in the British pound (the “GBP”) and as a result, the appreciation of the U.S. dollar versus the GBP during 2009 had a material adverse impact on our U.S. dollar translated revenues and results of operations within the U.K. See Note 14.b to our consolidated financial statements included elsewhere herein.


translation differences.

We cannot predict any future trends in the US dollar/ NIS exchange rate or the US dollar/GBP exchange rate. We cannot assure you that we will not be materially affected in the future by currency exchange rate fluctuations. See Item 11- "Quantitative and Qualitative Disclosures about Market Risk - Foreign Currency Risk."


Conducting business in Israel entails certain inherent risks that could harm our business.

Our corporate headquarters and research and development facilities are located in the State of Israel. Political, economic and military conditions in Israel directly affect our operations. We could be adversely affected by any major hostilities involving Israel, the interruption or curtailment of trade between Israel and its trading partners or a significant downturn in the economic or financial condition of Israel. In addition, several countries still restrict business with Israel and with companies doing business in Israel. These political, economic and military conditions in Israel could have a material adverse effect on our business, financial condition, results of operations and future growth.

Since September 2000,

Despite the progress towards peace between Israel and its Arab neighbors, the future of these peace efforts is uncertain and although Israel has entered into various agreements with Egypt, Jordan and the Palestinian Authority, there has been a markedan increase in violence, civil unrest and hostility, including armed clashes, between the Stateterrorist activity, which began in September 2000 and has continued with varying levels of Israel and the Palestinians, and acts of terror have been committed inside Israel and against Israeli targets in the West Bank and Gaza.  These developments have adversely affected the regional peace process, placed the Israeli economy under significant stress, and have negatively influenced Israel’s relationship with several Arab countries.  The establishment in 2006 of a government in the Palestinian Authority by representatives of the Hamas militant group resulted inseverity into 2012. There was an escalation in violence among Israel, Hamas, the Palestinian Authority and other groups, as well as extensive hostilities in December 2008 and has created additional unrest and uncertaintyJanuary 2009 along Israel’s border with the Gaza Strip, which resulted from missiles being fired from the Gaza Strip into Southern Israel. There were also extensive hostilities along Israel’s northern border with Lebanon in the region.  Further, during the summer of 2006, Israel was engaged in a war with Hez bollah, a Lebanese Islamist Shiite militia group, which involved rockets being fired from Lebanon up2006. Ongoing and revived hostilities or other Israeli political or economic factors could harm our operations and cause our revenues to 50 miles into Israel and disrupted most day-to-day civilian activity in northern Israel. In January 2009, Israel engaged in a military action against Hamas in Gaza to prevent continued rocket attacks against Israel. These developments have further strained relations between Israel and the Palestinians.decrease. Any future armed conflict, political instability or violence in the region, including acts of terrorism, may have a negative effect on our business condition, harm our results of operations and adversely affect our share price.


Some of our executive officers and employees in Israel are obligated to perform military reserve duty, currently consisting of approximately 30 days of service annually (or more for reserves officers or citizens with certain occupations). Additionally, they are subject to being called to active duty at any time upon the outbreak of hostilities. While we have operated effectively under these requirements since the establishment of Sapiens, no assessment can be made as to the full impact of such requirements on our business or work force and no prediction can be made as to the effect on us of any expansion of such obligations.

8

Risks Related to an Investment in our Common Shares

If we fail to meet the standards for continued listing of our shares on NASDAQ, the shares could be de-listed from the NASDAQ Capital Market.
A company must continue to comply with several requirements in order to remain listed on NASDAQ. One of the requirements is that a company maintains a $1.00 minimum bid price (the “Minimum Bid Price Requirement”).

Under the NASDAQ Listing Rules, a failure to meet the continued listing requirement for minimum bid price on the NASDAQ Capital Market shall be determined to exist only if the deficiency continues for a period of 30 consecutive business days.

Between February 17, 2009 and August 19 2009, the closing price of our Common Shares on the NASDAQ Capital Market was below $1.00 and since August 20, 2009, has been above $1.00. The closing price of our Common Shares on the NASDAQ Capital Market, on April 1, 2010, was $2.04 per share.

If we fail to comply with the Minimum Bid Price Requirement, our Common Shares could be de-listed from the NASDAQ Capital Market, which could have a material adverse effect on our share price and our standing with current and future investors.  In addition, if we are de-listed from the NASDAQ Capital Market, we may no longer be eligible for certain benefits granted by the Israel Securities Law to companies that are “dual listed” on the Tel Aviv Stock Exchange and a foreign (non-Israeli) securities exchange. The removal of such benefits would require us to incur additional costs relating to periodic reporting in Israel and would have a material adverse impact on our results of operations.
There can be no assurance that we will continue to meet all of the requirements for continued NASDAQ listing. Failure to meet one of NASDAQ's continued listing standards could result in the delisting of our Common Shares from NASDAQ.

Our Common Shares are traded on more than one market and this may result in price variations.

Our Common Shares are traded on the NASDAQ Capital Market and the TASE. Trading in our Common Shares on these markets will be madeis in different currencies (US dollars on the NASDAQ Capital Market and NIS on the TASE), and at different times (resulting from different time zones, different trading days and different public holidays in the U.S. and Israel). The trading prices of our Common Shares on these two markets may differ due to these and other factors. Any decrease in the trading price of our Common Shares on one of these markets could cause a decrease in the trading price of our Common Shares on the other market.

There is very littlelimited trading volume for our Common Shares, which causes the stock price to be volatile and which may lead to losses by investors.

There is very littlelimited trading volume for our Common Shares, both on the NASDAQ Capital Market and the TASE. As a result, our Common Shares have experienced significant market price volatility in the past and may experience significant market price and volume fluctuations in the future, in response to factors such as announcements of developments related to our business, announcements by competitors, quarterly fluctuations in our financial results and general conditions in the industry in which we compete.

Our quarterly results may be impacted by multiple short-term factors, thereby causing variability in such results and enhanced volatility in the market price of our Common Shares.
Our revenue and operating results could vary widely from quarter to quarter as a result of several different factors, such as the budgeting and purchasing practices of our customers, the length of our customers' product evaluation process, the timing of our customers’ system conversions, the timing and cost of new product introductions and product enhancements, and the timing of any acquisitions and associated costs. Employee hiring and the rate of utilization of such employees may also affect our revenues and results of operations. Such variation in results from quarter to quarter could cause enhanced volatility in the market price of our Common Shares.
9

Formula Systems (1985) Ltd. and its parent company, Emblaze Ltd.,Asseco, may exercise control and influence corporate actions in a manner that potentially conflicts with our other public shareholders.

shareholders and our election of “controlled company” status as a basis for exempting ourselves from certain NASDAQ corporate governance requirements may remove certain potential checks on such shareholders’ control of our company.

Formula Systems (1985) Ltd. (“Formula”), whose ADRs trade on the NASDAQ Global Market (under the trading symbol: FORTY) and whose shares trade on the TASE (under the trading symbol: FORT), directly owned (asas of December 31, 2009) 15,206,426, orMarch 1, 2012 approximately 70%,52% of our currently outstanding Common Shares.

In November 2006, Emblaze Ltd. (“Emblaze”), Asseco Poland SA, whose ordinary shares are tradedtrade on the LondonWarsaw Stock Exchange (under the trading symbol: BLZ.L)("Asseco"), purchased the controlling interestdirectly owns 51.7% of Formula, and as a result, control of us.  As of April 1, 2010, Emblaze owned 49.19% of theFormula's outstanding share capital of Formula and, therefore, has a controlling influence over us.
Emblaze,capital.

Asseco, through Formula, is and may continue to be in a position to exercise control over most matters requiring shareholder approval. While Formula currently has only one representative on our Board of Directors, Formula may nevertheless in the future use its share ownership or representation on our Board of Directors to substantially influence corporate actions that conflict with the interests of our other public shareholders including, without limitation, changing the size and composition of our Board of Directors and committees of our Board of Directors, causing the issuance of further securities, amending our governing documents or otherwise controlling the outcome of shareholder votes. Further,Furthermore, our exemption from certain NASDAQ corporate governance requirements as a “controlled company” of which greater than 50% of the voting power is held by a group (i.e., Asseco and Formula) and the determination to opt out of these NASDAQ corporate governance requirements as permitted for a foreign private issuer, may have the effect of removing potential checks on Asseco’s and Formula’s control over our company. As a result of such election, we are not required to comply with the following NASDAQ Listing Rule requirements: maintenance of a majority of independent directors on our board of directors; selection of director nominees by a wholly independent nominating committee of the board or a majority of our independent directors; adoption of a written charter or board resolution addressing the director nominations process; determination of our executive officers’ compensation by an independent compensation committee or a majority of our independent directors; and shareholder approval for certain matters. Our exemption from these requirements could strengthen Asseco’s and Formula’s control over our board of directors and management. See Item 6.C below “Board Practices— NASDAQ Exemptions for a Controlled Company” and “Board Practices— NASDAQ Opt-Out for a Foreign Private Issuer”.

Furthermore, actions by Formula with respect to the disposition of the Common Shares it beneficially owns, or the perception that such actions may occur, may adversely affect the trading price of our Common Shares.

Guy Bernstein from Emblaze and Formula serves as Chairman of our Board of Directors.

If we are classified as a passive foreign investment company, our U.S. shareholders may suffer adverse tax consequences.

Generally, if for any taxable year, after applying certain look-through rules, 75% or more of our gross income is passive income, or at least 50% of the value of our assets are held for the production of, or produce, passive income, we may be characterized as a passive foreign investment company or PFIC,(“PFIC”) for U.S. federal income tax purposes. Passive income for this purpose generally includes, among other things, certain dividends, interest, royalties, rental and gains from commodities and securities transactions and from the sale or exchange of property that gives rise to passive income. This characterization could result in adverse U.S. tax consequences to our shareholders who are U.S. taxpayers, including having gain realized on the sale of our Common Shares being treated as ordinary income rather than capital gain income, and could result in punitive interest charges being applied to such sales proceeds. Rules similar to those applicable to dispositions apply to amounts treated as “excess distributions.”

We believe we were not a PFIC in 2009,2011 just as we believe we were not a PFIC for at least the past 5 years. We currently expect that we will not be a PFIC in 2010.2011. However, PFIC status is determined as of the end of the taxable year and is dependent on a number of factors. Therefore, there can be no assurance that we will not become a PFIC for the year ending December 31, 20102011 or in a future taxable year. U.S. shareholders should consult with their own U.S. tax advisors with respect to the U.S. tax consequences of investing in our Common Shares. For a discussion of how we might be characterized as a PFIC and related tax consequences, please see Item 10.E, “Additional Information – Taxation - U.S. Federal Income Tax Considerations - Tax Consequences if We Are a Passive Foreign Investment Company.

INFORMATION ON THE COMPANY
"

Item 4.    Information on the Company

A.    History and Development of the Company.

Corporate Details

Our legal and commercial name is Sapiens International Corporation N.V., and we were incorporated and registered in the Netherlands AntillesCuraçao on April 6, 1990. We are a public limited liability company and operate under the provisions of the Netherlands AntillesCuraçao Commercial Code. Our registered office is located at Landhuis Joonchi, Kaya Richard J. Beaujon z/n, Curaçao, Netherlands Antilles and our telephone number in Curaçao is + 5999-736-6277. United International Trust N.V. is the Company’s agent in Curaçao and serves as a member of our Board of Directors. Our World Wide Web address is www.sapiens.com. The information contained on the web site is not a part of this annual report. We have not had any important events in the development of our business since January 1, 2010.

10

2012.

Capital Expenditures and Divestitures since January 1, 2007

2009

On April 27, 2010, we completed the acquisition of all of the issued and outstanding shares of Harcase, a company engaged in the development, implementation and marketing of software solutions and provision of related professional services for property and casualty insurance carriers. Under the terms of the share purchase agreement (the "SPA") we paid approximately $4 million to the selling shareholders of Harcase (the "Selling Shareholders") consisting of approximately $3 million in cash ($750,000 of which was placed into an escrow account to be released to the selling shareholders in accordance with the terms of the SPA) and 454,546 Common Shares (which were placed into an escrow account to be released to the Selling Shareholders in accordance with the terms of the SPA). Each Selling Shareholder was granted a put option to sell to us the Common Shares held by such Selling Shareholder for a price of $1.54 per share during a period of six months following the release of such Common Shares from escrow, if such Common Shares are so released.

On August 21, 2011, we completed the acquisition of all of the share capital of each of FIS and IDIT, for a consideration that consisted of $6.75 million in cash, 10,016,875 of our Common Shares and warrants to purchase 1,000,000 of our Common Shares for FIS and 7,483,125 of our Common Shares for IDIT. The aggregate shares issued upon completion of the foregoing transactions constituted, immediately upon such completion, 44.2% of our issued and outstanding share capital. In addition, options to purchase shares of IDIT and FIS were replaced at the closing with options to purchase an aggregate of 1,938,844 of our Common Shares. An aggregate of 1,750,000 of our Common Shares that were issued as consideration in these transactions were deposited in escrow for 12 months, in connection with certain indemnification arrangements.

Our principal capital expenditures during the last three years related mainly to the purchase of computer equipment and software for use by our subsidiaries. These capital expenditures totaled $190,000$324 in 2007, $768,0002009, $662 in 20082010 and $324,000$482 in 2009.

2011.

B.     Business Overview.

We are a global provider of innovative software solutions for the insurance industry. Our suite of insurance solutions, built to meet the core business needs of large and small insurance carriers, aligns ITfinancial services industry, with business demands for speed, flexibility and efficiency. Our solutions are supplemented by our methodology and consulting services, which address the complex issues related to the life-cycle of enterprise business applications. a focus on insurance.

We offer our customers the following:

·Solutions for Property & Casualty/General Insurance (“P&C”) and Life, Pensions and Annuities (“L&P”) core software solutions
·Field-tested project delivery and implementation methodologies for the implementation of our mission critical, complex solutions deployed at over 100 customers, including by 70 customers using our insurance software solutions
·Insurance best practices from across the globe, backed by more than 700 employees including many insurance and technology experts

Our portfolio of products includes the following solutions:

·Solutions for P&C/General Insurance
oRapidsure – A component-based software solution designed for the P&C market with the focus on the North American market
oIDIT- A component-based software solution, designed for the P&C market, with a focus on Europe and Asia Pacific markets
oInsight for Reinsurance-a software solution designed to enable P&C insurance carriers to manage their reinsurance programs
·Solutions for L&P
oALIS - a software solution for individual, group and worksite life and pension insurance products
oInsight for Reinsurance-a software solution designed to enable L&P insurance carriers to manage their reinsurance programs
·Decision - a business decision management solution for the financial services market
·eMerge – an application development platform, for fast deployment of tailor-made complex solutions.

We also continue to the two major lines of insurance business – Life & Pension (L&P) and Property & Casualty (P&C).

The Sapiens’ insuranceprovide support for our other legacy solutions, are deployed at leading insurance carriers globally, such as AXA, Norwich Union, Liverpool Victoria, IAT Group, ING, OneBeacon, Principal Financial Group,  Allianz Group, Texas Farm Bureau Insurance Companies, Menora Mivtachim InsuranceInsight for P&C and Santam. Insight for L&P.

Our service offerings include a standard consulting offering that helps customers make better use of IT in order to achieve its business objectives.

Sapiens eMerge™, is a rules-based model-driven architecture, that we use to develop most of our software products. It enables the creation of mission critical core enterprise applications with little or no coding using agile methodologies. Our technology allows customers to achieve legacy modernization and enterprise application integration. We believe that our software solutions, coupled with our understanding of the insurance marketplace help our customers gain a competitive edge in the rapidly changing business world while maximizing the value of their investments in existing IT systems.
Strategy

Our primary goal is to become a globalmarket leader of insurance solutions providers. Our mission is to drive customer profitability in the global insurance industry through thought leadership and the proven delivery methodology ofsoftware solutions marketplace. Our strategy is to continue our innovative solutions.growth while retaining profitability. We plan to achieve this objective by combining our insurance expertise and extensive experience in implementing feature-rich, robust, high volume solutions in order to deliver to our clients a set of customizable software products for life insurance, pensions and annuities, property and casualty, reinsurance and specialized underwriting.

focusing on the following principles:

-Expanding our market sharevia organic growth and acquisitions of insurance software vendors with sound customer bases

-Continuing to enhance our insurance software solutions to ensure their leading functional and technical edge for the benefit of our customers

-Sharing our knowledge and field-tested best practices to ensure successful roll-out and implementation of our software solutions

-Developing long-term relations with our customers by providing support services, maintenance and assistance and develop additional functionality to fully exploit our insurance software solutions in the future and strengthen our recurring revenue model

We market our solutions globally through our direct sales force, and through marketing alliancespartner with global IT solutionstechnology and service providers such as IBM Corporation, Microsoft,to optimize our offerings and iGate. extend market reach, where applicable.

We have been working closely with IBM for over 1020 years at what IBM refers to as a “Premier Business Partner” level. This cooperation is executed through close technology, project delivery, sales and marketing cooperation. We have recentlyare qualified as a Microsoft Gold certified partner. These alliances enable us to reach a broader basetarget market, enhance our delivery capabilities and leverage best technologies.

We work together with additional technology and standards providers, such as ISO and ACORD to further complement our portfolio, and offer our customers a comprehensive and innovative solution that addresses the entire breadth of their business needs.

Industry Background

Insurance Industry

Life Insurance, Pensions and Annuities. L&P providers offer their customers a wide range of products for long-term savings and insurance to assist policyholders in financial planning, including life insurance, retirement, pensions and investment products. Life insurance products can take on many forms, including term life, universal life, variable universal life, income protection, payment protection, critical illness, whole life, and endowment products. Many individuals purchase these products and they are often provided by employers as well. In addition, pension providers offer various types ofretirement plans including individual and group personal pensions, stakeholder pensions, transfer plans, group additional voluntary contribution plans, defined contribution plans, annuities and group self-invested pension plans. L&P providers are highly regulated, particularly in the United States.

Among the key functions needed by providers to administer their products are Quotation & Illustration, New Business, Policy Servicing, Underwriting, Billing & Collection, Claims Processing, Agency & Commission, Reinsurance and Document Management.

Property & Casualty/General Insurance. P&C insurance (known in the UK as General Insurance, or “GI”) protects policyholders against a range of losses on items of value including homes, vehicles, jewelry and commercial property, as well as from unforeseen events including burglary, bodily injury, natural disaster and litigation. P&C insurance is pervasive and is purchased by nearly all businesses and individuals. While some forms of P&C insurance are optional, others, such as automobile insurance, workers’ compensation insurance and medical malpractice insurance, are obligatory.

The key functional areas in P&C insurance are underwriting and policy administration, claims management and billing. Reinsurance ensures appropriate risk management and processes to recover reinsurers’ portions of claim payments. Each of these functions involves multiple touch points and information exchanges between individuals and systems.

15

Reinsurance. Reinsurance is insurance that is purchased by an insurance company from another insurance company as a means of risk management. The reinsurer and the insurer enter into a reinsurance agreement which details the conditions upon which the reinsurer would pay the insurer's losses. The reinsurer is paid a reinsurance premium by the insurer, and the insurer issues insurance policies to its own policyholders. The main reason for insurers to buy reinsurance is to transfer risk from the insurer to the reinsurer. Insurers’ key functions to analyze and manage their reinsurance coverage are premium and claims calculation and allocations, claims processing, financial accounting and reporting.

Insurance Software Solutions

The existing systems used by many insurance carriers are outdated and their technical and functional limitations have held back insurance carriers from growth and innovation through creation of new products, reaching new distribution channels and competing in the changing insurance market. These systems also subject these insurance carriers to financial and operational risk because of their age and inadequacy. In addition, these systems do not have the capabilities to support the many different types of products and product lines offered by large insurance carriers.

In order for carriers to manage their insurance products, their systems must be able to integrate with other internal systems, be highly configurable and have the ability to control the entire workflow process. In addition, regulatory requirements throughout the world and in various states in the United States require specialized data and business rules, which makes development of software solutions for insurers with a national or global presence particularly challenging. In addition, many IT providers have found it difficult to comply with the regulatory analysis and recordkeeping requirements imposed on insurers. These factors pose particular challenges to insurers seeking to update their solutions in order to meet these regulatory requirements and customer needs.

The needs of insurance carriers can change rapidly as business and marketing models and insurance products evolve. The insurance carriers must adapt rapidly to the shifting needs and behaviors of the consumer and to keep up with the needs of customers while complementing our partners’ offerings.

Industry Background
The globalof various types, including individual, corporate and government. For example, today’s private purchasers and agents compare insurance industry is highly competitive, constantly facing new regulations, growing number of sales channelsproducts and demanding customers. Theprices via Internet research, as well as through traditional phone and in-person channels. Therefore, insurance carriers require systems that allow customers and agents to access price quotes based on particular circumstances and requests and updated information regarding their policies and claims.

Insurers have begun to expect system solutions like Sapiens’ to incorporate and participate in their business more broadly. At the same time, to marketsupport their current and the flexibility of new insurance products become key differentiators forpast customers and claims, the insurance carriers but other, more traditional factors for success – such as reduced risk,must maintain their legacy systems and integrate them into the new systems to allow the insurance carriers to innovate while maintaining records of customer servicehistory. This challenge is faced by the majority of insurance carriers using legacy software yet seeking to keep pace with the changing insurance industry.

Furthermore, insurers are increasing their global reach through acquisitions and cost savingbusiness initiatives. These insurers in turn are still key factors.

While insurance companies’ current systems may not be appropriate for current challengesseeking sole providers who can deliver solutions that the insurers can use across markets which by meeting local regulatory requirements and may be outdated, they are still key part of an organization because ofcustomer needs across the vast investment of business know-how and rules, as well as the amounts of information they contain. Replacing them could cause a significant loss of business productivity.
11

Businesses try to address these challenges in a variety of ways.  Certain companies choose to dedicate significant in-house IT resources to address these issues. In most cases, and more commonly seen recently, however, organizations lack the requisite internal resources rely on the expertise of external IT service and solution providers.
globe.

Our Business Solutions for the Insurance Industry

As a company, we

We have focused our resources on delivering solutions to help the insurance industry become more agile in the face of the new and rapidly changing business environment, described above, while simultaneously reducing IT costs.

By creating cross-functional teams and working with leading insurance companies, we have formulated Sapiens INSIGHT™, a suite of modular business software solutions that helps insurance carriers adapt to the dynamic insurance marketplace.
We collaborate with our customers to tailor the Sapiens INSIGHT™ solutions to achieve the unique operational performance goals of each organization. In addition, we have executed independent projects for the insurance market, providing enhanced information access and visibility to empower the sales, agent and broker community, thus accelerating transaction processing for improved customer service and business efficiency.  Most of our insurance solutions, which include the Sapiens INSIGHT™ family, are based on Sapiens eMerge™, our rules-based model driven architecture, which enables rapid solution development and maintenance.  Sapiens INSIGHT™ is designed for both the Property and Casualty markets, and the Life and Pension markets.

For each of our target markets for our insurance solutions, – namely US, E urope and Israel, we have invested in matchingsought to adapt our solutions to the specific market needs, focusing on market standards and regulations. These solutions can be further customized to match specific legacy systems and business requirements, while providing pre-configured functionality.

Sapiens INSIGHT™ Suite for Property & Casualty
The Property These solutions can also be expanded and Casualty Suite is a comprehensive solution that meets the core business needsmodified, using our knowledge of a P&C carrier. It is comprised of 3 modules – Policy Administration, Billing, and Claims. As such, it can be offered either as a suite or as separate modules.
The modularity of the suite allows us to support our clients with gradual deployment of core systems, thus reducing risk and allowing a smooth integration into the organization.
Sapiens INSIGHT™ for Policy Administration
INSIGHT™ for Property & Casualty is a policy administration solution for the Property and Casualty insurance market.  This solution offers a strong product Configurator that allows the carriers to offer new and innovative products in an efficient and quick way. The solution will handle the whole life cycle of a policy.
By automating the process, this web-enabled solution reduces the cost of doing business and optimizes risk selection through the use of rules based underwriting. Sapiens INSIGHT™ for Property & Casualty is designed to improve internal efficiencies and simplify and accelerate the cycle from the creation of a new product through policy processing and administration, by automating policy lifecycle processes. The solution also provides functionality supporting the rapid development and launch of new products to keep pace with competitive pressures and market opportunities.
 Sapiens INSIGHT for Billing
Sapiens INSIGHT™ for Billing module is a flexible billing & collections solution for the P&C industry. This web-enabled solution is designed to enhance rapid implementation, support billing and collection rules and maintain transaction control, accountability for results and assurance of process consistency and continuity. Insight™ for Billing enables a carrier to adapt quickly to changing business conditions, deploy new billing-related initiatives easily and meet future billing needs. This module supports multiple installment and collection methods and manages all premium-related transactions and reconciliation of standard billing and collection activities. Sapiens INSIGHT™ for Billing module easily integrates with other policy administration, refund and accounting systems.
12

Sapiens INSIGHT™ for Claims
Sapiens INSIGHT™ for Claims is a solution that effectively manages and streamlines the information flow of claim handling across an insurance provider’s entire organization. The claims handled include disability and maturity claims (annuities, pensions), death claims and health claims. This solution uses accessible business rules and messaging standards and allows the use of a company’s existing information assets. Thus, the solution improves operational efficiency and enables better and more versatile customer service capabilities, with the goal of providing faster return on investment by reducing the total claims payout.
Sapiens INSIGHT™ for Reinsurance
Sapiens INSIGHT™ for Reinsurance is a solution designed to support insurance carriers in the management of all contracts and activities (of Property and Casualty carriers). This, web-enabled solution reduces the cost of handling all reinsurance functions through automation, is designed for a multi- language, multi- currency, multi- company environment.
Sapiens INSIGHT™ Suite for Life & Pensions (INSIGHT™ for Life & Health)
Sapiens INSIGHT™ for Life & Pensions, is a powerful and comprehensive framework-based life and pensions solution that serves companies administering life insurance, pension funds, health insurance and saving plans.
Sapiens INSIGHT™ for Life & Pensions is a dynamic, customizable solution, and can be easily accommodated to administer changes in processes. It is fully web-enabled, prepared to utilize the advantages of the Internet and intranets.
Sapiens INSIGHT™ for Underwriting
Sapiens INSIGHT™ for Underwriting is an underwriting solution for life, health and disability insurance. It reduces a customer’s costs by automating a larger portion of the process of evaluating the risks of new business and by streamlining the procedures for handling new business. By using this solution, an insurance company can make underwriting assessments on new cases earlier in the business cycle and achieve greater consistency in its decision-making. We market Sapiens INSIGHT™ for Underwriting on the basis of licensing and distribution agreements with MediRisk Solutions Ltd., which developed and holds the intellectual property rights to the solution.   Sapiens holds a minority interest (approximately 10%) in MediRisk Solutions Ltd.
Sapiens INSIGHT™ for Closed Blocks
Sapiens INSIGHT™ for Closed Blocks (known also as Sapiens INSIGHT™ for Closed Books) is a solution for life and pension insurance companies seeking ways to reduce the cost of maintaining closed books of business, where products are no longer open to new business. We provide customizable solutions that enable companies to efficiently and more effectively administer policies and claims relating to closed blocks, leading to significantly lower business administration and IT costs. Sapiens INSIGHT™ for Closed Blocks is currently deployed at Liverpool Victoria Friendly Society, the largest Friendly Society in the United Kingdom.
Sapiens eMerge™
Most of ourbest practices.

Our solutions are builtbased on Sapiens eMerge™ architecture. Sapiens eMerge™ is a model-driven architecture using rules-based, enterprise-scale transaction engine(incorporate “Service Oriented Architecture - SOA”) and are engineered to provide streamlined secure processing, while maintaining total platform independence and system reliability. Our solutions are component-based and scalable in order to help our customers implement our software into their environments to better serve their clients and quickly respond to insurance regulatory changes that facilitates business process integrity, application scalability and high performance. The use of Sapiens eMerge™ reduces the complexity of programming so that new applications and modifications of existing ones can be producedresult in a much shorterrapid time frame than through conventional programming.

13

Theto market. Our component-based solutions allow our customers to use of rapid application development allows enterprise-specific enhancements to be made in a shorter time and with a greatly reduced maintenance burden when compared to other technologies.
Sapiens eMerge™ is based on a multi-level architecture and operates in multi-platform environments, encompassing many hardware vendors, operating system environments and databases. Host-side platforms supported include IBM’s System z (zSeries), System i (iSeries), HP-UNIX, Linux and windows server.  Sapiens eMerge™ supports databases such as DB2, VSAM, IMS, DB2/400 Oracle and SQL server. Since Sapiens eMerge™ exemplifies open systems and cross-platform capabilities, solutions developed with it can be seamlessly migrated from platform to platform an d from database to database.
Our Services
IT Services. We offer services for the delivery of our solutions leveragingand expand them across different markets and regulatory regimes as they expand their businesses using our experienced insurance expertscomponents customized for local requirements and IT  team. We provide customers with specialized IT services in many areas, including project management, application development/enhancements, application platform porting services and general technical assistance. Our personnel work withintegrated through the customer for the duration of the entire project through proven methodologies on a fixed price and time basis. These IT services can be classified as: (1) consulting services that are not deemed essential to the functionality of the license (such as migration of applications to various platforms and technical assistance with project management), and (2) consulting services that involve significant i mplementation and customization of our software to customer specific requirements.
Outsourcing of Application Maintenance. Our outsourcing services performed on our customers' applications are based on our strong, long-term relationships with our customers. We are currently servicing multi-year outsourcing contracts involving mission-critical systems. The outsourcing engagements are typically performed with a combination of onsite and offsite mix as required by our customers.
For details of revenues by category of activity, see the table entitled “Selected Financial Data” under Item 3, “Key Information.”
common base platform.

Key Benefits of our TechnologySolutions to our Customers

Fast Time

Sapiens offers a broad range of insurance software solutions intended to Marketaddress all of the core systems IT needs of insurance companies.

Our expanded insurance solutions offer a broad range of advantages to the operational environment of our customers' organizations. We believe that these advantages, some of which are listed below, coupled with our ability to support the customer’s legacy systems based on our 30 years of experience in deploying core solutions for the large enterprises, create real added-value for our customers.

·Rapid deployment of new insurance products to create a clear competitive advantage in the P&C and L&P market

·Expansion of business globally while leveraging a single solution to support all operations

·Complying with regulatory requirements by introducing best practices in decision management systems

·Supporting multiple innovative channels to the customers, including social media and internet

·Prevention of claims leakage with comprehensive, auditable approach to management of reinsurance programs
·Meeting business goals of time to market and market reach while improving total cost of ownership

Our Solutions

Property & Casualty/General Insurance

RapidSure

RapidSure is a component-based software solution, designed specifically to meet the business requirements of P&C insurance providers, mainly in North America. Utilizing leading edge technologies, RapidSure provides insurance carriers with a flexible, comprehensive and High Returnadvanced software solution. RapidSure supports a broad range of general, personal and commercial lines of business, including homeowners, fleet insurance, and specialty lines insurance products, and is designed to handle complex policies and high volume transactions.

RapidSure is built on Investment. Our combinationSOA, which facilitates ease of integration with existing corporate and external systems such as ACORD and ISO.

RapidSure also offers a Rapid Application Development (RAD) methodology,unique, modern user experience which allows insurance carriers to improve efficiency through ease of operation.

Rapidsure provides a broad set of applications to support the P&C insurance core operations lifecycle. This includes:

·Policy Administration
·Product Configurator
·Point-of-Sale Portal

We expect to add a billing application to RapidSure during 2012.

Rapidsure’s rules-based development toolsPolicy Administration, along with its robust Product Configuration engine are intended to enable market agility and experienced consultants has resultedrapid deployment of insurance products. Rapidsure’s Point of Sale Portal was developed to assist insurers in significant productivity increases at customer sites. Declarative developmentoffering their products through multiple distribution channels, including directly through the internet and through insurance agents, to allow insurers to keep up with business rules replaces traditional programming methods,market trends.

Other components of RapidSure include:

·Customer Relationship Management (CRM)
·Enterprise Agency System (EAS)
·Insurance Enterprise Architecture
·Business Integration Platform
·Conversion

IDIT

IDIT is a component based software solution, addressing the specific needs of general insurance carriers for traditional insurance, direct insurance, banc assurance and brokers markets, primarily in Europe and in the Asia-Pacific markets. IDIT integrates multiple front office and back office processes, including insurance product design, policy administration, underwriting, call center, remote users and partners, backed by fully secured internet-based capabilities.

IDIT supports a broad range of general, personal and commercial lines of business, including homeowners, fleet insurance, health insurance, medical insurance and term-life insurance products.

IDIT provides a full application life cycle, meaning that no programming code development is required. Sapiens eMerge™ also employs a “positive inference” engine that streamlines application development by requiring only the definitionset of standard situations,applications to support insurance core operations lifecycle. This includes:

·Policy Administration
·Claims Management
·Billing and Collection

Modular software components can be customized to match specific insurance business requirements, while automatical ly generating the logic requiredproviding pre-configured functionality, including:

·Customer Relationship Management (CRM)
·Product Factory
·Workflow Management
·Insurance Accounting
·Document Management
·Business Intelligence

Insight for Reinsurance

Insight for Reinsurance enables P&C/General Insurance carriers and brokers to handle the non-standard ones. This representsall of their P&C/General reinsurance activities on a reduction in logic specificationsingle platform, with full financial control and application maintenance and enhances the qualityauditing support. By incorporating in-depth, fully automated functions readily adaptable to each company's business procedures, Insight for Reinsurance provides full financial control of the delivered application compared to conventional development environments where most “bugs” arisereinsurance practice, including support for all auditing requirements and regulatory reporting – Schedule F, P.

Insight for Reinsurance provides end-to-end processing, including:

·Setup of and definition of the reinsurance program
·Import of premium and claims transactions
·Automatic allocation of premiums and claims to reinsurance contracts

·Performing required calculations
·Production of statements & accounts to reinsurance participants

Insight for P&C

Insight for P&C is a software solution used by P&C carriers, in certain states in the non-standard logic.

●           Strong Technical Competence. Our solutions enable organizationsUnited States. Insight for P&C can be customized to capitalize on their existing large-scale applications and data by non-intrusively integrating them with modern applications and technologies.  Our solutions not only extendmeet the productive life of older computer systems but simultaneously provide a migration path to next-generation technologies. Our solutions are designed for an extensive list of computing platforms and technologies including IBM zSeries and iSeries, HP-Unixparticular business demands at the host server-sideinsurer level and Windows 2000 / XP Web Servers. Duethe regulatory needs at the state level.

Life, Pension and Annuity

ALIS

ALIS is a comprehensive L&P software solution for individual, group and worksite insurance products. ALIS incorporates all activities along the life, pensions and annuities lifecycle - from marketing through underwriting, insurance billing and servicing, to claims workbench and exit processing.

ALIS supports the separation between business logic, data access logicfollowing product lines:

·Individual Annuity Products
·Group/Worksite Life & Protection Products
·Individual Life & Protection Insurance Products
·Worksite Group & Voluntary Benefit Products
·Hybrid Products
·Retirement Plans

ALIS is a modular system and presentation logic, applicationsits functional components include all of those necessary for L&P insurers to manage their business:

·Quotation & Illustration
·New Business
·Policy Servicing
·Underwriting
·Billing & Collection
·Claims Processing
·Agency & Commission
·Document Management

ALIS has been developed for a particular comp uting platform and database are seamlessly portablespecifically to other supported computing platforms and databases.  The platform-independent nature of our solutions allows them to be scaled according tomeet the needs of L&P insurance carriers, who are highly regulated.

Insight for Reinsurance

Insight for Reinsurance, enables L&P carriers and brokers to handle all L&P reinsurance activities on a single platform, with the organization. Sapiens eMerge™capabilities described above.

Insight for L&P

Insight for L&P enables L&P carriers in Israel to handle a wide range of L&P activities, particularly in Israel, which has provenspecific regulatory requirements.

20

eMerge

Our eMerge is a rules-based model-driven architecture that enables the creation of mission critical core enterprise applications with little or no coding using agile methodologies. Our technology is intended to be extremely scalable, allowingallow customers to achieve legacy modernization and enterprise application integration.

DECISION

DECISION is a business decision management solution developed for the daily execution of hundreds of millions offinancial services market, including mortgage banks, investment banks and insurers. DECISION automatically structures business logic and then maps it directly to the organization’s rules engine data. By separating the business logic from the business process, the organization benefits from more efficient, fully audited and standardized policies.

DECISION can elicit, organize and manage business logic including all related business decisions & business rules. Decision seamlessly integrates with any business process management system (BPM) or business rules engine (BRE) and features a comprehensive graphical modeling component and robust enterprise grade software architecture.

In addition, DECISION enables business users to take full control of the entire process of decision management, including data quality management, allowing them to easily develop and deploy new policies and methodologies for tens of thousands of concurrent users.

14

optimal decision making.

DECISION is powered by The Decision Model which is a business logic framework developed by Knowledge Partners International ("KPI"), that connects business and technology and is rapidly becoming the standard for business decision management. We have a long term agreement with KPI that allows us to embed The Decision Model in our DECISION solution in exchange for royalty payments to KPI.

Our Target Markets

The principal markets in which we operate are North America, Europe, IsraelServices

We provide implementation and Japan. As of December 31, 2009, we had approximately 135integration services to help our customers realize benefits from our software solutions. Our implementation teams assist customers in allbuilding implementation plans, integrating our software solutions with their existing systems and defining business rules and specific requirements unique to each customer and installation. We also partner with several leading system integration consulting firms to achieve scalable, cost-effective implementations for our customers. We have developed an efficient, repeatable methodology that is closely aligned with the geographical areas in which we operate. Of these, our primary customers were Menora Mivtachim Insurance, Texas Farm Bureau Insurance Companies, Liverpool Victoria Friendly Society Limited, Occidental Fire and Casualty Company of North Carolina, and a large customer in Japan which collectively accounted for approximately 47%unique capabilities of our gross revenues during 2009.

Sapiens INSIGHT™
solutions.

Our service teams are experienced in both technology and insurance and the level of service and business understanding they provide contributes to the long term success of our customers. This approach increasingly helps us develop strategic relationships with our customers, enhances information exchange and deepens our understanding of the needs of companies within the industry.

Additional IT services that we provide include custom-made solutions that help leading organizations meet the complex business challenges they are facing quickly and cost-effectively while extending and leveraging existing assets. Leveraging the knowledge we have obtained designing and implementing products such as RapidSure Policy Administration for P&C and IDIT Software Suite for General Insurance, INSIGHT suites of insurancefor Reinsurance and ALIS for Life & Pension, we offer innovative legacy modernization solutions, are offered in two territories – North America and EMEA (Europe, Middle East and Africa). Our customers have direct written premiums (DWP) in themobile application solutions, as well as a full range of $80 million to in excess of $5 billion per year.  However, given the flexibility and modularity of the Sapiens INISGHT™ suite of solutions, our offerings can accommodate smaller and larger organizations.

Sapiens eMerge™
The Sapiens eMerge™ is offered primarily to corporate clients and government entities with large information technology budgets and ongoing maintenance and development needs. Our corporate customers include, among others, insurance companies, banks, government and manufacturing.
application delivery services.

Geographical Distribution of Revenues

The following is a breakdown of our revenues by geographical areas based on our geographic markets, both in thousands of dollars and as a percentage of total revenues for the years indicated:

  2007  2008  2009 
          
United Kingdom $13,417   31.6%  11,612   26.7%  12,323   27%
North America  10,061   23.7   7,846   18   7,759   17 
Israel  13,824   32.7   16,141   37.1   14,922   32.7 
Japan  4,071   9.6   6,375   14.6   9,950   21.7 
Europe  1,022   2.4   1,560   3.6   741   1.6 
Total $42,395   100.0%  43,534   100.0%  45,695   100%

  2009  2010  2011 
                   
Israel  14,922   33%  19,554   38%  21,470   31%
North America  7,759   17%  8,991   17%  20,889   30%
UK and rest of Europe  13,064   28%  12,610   24%  19,542   28%
Asia  9,950   22%  11,080   21%  8,026   11%
Total  45,695   100%  52,235   100%  69,927   100%

Following our acquisition of IDIT and FIS, we anticipate that the percentage of our revenues from customers in North America and the UK and the rest of Europe will continue to increase relative to our revenues from customers in Israel.

Competition

The market for enterprise software solutions for the insurance industry is highly competitive and characterized by rapidly changing technology,technologies, evolving industry standards and customer requirements, and frequent innovations. The following is a breakdown of the competition that we face in each of our primary markets:

Sapiens INSIGHT™ -

Insurance

.Our competitors in the market for insurance software solutions differ based on the size, geography and line of business in which we operate. Some of our competitors will offer a full suite, others only just one module,module; some operate in specific (domestic) geographies, while others operate on a global basis; and their delivery model will vary with some competitors keeping delivery in house or using IT Outsourcing (ITO) or Business Process Outsourcing (BPO)
15

BPO.

The entrance barriers to this market of insurance software solutions are very high, and maintaining a leading-edge position is challenging, due to several aspects:

·Development of new core insurance solutions requires heavy R&D investments

·Innovation in technology is mandatory to win new business

·Global presence and ability to support global insurance operations
·Regulatory requirements, which can be burdensome and require specified IT solutions

·Continued support and development of the solutions requires a critical mass of customers that will support the on-going R&D investment

·Know-how of insurance system requirements, and ability to bridge between new systems and old existing technologies that in many cases must be maintained

These requirements have led to a marked increase in acquisitions in the insurance software solutions vendor space, as small, local vendors cannot sustain growth without the ability to continue and fund their R&D developments and support the globalization trend.

We are well positioned to leverage our modern solutions, customer base and global presence to compete in this market. In addition, the years of accumulated experience and expert teams allow us to provide a comprehensive response to the IT challenges of this market.

Examples of theseour competitors are:

    In
·Global software providers, with their own IP, such as Accenture-Duck Creek, Oracle Admin Server or Guidewire

·Local/domestic software vendors, such as CCS in the United States:GuideWire, Duck Creek, Exigen, CSC, AGO, Oracle, Camilion, ISI, SOLCORP, Fineos, SunGard, Navisys, Fiserv, Accenture,Netherlands, BSB in West Europe, OneShield Insurity, Prima Solutions, IDP, The Innovation Group, DRC;in the US or TIA in the Nordics and certain Central European Countries
    In EMEA:
HP/EDS, SunGard, FIS Software, RebusIs; SOLCORP , SAP, Falmeyer (FJA), COR AG Insurance Technologies,

In addition, we face competition from internal IT departments, who often prefer to develop solutions in-house.

We differentiate ourselves from our competition via a fewcompetitors through the following key factors:

(i)·Sapiens INSIGHT™ is anOur products are award-winning innovative and modern solution,software solutions, with rich in functionality and Internet compatible,advanced intuitive user interface, using model driven architecture that drives more value toallows rapid deployment of the business and reducessystem while reducing the total cost of ownership.
(ii)Sapiens INSIGHT™ Our architecture allows customers to implement the full solution or parts of it, and readily integrate it into existing “legacy” systems.

(iii)·Sapiens INSIGHT™ is agile and flexible, based on its product configurator and its business rule technology.Our L&P solutions are updated for compliance with relevant regulations, particularly in the U.S., where L&P carriers are highly regulated

(iv)·SapiensOur P&C solutions are fully compliant with many country-specific regulations and legislations, from the U.S., across Western and Eastern Europe, through Southeast Asia and Australia

·We have a clear recognition of the technology trends and invest in adjusting our solutions to meet this rapid pace

·Thanks to the large and growing customer base, we are able to secure and justify future funding of R&D investments
·Our delivery methodology and team is built aroundbased on years of insurance industry experience and cooperation with the largestlarge insurance corporations in the world.companies globally
Sapiens eMerge™ Technology

·We leverage our proven track record of successful delivery to help our customers deploy the modern solutions while integrating with their legacy environment that must remain supported

eMerge.Our eMerge technology offers our clients flexibility to develop tailor-made solutions to meet their business challenges.

There has been an infusion of new vendors and new features into the business rules engine and management marketplace. Our competitors in the business rules engines and management marketplace include, among others, Fair Isaac (Blaze), Pegasystems, ILOG,iLOG, Computer Associates, Haley, Corticon, Versata, RuleBurst and ESI. These competitors may seek to replace our eMerge technology that has been implemented by our customers. We believe eMerg is differentied since whereas most competing business rules engines are characterized by delivery of specialized, decision support capabilities that must be later framed into an enterprise’s overall architecture at additional investment costs we have been able to deliver a comprehensive IT solution to our customers, including an automatically generated Web presentation layer and interfaces with various databases, legacy systems and third party software,

DECISION. Our DECISION is an early-stage product, which to a large extent drives an innovative approach in the market of business decision management systems. We believe that, since we believe we have developed an innovative approach which is not being used by other companies, we have not been able to identify a direct competitor in this market.

Some internal IT companies develop business decision management systems. We differentiate ourselves from our competition via a fewthrough the following key factors:

(i)·Our ability, utilizing Sapiens eMerge™DECISION is the first proven (already in production) true separation of the business logic in a decision management system

·Our track record of delivering complex, mission-critical solutions plays a key role in our success

·Our license from KPI together with our innovative technology to delivercreates a comprehensive IT solution, including an automatically generated Web presentation layer and interfaces with various databases, legacy systems and third party software. Most competing business rules engines are characterized by delivery of specialized, decision support capabilities that must be later framed into an enterprise’s overall architecture at additional investment costs.
(ii)Sapiens eMerge™ is highly optimized for performance of data-intensive tasks that characterize many enterprises’ transactional environments.
(iii)By leveraging our differentiating characteristics mentioned above, we competeunique proposition in the much larger IT solution delivery market, carving out for ourselves a niche attractive to mid-size enterprises seeking rapid and cost-effective custom software solutions.which is otherwise handled with complex spreadsheets that do not provide the adequate regulatory control

Sales and Marketing

To reach the broadest potential customer base, we use multiple distribution channels, including amainly through direct sales force andas well as relationships with system integrators and, in certain geographic areas, distributors.

16

In 2010, we have expanded our investment in Saleslocal and Marketing, by recruiting a new and experienced team for our operations in the United States, EMEA and headquarters.
regional distributors. Our sales team is located at our offices in North America, the United Kingdom, JapanBelgium, Israel, Australia and Israel.Japan. The direct sales force focuses onis geared to large organizations within select industries.
the financial services with a focus on the insurance industry.

In 2011 and the beginning of 2012, we expanded our investment in sales and marketing, through integration of the IDIT and FIS sales forces and recruitment of additional resources. We intend to further expand our sales and marketing efforts in North America and Europe, taking advantage of our current customer base and the investment in development of solutions that meet the requirements of insurance carriers in those markets. We intend to have our sales and marketing teams focused on more specific markets within those regions to better serve our customers in those markets and enhance our understanding of the needs of those customers in order to grow our business.

We are seeking to focus our marketing efforts on several areas, enhancing our relationships with our existing customers to create a strong reference base and engage in more recurring projects; generating new business opportunities; and creating brand awareness.

We invest in major industry trade shows to improve our visibility and our market recognition. We are improving traffic to our website and using the internet and social media to generate new leads and enhance our presence. We invest resources to improve our relationship within the global analyst community.

We are also focused on nourishinginvesting in strengthening our existing partnerships with IBM, Microsoft, HP iGate and others. These partnerships are key for both market recognition and market reach, leveraging their global presence to create additional business opportunities for us. Simultaneously, we invest in exploring new partnerships with leading playerssystem integrators in the financial services and the insurance market.

Customer Maintenance and Support
market in particular.

We believe that a high level of post-contract customer support is important to the successful marketing and sale of our solutions. We have recruited account managers for the United States and for Europe, thatwho are focused on nourishing relationsbuilding ongoing relationships with existing customers to maintain a high level of customer satisfaction and identify up-selling opportunities within these organizations. In addition, we employ a team of technical specialists who provide a full range of maintenance and support services to our customers.

The typical direct sale to a client includes initial maintenance,license, implementation, customization integration services and training and consulting services. In addition, substantially all of our clients for which we have developed applicationsdeployed our solutions elect to enter into an ongoing maintenance and support contract with us. The term of such a contract is usually twelve months. A maintenance contract entitles the customer to technology upgrades, when made generally available, and technical support. In addition, we offer introductory and advanced classes and training programs available at our offices and at customer sites.

We also work with a limited few distributors and system integrators who provide customers with training, product support and consulting services.  Each of our software distributors is capable of providing training in its respective country.

Seasonality

Even if not reflected in our 2008 or 2009 results, traditionally,

Traditionally, the first and third quarters of the fiscal year have tended to be slower quarters for us and the industries that we target. The first quarter is usually reflects a lullslow, following an active fourth quarter as(when companies rushtend to complete deals and utilize budgets before the end of the fiscal year.year). The slowdown in the third quarter reflects the summer months, during which usually have reduced activities in many of the regions where our customers are located.

located slow down.

Intellectual Property

In accordance with industry practice, we

We rely on a combination of contractual provisions and intellectual property law to protect our proprietary technology. We believe that due to the dynamic nature of the computer and software industries, copyright protection is less significant than factors such as the knowledge and experience of our management and personnel, the frequency of product enhancements and the timeliness and quality of our support services. We seek to protect the source code of our products as trade secret information and as an unpublished copyright work.work, although in some cases, we agree to place our source code into escrow. We also rely on security and copy protection features in our proprietary software. We distribute our products under software license agreements which grant customers a personal, non-transferable license to use our products and contain terms and conditions prohibiting the unaut horizedunauthorized reproduction or transfer of our products. In addition, we attempt to protect trade secrets and other proprietary information through agreements with employees, consultants and distributors. We do not believe that patent laws are a significant source of protection for our products and we do not hold any patents.

Our trademark rights include rights associated with our use of our trademarks, and rights obtained by registration of our trademarks. Our use and registration of our trademarks do not ensure that we have superior rights to others that may have registered or used identical or related marks on related goods or services. We have registrations for the mark “Sapiens” in Benelux, Germany, Italy and Switzerland, the United States, Israel, Brazilname “RapidSure” in the USA and a number of countries in Europe.Canada and the name ALIS, E-ALIS, CORE-ALIS and certain other related marks and the ALIS design. The initial terms of protection for our registered trademarks range from 10 to 20 years and are renewable thereafter.

17

Our Sapiens INSIGHT™ group of solutions include our proprietary technology as well as technology licensed by customers (such as Liverpool Victoria, OneBeacon Insurance Company, Allianz Suisse and Menora) or strategic partners (MediRisk Solutions).

Regulatory Impact.


The global insurance industry is heavily subject to government regulation, and is constantly changing as a result of regulatory changes. Insurance companies must comply with regulations such as the Sarbanes-Oxley Act, Solvency II, Retail Distribution Review (known as RDR) in the United States, Solvency II in EuropeKingdom and other directives regarding transparency. In addition, many individual countries have increased supervision over local insurance companies.


In Europe, regulators and insurers have been very active, and creative, motivated by past financial crises and the need for pension restructuring. Distribution of policies is being optimized with the increasing use of Bank Assurance (selling of insurance through a bank’s established distribution channels), supermarkets and kiosks (insurance stands). Such increased activity would generally tend to have a positive impact on the demand for our software solutions and services; nevertheless, insurers are cautiously approaching spending increases, and while many companies have not taken proactive steps to replace their software solutions in the past two years, many of them are now looking for innovative, modern replacements to meet the regulatory changes and the demanding market trends.

For further information, please see Item 5.D below, "Trend Information."

C.        Organizational Structure.

Sapiens International Corporation N.V. (Sapiens"("Sapiens N.V.") is the parent company of the Sapiens group of companies. We have a number of subsidiaries in Israel and throughout the world.  Our significant subsidiaries are as follows:

Sapiens International Corporation B.V. (“Sapiens B.V.”): incorporated in the Netherlands and 100% owned by Sapiens N.V.

Unless otherwise indicated, the other significant subsidiaries of Sapiens listed below are substantially all 100% owned by Sapiens B.V.:

Sapiens Israel Software Systems Ltd.: incorporated in Israel


Sapiens Technologies (1982) Ltd.: incorporated in Israel

Sapiens Americas Corporation: incorporated in New-York, USA
New York, US
Sapiens Internet Marketing Associates,North America Inc.: incorporated in Ontario, Canada.

Sapiens (UK) Limited: incorporated in England


Sapiens France S.A.S.: incorporated in France

Sapiens Deutschland GmbH: incorporated in Germany

Sapiens Japan Co.: incorporated in Japan and 90% heldowned by Sapiens B.V.

IDIT I.D.I. Technologies Ltd.: incorporated in Israel (owned 100% by Sapiens Technologies (1982) Ltd.)

IDIT Europe N.V.: incorporated in Belgium (owned 100% by IDIT)

IDIT APAC PTY. Limited: incorporated in NSW, Australia (owned 100% by IDIT)

IDIT Singapore PTE. Ltd.: incorporated in Singapore (owned 100% by IDIT)

FIS Software Ltd.: incorporated in Israel (owned 100% by Sapiens Technologies (1982) Ltd.)

FIS –EU Limited: incorporated in the UK (owned 100% by FIS)

FIS Software Inc.: incorporated in Delaware, US (owned 100% by FIS)

FIS France: incorporated in France (owned 100% by FIS-EU Limited)

FIS- AU Pty Ltd.: incorporated in Australia (owned 100% by FIS-EU Limited.)

Neuralmatic Ltd.: incorporated in Israel (owned 66% by FIS)

We are a member of the Formula Systems (1985) Ltd. Group (NASDAQ: FORTY and TASE: FORT).

Formula is a holding and managing company of publicly traded companies and their subsidiaries. Formula companiessubsidiaries which provide IT solutions worldwide, developing and implementing innovative, proprietary software, services and solutions, turnkey projects and outsourcing services as well as software distribution and support. As of AprilMarch 1, 2010,2012, Formula beneficially owned approximately 70%52.1% of our outstanding Common Shares.

In November 2006, Emblaze purchased a controlling interest in Formula, and as a result, controls us.  

As of AprilMarch 1, 2010, Emblaze2012, Asseco beneficially owned 49.19%50.2% of the outstanding share capital of Formula.

Based on Formula’s beneficial holding of over 50% of the outstanding Common Shares of the Company, and based on Emblaze’sAsseco's beneficial holding of 49.19%over 50% of the outstanding share capital of Formula, both Formula and Emblaze may beAsseco are considered to control us.

27
18

D.        Property, Plants and Equipment.

We lease office space in Israel, the United States, Canada, the United Kingdom, Belgium and Japan. The lease terms are generally five to ten years. In Israel, we lease approximately 45,00080,000 square feet of office space; in the United States, approximately 4,7009,200 square feet; in Canada, approximately 8,900 square feet; in the United Kingdom, approximately 13,80012,000 square feet, in Belgium, approximately 3,400 square feet and in Japan, approximately 3,7504,400 square feet. In the United Kingdom, we sub-lease to others approximately 7,364 square feet. In 2009,2011, our rent costs totaled $1.56$2.4 million in the aggregate for all of our leased offices. Our corporate headquarters are located in Israel and our core research and development activities are performed at our offices inacross Israel. We recently extended ourOur lease of our officecorporate headquarters in Israel tocontinues until July 2015 with an option to terminate earlier on 180 days prior notice on each of July 31, 2012, 2013 and 2014. O urThe leases of our other locations in Israel continue until February 2013 and January 2018. Our sales, marketing and general and administrative activities are performed in each of our offices. We believe that our existing facilities are adequate for our current needs.

UNRESOLVED STAFF COMMENTS

Item 4A.   UNRESOLVED STAFF COMMENTS

Not Applicable.

OPERATING AND FINANCIAL REVIEW AND PROSPECTS

ITEM 5.      OPERATING AND FINANCIAL REVIEW AND PROSPECTS

The following discussion and analysis by our management of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the notes thereto included elsewhere herein.

Overview

We are a global provider of a software solutions for the financial services market, with a focus on insurance. Within the insurance industry we offer our customers L&P and P&C core software solutions, using our field-tested project delivery and implementation methodologies for the delivery of mission critical, complex solutions and incorporating insurance best practices from across the globe, backed by over 700 employees, including many insurance and technology experts. Our solutions are supplemented by our consulting services, which address the complex issues related to the lifecycle of enterprise business applications. Our commitment to innovation is at the core of our business, and drives us to offer additional innovative solutions to large enterprises.

We derive our revenues principally from the sale, implementation, maintenance and support of our solutions and from the provision of consulting and other services in the Property & Casualty (P&C) and Life & Pension (L&P) insurance markets, as well as our eMerge customers. Revenues are comprised primarily of revenues from services, including systems integration and implementation and product maintenance and support and from licenses of our products. In each of 2011, 2010 and 2009, our revenues from licenses to our products represented less than 10% of our total revenues for such years. See “Critical Accounting Policies and Estimates” below for a discussion of how we account for our revenues and their associated costs.

28
Overview

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and result of operations is based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of our financial statements required us to make estimations and judgments in accordance with U.S. GAAP, that affect the reporting amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, bad debts, goodwill and other intangible assets, foreign currency fluctuation, capitalized software development costs, deferred taxes, income taxes, restructurings and legal contingencies.liabilities within the reporting period. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circ umstances,circumstances, the results of which form the basis of making judgments about the values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. More detailed descriptions of these policies are provided in Note 2 to our consolidated financial statements.

We believe that the following critical accounting policies affect the estimates and judgments that we made in preparing our consolidated financial statements.

statements:

·Revenue Recognition

·Business Combination

·Goodwill, long lived assets and other identifiable intangible assets

·Taxes on Income

Revenue Recognition

Our revenue recognition approach for

We generate revenues from sales of software licensing requireslicenses which normally include significant implementation services that in accordance with ASC 985-605 "Software Revenue Recognition", four basic criteria must be met before revenue can be recognized: (1)are considered essential to the functionality of the software license. In addition, we generate revenues from post implementation consulting services and maintenance services.

Sales of software licenses are recognized when persuasive evidence of an arrangement exists; (2)agreement exists, delivery of the product has occurred, or services rendered; (3) the fee is fixed or determinable, and determinable; and (4) collectibilitycollectability is reasonably assured.

Revenues under multiple-elementprobable. We consider all arrangements which may include software licenses, support and maintenance, and training and consulting services, are allocated to each element underwith payment terms extending beyond six months from the "residual method" when Vendors Specific Objective Evidence ("VSOE") of fair value exists for all undelivered elements and VSOE does not exist for alldelivery of the delivered elements. VSOEelements, not to be fixed or determinable. If the fee is determined for support and maintenance, training and consulting services based on the price charged when the respective elements are sold separatelynot fixed or renewed. The Company charges support and maintenance renewals at a fixed percentage of the total price of the licensed software products purchased by the customer. Under the residual method, we defer revenues related to the undelivered elements based on their vendor-specific objective evidence of fair value and recognize the remaining arrangement fee for the delivered elements.  When vendor-specific objective evidence of fair value for undelivered elements does not exist, revenuesdeterminable, revenue is recognized as payments become due from the entire arrangement are recognized over the term of the agreement.
19

We recognize revenue from support and maintenance agreements ratably over the term of the agreement, which is typically one year. We recognize revenues from training arrangements as the services are performed.
We generally do not grant a right of return to our customers.  When we do grant a right of return, we defer the recognition of revenue until the right of return expires,customer, provided that all other revenue recognition criteria arehave been met.
Amounts collected or billed prior to satisfying the above revenue recognition criteria are reflected

We usually sell our software licenses as deferred revenue.  Deferred revenue represents deferred maintenance revenue, andpart of an overall solution offered to a lesser extent, deferredcustomer that combines the sale of software license revenues.

Revenues from license fees that involvelicenses which normally include significant implementation and customizationthat is considered essential to the functionality of ourthe license. We account for the services (either fixed price or T&M -Time and Materials) together with the software to customer specific requirements are generated from fixed-price or time-and-materials contracts.  Revenues from fixed-price contracts are recognized based onunder contract accounting using the percentage-of-completion method in accordance with ASC 605-35, "Revenue recognition- Construction Type"Construction-Type and Production- Type Contracts,” which requires the accurate estimation of the cost, scope and duration for each project. Revenue and related cost for these projects are recognized onProduction-Type Contracts". The percentage of completion usingmethod is used when the input measurerequired services are quantifiable, based on the estimated number of labor hours necessary to assess the percent completed when enforceable right to services performed between milestones duringcomplete the project, exists,and under that method revenues are recognized using labor hours incurred as the measure of progress towards completion. In the years ending December 31, 2011, 2010 and 2009 our revenues from licenses represented less than 10% of our revenues.  

The use of the percentage-of-completion method for revenue recognition requires the use of various estimates, including among others, the extent of progress towards completion, contract completion costs and contract revenue. Profit to be recognized is dependent upon the accuracy of estimated progress, achievement of milestones and other incentives and other cost estimates. Such estimates are dependent upon various judgments we make with revisionsrespect to those factors, and some are difficult to accurately determine until the project is significantly underway. Progress is evaluated each reporting period. We recognize adjustments to profitability on contracts utilizing the percentage-of-completion method on a cumulative basis, when such adjustments are identified. We have a history of making reasonably dependable estimates reflectedof the extent of progress towards completion, contract revenue and contract completion costs on our long-term contracts. However, due to uncertainties inherent in the period in which changes become known. estimation process, it is possible that actual completion costs may vary from estimates.

If we do not accurately estimate the resources required or the scope of work to be performed, or do not manag emanage the project properly within the projected periods of time or satisfy our obligations under the contract, project margins may be significantly and negatively affected, which may result in losses on existing contracts. Any such resulting reductions in margins or contract losses in a large, fixed-price contract may have a material adverse impact on our results of operations.

Revenues from consulting services thatoperations.Provisions for estimated losses on uncompleted contracts are not deemed essential tomade in the functionalityperiod in which such losses are first determined, in the amount of the licenseestimated loss on the entire contact.

In accordance with ASC 985-605, we established Vendor Specific Objective Evidence ("VSOE") of fair value of maintenance services (PCS) based on the Bell-Shaped approach and determined VSOE for PCS, based on the price charged when the element is sold separately (that is, the renewal rate). Our process for establishing VSOE of fair value of PCS is through performance of VSOE compliance test which is an analysis of the entire population of PCS renewal activity for its installed base of customers.

Provisions for estimated losses on contracts in progress are made in the period in which they are first determined, in the amount of the estimated loss on the entire contact. Provisions for estimated losses are presented in accrued expenses and other liabilities.  

In addition, we derives significant portion of our revenues from post implementation consulting services provided on a "timetime and materials"materials ("T&M") basis which are recognized as services are performed.


Revenues

Maintenance revenue is recognized ratably over the term of the maintenance agreement. Deferred revenues include unearned amounts received under maintenance and support agreements and amounts received from IT outsourcing services that mainly include maintenance of customers' applications integratedcustomers, for which revenues have not yet been recognized.

We perform ongoing credit evaluations on our license performed on a fixed fee basis are recognized on a straight line basis over the contractual period that the services are rendered, since no other pattern of outputs is discernible. Revenues from IT outsourcing services that are performed on a "timecustomers and materials" basis are recognized as services are performed.


Bad Debt
We maintain allowancesto date we did not experienced any material losses. In certain circumstances, we may require prepayment. An allowance for doubtful accounts is determined with respect to those amounts that we determined to be doubtful of collection. Provisions for doubtful accounts were recorded in general and administrative expenses.

Business Combination

According to ASC 805 “Business Combination” we are required to allocate the purchase price of acquired companies to the tangible and intangible assets acquired and liabilities assumed based on their estimated losses resultingfair values.In connection with our acquisition of FIS and IDIT, we recorded $19.6 million of intangible assets, relating principally to customer related intangible assets and acquired technology. In addition, we recorded a liability in the amount of $2.2 million relating to FIS' long term contracts.In allocating the purchase price of the acquired companies to the tangible and intangible assets acquired and liabilities assumed, we developed the required assumptions underlying the valuation work.Critical estimates in developing such assumptions underlying the valuing of certain of the intangible assets include but are not limited to: future expected cash flows from customer contracts, acquired developed technologies and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, utilizing a market participant approach, but which are inherently uncertain and unpredictable. Assumptions may be incomplete or inaccurate, and unanticipated events and circumstances may occur. We were assisted by third party valuators in applying the inabilityrequired economic models (such as income approach), in order to estimate the fair value of our customers to make required payments. Ifassets acquired and liabilities assumed in the financial condition of our customers was to deteriorate, resulting in an impairment of their ability to make payments, additional allowances would be required.

business combination.

Goodwill, long lived assets and other identifiable intangible assets

ASC 350, “Intangibles-

Goodwill and Other” requires that goodwill be tested for impairment at least annually or between annual testsrepresents the excess of the purchase price in certain circumstances. Goodwill is required to be written down when impaired, rather than amortized as previous accounting standards required. Goodwill is tested for impairment by comparinga business combination over the fair value of the net tangible and intangible assets acquired. Under ASC 350," Intangibles—Goodwill and Other" goodwill is subject to an annual impairment test or more frequently if impairment indicators are present. Goodwill impairment is deemed to exist if the net book value of a reporting unit exceeds its estimated fair value. Following the acquisition of FIS and IDIT, we started to operate in two reporting units: Sapiens and IDIT. In connection with our acquisition of FIS and IDIT, we recorded an additional $60.9 million as goodwill.

In September 2011, the FASB issued ASU 2011-08 which amends the rules for testing goodwill for impairment. Under the new rules, an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying value. Fairamount. If, after assessing the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit is generallyless than its carrying amount, then performing the two-step impairment test is unnecessary.

We effected an early adoption of the provisions of ASU 2011-08 for our annual impairment test in the fourth quarter of 2011. This analysis determined usingthat no indicators of impairment existed primarily because (1) our market capitalization.

capitalization has consistently exceeded our book value by a sufficient margin, (2) the acquisition of IDIT, which, as of December 31, 2011, was considered a separate reporting unit for accounting purposes, was consummated on August 21, 2011 and no significant changes in its business operations occurred since the acquisition, (3) our overall financial performance has been stable since the acquisition, and (4) forecasts of operating income and cash flows appear sufficient to support the book values of the net assets of each reporting unit.

However, it is possible that our determination that goodwill for a reporting unit is not impaired could change in the future if current economic conditions deteriorate or remain difficult for an extended period of time. We selected December 31stwill continue to monitor the relationship between our market capitalization and book value, as well as the date on which we performability of our annual indefinite life impairment tests for our goodwillreporting units to deliver current and intangible assets. Throughincome and cash flows sufficient to support the book values of the net assets of their respective businesses.

As of December 31, 2009, no impairment was required.

20

2011, our intangible assets were $31.6 million, primarily comprised of capitalized software as well as core technology and customer relationship mainly from the acquisitions of IDIT and FIS in August 2011.

In accordance with ASC 360, "Property, Plant and Equipment" our long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. In measuring the recoverability of assets, we are required to make estimates and judgments in assessing our forecast and cash flows and compare that with the carrying amount of the assets. Additional significant estimates used by management in the method ologiesmethodologies used to assess the recoverability of our long-lived assets include estimates of future cash-flows, future short-term and long-temlong-term growth rates, market acceptance of products and services, and other judgmental assumptions, which are also affected by factors detailed in our Risk Factors section in this annual report (see Item 3, “Key Information – Risk Factors”). If these estimates or the related assumptions change in the future, we may be required to record impairment charges for our long-lived assets.

Share-Based Payments

We applyevaluate our intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable, in accordance with ASC 718 with respect360 (see above). In evaluating potential impairment of these assets, we specifically consider whether any indicators of impairment are present, including, but not limited to options issuedwhether there:

·has been a significant adverse change in the business climate that affects the value of an asset;

·has been a significant change in the extent or manner in which an asset is used; and/or

·is an expectation that the asset will be sold or disposed of before the end of its originally estimated useful life.

If indicators of impairment are present, we compare the estimated undiscounted cash flows that the specific asset is expected to employees. .ASC 718 requires usgenerate to estimateits carrying value. These estimates involve significant subjectivity. If such assets are considered to be impaired, the fair value equity-based payment awards onimpairment to be recognized is measured by the date of grant using an option-pricing model. The valueamount by which the carrying amount of the portion of the awards that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company’s consolidated statement of operations. Beginning on the date of adoption of ASC 718, we estimate forfeitures based on historical experience and other factors; previously, we recorded forfeitures as they occurred.

Foreign Currency Fluctuation
We expect that, in addition to the US dollar, a significant portion of our revenues will continue to be denominated in the GBP and in the NIS and a smaller portion will be denominated in the Euro and Japanese yen.  As a result, changes in the exchange rates between the US dollar and the GBP, the US dollar and the NIS, and to a lesser extent the US dollar and the Euro and the US dollar and the Japanese yen, could have a material adverse impact on our revenues and results of operations within the U.K., the rest of Europe, Israel and Japan. We regularly assess our currency exchange exposures and determine whether to adjust or hedge our position. We may use derivative instruments to hedge or adjust our exposures. As a matter of policy we do not enter into transactions of a speculative or trading nature. Foreign exchange exposures are monitored by tracking actual and projected commitments and through the use of sensitivity analysis.
Capitalized Software Development Costs
asset exceeds its fair value.

Our policy onfor capitalized software costs determines the timing of our recognition of certain development costs. Software development costs incurred from the point of reaching technological feasibility until the time of general product release should beare capitalized. We generally define technological feasibility as the completion of a detailed program design. The determination of technological feasibility requires the exercise of judgment by our management. Since we sell our products in a market that is subject to rapid technological changes, new product development and changing customer needs, changes in circumstances and estimations may significantly affect the timing and the amounts of software development costs capitalized and thus our financial condition and results of operations.

Capitalized software development costs are amortized commencing with general product release by the greater of the amount computed using: (i) the ratio that current gross revenues from sales of the software bear to the total of current and anticipated future gross revenues from sales of that software, or (ii) the straight-line method between three to five years, which isover the estimated useful life of the software product.product (between 3-7 years). We assess the recoverability of this intangible asset on a regular basis by determining whether the amortization of the asset over its remaining life can be recovered through undiscounted future operating cash flows from the specific software product sold.

In recent years, we developed a new generation of Sapiens eMerge™ products, which includes Service Oriented Architecture based products ("SOA"), eMerge™ for Linux

Taxes on Income

We and eMerge™ for Windows. In 2007, we determined the useful life of Sapiens eMerge™ products to be five years. In addition, we developed a new insurance product, Sapiens INSIGHT™ for Life and Pensions, and also determined its useful life to be five years. We based our determination of useful life on internal product road map analysis past history, technological obsolescence and market research. The life expectancy was established based on the contents, characteristics and capabilities of the products suite, on the technology trends in the IT market in the next decade and on the rate of adoption of new technologies by our customers. To assure a long life expectancy in a dynamic market, software components that support SOA, MS Windows and Linux environments were developed and released during 2006 and 2007.

21

 (i) Sapiens eMerge™ products. The new Sapiens eMerge™ products suite, which is SOA compliant, supports adaptation of existing applications to the new standards without necessitating long and expensive re-implementation and agile incorporation of new business models, effectively extending the lifetime of existing applications. eMerge™ product suite, as well as the eMerge™ based applications, are based on mainstream technologies that are industry standards and were adopted by most of the software vendors. Based on life cycles for these mainstream key technologies, it is expected that the Microsoft and Linux platforms will exist for at least five years. We are not aware, nor do we anticipate, technological changes that are expected to have an impact on new Sapiens eMerge™ product suite in the next five years. Additionally, we believe that if there are major technology changes or advancements in the future, the technologies used by Sapiens eMerge™ products would be at the root of those advancements. We believe that these facts support a longer technological life for Sapiens eMerge™ products. The historical survival rates of similar technologies support a longer life for the eMerge™ product suite. Sapiens’ previous ObjectPool™ software was developed over a decade ago and was an integral part of our business solutions. This platform was used by our customers for their applications development and maintenance for over five years. The expanded functionality of eMerge™ is compatible with the capabilities of ObjectPool™. We believe that the long life of our previous product, ObjectPool™, supports a longer useful life of the eMerge™ products suite. Our estimate of the product life cyc le is based on the contents, characteristics and capabilities of the respective products. The new eMerge™ product suite enables extending the productive life of existing legacy systems, while simultaneously providing a rapid migration path to new technologies. The advanced rapid application development technology allows making enterprise-specific enhancements in a significantly shortened timeframe resulting in a vastly reduced maintenance burden as compared to other technologies, application lifecycle costs reduced by approximately 80% and a significant prolongation of applications’ lifecycle. We estimate the technological life of the underlying platforms and architecture (SOA) to be five years. We do not anticipate any major variance or trend impacting our cost of revenues and profit margins as a result of such change.
(ii) Sapiens INSIGHT™ for Life and Pensions.  In the life insurance market, there are very high costs of migrating old life insurance programs to a new system. Based on the industry and our experience with insurance companies that have already implemented Life & Pensions products, we estimate the useful life of this product to be at least five years. In addition, we do not plan to develop any new products in the next five years that will replace the INSIGHT™ for L&P. As further described above, the INSIGHT™ for Life & Pension is a SOA compliant product that is multi-company, multi-currency, multi-language, and web-enabled, leveraging the advantages of the Internet and company intranet. Sapiens INSIGHT™ for Life &a mp; Pension’s domain is significantly more complex and robust than other insurance domains (such as re-insurance or property and casualty) as it handles more product modules, engines and algorithms which are also implemented during a longer average period than other insurance domains. Due to the extensive capabilities of the system, we estimate the product life cycle to be five years. We do not anticipate any major variance or trend impacting our cost of revenues and profit margins as a result of such change.
Deferred Taxes
Management judgment is required in determining our future taxable income for purposes of assessing our ability to realize any future benefits from our deferred tax assets. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. If actual results differ from these estimates or we adjust these estimates in future periods, our operating results and financial position could be materially affected. If we determine that we will be able to realize the deferred tax assets in the future in excess of their net recorded amount, an adjustment to the deferred tax asset would increase income in the period in which such determination is made. On the other hand, should we determine that we will not be able to realize all or part of the net deferred tax assets in the future, an adjustment to the defer red tax assets will be charged to expenses in the period in which such determination is made.
22

Income Taxes
Through our operating subsidiaries, we operate within multiple tax jurisdictions and may be subject to tax audits in these jurisdictions. These tax audits can involve complex issues, which may require an extended period of time to resolve. In management’s opinion, adequate provisions for income taxes have been made for all years. However, though our income tax reserves are based on our best knowledge, we may be subject to unexpected audits by tax authorities in the various countries where we have subsidiaries, which may result in material adjustments to the reserves established in our consolidated financial statements and have a material adverse effect on our results of operations.
Accounting for Income Taxes
The Company and its subsidiaries account for income taxes in accordance with ASC 740 (Formerly SFAS 109) “Income Taxes” (“. ASC 740”). This Statement740 prescribes the use of the asset and liability method, whereby deferred tax assets and liability account balances are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The CompanyFuture realization of our deferred tax assets ultimately depends on the existence of sufficient taxable income within the available carryback or carryforward periods. Sources of taxable income include future reversals of existing taxable temporary differences, future taxable income, taxable income in prior carryback years and its subsidiaries providetax planning strategies. We record a valuation allowance if necessary, to reduce our deferred tax assets to their estimated realizable value.

an amount we believe is more likely than not to be realized. Changes in our valuation allowance impact income tax expense in the period of adjustment. Our deferred tax valuation allowances require significant judgment and uncertainties, including assumptions about future taxable income that are based on historical and projected information.

ASC 740 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC 740, a company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. TheWe assess our income tax positions and record tax benefits recognized inbased upon management’s evaluation of the financial statements from suchfacts, circumstances, and information available at the reporting date. For those tax positions where it is more-likely-than-not that a position shouldtax benefit will be measured based onsustained, we record the largest amount of tax benefit that haswith a greater than fifty50 percent likelihood of being realized upon ultimate settlement.


Legal Contingencies
settlement with a taxing authority having full knowledge of all relevant information. For those income tax positions where it is not more-likely-than-not that a tax benefit will be sustained, no tax benefit is recognized in the financial statements. We are currently involvedclassify liabilities for uncertain tax positions as non-current liabilities unless the uncertainty is expected to be resolved within one year. The Company classifies interest as financial expenses and penalties as selling, marketing, general and administration expenses.

As a global company, we use significant judgment to calculate and provide for income taxes in certain legal proceedings and claims that aroseeach of the tax jurisdictions in which we operate. In the ordinary course of our business, there are transactions and calculations undertaken whose ultimate tax outcome cannot be certain. Some of these uncertainties arise as discusseda consequence of transfer pricing for transactions with our subsidiaries and tax credit estimates. In addition, the calculation of acquired tax attributes and the associated limitations are complex and although our income tax reserves are based on our best knowledge, we may be subject to unexpected audits by tax authorities in Note 10the various countries where we have subsidiaries, which may result in material adjustments to the reserves established in our consolidated financial statements. As of December 31, 2009, we have accrued our estimate of the probable costs for the resolution of those claims where we believe it is probable that we will incur a loss. This estimate has been developed in consultation with outside counsel handling our defense in these mattersstatements and is based upon an analysis of potential results, assuming a combination of litigation and settlement strategies.  We do not expect these claims and/or proceedings to have a material adverse effect on our consolidated financial position. It is possible, however, that future results of operations or cash flows for any particular quarterly or annual period could be materially affected by change s inoperations. We estimate our assumptionsexposure to unfavorable outcomes related to these claimsuncertainties and proceedings.

Fair Value Measurements
The carrying amounts ofestimate the probability for such outcomes.

Although we believe our financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate fair value because of their generally short-term maturities.


Effective January 1, 2008, the Company adopted ASC 820 (Formerly SFAS 157), "Fair Value Measurements and Disclosures". ASC 820 clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:
Level 1-Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2-Include other inputs that are directly or indirectly observable in the marketplace.
Level 3-Unobservable inputs which are supported by little or no market activity.

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
23


Recent Accounting Pronouncements
In October 2009, the FASB issued ASU 2009-13, "Revenue Recognition (ASC Topic 605)-Multiple-Deliverable Revenue Arrangements" (ASU 2009-13). ASU 2009-13 amends the criteria in ASC Subtopic 605-25, "Revenue Recognition-Multiple-Element Arrangements", for separating consideration in multiple-deliverable arrangements. This Update addresses the accounting for multiple-deliverable arrangements to enable vendors to account for products or services (deliverables) separately rather than as a combined unit. ASU 2009-13 modifies the requirements for determining whether a deliverableestimates are reasonable, no assurance can be treated as a separate unit of accounting by removinggiven that the criteria that verifiablefinal tax outcome will not be different from what is reflected in our historical income tax provisions, returns, and objective evidence of fair value exists for the undelivered elements. This guidance eliminates the residual method of allocation and requires that arrangement consideration be allocated at th e inception of the arrangementaccruals. Such differences, or changes in estimates relating to all deliverables using the relative selling price method. This guidance establishes a selling price hierarchy for determining the selling price of a deliverable, which is based on: a) vendor-specific objective evidence; b) third-party evidence; or c) estimates. In addition, this guidance significantly expands required disclosures related to a vendor's multiple-deliverable revenue arrangements. ASU 2009-13 is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010, with early adoption permitted. The Company has chosen not to early adopt ASU 2009-13. We are currently evaluating the potential impact, if any, of the adoption of the standard on our consolidated financial statements.

In June 2009, the FASB issued ASU No. 2009-01, Topic 105 — Generally Accepted Accounting Principles amendments based upon Statement of Financial Accounting Standards No. 168, The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles — a replacement of FASB Statement 162 ("ASU 2009-01"). ASU 2009-01 establishes the FASB ASC as the single source of authoritative accounting principles to be applied to financial statements of nongovernmental entities in conformity with U.S. GAAP. ASU 2009-01 was effective for financial statements issued for interim and annual periods ending after September 15, 2009. Our adoption of ASU 2009-01 did not affect our consolidated results of operations or financial condition.

In December 2007, the FASB issued new authoritative accounting guidance under FASB ASC Topic 810 (formerly SFAS No. 160) which establishes accounting and reporting standards for the non-controlling interest in a subsidiary and for the deconsolidation of a subsidiary. ASC Topic 810 clarifies that a non-controlling interest in a subsidiary, which is sometimes referred to as minority interest, is an ownership interest in the consolidated entity that should be reported as a component of equity in the consolidated financial statements. Among other requirements, ASC 810 requires consolidated net income to be reported at amounts that include the amounts attributable to both the parent and the non-controlling interest. It also requires disclosure, on the face of the consolidated income statement, of the amounts of consolidated net income attributable to the pa rent and to the non-controlling interest. ASC Topic 810 is effective for fiscal years beginning on or after December 15, 2008. The adoption of ASC topic 810 on January 1, 2009 did notdifferences, could have a material impact on our income tax provision and operating results in the period in which such a determination is made.

Recent Accounting Pronouncements

In June 2011, the FASB issued ASU 2011-05 Presentation of Comprehensive Income, codified in ASC 220 "Comprehensive Income". The guidance requires an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The guidance also eliminates the option to present the components of other comprehensive income as part of the statement of equity. In December 2011, the FASB issued ASU 2011-12, deferring the effective date for amendments outlined in ASU 2011-05. We are still evaluating whether to present other comprehensive income in a single continuous statement of comprehensive income or in two separate but consecutive statements.

In May 2011, the FASB issued ASU 2011-04 Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS, codified in ASC 820 "Fair Value Measurement". The guidance requires an entity to provide a consistent definition of fair value to ensure that the fair value measurement and disclosure requirements are similar between U.S. GAAP and International Financial Reporting Standards. The guidance changes certain fair value measurement principles and enhances the disclosure requirements particularly for Level 3 fair value measurements, and will become effective for us beginning January 1, 2012. We do not expect the adoption of this new guidance to have a material impact on its financial position or results of operations and financial condition.


statements.

A.           Operating Results

Years ended December 31, 20082011 and 2009

2010

Revenues.

Revenues from the sale of products are comprised of revenues from sales of Sapiens eMerge™ licenses, license upgrades, fixed price projects, and licenses for “Sapiens INSIGHT™" suite of solutions for the insurance industry. Revenues from services include mainly consulting on a time and materials basis, maintenance and support.

Total revenues in 20092011 increased 5.1% to $45.7$69.9 million in 2011 from $52.2 million in 2010. This increase of $17.7 million, or 34%, was due primarily to revenues of approximately $16.3 million from $43.5the FIS and IDIT businesses that were acquired in August 2011. Our revenues in North America increased by a total of $11.9 million to $20.9 million in 2008. Product2011 from $9.0 million in 2010, including $8.1 million from new and existing customers and $3.8 million from FIS and IDIT. Our revenues in 2009Asia decreased 24.4% toby a net aggregate of $3.1 million in 2009 from $4.1to $8.0 million in 2008. Consulting2011 from $11.1 million in 2010 including a decrease of $5.1 million, due primarily to the impact of the economic crisis in Japan in 2011, offset by $1.7 million from FIS and other serviceIDIT. Our revenues in 2009Europe, including the United Kingdom, increased 8.1%by a total of $7.7 million to $42.6 million from $39.4$19.5 million in 2008.

24

2011 from $12.6 million in 2010 primarily from revenues from the FIS and IDIT businesses.

Cost of Revenues and Gross Profit

Cost of revenues increased 0.4% to $26.6$40.1 million in 20092011 from $26.5$29.9 million in 2008.2010. This increase of $11.2 million or 34% was due primarily to an increase in costs of revenues from the FIS and IDIT businesses of $11.6 million. Cost of revenues relating to products iswas comprised of salaries and other personnel-related expenses of software consultants and engineers ($1.1of $31.6 million, or 57.9%79% of our total costs of products,revenues in 2009, and $1.22011 compared to $23.0 million, or 48%77% of our total costs of products, in 2008), depreciation costs ($0.2 million, or 10.5% of our total costs of products, in 2009 and $0.3 million, or 12.0% of our total costs of products, in 2008), amortization of capitalized software development costs ($0.3 million, or 15.8% of our total costs of products, in 2009 and $0.4 million, or 16.0% of our total costs of products, in 2008), royalties to the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor of Israel (“OCS”) ($0.1 million, or 5.3% of our total costs of pr oducts, in 2009, and $0.1 million, or 4.0% of our total costs of products in 2008) and other costs ($0.2 million, or 10.5% of our total costs of products, in 2009, and $0.5 million, or 20.0% of our total costs of products, in 2008).  Costcost of revenues relating to consulting and other services is comprised of salaries and other personnel-related expenses, and amortization of capitalized software development costs.  Salaries and other personnel-related expenses amounted to $19.8 million, or 80.2% of our total costs of consulting and other services, in 2009, and $19.6 million, or 81.7% of our total costs of consulting and other services, in 2008.2010. Amortization of capitalized software development costs amounted to $4.3was $4.5 million, or 17.4%11% of our costtotal costs of revenues, relatedin 2011 compared to consulting, in 2009, and $3.8$5.9 million, or 15.8%20% of our costtotal costs of revenues, related to consulting, in 2008. The increase of the amortization is mainly due commencement of the amortization of new capitalized software developmen t costs.

2010.

Our gross profit in 20092011 increased 11.7%34% to $19.1$29.9 million from $17.1$22.3 million in 2008 as the overall increase in our revenues outpaced the slight increase in our cost of revenues.2010. The gross profit margin increased by 6.7% in 20092011 stayed flat at 42.7% compared to 41.9 % from 39.3% in 2008.

Gross profit from product revenues decreased 29.4% in 2009 to $1.2 million from $1.7 million in 2008. Gross margin from product revenues was 40.0% in 2009, with no change from 2008. Gross profit from consulting, maintenance and other services increased 16.2% to $17.9 million in 2009 from $15.4 million in 2008. Gross margin from consulting, maintenance and other services increased 7.3% in 2009 to 42.0% from 39.1% in 2008. These results are mainly due to reduction in labor cost and tight control on all related expenses.
Amortization of capitalized software development costs increased 9.5% to $4.6 million in 2009 from $4.2 million in 2008. The increase was due to beginning of the amortization of new capitalized software development costs in 2009.
2010.

Research and Development, net.

Research and development (“R&D”) costs are mainly comprised of labor costs, and depreciation of property and equipment, reduced by capitalization of software development costs. Net

Research and development, net, increased 52% to $5.0 million in 2011 compared to $3.3 million in 2010. Gross R&D expenses decreased 30.8% in 2009 to $2.7 million from $3.9were $9.7 million in 2008. The decrease2011 compared to $8.7 million in spending on R&D recorded in 2009, as compared with the previous year, resulted mainly2010. This increase of $1.0 million or 11% was primarily due to the devaluation of the NIS against the US dollar in 2009 compared to 2008, as most of our research and development group is located in Israel and accordingly, related compensation and otherincreased R&D expenses are recorded in NIS, as well as due to the decrease in labor expenses due to the reduction in salaries as well as due to income derived from a decrease in our obligations to contribute to employees pension funds resulting from the increaseacquisition of FIS and IDIT in August 2011 and investment in development of our existing products. Labor costs comprised 94% of the valuegross R&D expenses. Capitalization of such pension fun ds.

Capitalized software development costs increased 5.7% to $3.7were $4.7 million in 20092011 compared with $3.5to $5.4 million in 2008. Direct labor costs decreased 14.3% in 2009 to $4.8 million from $5.6 million in 2008, mainly due to the devaluation of the NIS against the US dollar in 2009 compared to 2008, as most of our research and development group is located in Israel and accordingly related compensation and other expenses are recorded in NIS, as well as due to the decrease in labor expenses due to the reduction in salaries as well as due to income derived from a decrease in our obligations to contribute to employees pension funds resulting from the increase in the value of such pension funds.
2010.

Selling, Marketing, General and Administrative expenses.

Selling, marketing, generalMarketing, General and administrative,Administrative expenses (“SG&A expenses”) include costs of salaries of sales, marketing, management and administrative employees, office expenses, communications, external consultants and other expenses.

SG&A expenses increased 2.8% in 2009 to $11 million from $10.7$18.1 million in 2008. SG&A expenses consist2011 from $12.3 million in 2010. This increase of $5.8 million, or 47%, was primarily due to increased headcount in our global sales team, marketing and management and administration, including $3.9 million resulting from the acquisition of salariesFIS and IDIT. Salaries and other personnel-related expenses which in 2009 amounted to $6.5were $9.9 million, or 59.1%54% of total SG&A expenses, and in 20082011 compared to $6.4$6.9 million, or 59.8%56% of total SG&A expenses, in 2010. The increase in salary and other personnel related expenses primarily resulted from an increase of $2.5 million from the acquisition of FIS and IDIT as well as other costs associated with our sales and marketing effortsefforts.

35

Acquisition-related and our generalrestructuring costs

Acquisition-related and administrative activities such as rent which amounted to $1.4restructuring costs were $1.1 million in 20092011 and $1.3consisted of $0.5 million of restructuring charges relating primarily to our operational restructuring plan and $0.6 million of other transaction-related costs including legal, due diligence, accounting and other costs, all in connection with our acquisition of IDIT and FIS. There were no similar costs in 2010.

Financial income (expenses), net.

Financial income, net, was $0.1 million in 2008, accounting, legal and other public company2011 compared to expenses, which amounted to $0.8net of $0.4 million in 20092010. This change was primarily due to interest income from bank deposits which increased in 2011 and $1.0the effect of changes in currency rates and additional available cash.

Taxes on Income.

Net tax benefit in 2011 was $0.2 million in 2008, depreciation costscompared to expenses of $0.2 million eachin 2010. This change resulted from an increase in net deferred tax income of 2009$0.4 million due to operating loss carryforwards and 2008, and marketing costs, including tradeshows and design,temporary differences which more likely than not be utilized in the amount of $0.1 million in 2009 and $0.2 million  in 2008. General and administrative expenses include management salaries, offices and office maintenance, communications, external consultants and other expenses.

25

Financial expenses, net.
Our financial expenses, net, decreased 59.1% to $0.9 million in 2009 from $2.2 million in 2008. The decrease is mainly due to the decrease in the aggregate amount of our outstanding debentures and short term loans from financial institutions in 2009 compared to 2008. During 2009, we paid $0.3 million as interest to our debenture holders and $5.8 million for the repayment and repurchase of our convertible debentures consisting of a payment of $5.4 million for the fourth installment repayment of the principal amount due under the debentures and $0.4 million for the repurchase of our convertible debentures in the market.
Taxes on Income.
Our net tax expense in 2009 was $0.26 million compared with $0.58 million in 2008.
foreseeable future.

Our provision for taxes on income relates to operations in jurisdictions other than the Netherlands Antilles.Curaçao. The effective income tax rate varies from period to period as a result of the various jurisdictions in which we operate and where each one has its own system of taxation (not only with respect to the nominal rate, but also with respect to the allowance of deductions, credits and other benefits). We record a valuation allowance if we believe that it is more likely than not that the deferred income taxes regarding the loss carry forwards and other temporary differences, on which a valuation allowance has been provided, will not be realized in the foreseeable future. We did not recognize a majority of the deferred tax assets relating to the net operating losses of our subsidiaries worldwide due to the uncertainty of the realization of such tax ben efitsbenefits in the foreseeable future.

Net Income (loss).

attributable to Sapiens shareholders.

Net income attributable to holders of our Common Shares was $4.2Sapiens shareholders decreased to $6.0 million in 2009 compared to net loss of $0.32011 from $6.2 million for 2008.2010. The increase in net income for shareholders in 2009decrease of $0.2 million, or 3%, was due to (a) the $2.8a $1.1 million increasedecrease in operational profit in 2009,2011, from $2.5$6.7 million in 20082010 to $5.3$5.6 million in 2009,2011, which was triggereddriven by higherrestructuring and other transaction costs associated with the acquisition of FIS and IDIT of $1.1 million offset by an increase of $0.5 million in financial income, net and an increase in tax income of $0.4 million. Our operational profit in 2011 also decreased as a result of the increase in gross profit on our productsof $7.5 million which was offset by an increase in R&D expenses of $1.7 million and services ($19.1 millionan increase in 2009 compared to $17.1 million in 2008) and reduced overall operatingSG&A expenses ($13.8 million in 2009 relative to $14.6 million in 2008), and (b) the $1.3 million decrease in financial expenses, net in 2009, from $2.2 million in 2008 to $0.9 million in 2009.

of $5.8 million.

Years ended December 31, 20072009 and 2008

2010

Revenues.

Revenues

Total revenues increased to $52.2 million in 2010 from $45.7 million in 2009. This increase of $6.5 million, or 14%, was due primarily to an increase in sales to our existing and new customers of $3.4 million and $3.1 million resulting from the saleacquisition of products are comprised of revenues from sales of Sapiens eMerge™ licenses, license upgrades, fixed price projects, and licenses for “Sapiens INSIGHT™" suite of solutions for the insurance industry. Revenues from services include mainly consulting on a time and materials basis, maintenance and support.

Total revenues in 2008 increased 2.6% to $43.5 million from $42.4 million in 2007. Product revenues in 2008 decreased 26.8% to $4.1 million in 2008 from $5.6 million in 2007. Consulting and other service revenues in 2008 increased 7.1% to $39.4 million from $36.8 million in 2007.
Our product revenues for the year 2008 decreased and our consulting and other service revenues increased mainly due to a planned shift from fixed price projects to time and material based projects, and the completion of certain fixed price projects during the year.
26

Harcase.

Cost of Revenues and Gross Profit.

Profit

Cost of revenues increased 3.5% to $26.5$29.9 million in 20082010 from $25.6$26.6 million in 2007. Cost2009. This increase of revenues relating to products is comprised of$3.3 million, or 12.6%, resulted from an increase in salaries and other personnel-related expenses of software consultantsprimarily due to increased headcount and engineers ($1.2 million, or 48% of our total costs of products,an increase in 2008, and $1.0 million, or 30.3% of our total costs of products, in 2007), depreciation costs ($0.3 million, or 12.0% of our total costs of products, in 2008 and $0.4 million, or 16.0% of our total costs of products, in 2007), amortization of capitalized software development costs ($0.4 million, or 16.0% of our total costs of products, in 2008 and $1.0 million, or 30.3% of our total costs of products, in 2007), royalties to the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor of Israel (“OCS”) ($0.1 million, or 4.0% of our total costs of pr oducts, in 2008, and $0.6 million, or 18.2% of our total costs of products in 2007) and other costs ($0.5 million, or 20.0% of our total costs of products, in 2008, and $0.3 million, or 9.1% of our total costs of products, in 2007).  Cost of revenues relating to consulting and other services is comprised of salaries and other personnel-related expenses, and amortization of capitalized software development costs. Salaries and other personnel-related expenses amounted to $19.6of software consultants and engineers were $23.0 million, or 81.7%77% of our total costs of consulting and other services,revenues in 2008, and $20.32010 compared to $20.9 million, or 91%79% of our total costs of consulting and other services,revenues, in 2007.2009. Amortization of capitalized software development costs amounted to $3.8was $5.9 million, or 15.8%20% of our costtotal costs of revenues, relatedin 2010 compared to consulting, in 2008, and $2.0$4.6 million, or 9.0%17% of our costtotal costs of revenues, related to consulting, in 2007.2009. The increase of thein amortization iswas mainly due to the devaluation of the NIS against the US dollar and the commencement o f the amortization of new capitalized software development costs.

Our gross profit in 2008 increased 1.8% to $17.1 million from $16.8 million in 2007. The gross profit margin decreased by 0.8% in 2008 to 39.3 % from 39.6% in 2007 mainly due to the increase in amortization costs.
Gross profit from product revenues decreased 30.4% in 2008 to $1.6 million from $2.3 million in 2007. Gross margin from product revenues was 39.0% in 2008, a decrease of 5.1% from 41.1% in 2007. Gross profit from consulting, maintenance and other services increased 6.2% to $15.4 million in 2008 from $14.5 million in 2007. Gross margin from consulting, maintenance and other services decreased 0.8% in 2008 to 39.1% from 39.4% in 2007.
Amortization of capitalized software development costs increased 40.0% to $4.2 million in 2008 from $3.0 million in 2007. The increase is due to beginning of the amortization of new capitalized software development costs.
costs that were ready for general release of a product in 2010.

Our gross profit in 2010 increased 16.8% to $22.3 million from $19.1 million in 2009 as the overall increase in our revenues outpaced the slight increase in our cost of revenues. The gross profit margin increased by 2.1% in 2010 to 42.7 % from 41.9% in 2009.

Research and Development, net.

Research and development (“R&D”) costs are mainly comprised of labor costs and depreciation of property and equipment, reduced by capitalization of software development costs. NetDevelopment, net, increased 22.2% to $3.3 million in 2010 from $2.7 million in 2009. Gross R&D expenses increased 11.4%44% in 20082010 to $3.9$8.7 million from $3.5$6.4 million in 2007. The2009, mainly due to the Harcase acquisition which increased our R&D resource team and additional expenses related to compensation of Harcase selling shareholders, as well as the increase in spending onthe resource team developing our existing products. Labor costs comprised 94% of the gross R&D recorded in 2008, as compared with the previous year, resulted mainly from the devaluation of the NIS against the US dollar during the first three quarters of 2008, as most of our research and development group is located in Israel and accordingly its expenses are recorded in NIS.

expenses. Capitalized software development costs increased 12.9%45.9% to $3.5$5.4 million in 20082010 compared with $3.1$3.7 million in 2007. Direct labor costs increased 36.6% in 2008 to $5.6 million from $4.1 million in 2007, mainly due to the devaluation of the NIS against the US dollar during the first three quarters of 2008.
2009.

Selling, Marketing, General and Administrative expenses, net.

Selling, marketing, general and administrative, net expenses (“expenses.

SG&A expenses”) decreased 14.4% in 2008expenses increased to $10.7 million from $12.5$12.3 million in 2007. SG&A expenses consist2010 from $11.0 million in 2009. This increase of $1.3 million, or 11.8%, was due primarily of salariesto increased headcount resulting from the Harcase acquisition, as well as an increase in our global sales and marketing team. Salaries and other personnel-related expenses which in 2008 amounted to $6.4were $6.9 million, or 59.8%56% of total SG&A expenses, in 2010 and in 2007 to $6.8$6.5 million or 54.4%59.1% of total SG&A expenses, as well asin 2009. SG&A expenses also included other costs associated with our sales and marketing efforts and our general and administrative activities such as rent which amounted to $1.3 million in 2008, accounting, legal and other public company expenses in the amount ofwhich amounted to $1.0 million depreciation costs of $0.2 million, marketing costs, including tradeshowsin 2010 and design, in the amount of $0.2 million and bad debt income in the amount of $0.4 million (bad debt expenses in the amount of $0.4 million offs et by the proceeds of a creditors' claim in the  amount of $0.8 million granted to our German subsidiary). General and administrative expenses include management salaries, offices and office maintenance, communications, external consultants and other expenses. The decrease in SG&A expenses in 2008 was the result of a reduction in headcount and consistent efficiency measures implemented by our management, which resulted in reduced expenses.

27

2009.

Financial expenses,income (expenses), net.

Our financial

Financial expenses, net, decreased 21.4%55.6% to $2.2$0.4 million in 20082010 from $2.8$0.9 million in 2007. Total financial income decreased $0.2 million to $0.6 million in 2008 from $0.8 million in 2007, which was offset by the decrease in financial expenses of $0.8 million to $2.8 million in 2008 from $3.6 million in 2007.2009. The decrease iswas mainly due to the decreaserepayment in the aggregate amountfull of our outstanding debentures and short term loans from financial institutions during 2008.   In January and February 2008, we repurchased an aggregate amount of NIS 7,600,000 nominal value of debentures, representing approximately, $2.1 million of the outstanding debentures. As a result, the amount of the annual interest payment that we paid in 2008 was reduced to approxim ately NIS 2.1 million or $0.6 million. In addition, in December 2008, we paid to our debenture holders, $3.5 million for the third installment repayment of the principal amount due under the debentures.

Taxes on Income.
Our net tax expenses in 2008 were $0.58 million compared with $0.34 million in 2007.
Our provision for taxes on income relates to operations in jurisdictions other than the Netherlands Antilles. The effective income tax rate varies from period to period as a result of the various jurisdictions in which we operate and where each one has its own system of taxation (not only with respect to the nominal rate, but also with respect to the allowance of deductions, credits and other benefits). We record a valuation allowance if we believe that it is more likely than not that the deferred income taxes regarding the loss carry forwards and other temporary differences, on which a valuation allowance has been provided, will not be realized in the foreseeable future. We did not recognize a majority of the deferred tax assets relating to the net operating losses of our subsidiaries worldwide due to the uncertainty of the realization of such tax ben efits in the foreseeable future.
Net Loss.
Net loss to holders of our Common Shares was $0.3 million for 2008, a decrease of 88.0% compared with a net loss to shareholders of $2.5 million in 2007. The decrease in net loss to shareholders in 2008 was due to the increase in operational profit of $1.7 million to $2.5 million in 2008, compared with an operational profit of $0.8 million in 2007.
Impact of Foreign Currency Fluctuations and Inflation.
For a discussion of the impact of inflation and foreign currency fluctuations upon our results, please see the risk factors entitled "We face currency exchange risks, as changes in exchange rates between the US dollar and other currencies, especially the NIS, may negatively impact our costs" and "We may be adversely affected if the rate of inflation in Israel exceeds the rate of devaluation (if any) of the New Israeli Shekel against the dollar" in Item 3.D, “Risk Factors,” above.
Effects of Government Regulations and Location on our Business.
For a discussion of the effects of Israeli governmental regulation and our location in Israel on our business, see the “Risks Relating to Our International Operations, Particularly in Israel” in Item 3.D above, and “Israeli Tax Considerations and Government Programs” in Item 10.E below.
B.           Liquidity and Capital Resources.
Our cash and cash equivalents at the end of 2009 were $11.1 million, compared with $7.9 million at the end of 2008. The increase in such liquid assets was due to improved collection and positive cash flow from operating activities, which was partially offset by payment of the fourth and last installment of the principal amount of outstanding debentures, as well as the repurchase of our convertible debentures of approximately $5.8 million
28


Net cash provided by operating activities was $13.5 million in 2009, compared with net cash provided by operating activities of $9.8 million in 2008. This change reflects the improved operational profit in 2009 of $5.3 million compared to $2.5 million during 2008.
Net cash used in investing activities was $4.0 million in 2009, compared with net cash used in investing activities in 2008 of $3.9 million. In2009. During 2009, we consummated investments in software development of $3.7 million and purchase of property and equipment of $0.3 million.
Net cash used in financing activities totaled $6.5 million in 2009, compared with $10.9 million used in financing activities in 2008. In 2009, we decreased our long term loan in the amount of $0.6 million, paid $0.3 million as interest to our debenture holders and $5.8 million for the repayment and repurchase of our convertible debentures consisting of a payment of $5.4 million for the fourth and last installment repayment of the principal amount due under our convertiblethe debentures and $0.4 million for the repurchase of our convertible debentures in the market.

37
Credit Lines
We had a revolving credit line facility

Taxes on Income.

Net tax expense in 2010 decreased 33% to $0.2 million compared with $0.3 million in 2009. The decrease is due to an increase in current income taxes in certain jurisdictions, offset by an increase in net deferred tax assets of $0.3 million due to operating loss carryforwards and temporary differences which will more likely than not be utilized in the foreseeable future.

Net Income attributable to Sapiens shareholders.

Net income attributable to Sapiens shareholders increased to $6.2 million in 2010 from $4.2 million for borrowings2009. The increase of up47.6% was due to $9.2the $1.4 million until June 30,increase in operational profit in 2010, from $5.3 million in 2009 which we did not utilize. We closed such line of credit with no liability with respect thereto.

Fund raising
In June 2007, we entered into a private placement investment transaction with several institutional investors, private investors and Formula for an aggregate gross investment amount of $20to $6.7 million (excluding finders' fees and out of pocket expenses), $6.5 million ofin 2010, which was investedtriggered by Formula.  We issuedhigher gross profit on our products and services ($22.3 million in 2010 compared to $19.1 million in 2009) offset by higher overall operating expenses ($15.6 million in 2010 compared to $13.8 million in 2009) and the investors an aggregate$0.5 million decrease in financial expenses, net in 2010, from $0.9 million in 2009 to $0.4 million in 2010.

Impact of 6,666,667 Common Shares (of which 2,166,666 Common Shares were issued to Formula), atForeign Currency Fluctuations and Inflation.

For a price per share of $3.00 which reflected a premium of approximately 25% above the trading price of our Common Shares (asdiscussion of the impact of inflation and foreign currency fluctuations upon our results, please see the risk factors entitled “Our international operations involve inherent risks, such as foreign currency fluctuations and compliance with various regulatory and tax regimes.” and "We face currency exchange risks, as changes in exchange rates between the US dollar and other currencies, especially the NIS, may negatively impact our costs." in Item 3.D, “Risk Factors,” above.

Effects of Government Regulations and Location on our Business.

For a discussion of the effects of Israeli governmental regulation and our location in Israel on our business, see the “Risks Relating to Our International Operations” in Item 3.D above, and “Israeli Tax Considerations and Government Programs” in Item 10.E below.

B.           Liquidity and Capital Resources.

Our cash and cash equivalents at the end of 2011 were $21.5 million, compared with $16.2 million at the end of 2010. The increase in cash and cash equivalents was due to our profitability in 2011, cash balances of IDIT and FIS at the date of the acquisition thereof on which our BoardAugust 21, 2011, net of Directors approved the investment).

Debenture Issuance, Repayments and Buybacks
A prior source of liquidity for our Company was our offering of convertible debentures on the TASE in December 2003, which provided gross proceeds to us in an approximate amount of $18.6 million (after including approximately $1.5 million of additional debentures that were purchased in March 2004 pursuant to options that were issuedcash payments made as part of the December 2003 closing).FIS acquisition.

Net cash provided by operating activities was $8.4 million in 2011, compared with net cash provided by operating activities of $12.0 million in 2010. The debentures bore interest at an annual ratedecrease was attributable mainly to the increase in trade receivables of 6.0%, payable on the 5th$3.3 million in 2011 compared to a decrease of June$0.3 million in 2010 and the 5thdecrease in trade payables of December each year commencing on June 5, 2004$1.3 million in 2011 compared to an increase of $0.2 million in 2010. Net cash used in investing activities was $2.5 million in 2011, compared with net cash used in investing activities of $7.5 million in 2010. The increase was mainly due to net cash provided by the acquisition of IDIT and ending on December 5, 2009. Principal was payableFIS of $3.7 million in four installments, on2011 compared to net payment of $1.4 million for the 5thacquisition of DecemberHarcase in 2010, an earn-out payment of the years 2006-2009.  Our obligations under the debentures were denominated in NIS but would become linked$1 million with respect to the US dollar if the exchange rate between the NISacquisition of Harcase in 2011 and the US dollar rose above NIS 4.394 per 1 US dollar (on Mar ch 31, 2009, the exchange rate between the NIS and the US dollar was NIS 4.188 per 1 US dollar).

In June 2007, we repurchased an aggregate amountdecrease in capitalized software development cost of NIS 15,000,000 nominal value, representing approximately $3.5$0.7 million of the then outstanding debentures. In January and February 2008, we repurchased an additional aggregate amount of NIS 7,600,000 nominal value, representing approximately $2.1to $4.7 million of the outstanding debentures.
In January 2009, we repurchased an aggregate amount of NIS1,605,799 nominal value, representing approximately $0.4 million, of the outstanding debentures. Pursuant to the terms of the prospectus governing the debentures, the debentures repurchased by us were retired and removedin 2011 from circulation.
In December 2009, we paid the fourth and final annual repayment of the principal of the debentures in the amount of approximately $5.4 million thereby retiring the remaining outstanding debentures
in 2010.

Net cash provided by financing activities was immaterial in both 2010 and 2011.

Outlook

In 2009,2011, we generated positive operating cash flow on an annual basis in the amount of $13.5$5.3 million overall, following upon positive operating cash flow of $ 9.8 million in 2008.overall. Management believes that positive cash flow generated during 20082009, 2010 and 20092011 and our existing cash balances will be sufficient for our present requirements, and at least until December 31, 2010,2012, to support our operating and financing requirements. However, in the event that we make one or more acquisitions for consideration consisting of all or a substantial part of our available cash, we might be required to seek external debt or equity financing for such acquisition or acquisitions or to fund subsequent operations.

29

C.           Research and Development, Patents and Licenses, etc.

See the captions titled "Research and Development, net" insection A. “Operating Results” of this Item 5 above for a description of our R&D policies and amounts expended thereon during the last two fiscal years.

D.           Trend Information

General

Despite the global economic stagnation, low interest rates and persistently high unemployment, according to a recent report from Celent, a research and consulting firm focused on information technology in the global financial services industry, the annual IT spending of insurance companies, including internal IT, hardware, external software and external services, is expected to reach $140.6 billion globally in 2012 and US$157.5 billion by 2014, a 5.8% CAGR from 2012 to 2014. Celent also projects that IT spending in North America will climb to US$58.6 billion in 2014, a CAGR of 7.6% from 2012 to 2014, IT spending in Europe will climb to US$56.4 billion in 2014, a CAGR of 2.2% from 2012 to 2014 and that IT spending in the Asia Pacific region is expected to grow to US$29.6 billion in 2014 a CAGR of 6.1% from 2012. According to Celent, in 2010, insurance IT spending was $130.9 billion, with $48 billion from North America and $52.8 billion from Europe.

IT spending in external software and services, which is the market we address, reached $51 billion in 2011 and Celent projects that it will grow to $63 billion by 2014, representing a CAGR of 7.3%. Celent reports that growth in external software and services is driven both by pure growth in IT spending, but also from shift of IT spending from internal to external providers, like Sapiens. This is due to the move from in-house, home-grown solutions to packaged solutions, as IT departments recognize the value of buying software solutions from specialized vendors, rather than develop internal solutions that are hard to maintain and do not have the advantage the R&D investments at the rate that is invested by outside vendors.

In the insurance industry, premium growth rates increased slowly in 2010 and 2011 due to the ongoing economic and political challenges facing the global economy. According to Celent, projections are indicating a positive trend for 2012 and beyond, which could result in an increase in insurers looking to modernize their IT systems.

The global insurance industry is constantly changingevolving in a number of areas, and insurance carriers require support from their software and their IT service providers to keep up. The primary areas of evolution include:

·Tighter competition
·Tougher regulations
·Customer Sophistication
·Globalization & M&A

With the growing need for insurance, as a result of regulatory changes. Insurance companies must comply with regulations such as the Sarbanes-Oxley Act in the United States, Solvency II in Europepeople accumulate more property and other directives regarding transparency. In addition, many individual countries have increased supervision over local insurance companies.


Globally,live longer, the insurance industry has witnessed cross-border mergersbecome more competitive. The competition for the customer’s business requires the insurers to improve customer experience, be faster to market with new products and acquisitions,offer innovative channels such as social media and the entry of international insurance companies into new emerging markets.

mobile. Innovative technology infrastructure is necessary to support these business initiatives.

In Europe, regulators andaddition, insurers have been very active and creative, motivated by past financial crises and the need for pension restructuring. Distribution of policies is being optimizedare faced with the increasing usesignificance of Bank Assurance (sellingregulatory changes to protect the policyholder in many markets, particularly with respect to large insurers which are considered important to the stability of insurance through a bank’s established distribution channels), supermarkets and kiosks (insurance stands). Nevertheless, European insurers, and to some extent North Americanthe world economic system. Many insurers are cautiously approaching spending increases and most companies have not decided to change their software.


Finally, in recent years there has been constant significant growth in income from annual premiums. The recent financial developments worldwide may reduce insurers' revenues from such premiums, however, thereby reducingintegrating enterprise risk management as a standard operating procedure, while spreading ownership of risk throughout the likelihood that insurers will make additional expenditures to purchase ourstrategic decision-making process.

As the customers become more sophisticated, the support of innovative products and services.


We believe thatdistribution channels is mandatory. Insurers are identifying growth opportunities by attracting new customers and retaining current customers by seeking to reinvent the customer experience and provide quote and policy information to their customers as they request.

Mergers and acquisitions volume among insurance market is changing and the reasons that contributed to the delays we experiencedcompanies increased in penetration of the insurance industry are gradually fading away. However, the recent financial developments worldwide may still cause delays in our growth and expansion


Under current circumstances,  we expect that additional time will be required to fully implement our strategy of focusing on the insurance industry, and that our results of operations and financial condition could continue2011. Transactions tended to be adversely affected, especiallystrategic, with focus on adding new product lines and distribution channels, and expanding geographic reach into emerging markets. With more strategic transaction activity expected in light of2012, there will likely be additional opportunities for IT providers with the recent worldwide economic slowdown. We are addressing the challenges posed by the market environment by focusing our marketing and selling efforts and by further reducing the expenses of our operations.
need to integrate multiple systems.

E.           Off-Balance Sheet Arrangements

During 2009, we entered into hedging transactions, by purchasing put options

We have not engaged in the total amount of $5.8 million (whereby we could exchange such amount of US dollars for NIS), to protect against the devaluation of the US dollar, in the range of NIS 3.80 – 4.00 per Dollar.  As of December 31, 2009, these hedging transactions were settled.

As of December 31, 2009, we are notnor been a party to any material off-balance sheet arrangements.
30

transactions.

F.           Contractual Obligations

The following table sets forth information on our short-term and long-term contractual obligations as at December 31, 20092011 (in thousands of dollars).

 Payments due by period 
 Total Less than 1 year 1 to 3 years 3 to 5 years Over 5 years 
           
Long-term loan  15   15   --   --   -- 
Accrued severance pay  938   --   --   --   938 
Operating leasing  3,328   2,105   1,159   64   -- 
Total $4,281  $2,120  $1,159  $64  $938 

  Payments due by period 
  Total  Less than 1
year
  1 to 3
years
  3 to 5
years
  Over 5
years
 
                
Accrued severance pay, net(1) $539              $539 
Put option liability $303   227   76         
Operating leases $6,643  $2,487  $4,156         
Liability to the OCS(2) $1,591  $1,591             
Total $9,076  $4,305  $4,232       $539 

(1)Accrued severance pay relates to accrued severance obligations mainly to our Israeli employees as required under Israeli labor law.  We are legally required to pay severance upon certain circumstances, primarily upon termination of employment by our company, retirement or death of the respective employee.  Our liability for all of our Israeli employees is fully provided for by monthly deposits with insurance policies and by an accrual.
(2)Does not include contingent liabilities to the OCS of approximately $6.3 million as described in Note 9(a) of our consolidated financial statements contained elsewhere in this report.

As discussed in Note 1110(i) of our consolidated financial statements contained elsewhere in this annual report, as of December 31, 20092011 we had a total liability of $300 thousand$1.6 million for gross unrecognized tax benefits. Due to the uncertainties related to those tax matters, we are currently unable to make a reasonably reliable estimate of when cash settlement with a relevant tax authority will occur.


Directors, Senior Management and Employees

A.           Directors and Senior Management

The following table sets forth certain information regarding the current executive officers and directors of the Company.

Company as of March 15, 2012.

Name Age Position
Guy Bernstein (1) 4244 Chairman of the Board of Directors
Ron Al Dor 4951 President, Chief Executive Officer and Director
Roni Giladi39Chief Financial Officer
Rami Doron52Chief Operating Officer
Naamit Salomon (1) 4648 Director
Yacov Elinav (2) 6567 Director
Uzi Netanel (2) 7476 Director
Eyal Ben Chlouche (2) 4850 Director
United International Trust N.V. (3)   Director
Amit Ben-Yehuda47Director
Roni Giladi41Chief Financial Officer

(1)           Member of Compensation Committee
(2)           Member of Audit Committee

(1)Member of Compensation Committee
(2)Member of Audit Committee
(3)United International Trust N.V. or UIT, is a corporate body organized under the laws of the Netherlands Antilles.Curaçao. Mr. Gregory Elias exercises decision making authority for UIT.  The Articles of Incorporation of the Company provide that a corporate body may be a member of the Board of Directors.

Guy Bernstein has served as a director of the Company since January 1, 2007 and was appointed Chairman of the Board of Directors on November 12, 2009. Mr. Bernstein joinedhas served as the chief executive officer of Formula Systems, our parent company, since January 2008.  From December 2006 to November 2010, Mr. Bernstein served as a director and the chief executive officer of Emblaze Group as Chief Financial Officer and member of the Board of Directors inLtd. or Emblaze, our former controlling shareholder. From April 2004 and was appointed Group Chief Executive Officer into December 2006.2006, Mr. Bernstein served as the chief financial officer of Emblaze. He also served as a director of Emblaze from April 2004 until November 2010. Prior to joining Emblaze, Mr. Bernstein served as Chief Financial and Operations Officer of Magic Software Enterprises Ltd. ("Magic") (NASDAQ: MGIC), a position he held since 1999. He also acted as the Interim CEO for Magic's subsidiaries: MSE Israel Ltd. and Coretech Consulting Group. Mr. Bernstein joined Magic from Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, where he acted as senior manager from 1994 to 1997. Mr. Bernstein also serves as Chief Executive Officer of Formula, Chairman of the Board of Ma gicMagic and Chairman of the Board of Matrix IT Ltd. Mr. Bernstein is a Certified Licensed Public Accountant and holds a BA in Accounting and Economics from Tel Aviv University

31


University.

Roni Al Dor joined the Company as President and Chief Executive Officer in November 2005 and has served as a director of the Company since November 2005. Prior to joining the Company, Mr. Al Dor was one of the two founders of TTI Team Telecom International Ltd. ("TTI"), a global supplier of operations support systems to communications service providers and from August 1996 until 2004, Mr. Al Dor served as President of TTI. Prior to that, Mr. Al Dor served as TTI's Co-President from November 1995 until August 1996 and its Vice President from September 1992 to November 1995. During his service in the Israeli Air Force, Mr. Al Dor worked on projects relating to computerization in aircrafts. Mr. Al Dor is a graduate of the military computer college of the Israeli Air Force, studied computer science and management at Bar Ilan University and atten dedattended the Israel Management Center for Business Administration.


Eyal Ben-Chlouche has served as a director of the Company since August 15, 2008, Mr. Ben-Chlouche served as the Commissioner of Capital Market Insurance and Savings at the Israeli Ministry of Finance from 2002 through 2005, where he was responsible for implementation of fundamental reforms in pension savings. Prior to that, he served as a Deputy Commissioner of Capital Market Insurance and Savings and as a Senior Foreign Exchange and Investment Manager in the Foreign Exchange Department of the Bank of Israel. He also served as an Investment Officer in the Foreign Exchange Department of the Bank of England, in London. Mr. Ben-Chlouche served as Chairman of the Board of Directors of the Shahar Group, Chairman of the Advisory Board of Directors of the Shekel Group until the end of 2007 and serves as a director of Matrix IT Ltd. and Migdal Holdi ngHolding Ltd. Mr. Ben-Chlouche also serves on the Board of Directors of several other private companies. Mr. Ben-Chlouche also serves as Chairman of the Advisory Board of the Caesarea Center for Capital Markets and Risk Management. In 2005, Mr. Ben-Chlouche served as a member of the Bachar Committee on Capital Market Reform in Israel. Mr. Ben-Chlouche is an independent director.


Naamit Salomon has served as a director of the Company since September 2003. She held the position of Chief Financial Officer of Formula from August 1997 until December 2009. Since January 2010 Ms. Salomon has served as a partner in an investment company. Ms. Salomon also serves as a director of Magic Software Enterprises ("Magic") (NASDAQ: MGIC). From 1990 through August 1997, Ms. Salomon was a controller of two large, privately held companies in the Formula Group. Ms. Salomon holds a BA in economics and business administration from Ben Gurion University and an LL.M. from the Bar-Ilan University.

Yacov Elinav has served as a director of the Company since March 2005. For over 30 years, Mr. Elinav served in various positions at Bank Hapoalim B.M., which is listed on the London and Tel Aviv Stock Exchanges, including over 10 years as a member of the Board of Management, responsible for subsidiary and related companies. From 1992 through 2006, Mr. Elinav served as Chairman of the Board of Directors of Diur B.P. Ltd., the real estate subsidiary of Bank Hapoalim. SinceFrom August 2004 until 2009, Mr. Elinav has served as Chairman of the BoardsBoard of Directors of DS Securities and Investments, Ltd. andFrom August 2004 through 2008, Mr. Elinav served as Chairman of the Board of Directors of DS Provident Funds Ltd. and Golden Pages Ltd. Mr. Elinav also serves on the Board of Directors of several other public and private companies. Mr. Elinav is an independent director.


Uzi Netanel has served as a director of the Company since March 2005. He has served as Chairman of the Board of Directors of Maccabi Group Holdings Ltd. since 2005. From 2004 through 2007, Mr. Netanel served as Chairman of the Board of Directors of MLL Software & Computers Industries Ltd. and as Chairman of the Executive Committee of Carmel Olephines. From 2001 through 2003, Mr. Netanel served as a partner in the FIMI Opportunity Fund. From 1993 through 2001, he served as Active Chairman of Israel Discount Capital Markets and Investments Ltd. From 1997 to 1999, Mr. Netanel served as Chairman of Poliziv Plastics Company (1998) Ltd. Mr. Netanel also serves on the Board of Directors of Israel Oil Refineries (alternate director), Carmel Olephines, Gaon Real Estate, The Maman Group, Acme Trading, , Harel-PIA funds, Scope Metals Ltd.(external director) and Oil Refineries Ltd (alternate (external director). Mr. Netanel is an independent director.


United International Trust N.V. ("UIT") is a corporate body organized and existing under the laws of the Netherlands Antilles. It, or one of its predecessor entities, has provided the Company with corporate-related services since April 1990, including serving as the Company's transfer agent and register,registrar, maintaining the corporate-related records of the Company, and filing various corporate documents and the annual corporate tax return with the governmental authorities in the Netherlands Antilles. In January 1, 2007, UIT was established by former shareholders of Intertrust (Curacao) N.V., including Mr. Elias which subsequently operated under the names of MeesPierson Intertrust (Curacao) N.V. and Fortis Intertrust (Curacao) N.V.

32


Between 2005 and June 2009, Mr. Elias acted as a Supervisory Board Member of Banco di Caribe and currently acts as Of Counsel thereto. Mr. Elias also serves as special counsel to the Government of Curaçao, in international finance / tax matters. He holds board positions in several organizations of a social, economic, (e)-commercial and charitable nature. Mr Elias holds two Masters degrees in Law from the University of Amsterdam, the Netherlands.

Amit Ben Yehuda is the Chief Executive Officer and a director of Kardan Communications Ltd. (“Kardan Communications”), a holding company that focuses on communication and media companies, and the Chief Executive Officer and a director of Kardan Technologies Ltd. (“Kardan”), an Israeli company whose ordinary shares are listed on the Tel-Aviv Stock Exchange.  Prior to becoming the Chief Executive Officer of Kardan Communications in January 2006, Mr. Ben-Yehuda served in other capacities for Kardan Communications since October 1999, including as Vice President of Business Development until January 2005 and then as Deputy CEO until January 2006.  Before joining Kardan Communications, Mr. Ben-Yehuda served as the Director of Business Development of Cellcom Israel Ltd., a leading wireless telecommunications operator in Israel, from late 1996 until late 1999.  From 1992 until 1996, Mr. Ben-Yehuda served as a senior advisor to the Israeli Ministry of Tourism and the Israeli Ministry of Interior Affairs. Mr. Ben-Yehuda also serves as a director of RRsat Global Communications Network Ltd., a public Israeli company whose ordinary shares are listed on NASDAQ, and of several privately held companies.  Mr. Ben-Yehuda holds a B.A. in Economics and Political Science and an M.B.A. from Tel-Aviv University. Mr. Ben-Yehuda’s appointment was effected in connection with the acquisition of FIS and IDIT.

Roni Giladi joined the Company as Chief Financial Officer in July 2007. Prior to joining the Company, Mr. Giladi served as the Director of Finance at Emblaze sincefrom January 2007. Prior to joining Emblaze, Mr. Giladi served as Chief Financial Officer of RichFX, from August 2003 until November 2006, after serving as Corporate Controller sincefrom June 2002. Prior to RichFX, Mr. Giladi worked at Ernst & Young Israel, from 1997-2002, as a manager in the high-tech practice group. SinceFrom July 2007 until July 2010, Mr. Giladi has served as a director of MediRisk Solutions Ltd., as the nominee of the Company. Mr. Giladi is Certified Licensed Public Accountant and holds a BA in Business Management and Accounting from the College of Management in Israel.


Rami Doron joined the Company as Chief Operating Officer in February 2007. Prior to joining the Company, Mr. Doron led a business unit at Comverse Ltd. from January 2006 until February 2007. Prior to that, Mr. Doron was one of the founders of TTI where he led the professional services, R&D and existing customers’ sales units from December 1993 until May 2005. At TTI, Mr. Doron was involved in defining and building support systems, and was responsible for delivering, maintaining and enlarging the business with worldwide customers. Prior to founding TTI, Mr. Doron led the software division at TEAM Computers Ltd. (“TEAM”) from October 1985 until December 1993, where he was responsible for supporting a large customer base in Israel with TEAM’s R&D and system support. Mr. Doron also has a software development background, havi ng served as a database expert for several years. During his service in the Israeli Air Force, Mr. Doron was an electronics officer for six years. Mr. Doron is a graduate of Hadassah College with a degree in Software Engineering and he studied management at Bar-Ilan University.

The Board of Directors must have a minimum of three, and may have a maximum of 24, directors. Directors of the Company are appointed by our General Meeting of Shareholders and hold office until the expiration of the term of their appointment by our General Meeting of Shareholders, or until they resign or are suspended or dismissed by the General Meeting of Shareholders. The Board of Directors may appoint up to four directors in addition to the directors elected by the General Meeting of Shareholders, subject to the maximum number of directors permitted, and any such appointment shall be effective until the next General Meeting of Shareholders. The Board of Directors may fill any vacancies on the Board of Directors, whether as a result of the resignation or dismissal of a director, or as a result of a decision of the Board of Directors to expand the Boa rdBoard of Directors.

Our executive officers are appointed by, and serve at the discretion of, our Board of Directors.

Our Chairman, Guy Bernstein, serves as an executive officerthe Chief Executive Officer of Emblaze, and Formula. In addition, Ms. Salomon, another Board member of ours, who served as an executive officer of Formula until December 2009, is a member of the Board of Directors of our affiliate Magic Software Enterprises Ltd., an affiliate of ours. Formula directly owns (as of AprilMarch 1, 2009)2012) approximately 70%52.1% of our currently outstanding Common Shares, and, since November 2006, Emblaze2010, Asseco holds a controlling interest in Formula (49.19%(51.7% of the outstanding share capital of Formula as of AprilMarch 1, 2010)2012). Based on public disclosure made by Formula, Formula has entered into an agreement with Kardan, which agreement, as amended, provides that as long as Kardan holds, directly or indirectly, at least 9% of our issued and outstanding share capital, Formula will vote in favor of Kardan's nominee to our board of directors, provided that, at Formula's request, such appointee will resign from our board of directors, which resignation is conditioned upon such Kardan appointee being appointed as an observer to our board. Other than as described immediately above, there are no arrangements or understandings with major shareholders, customers, suppliers or others pursuant to which any of our directors or members of senior management were selected as such. In addition, there are no family relationships among our executive officers or directors

B.           Compensation of Directors and Officers
directors.

B.Compensation of Directors and Officers

The aggregate amount of compensation paid by us, or accrued by us, during the fiscal year ended December 31, 20092011 with respect to such year, to all directors and executive officers as a group for services in all capacities was $1,470,000.$1.1 million. This amount does not include amounts expended by us for automobiles made available to itsour officers or expenses (including business travel and professional and business association dues) reimbursed to such officers. The aggregate amount set aside or accrued by us during our fiscal year ended December 31, 20092011 to provide pension, retirement severance, vacation accrual and similar benefits for directors and executive officers of the Company was $112,000.$75,000. The foregoing amounts also exclude stock option grants to our directors and officers pursuant to our 1992 Stock Option and Incentive Plan, our 2003 Share Option Plan, and our 2005 Special Incentive Share Option Plan and our 2011 Share Incentive Plan, which are described below.

We have employment agreements with our officers. We, in the ordinary course of our business, enter into confidentiality agreements with our personnel and have entered into non-competition and confidentiality agreements with our officers and high-level technical personnel. We do not maintain key person life insurance on any of our executive officers.

33

Board Fees and Expenses

We reimburse all members of our Board of Directors for reasonable out-of-pocket expenses incurred in connection with their attendance at Board of Directors or committee meetings.

We grant to each of our independent directors a fee for attending or participating in Board of Directors meetings and committee meetings, and participating in unanimous written consents.

We pay the fees to our independent directors according to the rates paid to outside directors under the Israeli Companies Law 5759-1999, even though we are not an Israeli company and are not subject to the Israeli Companies Law (as we deem the standards of such body of law relevant to a company such as ours that has a substantial percentage of Israeli operations and Israeli employees).

In 2005, we granted to two of our independent directors options to purchase 4,000 Common Shares annually. The options were granted at an exercise price equal to the fair market value of the Company’s Common Shares on the date of grant. The term of the options was set at 10 years and the options become exercisable in four equal, annual installments, beginning with the first anniversary of the grant date.

We pay the fees

In 2010, we granted to three of our independent directors accordingand another director options to purchase 15,000 Common Shares each. The options were granted at an exercise price equal to the rates paid to outside directors underfair market value of the Israeli Companies Law 5759-1999, even though we are not an Israeli companyCompany’s Common Shares on the date of grant. The term of the options was 6 years and are not subject to the Israeli Companies Law (as we deemoptions become exercisable in four equal, annual installments, beginning with the standardsfirst anniversary of such body of law relevant to a company such as ours that has a substantial percentage of Israeli operations and Israeli employees.

the grant date.

Stock Option and Incentive Plans

1992 Stock Option and Incentive Plan and 2003 Share Option Plan

In 1992, our Board of Directors and shareholders approved the 1992 Stock Option and Incentive Plan (the “1992 Stock Plan”) pursuant to which our officers, directors and employees are eligible to receive awards of stock options and restricted stock. In February 2003, the Board of Directors authorized the extension of the 1992 Stock Plan until April 2012 and our shareholders approved that extension. In 2003, our Board of Directors and shareholders approved the 2003 Share Option Plan (the “2003 Option Plan”), pursuant to which our officers, directors, employees, consultants and contractors are eligible to receive awards of stock options. In the following description, the 1992 Stock Plan and 2003 Option Plan will be referred to together as the “Incentive“Prior Incentive Plans” and each may each be referred to individually as an “Incent ivea “Prior Incentive Plan.”

Options granted under the 1992 Stock Plan may be “incentive stock options” (“ISOs”), within the meaning of section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or non-qualified stock options (“non-Qualified Stock Options”). Restricted stock may be granted in addition to or in lieu of any other award granted under the 1992 Stock Plan. Option grants under the 2003 Option Plan are intended to comply with, and benefit from, applicable tax laws and regulations in Israel.

Each of the Prior Incentive Plans is administered by the Compensation Committee of our Board of Directors (the “Committee”). Subject to the provisions of each Incentive Plan, the Committee determines the type of award, when and to whom awards will be granted and the number of shares covered by each award. The Committee also determines the terms, provisions, and kind of consideration payable (if any), with respect to awards. The Committee has discretionary authority to interpret the Incentive Plans and to adopt rules and regulations related thereto. In determining the persons to whom awards shall be granted and the number of shares covered by each award, the Committee takes into account the contribution to the management, growth and/or profitability of the business of the Company by the respective person spersons and such factors as the Committee shall deem relevant, including the length of employment of the respective persons, the nature of their responsibilities to the Company, and their flexibility with regard to location of their employment and other employment-related factors.

An option may be granted on such terms and conditions as the Committee may approve, and generally may be exercised for a period of up to 10 years from the date of grant. In 2008, certain grants were limited to an exercise period of 6 years. Options granted under the Prior Incentive Plans become exercisable in four equal, annual installments, beginning with the first anniversary of the date of the grant, or pursuant to such other schedule as the Committee may provide in the option agreement. The exercise price of such options generally will be not less than 100% of the fair market value per share of the Common Shares at the date of the grant. In the case of ISOs, certain limitations will apply with respect to the aggregate value of option shares which can become exercisable for the first time during any one calendar year, and certain additional limitations will apply to “Ten Percent Stockholders” (as defined in the 1992 Stock Plan). The Committee may provide for the payment of the option price in cash, by delivery of other Common Shares having a fair market value equal to such option exercise price, by a combination thereof or by any method in accordance with the terms of the option agreements. The Incentive Plans contain special rules governing the time of exercise of options in the case of death, disability, or other termination of employment. Options are not transferable except by will or pursuant to applicable laws of descent and distribution upon death of the employee.

34

The 1992 Stock Plan also provides for the granting of restricted stock awards, which are awards of Common Shares that may not be disposed of, except by will or the laws of descent and distribution, for such period as the Committee determines (the “restricted period”). The Committee may also impose such other conditions and restrictions on the shares as it deems appropriate, including the satisfaction of performance criteria. The Committee may provide that such restrictions will lapse with respect to specified percentages of the awarded shares on successive anniversaries of the date of the award. During the restricted period, the grantee is entitled to receive dividends with respect to, and to vote the shares awarded to him or her. If, during the restricted period, the grantee’s continuous employment wi thwith the Company terminates for any reason, any shares remaining subject to restrictions will be forfeited. The Committee has the authority to cancel any or all outstanding restrictions prior to the end of the restricted period, including cancellation of restrictions in connection with certain types of termination of employment.

As of December 31, 2009, we had 1,365,204 Common Shares available for future issuance of awards under the Incentive Plans. As of December 31, 2009,2011, options to purchase 2,306,9631,600,159 Common Shares, 1,661,867447,569 of which were held by officers and directors, were outstanding.outstanding under the Prior Incentive Plans. As of that date, there were 22,2806,800 shares of restricted stock that the Company had granted to employees and other eligible grantees (none of which were held by current or former officers and directors), and all of which had vested (prior to 1998) under the restricted stock awards.

During 2007, under the Incentive Plans, we granted to our directors and executive officers a total of 350,000 options to purchase Common Shares (including 200,000 options to the Company's President and Chief Executive Officer) at exercise prices per Common Share ranging between $1.50 and $2.31, which options will expire at the conclusion of ten years. A portion of such options were re-priced. See "Re-pricing of Options" below.
During 2008, under the Incentive Plans, we granted to our directors and executive officers a total of 65,000 options to purchase Common Shares at an exercise price of $1.50 per Common Share, which options will expire at the conclusion of six years.

During 2009, under the Prior Incentive Plans, we granted to our directors and executive officers a total of 57,892 options to purchase Common Shares at an exercise price of $1.50 per Common Share, which options will expirehave a term of six years.

During 2010, under the Prior Incentive Plans, we granted to our directors and executive officers a total of 110,000 options to purchase Common Shares at the conclusionan exercise price of 6$1.60 per Common Share, as applicable, which options have a term of six years.

New Incentive Stock Option Plan

In 2005, our Board of Directors authorized a new Incentive Stock Option Plan (the “Special Plan”) and our shareholders approved the Special Plan in 2006. The number of Common Shares available for grants pursuant to the Special Plan was set at 2,000,000 shares. The Special Plan is intended to be used solely to attract or retain senior management and/or members of the Board of Directors. Unless otherwise determined by the Committee, options granted pursuant to the Special Plan have an exercise price of $3.00 per share,share. In addition, shares issued upon exercise are locked up for up to five years following the grant date, and the right to obtain shares is contingent upon the optionee providing services to the Company throughout the entire five year period. In the event of a change of control of the Company, any unvested options will be accelerated.

The Special Plan is administered by the Committee. Subject to the provisions of the Special Plan, the Committee determines the type of award, when and to whom awards will be granted and the number of shares covered by each award. The Committee also determines the terms and provisions with respect to awards. The Committee has discretionary authority to interpret the Special Plan and to adopt rules and regulations related thereto.

35

Pursuant to the Special Plan, in November 2005, the Company’s President and Chief Executive Officer was granted options to purchase 1,000,000 Common Shares at an exercise price of $3.00 per share.  In December 2005, we accelerated the vesting of all 1,000,000 options.  In 2007, the Company’s Chief Operating Officer was granted options to purchase 250,000 Common Shares, pursuant to the Special Plan at an exercise price of $3.00 per share. During 2009, all the outstanding options under the Special Plan were re-priced, See "Re-pricing of Options" below. Following the re-pricing, as

During 2010 we granted to our directors and executive officers a total of December 31, 2009 the President and the Chief Operating Officer had100,000 options to purchase 715,849 and 210,021 Common Shares respectively, at an exercise price of $1.50$1.60 per Common Share, as applicable, which options have a term of six years. As of December 31, 2011, options to purchase 1,245,298 Common Shares, 1,035,277 of which were held by our directors and executive officers, were outstanding under the Special Plan.

Upon the approval of our 2011 Share Incentive Plan, which is described below, our board of directors determined that no further awards would be issued under the Prior Incentive Plans and the Special Plan.

2011 Share Incentive Plan

In 2011, in connection with the acquisition of IDIT and FIS, our board of directors approved our 2011 Share Incentive Plan (the “2011 Plan”) pursuant to which our employees, directors, officers, consultants, advisors, suppliers, business partner, customer and any other person or entity whose services are considered valuable are eligible to receive awards of share options, restricted shares, restricted share units and other share-based awards The number of Common Shares available under the 2011 Plan was set at 4,000,000.

Options granted under the 2011 Plan may be “incentive stock options” (“ISOs”), within the meaning of section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or non-qualified stock options (“non-Qualified Stock Options”). Restricted shares may be granted in addition to or in lieu of any other award granted under the 2011 Plan. In addition, the Company may grant restricted share units and other share-based compensation. Option grants under the 2011 Plan are intended to comply with, and benefit from, applicable tax laws and regulations in Israel to the extent applicable the recipient of the grant.

The 2011 Plan is administered by the Committee. Subject to the provisions of the 2011 Plan, the Committee determines the type of award, when and to whom awards will be granted and the number of shares covered by each award. The Committee also determines the terms, provisions, and kind of consideration payable (if any), with respect to awards. The Committee has discretionary authority to interpret the 2011 Plan and to adopt rules and regulations related thereto. In determining the persons to whom awards shall be granted and the number of shares covered by each award, the Committee takes into account their present and potential contributions to the success of the Company and such other factors as the Committee shall deem relevant in connection with accomplishing the purpose of the 2011 Plan.

An option may be granted on such terms and conditions as the Committee may approve, and generally may be exercised for a period of up to 6 years from the date of grant. Options granted under the 2011 Plan become exercisable in four equal, annual installments, beginning with the first anniversary of the date of the grant, or pursuant to such other schedule as the Committee may provide in the option agreement. The exercise price of such options generally will be not less than 100% of the fair market value per share of the Common Shares at the date of the grant. In the case of ISOs, certain limitations will apply with respect to the aggregate value of option shares which can become exercisable for the first time during any one calendar year, and certain additional limitations will apply to “Ten Percent Shareholders” (as defined in the 2011 Plan). The Committee may provide for the payment of the option price in cash, by delivery of other Common Shares having a fair market value equal to such option exercise price, by a combination thereof or by any method in accordance with the terms of the option agreements. The Incentive Plans contain special rules governing the time of exercise of options in the case of death, disability, or other termination of employment. Options are not transferable except by will or pursuant to applicable laws of descent and distribution upon death of the employee, unless otherwise approved by the Company’s Board of Directors.

The 2011 Plan also provides for the granting of restricted share awards, which are awards of Common Shares that may not be disposed of, except by will or the laws of descent and distribution, for such period as the Committee determines (the “restricted period”). The Committee may also impose such other conditions (a kick-in featureand restrictions on the shares as it deems appropriate, including the satisfaction of performance criteria. The Committee may provide that such restrictions will lapse with respect to specified percentages of the awarded shares on successive anniversaries of the date of the award. During the restricted period, the grantee is entitled to receive dividends with respect to, and to vote the shares awarded to him or her. If, during the restricted period, the grantee’s continuous employment with the Company terminates for any reason, any shares remaining subject to restrictions will be forfeited. The Committee has the authority to cancel any or all outstanding restrictions prior to the end of the restricted period, including cancellation of restrictions in connection with certain types of termination of employment.

The 2011 Plan also provides for the granting of restricted share units, which are awards that are settled by the issuance of a $2.10 market price).

number of Common Shares. The grantee has no rights with respect to such Common Shares until they are actually issued to the grantee. The Committee may also grant other share-based awards, such as share appreciation rights.

Upon the consummation of the acquisition of IDIT and FIS, 1,938,844 share options with a weighted average exercise price of $2.09 were issued under the 2011 Plan to former employees of IDIT and FIS in exchange for the share options which had been granted to them by IDIT and FIS, which were cancelled upon the closing of the acquisition.

During 2011 we granted to the Company’s directors and officers options to purchase 300,000 Common Shares, at an exercise price of $3.00 per Common Share, which options have a term of six years.

As of December 31, 2011, options to purchase 2,369,689 Common Shares, 300,000 of which were held by our directors and officers, were outstanding under the 2011 Plan. As of December 31, 2011, 1,581,927 shares were available for future grant under the 2011 Plan.

Re-pricing of Options

During 2009, our Board of Directors approved the re-pricing of options outstanding under the Incentive Plans and Special Plan. As a result of the re-pricing 1,985,650 stock options at an exercise price range of $1.74 to $5.30 were re-priced to 1,554,627 stock options at an exercise price of $1.50 per share (925,870 stock options of the 1,554,627 stock options are at market conditions (a kick-in feature of a $2.10 market price). In addition, the expiration of the exercise period for all remaining outstanding options was reduced to no later than September 2015.

C.           Board Practices

C.Board Practices

Members of the Company’s Board of Directors are elected by a vote at the annual general meeting of shareholders and serve for a term of one year.year from the date of the prior year's annual meeting. Directors may serve multiple terms and are elected by a majority of the votes cast at the meeting. The Chief Executive Officer serves until his removal by the Board of Directors or resignation from office. Our non-employee directors do not have agreements with the Company for benefits upon termination of their service as directors.

Audit Committee

The Audit Committee of our Board of Directors is comprised of three independent directors (such independence determination having been made by our Board of Directors, in accordance with the NASDAQ Listing Rules), who were nominated by the Board of Directors: Yacov Elinav, Uzi Netanel and Eyal Ben Chlouche. The Board of Directors has determined that Mr. Elinav meets the definition of an audit committee financial expert (as defined in Item 16A (b) of Form 20-F promulgated by the SEC). The primary function of the Audit Committee is to assist the Board of Directors in fulfilling its oversight responsibilities by reviewing financial information, internal controls and the audit process. In addition, the Committee is responsible for oversight of the work of our independent auditors. The Committee is governed by a charter and meets at regularly sche duledscheduled quarterly meetings.

Compensation Committee

The Compensation Committee of our Board of Directors is comprised of two directors, nominated by the Board of Directors: Naamit Salomon and Guy Bernstein. The primary function of the Compensation Committee is to manage the Company’s Stock Option Plan and review and approve all matters relatingmake recommendations to the board of directors with respect to the grant of options to our employees and other compensation ofmatter as requested by the Company���s officers and directors. The Committee is governed by a charter and meets at regularly scheduled quarterly meetings.

Board from time to time.

NASDAQ Exemptions for a Controlled Company

We are a controlled company within the meaning of NASDAQ Listing Rule 5615(c)(1) since Formula holds more than 50% of our voting power.

36

Under Rule 5615(c)(2), a controlled company is exempt from the following requirements of NASDAQ Listing Rules 5605(b), (d) and (e) (we rely upon such exemption with respect to each of the requirements described below):

listed below:

·
The majority of the company’s board of directors must qualify as independent directors, as defined under NASDAQ Listing Rule 5605(a)(2).

·
The compensation of the chief executive officer and all other executive officers must be determined, or recommended to the board of directors for determination, either by (i) a majority of the independent directors or (ii) a compensation committee comprised solely of independent directors (subject to limited exceptions).

·
Director nominees must either be selected or recommended for the board of directors’ selection, either by (a) a majority of independent directors or (b) a nominations committee comprised solely of independent directors (subject to limited exceptions).

·
The company must certify that it has adopted a formal written charter or board resolution, as applicable, addressing the nominations process and such related matters as may be required under US federal securities laws.

NASDAQ ExemptionOpt Out for a Foreign Private Issuer

We are a foreign private issuer within the meaning of NASDAQ Listing Rule 5000(a)5005(a)(18), since we are incorporated ingoverned by the Netherlands Antilleslaws of Curaçao and we meet the other criteria set forth for a "foreign private issuer" under Rule 3b-4(c) under the Exchange Act.

Pursuant to NASDAQ Listing Rule 5615(a)(3), a foreign private issuer may follow home country practice in lieu of certain provisions of the NASDAQ Listing Rule 5600 series and certain other NASDAQ Listing Rules. Please see Item 16G below ("Corporate Governance") for a description of the manner in which we rely upon home country practice in lieu of NASDAQ listing requirements.

D.           Employees
Listing Rules. We rely on home country practice with respect to a number of matters for which we would otherwise be exempt under the controlled company exemption described above under "NASDAQ Exemptions for a Controlled Company"

D.Employees

As of December 31, 2009,2011, we had a total of 295688 employees, a 4.2%91% increase from the end of 2008.

2010.

The following table sets forth the number of employees in (1) research and development, (2) consulting, delivery and technical support and (3) SG&A at the end of each of the past three years, as well as their geographic area of employment:

  Total Employees  Research & Development  Consulting, Delivery & Technical Support  SG&A 
2009  295   66   193   36 
2008  283   56   186   41 
2007  302   48   207   47 

Geographic Area  Total Number of Employees, in All Categories of Activities 
   2009  2008  2007 
Israel   214   202   199 
United States   18   21   36 
United Kingdom   37   34   37 
Japan   23   23   23 
France   3   3   5 
Germany   0   0   1 
Switzerland   0   0   1 
Total Employees   295   283   302 
37

  Total Employees  Research &
Development
  Consulting,
Delivery &
Technical
Support
  SG&A 
2011  688   162   435   91 
2010  361   80   230   51 
2009  295   66   193   36 

Geographic Area Total Number of Employees, in All Categories of
Activities
 
  2009  2010  2011 
Israel  214   254   464 
UK and Europe  40   39   116 
North America  18   45   71 
Asia Pacific  23   23   37 
Europe  3   2   10 
Total Employees  295   361   688 

E.Share Ownership

The number of our Common Shares beneficially owned by each of our directors and executive officers individually, and by our directors and executive officers as a group, as of AprilMarch 1, 2010,2012, is as follows:

  Shares Beneficially Owned 
  Number  
Percent (1)
 
       
Roni Al Dor  1,061,613(2)  4.68%
         
All directors and executive officers        
as a group (9 persons,        
including Roni Al Dor)(3)  1,288,961(4)  5.63%

  Shares Beneficially Owned 
  Number  Percent (1) 
       
Roni Al Dor  1,174,781(2)  2.9%
         
All directors and executive officers as a group (7 persons, including Roni Al Dor)(3)  1,367,123   3.3%

(1)Unless otherwise indicated below, the persons in the above table have sole voting and investment power with respect to all shares shown as beneficially owned by them. The percentages shown are based on 21,602,46039,701,784 Common Shares outstanding as of AprilMarch 1, 20102012 plus such number of Common Shares as the indicated person or group had the right to receive upon the conversion of our debentures and upon the exercise of options which are exercisable within 60 days of AprilMarch 1, 2010.2012.
(2)Includes options to purchase 345,764189,504 Common Shares under the Prior Incentive Plans at an exercise price of $1.5$1.50 per share expiring no later than September 2015, and options to purchase 715,849935,277 Common Shares under the Special Plan at an exercise price of $1.5$1.50 per share expiring no later than September 2015.2015 and options to purchase 50,000 Common Shares under the Incentive Plans at an exercise price of $1.60 per share expiring no later than March 2016, which are vested or will become vested within 60 days of March 1, 2012. In additional Mr. Al Dor has options to purchase 350,000 Common Shares with exercise prices between $1.50 and $3.00 per share which are not vested or becoming vested within 60 days of March 1, 2012). See Item 6, “Directors, Senior Management and Employees - Compensation of Directors and Officers.

(3)Each of our directors and executive officers who is not separately identified in the above table beneficially owns less than 1% of our outstanding Common Shares (including options held by each such party and which are vested or will become vested within 60 days of AprilMarch 1, 2010)2012) and has therefore not been separately identified.

(4)TheIncludes options held by the directors and executive officers not separately identified in the above table haveto purchase 1,367,123 Common Shares at exercise prices ranging from $1.05$1.50 to $2.24 per share, which are vested or will become vested within 60 days of March 1, 2012, and none of such options expires before 2015.

Item 7.  Major Shareholders and Related Party Transactions

MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONSA.Major Shareholders.
A.           Major Shareholders.

The following table sets forth, as of AprilMarch 1, 2010,2012, certain information with respect to the beneficial ownership of the Company’s Common Shares by each person known by the Company to own beneficially more than 5% of the outstanding Common Shares, based on information provided to us by the holders or disclosed in public filings with the Securities and Exchange Commission.

We determine beneficial ownership of shares under the rules of Form 20-F promulgated by the SEC and include any Common Shares over which a person possesses sole or shared voting or investment power, or the right to receive the economic benefit of ownership, or for which a person has the right to acquire any such beneficial ownership at any time within 60 days.

  Shares Beneficially Owned 
Name and Address Number  
Percent (1)
 
Formula Systems (1985) Ltd. (2)
3 Abba Eban Boulevard
Herzlia 46725, Israel
  15,206,426   70 
38

(1)          

  Shares Beneficially Owned 
Name and Address Number  Percent (1) 
Formula Systems (1985) Ltd. (2)
5 HaPlada Street
Or Yehuda 60218, Israel
  20,650,035   52.1%
Kardan Technologies Ltd. (3)
154 Menachem Begin Street
Tel Aviv 64921, Israel
  5,409,793   13.7%

Unless otherwise indicated below, the persons in the above table have sole voting and investment power with respect to all shares shown as beneficially owned by them.

(2)(1)The percentages shown are based on 21,602,46039,701,784 Common Shares outstanding as of April1, 2010.March 1, 2012.
(3)           As of April 1, 2010, Emblaze beneficially owns 49.19% of the outstanding share capital of Formula. As such, Emblaze may be deemed to be the beneficial owner of the aggregate 15,206,426 Common Shares held directly by Formula Systems Ltd.  The address of Emblaze is 1 Emblaze Square, P.O.Box 2220, Industrial Park Ra'anana 43662, Israel.

(2)As of March 1, 2012, Asseco beneficially owns 50.2% of the outstanding share capital of Formula. As such, Asseco is deemed to be the beneficial owner of the aggregate 20,650,035 Common Shares held directly by Formula. The address of Asseco is Olchowa 14 35-322 Rzeszow, Poland.

(3)Based on Amendment No. 4. to Schedule 13D filed by Kardan and certain other parties on February 2, 2012, Kardan directly beneficially owns 4,656,168 Common Shares. Kardan Technologies is the limited partner of Formula Vision LP (“FVLP”) and owns 49% of the shares of Formula Vision GP (“FVGP”). By reason of its ability to influence the control of FVLP and FVGP, Kardan may be deemed to indirectly beneficially own, and share the power to vote and dispose of, 753,625 Common Shares directly beneficially owned by FVLP. Kardan Israel Ltd. (“Kardan Israel”) owns 84.94% of the shares of Kardan and Kardan Yazamut (2011) Ltd. (“Kardan Yazamut”) owns 73.67% of Kardan Israel. By reason of Kardan Israel’s ability to influence the control of Kardan and by Kardan Yazamut’s ability to influence the control of Kardan Israel, each of Kardan Israel and Kardan Yazamut may be deemed to indirectly beneficially own, and share the power to vote and dispose of, (i) the 4,656,168 Common Shares directly beneficially owned by Kardan and (ii) the 753,625 Common Shares directly beneficially owned by FVLP. Each of Kardan, Kardan Israel and Kardan Yazamut disclaims beneficial ownership of the Common Shares other than the 4,656,168 Common Shares directly beneficially owned by Kardan. The address of Kardan is 154 Menachem Begin Street, Tel Aviv 64921, Israel.

Significant changes in holdings of major shareholders

1.Formula
In June 2007, we entered into a private placement investment transaction (the "June 2007 Private Placement") with several institutional investors, private investors and Formula (which was then a holder of approximately 60% of our outstanding Common Shares) for an aggregate gross investment amount of $20 million (excluding finders' fees and out of pocket expenses), $6.5 million of which was invested by Formula.  As a result, we issued to Formula 2,166,666 Common Shares, at a price per share of $3.00 which reflected a premium of approximately 25% above the trading price of our Common Shares (as of the date our Board of Directors approved the investment).

From time to time, following the June 2007 Private Placement, Formula has increased its beneficial shareholding in theour Company through market purchases of additional Common Shares. From October 2007JJanuary 2010 through June 2008,July 10, 2011, Formula increased its holding of our Common Shares by approximately 914,8581,198,431 additional Common Shares through purchases on the public market.market and in private transactions. See the Schedule 13D/As filed by Formula with the SEC on July 26, 2010, June 14, 2011and July 13, 2011 with respect to such purchases. On August 21, 2011, KCPS Technology Investments (2006) Ltd. acquired 3,759,806 Common Shares in connection with our acquisition of IDIT and FIS. See the Schedule 13G filed by KCPS Technology Investments (2006) Ltd. with the SEC on July 25, 2011 with respect to such acquisition. On August 21, 2011, Kardan acquired shared beneficial ownership of 7,536,243 Common Shares and Formula Vision Technologies (F.V.T.) Ltd. (“FVT”) and Dan Goldstein acquired shared beneficial ownership of 9,638,337 Common Shares. See the Schedule 13D filed by Kardan and other parties with the SEC on July 29, 2011 with respect to such acquisition. Between July 11, 2011 through August 25, 2011, Formula purchased 356,555 Common Shares in private transactions. See the Schedule 13D/As filed by Formula with the SEC on August 18, 2011 and August 25, 2011 with respect to such purchases. Between September 28, 2011 and November 14, 2011, Formula purchased 1,891,885 Common Shares from FVT. See the Schedule 13D/As filed by Formula with the SEC on October 4, 2011 and November 22, 2011 with respect to such purchases. From December 28, 2011 through January 29, 2012, Formula purchased an aggregate of 2,005,738 Common Shares in private transactions. Of such Common Shares, 1,600,000 were purchased from FVT and Kardan. See the Schedule 13D/A filed by Formula with the SEC on June 12, 2008January 31, 2012 with respect to such purchases. From June 2008 through August 2008, Formula increased its holding of our Common Shares by approximately 2,201,010 additional Common Shares through purchases on the public market. See the Schedule 13D/A filed by Formula with the SEC on September 2, 2008 with respect to such purchases.  From September 2008 through November 2008, Formula increased its holding of our Common Shares by approximately 409,576 additional Common Shares through purchases on the public market. See the Schedule 13D/A filed by Formula with the SEC on December 11, 2008 with respect to such purchases.

54
As of April 1, 2010, Formula was the holder of approximately 70% of our outstanding Common Shares.
2.           Highbridge International LLC
Pursuant to the June 2007 Private Placement, Highbridge International LLC invested $6.5 million in the Company in return for the issuance of 2,166,667 Common Shares, which equaled 10.5% of our outstanding Common Shares at the time.
As of December 31, 2008, Highbridge International LLC no longer beneficially owns any of our outstanding Common Shares

Voting rights of major shareholders

The major shareholders disclosed above do not have different voting rights than other shareholders with respect to the Common Shares that they hold.

Holders of Record

As April 21, 2010March 1, 2012 there were 75100 holders of record of the Company’s Common Shares, including 50 holders of record with addresses in the United States who hold a total of 11,914,81946,057 Common Shares, representing approximately 54%49% of our issued and outstanding Common Shares.  The number of record holders in the United States is not representative of the number of beneficial holders, nor is it representative of where such beneficial holders are resident, because many of these Common Shares were held of record by nominees (including CEDE &Co.& Co., as nominee for a large number of banks, brokers, institutions and underlying beneficial holders of our Common Shares). In particular, based on our inquiry, we are aware that many of the Common Shares that are beneficially held by Formula, a non-U.S. resident that holds approximately 7 0% of our outstanding Common Shares, are held of record via nominees located in the United States.  

39

Control of the Company

Based on Formula’s beneficial holding of over 50% of the outstanding Common Shares of the Company, and based on Emblaze’sAsseco's beneficial holding of 49.19%51.7% of the outstanding share capital of Formula, both Formula and EmblazeAsseco may be considered to control the Company. We are unaware of any arrangements the operation of which may at a subsequent date result in a change of control of the Company.

B.           Related Party Transactions.
None.
C.           Interests

B.Related Party Transactions.

On August 21, 2011, in connection with the consummation of Expertsthe acquisition of IDIT and Counsel.

FIS, we entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with Formula and Kardan and other former shareholders of IDIT and FIS (collectively, the “Holders”). Pursuant to the Registration Rights Agreement, the Holders are entitled to piggyback registration rights in connection with any registration statement we file (subject to customary exceptions). In addition, if the registration statement is for an underwritten offering and the number of Common Shares to be included in the offering is insufficient to permit the inclusion of all Common Shares which are considered registrable securities under the Registration Rights Agreement, Formula (and any of its affiliates) will be entitled to include Common Shares of up to 25% of such registrable securities participating in the offering. The Holders also agreed to execute a lock-up agreement if requested by the representative of the underwriters in any underwritten offering.

C.Interests of Experts and Counsel.

Not applicable.

Item 8.   Financial Information

FINANCIAL INFORMATIONA.Consolidated Statements and Other Financial Information.
A.           Consolidated Statements and Other Financial Information.

Financial Statements

See the Consolidated Financial Statements and related notes in Item 18.

Export Sales

In 2009, 67.3%2011, 69% of our revenues originated from customers located outside of Israel. For information on our revenues breakdown by geographic market for the past three years, see Item 4, “Information on the Company – Business Overview - Geographical Distribution of Revenues.”

Legal Proceedings

In February 2008,July 2010, one of our subsidiaries, Sapiens Americas, was served with a claim submitted to the Court of Arbitration at the Polish Chamber of Commerce in Warsaw by Powszechny Zaklad Ubezpieczen SA ("PZU"), a former employeecustomer in Poland, claiming an amount of ours filedapproximately €3.4 million. The claim relates to a claim against usdispute regarding Sapiens Americas' performance of its contractual duties in a project for PZU in 2008.

In November 2011, we entered into a settlement agreement with PZU, pursuant to which Sapiens paid PZU Euro 1.1 million and PLN 102,719.73 for full and final settlement of the claim. On December 12, 2011, the Court of Arbitration approved the settlement agreement and withdrawal of the claim. We received an amount that such former employee was required to pay to the Israel Tax Authorities approximately NIS 4.5 million (approximatelyof $1.2 million as of December 31, 2009)-as a result of his exercise of stock options. We believe that such claim lacks merit, and we believe, based on the advice of its legal counsel, that we have a reasonable defense.

from our insurance company in connection with this case.

In addition, we are a party to various other legal proceedings and claims that arise in the ordinary course of business. The total aggregate amount of exposure of such proceedings and claims, except for the above mentioned claim, is approximately $0.2 million.

We have made provision in our financial statements for an amount which we believe is sufficient to cover damages, if any, which may result from these claims.
Dispute with the Office of Chief Scientist
In June 2009, the Chief Scientist of the Israeli Ministry of Industry and Trade (“OCS”) imposed a lien in the amount of approximately NIS13 million (approximately $3.3 million) on certain of our bank accounts in connection with a historic dispute between us and the OCS concerning royalty payments which the OCS claimed is owing to the OCS in connection with past grants received by us from the OCS.
In September 2009, we signed a settlement agreement with the OCS pursuant to which we agreed to pay  the OCS an interim amount of NIS 6 million (approximately $1.6 million) in installments (of which an amount of NIS 2 million, approximately $0.5 million, was paid subsequent to balance sheet date). In addition, we are undergoing a technological review by the OCS based on the results of which, the amount owing to the OCS will be finally determined. As part of the settlement, the liens imposed by the OCS were removed. The interim payment is covered by an existing provision in our financial statements.
40

Dividend Policy

We have never declared or paid any cash dividends on our Common Shares and we do not anticipate paying cash dividends in the foreseeable future. It is the present intention of our Board of Directors to retain all earnings in the Company in order to support the future growth of our business. Any determination in the future to pay dividends will be dependent upon our consolidated results of operations, financial condition, cash requirements, future prospects and other factors. For more information about distribution of dividends and various tax implications, see Item 10, “Additional Information - Memorandum and Articles of Association;” Item 10, “Additional InformationExchange Controls,” and Item 10, “Additional InformationTaxation.”

B.           Significant Changes
On April 27, 2010, we entered into Share Purchase Agreement ("SPA") with Harcase Software Ltd. ("Harcase"), a company that develops, implements and promotes software solutions and provides related professional services for property and casualty insurance carriers, for the acquisition of all of the outstanding shares of Harcase from its selling shareholders.

Under the terms of the SPA, we will pay consideration in the amount of approximately $4,000, of which approximately $3,000 will be paid in cash and the remaining balance will be paid by issuance of 454,546 of ours common shares. In addition, we obligated to pay additional consideration to the selling shareholders of Harcase contingent upon achievement of certain performance targets as well as partially contingent upon continued employment of the selling shareholders.

Due to the fact that the acquisition occurred on April 27, 2010, we are currently evaluating the accounting treatment of the above acquisition on our financial statements.
56
THE OFFER AND LISTING
A.           Offer and Listing Details.

B.Significant Changes

None

ITEM 9.  THE OFFER AND LISTING

A.Offer and Listing Details.

The Company’s Common Shares are quoted on the NASDAQ Capital Market and on the TASE under the symbol “SPNS”.

NASDAQ:

The table below sets forth the high and low market prices (in US dollars) for our Common Shares on the NASDAQ National Market (now known as the NASDAQ Global Market) until September 27, 2005 and on the NASDAQ Capital Market (formerly known as the NASDAQ SmallCap Market) thereafter on an annual basis for the years 20052007 through 2009,2011, and on the NASDAQ Capital Market on a quarterly basis for 2008, 2009, 2010, 2011, and the first quarterthree months of 2010.

  HIGH  LOW 
2005 (Annual) $2.89  $1.00 
2006 (Annual)  2.10   1.02 
2007 (Annual)  3.66   1.20 
2008 (Annual)  2.40   0.82 
2009 (Annual)  2.00   0.76 
2010 (Annual through March 31, 2010)  2.20   1.33 
2008        
First Quarter $1.50  $1.01 
Second Quarter  1.88   0.82 
Third Quarter  2.40   1.32 
Fourth Quarter  2.35   1.21 
2009        
First Quarter $2.00  $0.76 
Second Quarter  1.44   0.76 
Third Quarter  1.27   0.85 
Fourth Quarter  1.95   1.01 
2010        
First Quarter 2010 $2.20  $1.33 
41


2012.

  HIGH  LOW 
       
2007 (Annual)  3.66   1.20 
2008 (Annual)  2.40   0.82 
2009 (Annual)  2.00   0.76 
2010 (Annual )  3.20   1.33 
2011 (Annual)  4.74   2.31 
2012 (Annual through March 31, 2012)  4.33   3.03 
         
2009        
First Quarter $2.00  $0.76 
Second Quarter  1.44   0.76 
Third Quarter  1.27   0.85 
Fourth Quarter  1.95   1.01 
2010        
First Quarter $2.20  $1.33 
Second Quarter  3.20   1.91 
Third Quarter  3.14   1.68 
Fourth Quarter  2.90   2.21 
2011        
First Quarter  4.74   2.31 
Second Quarter  4.07   2.96 
Third Quarter  4.37   2.67 
Fourth Quarter  4.20   2.72 

The table below sets forth the high and low market prices for our Common Shares on the NASDAQ Capital Market on a monthly basis during the most recent six-month period.

  HIGH  LOW 
       
October  2009 $1.45  $1.01 
November  2009  2.20   1.10 
December  2009  1.78   1.23 
January  2010  1.56   1.33 
February  2010  1.57   1.36 
March  2010  2.20   1.48 

  HIGH  LOW 
       
October  2011  3.68   2.75 
November  2011  4.20   3.18 
December  2011  3.85   2.72 
January  2012  4.33   3.62 
February  2012  4.25   3.81 
March 2012  4.08   3.03 

The closing price of our Common Shares on the NASDAQ Capital Market on April 1, 2010,March 31, 2012, being the last practicable date prior to publication of this annual report, was $2.04.

$3.52.

TASE:

Our Common Shares began trading on the TASE effective March 6, 2003. Under current Israeli law, the Company will satisfy its reporting obligations in Israel by furnishing to the applicable Israeli regulators only those reports which the Company is required to file or submit in the United States. The table below sets forth the high and low market prices, in US dollars, for our Common Shares on the TASE on an annual basis for the years 20052007 through 20092011 and on a quarterly basis for the years 2008, 2009,2010 and 2011, and the first quartertwo months of 2010.2012. The conversion from NIS into US dollars for the following two tables is based on the average monthly representative rate of exchange published by the Bank of Israel then in effect for the month in which such high or low price per share was recorded, except for the month of March 2010 and the date of April 1, 2010, where the conversion is based on the repre sentative rate of exchange as published by the Bank of Israel for the specific date recorded.

  HIGH  LOW 
       
2005 (Annual) $3.57  $1.23 
2006 (Annual)  1.88   1.12 
2007 (Annual)  3.89   0.97 
2008 (Annual)  2.31   0.88 
2009 (Annual)  2.06   0.92 
2010 (Annual) (through March 31,  2010)  2.21   1.30 
         
2008        
First Quarter $1.46  $1.08 
Second Quarter  2.04   0.92 
Third Quarter  2.38   1.56 
Fourth Quarter  2.04   1.53 
         
2009        
First Quarter $2.00  $0.94 
Second Quarter  1.45   0.91 
Third Quarter  1.44   0.94 
Fourth Quarter  1.91   1.12 
         
2010        
First Quarter $2.21  $1.30 
42

  HIGH  LOW 
       
2007 (Annual)  3.89   0.97 
2008 (Annual)  2.31   0.88 
2009 (Annual)  2.06   0.92 
2010 (Annual)  3.30   1.30 
2011 (Annual)  4.45   2.34 
         
2012 (Annual) (through March 31, 2012)  4.24   3.05 
2010      
First Quarter $2.21  $1.30 
Second Quarter  3.26   2.01 
Third Quarter  3.02   2.06 
Fourth Quarter  3.08   2.24 
         
2011        
First Quarter  4.42   2.44 
Second Quarter  4.18   2.44 
Third Quarter  4.26   3.08 
Fourth Quarter  4.17   2.69 

The table below sets forth the high and low market prices for our Common Shares on TASE during the most recent six-month period:

  HIGH  LOW 
       
October 2009  1.36   1.13 
November 2009  1.91   1.27 
December  2009  1.77   1.39 
January  2010  1.60   1.30 
February  2010  1.57   1.44 
March  2010  2.21   1.30 

  HIGH  LOW 
       
October 2011  3.73   2.73 
November 2011  4.17   3.34 
December  2011  3.97   2.76 
January  2012  4.18   3.59 
February  2012  4.24   3.92 
March 2012  4.09   3.05 

The closing price of our Common Shares on the TASE on April 1, 2010,March 31, 2012, being the last practicable date prior to publication of this annual report, was $2.04.

B.           Plan of Distribution.
$3.36.

B.Plan of Distribution.

Not applicable.

C.           Markets.

C.Markets.

The Company’s Common Shares are quotedlisted on the NASDAQ Capital Market and on the TASE under the symbol “SPNS”.

D.           Selling Shareholders.

D.Selling Shareholders.

Not applicable.

E.           Dilution.

E.Dilution.

Not applicable.

F.           Expenses of the Issue.

F.Expenses of the Issue.

Not applicable.

43

Item 10.  Additional Information

ADDITIONAL INFORMATIONA.Share Capital.
A.           Share Capital.

Not applicable.

B.           Memorandum and Articles of Association (the “Articles”).

B.Memorandum and Articles of Association (the “Articles”).

1.
Registration and Purposes.The Company is organized and existing under the laws of the Netherlands Antilles.Curaçao. Its registered number is 53368.

The objects and purposes of the Company, which are itemized in Article II of the Articles, may be summarized as follows:

The objects and purposes of the Company, which are itemized in Article II of the Articles, may be summarized as follows:
·
to establish, participate in or have any other interest in business enterprises concerned with the development and commercial operation of software;

·
to finance directly or indirectly the activities of the Company, its subsidiaries and affiliates;

·
to borrow and to lend moneys;

·
to engage in the purchase and sale of securities, futures, real estate, business debts, commodities and intellectual property;

·
to undertake, conduct and promote research and development;

·
to guarantee, pledge, mortgage or otherwise encumber assets as security for the obligations of the Company or third parties; and

·
to do all that may be useful or necessary for the attainment of the above purposes.

2.
Board of Directors.A member of the Board of Directors may vote on a proposal or transaction in which he/she has a material interest if the material facts as to the director’s self-interest are disclosed to the Board of Directors. Neither the Articles nor Netherlands AntillesCuraçao law requires a majority of the disinterested directors to authorize the proposal or transaction. Members of the Board of Directors have the power to vote compensation to themselves, even if they lack an independent quorum.

The Articles do not grant borrowing powers to directors; nor do they require directors to resign at a certain age or to purchase a certain number of Common Shares.

The Articles do not grant borrowing powers to directors; nor do they require directors to resign at a certain age or to purchase a certain number of Common Shares.
3.
Rights and Preferences.The Company has only one class of shares of common stock, the Common Shares, currently outstanding. All previous issuances of preferred shares have been converted into Common Shares. The rights and preferences of the holders of Common Shares are summarized below. The Articles authorize a class of undefined preferred shares (the “Blank Preferred Shares”). There are no rights associated with the Blank Preferred Shares and none have been issued.

(a)Common Shares

Holders of the Common Shares are entitled to one vote for each whole share on all matters to be voted upon by shareholders, including the election of directors. Holders of the Common Shares do not have cumulative voting rights in the election of directors. All Common Shares are equal to each other with respect to liquidation and dividend rights. Holders of the Common Shares are entitled to receive dividends, subject to shareholder approval, out of funds legally available under Curaçao law. See “Dividend Policy” below. In the event of the liquidation of the Company, all assets available for distribution to the holders of the Common Shares are distributable among them according to their respective holdings, subject to the preferences of any shares having a preference upon liquidation that may be then outstanding. Holders of the Common Shares have no preemptive rights to purchase any additional, unissued Common Shares. The foregoing summary of the Common Shares does not purport to be complete and is subject to, and qualified in its entirety by, the provisions of the Articles.

Holders of the Common Shares are entitled to one vote for each whole share on all matters to be voted upon by shareholders, including the election of directors. Holders of the Common Shares do not have cumulative voting rights in the election of directors. All Common Shares are equal to each other with respect to liquidation and dividend rights. Holders of the Common Shares are entitled to receive dividends, subject to shareholder approval, out of funds legally available under Netherlands Antilles law. See “Dividend Policy” below. In the event of the liquidation of the Company, all assets available for distribution to the holders of the Common Shares are distributable among them according to their respective holdings, subject to the preferences of any shares having a preference upon liquidation that may be then outstanding. Holders of the Common Shares have no preemptive rights to purchase any additional, unissued Co mmon Shares. The foregoing summary of the Common Shares does not purport to be complete and is subject to, and qualified in its entirety by, the provisions of the Articles.
44

(b)Dividend Policy

The Company has never declared or paid any cash dividends on its Common Shares and does not anticipate paying cash dividends in the foreseeable future. It is the present intention of the Company’s Board of Directors to retain all earnings in the Company in order to support the future growth of its business. Any determination in the future to pay dividends will be dependent upon the Company’s consolidated results of operations, financial condition, cash requirements, future prospects and other factors. In addition, the ability of the Company to pay dividends is subject to the limitations of the Corporate Law of Curaçao, which provides, among other things, that dividends, while permitted to be paid periodically during a fiscal year, are subject to being proposed by the Board of Directors of the Company and approved thereafter at the General Meeting of Shareholders. The Corporate Law of Curaçao also provides that a distribution of dividends can only occur if, at the moment of distribution, the equity of the Company equals at least the nominal capital of the Company and, as a result of the distribution, will not fall below the nominal capital. Nominal capital is the sum of the par values of all of the issued shares of the Company’s capital stock at any moment in time.

61
 The Company has never declared or paid any cash dividends on its Common Shares and does not anticipate paying cash dividends in the foreseeable future. It is the present intention of the Company’s Board of Directors to retain all earnings in the Company in order to support the future growth of its business. Any determination in the future to pay dividends will be dependent upon the Company’s consolidated results of operations, financial condition, cash requirements, future prospects and other factors. In addition, the ability of the Company to pay dividends is subject to the limitations of the Corporate Law of the Netherlands Antilles, which provides, among other things, that dividends, while permitted to be paid periodically during a fiscal year, are subject to being proposed by the Board of Directors of the Company and approved thereafter at the General Meeting of Shareholders.  The Corporate Law of the N etherlands Antilles also provides that a distribution of dividends can only occur if, at the moment of distribution, the equity of the Company equals at least the nominal capital of the Company and, as a result of the distribution, will not fall below the nominal capital.  Nominal capital is the sum of the par values of all of the issued shares of the Company’s capital stock at any moment in time.

(c)The Blank Preferred Shares

There are no preferences or any rights whatsoever associated with the Blank Preferred Shares. These shares are unissued and are not owned by any of the current shareholders of the Company. Any issuance of these preferred shares is solely within the discretion of the Company’s Board of Directors. The Company has undertaken toward the TASE that so long as its Common Shares are listed for trading on the TASE, the Company shall not issue or grant any shares of a different class of shares than those that are listed for trading on the TASE. This undertaking does not apply to Preferred Shares as defined in Section 46B(b) of the Israel Securities Law, on the condition that such Preferred Shares are issued in accordance with the conditions set forth in Section 46A(1) therein.

There are no preferences or any rights whatsoever associated with the Blank Preferred Shares. These shares are unissued and are not owned by any of the current shareholders of the Company. Any issuance of these preferred shares is solely within the discretion of the Company’s Board of Directors. The Company has undertaken toward the TASE that so long as its Common Shares are listed for trading on the TASE, the Company shall not issue or grant any shares of a different class of shares than those that are listed for trading on the TASE. This undertaking does not apply to Preferred Shares as defined in Section 46B(b) of the Israel Securities Law, on the condition that such Preferred Shares are issued in accordance with the conditions set forth in Section 46A(1) therein.
4.
Changing the Rights of the Shareholders. The general meeting of shareholders decides upon any change in the Articles. A resolution to amend the Articles requires the approval of the absolute majority of all shares outstanding and entitled to vote.

5.
General Meetings. At least one general meeting of shareholders must be held each year. General meetings must be held in Curaçao. Special general meetings of shareholders may be called at any time by the Chairman of the Board or by the Board of Directors upon no less than 10 nor more than 60 days’ written notice to the Company’s shareholders. Every shareholder has the right to attend any meeting of shareholders in person or by proxy and to address the meeting. No action may be taken at any meeting of shareholders unless a quorum consisting of holders of at least one-half of the shares outstanding and entitled to vote are present at the meeting in person or by proxy.

6.
Limitations to Own Securities. The Articles contain no limits on the right to own securities.

7.
Change of Control. The Articles contain no provisions that would prevent or delay a change of control of the Company.

8.
Disclosure of Ownership.By-laws do not exist under Netherlands AntillesCuraçao law. The Articles contain no provisions requiring a shareholder to disclose his or her interest at a certain time; however, holders of our shares are subject to the reporting provisions of the Securities and Exchange Commission.
45

C.Material Contracts

Share Purchase Agreement

On July 21, 2011, we, Sapiens Technologies (1982) Ltd., our Israeli wholly-owned subsidiary ("Purchaser"), IDIT, the shareholders of IDIT (the "IDIT Selling Shareholders"), Amit Ben-Yehuda, as the IDIT Shareholder Representative, FIS, the shareholders of FIS (the "FIS Selling Shareholders") and Dan Goldstein as the Shareholders Representative, entered into a Share Purchase Agreement (the "Share Purchase Agreement"). Under the terms of the Share Purchase Agreement, the Purchaser agreed to purchase all of the share capital (on a fully diluted basis) of each of IDIT and FIS (each, an "Acquisition" and together, the "Acquisitions").

The consideration paid under the Share Purchase Agreement to the FIS Selling Shareholders was composed of $6.75 million in cash (payable to two of the FIS Selling Shareholders), 10,016,875 newly issued Common Shares and warrants to purchase an aggregate of 1,000,000 newly issued Common Shares (issuable to two of the FIS Selling Shareholders). The consideration to be paid under the Share Purchase Agreement to the IDIT Selling Shareholders is composed of 7,483,125 newly issued Common Shares.

In addition to the purchase of IDIT's and FIS' share capital, we agreed to replace all options to purchase ordinary shares of IDIT and FIS that were outstanding as of the closing of the respective Acquisition with options to purchase Common Shares under our new 2011 option plan, according to conversation ratios set forth in the Share Purchase Agreement. See Item 6(B) “2011 Share Incentive Plan” above.

The Share Purchase Agreement includes customary representations, warranties and covenants of the parties, as well as certain indemnification and escrow arrangements. The parties have agreed on the terms pursuant to which a representative of Kardan is to be appointed to our board of directors.

The Acquisitions were consummated on August 21, 2011.

Pursuant to the Share Purchase Agreement, upon consummation of the IDIT Transaction, 10% of the Common Shares issued to the IDIT Selling Shareholders were placed in escrow with an escrow agent for a period of 12 months after the closing to secure the indemnification and other obligation of the IDIT Selling Shareholders to the Purchaser pursuant to the Share Purchase Agreement. During the escrow period, the IDIT Selling Shareholders will have the right to vote their respective Common Shares that were placed in escrow. Upon consummation of the FIS Transaction, 10% of the Common Shares issued to the FIS Selling Shareholders were placed in escrow with an escrow agent for a period of 12 months after the closing to secure the indemnification and other obligations of the FIS Selling Shareholders to the Purchaser pursuant to the Share Purchase Agreement. During the escrow period, the FIS Selling Shareholders shall have the right to vote its Common Shares that were placed in escrow.

Agreement with Menora

In 2011, we entered into a new agreement with Menora Insurance, an Israeli insurance and financial services provider (the "Menora Agreement"). The term of the Menora Agreement is 4 years. Under the Menora Agreement, the services provided are based upon an annual budget provided to us by Menora pursuant to which Menora purchases from us mainly consulting services, which are to be provided over the course of the relevant year. The agreement includes fixed time and material billing rates for consulting services, maintenance services for the licensed software, an escrow arrangement and also a royalty payment arrangement in favor of Menora in case we outlicense a similar solution (that includes all the specific features developed in the course of the Menora Agreement) to other third parties in the future. Under the Menora Agreement, Menora will have to compensate us if it did not meet the targeted budget during the course of the 4 year term.

NoneD.Exchange Controls
D.           Exchange Controls

Although there are Netherlands AntillesCuraçao laws which may impose foreign exchange controls on the Company and may affect the payment of dividends, interest or other payments to non-resident holders of the Company’s securities, including the Common Shares, the Company has been granted an exemption from such foreign exchange control regulations by the Central Bank of the Netherlands Antilles.Curaçao. Other jurisdictions in which the Company conducts operations may have various currency or exchange controls. In addition, the Company is subject to the risk of changes in political conditions or economic policies which could result in new or additional currency or exchange controls or other restrictions being imposed on the operations of the Company. As to the Company’s securities, Netherlands AntillesCuraçao law and the Articles impose no li mitationslimitations on the right of non-resident or foreign owners to hold or vote such securities.

E.           Taxation

E.Taxation

Israeli Tax Considerations and Government Programs

General

The following is a general discussion only and is not exhaustive of all possible tax considerations. It is not intended, and should not be construed, as legal or professional tax advice and should not be relied upon for tax planning purposes. In addition, this discussion does not address all of the tax consequences that may be relevant to purchasers of our Common Shares in light of their particular circumstances, or certain types of purchasers of our Common Shares subject to special tax treatment. Examples of this kind of investor include residents of Israel and traders in securities who are subject to special tax regimes not covered in this discussion. Each individual/entity should consult its own tax or legal advisor as to the Israeli tax consequences of the purchase, ownership and disposition of our Common Shares.

To the extent that part of the discussion is based on new tax legislation, which has not been subject to judicial or administrative interpretation, we cannot assure you that the tax authorities or the courts will accept the views expressed in this section.

The following summary describes the current tax structure applicable to companies in Israel, with special reference to its effect on us. The following also contains a discussion of the material Israeli tax consequences to holders of our Common Shares.

Taxation of Companies

General Corporate Tax Structure

Generally, in 2011, Israeli companies arewere subject to "Corporate Tax"a corporate tax at the rate of 24% of their taxable income. On July 25, 2005, the Knesset (Israeli Parliament) approvedincome for such year. The corporate tax rate was scheduled to decline to 23% in 2012, 22% in 2013, 21% in 2014, 20% in 2015 and 18% in 2016 and onwards. Recently, the Law for Change in the Tax Burden (Legislative Amendments) (Taxes). 2011 (the “Tax Burden Law”), was published by the Government of Israel. The Tax Burden Law canceled the Amendmentscheduled progressive reduction of the Income Tax Ordinance (No. 147), 2005, which prescribes, among others, a gradual decreased in the corporate tax rate in Israel toand instead fixed the following tax rates: in 2006 - 31%, in 2007 - 29%, in 2008 - 27%, in 2009 - 26% and in 2010 and thereafter - 25%.   Capital gains are subject to tax at a rate of 25% (other than gains derived from the sale of listed securities that are taxed at the prevailing corporate tax rates) derived after January 1, 2003.

46

In July 2009, the Knesset passed the Law for Economic Efficiency (Amended Legislation for Implementing the Economic Plan for 2009rate at 25% from 2012 and 2010), 2009, which prescribes, among others, an additional gradual reduction in the rates of the Israeli corporate tax and real capital gains tax, commencing 2011, to the following tax rates: 2011 – 24%, 2012 – 23%, 2013 – 22%, 2014 – 21%, 2015 – 20%, 2016 and thereafter – 18%.
onwards. However, the effective tax rate payable by a company whichthat derives income from an approved enterprise (asApproved Enterprise, a Benefited Enterprise or Preferred Enterprise, as further discussed below)below, may be considerably less.
Law See “Law for the Encouragement of Industry (Taxes)Capital Investments” in this Item 10.E below.

Beginning as of 2010, Israeli companies are subject to regular corporate tax rate for their capital gains. In 2009, Israeli companies were generally subject to capital gains tax at a rate of 25% for such gains (other than capital gains from the sale of listed securities derived by companies with respect to which the provisions of Section 6 of the Israeli Income Tax Law (Inflationary Adjustments) 5745-1985 (the “Inflationary Adjustments Law”), 1969.

Accordingor the provisions of Section 130A of the Income Tax Ordinance, 1961 (the “Ordinance”), applied immediately before the 2006 tax reform came into force, which were instead subject to the regular corporate tax rate).

Besides being subject to the general corporate tax rules in Israel, certain of our Israeli subsidiaries have also, from time to time, applied for and received certain grants and tax benefits from, and participate in, programs sponsored by the Government of Israel, as described below.

Law for the Encouragement of Industry (Taxes), 1969 (“

The Law for the Encouragement of Industry (Taxes), 5729-1969 (the “Industry Encouragement Law”Law), industrial companies are entitled provides several tax benefits for an “Industrial Company”. Pursuant to the following tax benefit, among others:

deduction of purchases of know-how and patents over an eight-year period for tax purposes;

expenses involved with the issuance and listing of shares on the TASE or on a recognized stock market outside of Israel, are deductible over a three-year period;

the right to elect, under specified conditions, to file a consolidated tax return with other related Israeli industrial companies; and

accelerated depreciation rates on equipment and buildings.

According to the law, an “industrial company” is defined asIndustry Encouragement Law, a company qualifies as an Industrial Company if it is an Israeli resident in Israel,and at least 90% of theits income of which, in any tax year determined in Israeli currency (exclusive of(other than income from certain government loans, capital gains, interest and dividends)loans) is derivedgenerated from an “industrial enterprise” owned by it.“Industrial Enterprise” that it owns. An “industrial enterprise”“Industrial Enterprise” is defined as an enterprise whose major activity, in a given tax year, is industrial production activity. production.

An Industrial Company is entitled to certain tax benefits, including:

§Deduction of the cost of the purchases of patents, or the right to use a patent or know-how used for the development or promotion of the Industrial Enterprise, over an eight year period commencing on the year in which such rights were first exercised;
§Straight-line deduction of expenses related to a public offering in equal amounts over a three-year period commencing on the year of offering; and
§The right to elect, under certain conditions, to file a consolidated tax return with additional Israeli Industrial Companies controlled by it.
§Accelerated depreciation rates on equipment and buildings.

Eligibility for benefits under the Industry Encouragement Law is not subject to receipt of prior approval from any governmental authority.


We believe that certain of our subsidiary, Sapiens Technologies (1982) Ltd,Israeli subsidiaries currently qualifiesqualify as an industrial companyIndustrial Companies within the definition under the Industry Encouragement Law. However, weWe cannot give any assuranceassure you that we will continue to qualify as an “industrial company”Industrial Companies or that the benefits described above will be available in the future.


Law for the Encouragement of Capital Investments, 1959.

1959

The Law for the Encouragement of Capital Investments, 1959,5719-1959 (the “Investment Law”), provides certain incentives for capital investments in effect priora production facility (or other eligible assets). Generally, an investment program that is implemented in accordance with the provisions of the Investment Law, referred to as an “Approved Enterprise”, is entitled to benefits. These benefits may include cash grants from the Israeli government and tax benefits, based upon, among other things, the location of the facility in which the investment is made or the election of the grantee. In order to qualify for these incentives, an Approved Enterprise is required to comply with the requirements of the Investment Law.

The Investment Law has been amended several times over the last years, with the two most significant changes effective as of April 1, 2005 (the “Investments Law”2005 Amendment), providesand as of January 1, 2011 (the “2011 Amendment”). Pursuant to the 2005 Amendment, tax benefits granted in accordance with the provisions of the Investment Law prior to its revision by the 2005 Amendment remain in force but any benefits granted subsequently are subject to the provisions of the amended Investment Law. Similarly, the 2011 Amendment introduced new benefits instead of the benefits granted in accordance with the provisions of the Investment Law prior to the 2011 Amendment, yet companies entitled to benefits under the Investment Law as in effect up to January 1, 2011 may choose to continue to enjoy such benefits, provided that certain conditions are met, or elect instead to forego such benefits and elect the benefits of the 2011 Amendment.

The following discussion is a capital investmentsummary of the Investment Law prior to its amendments as well as the relevant changes contained in eligible facilities may, upon applicationthe new legislation.

Tax benefits for Approved Enterprises approved before April 1, 2005. Under the Investment Law prior to its amendment, a company that wished to receive benefits had to receive an approval from the Investment Center of the Israeli Ministry of Industry, Trade and Labor, ofwhich we refer to as the State of Israel, be designated as an “approved enterprise.”Investment Center. Each certificate of approval for an approved enterpriseApproved Enterprise relates to a specific investment program in the Approved Enterprise, delineated both by the financial scope of the investment and by the physical characteristics of the facility or the asset.

An approved enterprise is entitledApproved Enterprise may elect to benefits including Israeli government cashforego any entitlement to the grants and tax benefits in specified development areas. The extent of the tax benefitsotherwise available under the InvestmentsInvestment Law and, instead, participate in an alternative benefits program. Certain of our Israeli subsidiaries have chosen to receive the benefits through the alternative benefits track with respect to their respective programs. Under the alternative benefits track, a company’s undistributed income derived from an Approved Enterprise will be exempt from corporate tax for a period for which tax benefits are available are determined byof between two and ten years from the geogra phicfirst year of taxable income, depending upon the geographic location within Israel of the enterprise.Approved Enterprise. The benefits commence on the date in which that taxable income is first earned. Upon expiration of the exemption period, the Approved Enterprise is eligible for the reduced tax rates otherwise applicable under the Investment Law for any remainder of the otherwise applicable benefits period. The benefits period under Approved Enterprise status is limited to 12 years from commencement of production, or 14 years from the date of the approval, whichever ends earlier. If a company has more than one Approved Enterprise program or if only a portion of its capital investments are dependent uponapproved, its effective tax rate is the fulfillmentresult of conditions stipulated ina weighted combination of the Investments Law and its regulations, including the criteria set forth in the specific certificate of approval.applicable rates. The tax benefits from any certificate of approval relate only to taxable profits attributable to the specific approved enterprise. If a company has more than one approval or only a portion of its enterpriseApproved Enterprise. Income derived from activity that is approved, its effective tax rate isnot integral to the result of a weighted averageactivity of the Approved Enterprise will not enjoy tax benefits. In our case, subject to compliance with applicable rates (such weighted average is calculatedrequirements stipulated in accordance with the guidelines of the Investment Law).

Tax benefits given under the Investment Law also apply to income generated by a company fromand its regulations and in the grantspecific certificate of a usage right with respect to know-how developed byapproval, as described above, the approved enterprise, income generated from royalties, andportion of certain of our Israeli subsidiaries’ undistributed income derived from their Approved Enterprise programs will be exempt from corporate tax for a service whichperiod of two to four years, followed by five to eight years with reduced tax rate of 25% on income derived from Approved Enterprise investment programs. Because such subsidiaries have not yet generated any taxable income under any of their Approved Enterprise programs, however, the benefit periods for those programs have not yet commenced, and, accordingly, we have not yet reaped any tax benefits from those programs.

A company that has an Approved Enterprise program is auxiliary to such usage righteligible for further tax benefits if it qualifies as a Foreign Investors’ Company, or royalties, provided that such incomeFIC. An FIC eligible for benefits is generatedessentially a company with a level of foreign investment, as defined in the courseInvestment Law, of more than 25%. The level of foreign investment is measured as the approved enterprise’s ordinary coursepercentage of business.

47

Each applicationrights in the company (in terms of shares, rights to the Investment Center is reviewed separatelyprofits, voting and a decisionappointment of directors), and of combined share and loan capital, that are owned, directly or indirectly, by persons who are not residents of Israel. The determination as to whether or not a company qualifies as an FIC is made on an annual basis. An FIC that has an Approved Enterprise program will be eligible for an extension of the period during which it is entitled to approve such applicationtax benefits under its Approved Enterprise status (so that the benefit periods may be up to ten years) and for further tax benefits if the level of foreign investment exceeds 49%. If a company that has an Approved Enterprise program is a wholly owned subsidiary of another company, then the percentage of foreign investment is determined based among other things, on the then-prevailing criteriapercentage of foreign investment in the parent company.

The tax rates and related levels of foreign investments with respect to an FIC that has an Approved Enterprise program are set forth in the law, the specific objectives of the applicantfollowing table:

Percentage of non-Israeli ownershipTax Rate
Over 25% but less than 49%25%
49% or more but less than 74%20%
74% or more but less than 90%15%
90% or more10%

A company set forth in such application and certain financial criteria of the applicant company. Accordingly, there can be no assurance that any future application will be approved. In addition, as described above, the benefits availablehas elected to an approved enterprise are dependent upon the fulfillment of certain conditions stipulatedparticipate in the Investments Lawalternative benefits program and its regulations and the criteria set forth in the specific certificatethat subsequently pays a dividend out of approval. In the event that these conditions are violated, in whole or in part, we would be required to refund the amount of tax benefits, with the addition of the Israeli consume r price index linkage adjustment and interest.

Our subsidiary, Sapiens Technologies (1982) Ltd., which is incorporated in Israel, was granted approved enterprise status by the Investment Center for six investment programs in 1984, 1991, 1993, 1995, 1998 and 2000 under the Investments Law.
We believe our approved enterprise operates in substantial compliance with all such conditions and criteria.
On April 1, 2005, a comprehensive amendment to the Investments Law came into effect. As the amended Investments Law does not retroactively apply to investment programs having an approved enterprise approval certificate issued by the Investment Center prior to December 31, 2004, our current tax benefits are subject to the provisions of the Investments Law prior to its revision. Our approved plans subsequent to 2005 and others that may be received in the future will be subject to the provisions of the Investments Law, as amended. Accordingly, the following description includes a summary of the Investments Law prior to its amendment as well as the relevant changes contained in the Investments Law.
Under the terms of our approved enterprise, once we begin generating taxable net income, we will be entitled to a tax exemption with respect to the income derived from our approved enterprise program for two years andthe portion of its facilities that have been granted Approved Enterprise status during the tax exemption period will be subjectrequired to a reduced companyrecapture the deferred corporate tax rate of between 10% and 25% for the following five to eight years, depending on the extent of foreign (non-Israeli) investment in our company during the relevant year. The tax rate will be 20% if the foreign investment level is more than 49% but less than 74%, 15% if the foreign investment level is more than 74% but less than 90%, and 10% if the foreign investment level is 90% or more. The lowest level of foreign investment during a particular year will be used to determine the relevant tax rate for that year. The period in which we receive these tax benefits is limited to 12 years from the year in which operations or production by the enterprise commenced or 14 years from the year in which approval was granted, whichever is the earlier (the "year of limitation"). The year of limitation does not applyapplicable to the exemption period. Dividends distributed from tax-exempt income would be taxed in respect of the gross amount distributed according(grossed up to reflect such tax) at the company tax rate that would have been applicable had the companysuch income not been exempt from taxation that year.tax-exempted under the alternative route. This rate is generally ranges from 10% to 25%, depending on the extent of foreign investment in the company.
Dividendsto which non-Israeli shareholders hold such company’s shares. Such company may also be required to record a deferred tax liability with respect to such tax-exempt income prior to its distribution.

In addition, dividends paid out of income generated by an approved enterpriseApproved Enterprise (or out of dividends received from a company whose income is generated by an approved enterprise)Approved Enterprise) are generally subject to withholding tax at the rate of 15%, or at the lower rate provided under an applicable tax treaty. The 15% tax rate is limited to dividends from approved enterprises (15%), unless a different rate is provided according to a treaty between Israel and the shareholder’s country of residence (if the dividend is distributeddistributions out of income derived during the tax exemptionbenefits period or withinand actually paid at any time up to 12 years thereafter). thereafter. After this period, the withholding tax is applied at a rate of up to 30%, or at the lower rate under an applicable tax treaty. In the case of an FIC, the 12-year limitation on reduced withholding tax on dividends does not apply.

The company must withhold this tax at source.

The InvestmentsInvestment Law also provides that an approved enterpriseApproved Enterprise is entitled to accelerated depreciation on its property and equipment that are included in an approved investment program. We have not utilized this benefit.
PursuantThis benefit is an incentive granted by the Israeli government regardless of whether the alternative benefits program is elected.

The benefits available to an Approved Enterprise are subject to the amendmentfulfillment of conditions stipulated in the Investment Law and its regulations and the criteria in the specific certificate of approval with respect thereto, as described above. If a company does not meet these conditions, it may be required to refund the Investments Law,amount of tax benefits, together with consumer price index linkage adjustment and interest.

Tax benefits under the 2005 Amendment that became effective as ofon April 1, 2005.On April 1, 2005, the basic condition for receiving the benefits (both under the grant and the tax benefits programs) is the enterprise’s contribution to the economic independence of the State of Israel and its contribution to the gross domestic product. In order to fulfill these conditions, the enterprise is required to be categorized asIsraeli Parliament passed an industrial enterprise which complies with any of the following:

its major activity is in the field of biotechnology or nano-technology;
48

its revenues during the applicable tax year from any single market (i.e. country or a separate customs territory) do not exceed 75% of the privileged enterprise's aggregate revenues during such year; or

25% or more of its revenues during the applicable tax year are generated from sales into a single market (i.e. country or a separate customs territory) with a population of at least 12 million residents.

According to the amendment to the InvestmentsInvestment Law, onlyin which it revised the criteria for investments qualified to receive tax benefits. An eligible investment program under the 2005 Amendment will qualify for benefits as a Benefited Enterprise (rather than the previous terminology of Approved Enterprise). Among other things, the 2005 Amendment provides tax benefits to both local and foreign investors and simplifies the approval process.

The 2005 Amendment applies to new investment programs and investment programs commencing after 2004, and does not apply to investment programs approved prior to December 31, 2004. The 2005 Amendment provides that terms and benefits included in any certificate of approval that was granted before the 2005 Amendment came into effect will remain subject to the provisions of the Investment Law as in effect on the date of such approval. Pursuant to the 2005 Amendment, the Investment Center will continue to grant Approved Enterprise status to qualifying investments. However, the 2005 Amendment limits the scope of enterprises receiving cash grants requirethat may be approved by the Investment Center by setting criteria for the approval of a facility as an Approved Enterprise, such as provisions generally requiring that at least 25% of the Approved Enterprise’s income be derived from export.

The 2005 Amendment provides that the approval of the Investment Center.Center is required only for Approved enterprises, which do notEnterprises that receive benefits in the form of governmental cash grants, such as benefits in the form of tax benefits, aregrants. As a result, a company is no longer required to obtain thisthe advance approval (such enterprisesof the Investment Center in order to receive tax benefits. Rather, a company may claim the tax benefits offered by the Investment Law directly in its tax returns, provided that its facilities meet the criteria for tax benefits set forth in the 2005 Amendment. A company that has a Benefited Enterprise may, at its discretion, approach the Israeli Tax Authority for a pre-ruling confirming that it is in compliance with the provisions of the Investment Law.

Tax benefits are referredavailable under the 2005 Amendment to as “privileged enterprises”).production facilities (or other eligible facilities) that derive more than 25% of their business income from export to specific markets with a population of at least 12 million. In order to be eligible forreceive the tax benefits, privileged enterprisesthe 2005 Amendment states that a company must make an investment which meets all the conditions that are required to comply with certain requirementsset out in the amendment for tax benefits and make certain investments aswhich exceeds a minimum amount specified in the amended InvestmentsInvestment Law. Such investment entitles a company to a Benefited Enterprise statuswith respect to the investment, and may be made over a period of no more than three years ending at the end of the year in which the company requested to have the tax benefits apply to the Benefited Enterprise. Where a company requests to have the tax benefits apply to an expansion of existing facilities, only the expansion will be considered to be a Benefited Enterprise, and the company’s effective tax rate will be the weighted average of the applicable rates. In such case, the minimum investment required in order to qualify as a Benefited Enterprise must exceed a certain percentage of the value of the company’s production assets before the expansion.

The privileged enterprisesextent of the tax benefits available under the 2005 Amendment to qualifying income of a Benefited Enterprise are determined, among other things, by the geographic location of the Benefited Enterprise. Such tax benefitsinclude an exemption from corporate tax on undistributed income for a period of between two to ten years, depending on the geographic location of the Benefited Enterprise within Israel, and a reduced corporate tax rate of between 10% to 25% for the remainder of the benefit period, depending on the level of foreign investment in the company in each year, as explained above.

Dividends paid out of income derived by a Benefited Enterprise (or out of dividends received from a company whose income is derived from a Benefited Enterprise) are generally subject to withholding tax at the rate of 15% or such lower rate as may be provided in an applicable tax treaty. The reduced rate of 15% is limited to dividends and distributions out of income derived from a Benefited Enterprise during the benefits period and actually paid at any time up to 12 years thereafter, except with respect to a qualified FIC, in which case the 12-year limit does not apply. A company qualifying for tax benefits under the 2005 Amendment which pays a dividend out of income derived by its Benefited Enterprise during the tax exemption period will be subject to corporate tax at a rate otherwise applicable to the company in the year the income was earned (i.e., 25%, or lower in the case of an FIC which is at least 49% owned by non-Israeli residents) on an amount consisting of such divided amount, grossed up by the otherwise applicable corporate tax rate. Such company may also be required to record a deferred tax liability with respect to such tax-exempt income prior to its distribution.

The benefits available to a Benefited Enterprise are subject to the responsibilityfulfillment of conditions stipulated in the Investment Law and its regulations. If a company does not meet these conditions, it may be required to refund the amount of tax benefits, together with consumer price index linkage adjustment and interest, or other monetary penalty.

To date, one of our Israeli subsidiaries has a Benefited Enterprise but it did not utilized any tax benefits, since it has carryforward losses for tax purposes.

69

Tax benefits under the 2011 Amendment that became effective on January 1, 2011.The 2011 Amendment canceled the availability of the benefits granted in accordance with the provisions of the Investment Law prior to 2011 and, instead, introduced new benefits for income generated by a “Preferred Company” through its Preferred Enterprise (as such term is defined in the Investment Law) effective as of January 1, 2011 and onward. A Preferred Company is defined as either (i) a company incorporated in Israel and not fully owned by a governmental entity or (ii) a limited partnership (a) that was registered under the Israeli Partnerships Ordinance and (b) all limited partners of which are companies incorporated in Israel, but not all of them are governmental entities, which, in the case of the company and companies referenced in clauses (i) and (ii)(b), have, among other things, Preferred Enterprise status and are controlled and managed from Israel. Pursuant to the 2011 Amendment, a Preferred Company is entitled to a reduced corporate tax rate of 15% with respect to its preferred income derived by its Preferred Enterprise in 2011-2012, unless the Preferred Enterprise is located in a certain development zone, in which case the rate will be 10%. Such corporate tax rate will be reduced to 12.5% and 7%, respectively, in 2013-2014 and to 12% and 6% in 2015 and thereafter, respectively. Income derived by a Preferred Company from a ‘Special Preferred Enterprise’ (as such term is defined in the Investment Law) would be entitled, during a benefits period of 10 years, to further reduced tax rates of 8%, or to 5% if the Special Preferred Enterprise is located in a certain development zone.

Dividends paid out of income attributed to a Preferred Enterprise are generally subject to withholding tax at source at the rate of 15% or such lower rate as may be provided in an applicable tax treaty. However, if such dividends are paid to an Israeli company, no tax will be withheld.

The 2011 Amendment also provided transitional provisions to address companies already enjoying current benefits. These transitional provisions provide, among other things, that: (i) terms and benefits included in any certificate of approval that was granted to an Approved Enterprise, which chose to receive grants, before the 2011 Amendment came into effect, will remain subject to the provisions of the Investment Law as in effect on the date of such approval, while the 25% tax rate applied to income derived by an Approved Enterprise during the benefit period will be replaced with the regular corporate income tax rate (24% in 2011 and 25% in 2012), unless a request is made to apply the provisions of the Investment Law as amended in 2011 with respect to income to be derived as of January 1, 2011 (such request should have been made by way of an application to the Israeli Tax Authority by June 30, 2011 and may at their discretion,not be withdrawn); and (ii) terms and benefits included in orderany certificate of approval that was granted to provide greater certainty, electan Approved Enterprise, which had participated in an alternative benefits program, before the 2011 Amendment came into effect will remain subject to apply for a pre-ruling from the Israeli tax authorities confirming that they are in compliance w ith the provisions of the Investment Law as in effect on the date of such approval, provided that certain conditions are met. However, a company that has such Approved Enterprise can file a request with the Israeli Tax Authority, according to which its income derived as of January 1, 2011 will be subject to the provisions of the Investment Law, as amended Investments Lawin 2011; and therefore are entitled(iii) a Benefited Enterprise can elect to receivecontinue to benefit from the benefits provided underto it before the amended Investments Law. The amended Investments Law also specifies2011 Amendment came into effect, provided that certain conditions are met, or file a request with the Israeli Tax Authority according to which its income derived as of January 1, 2011 will be subject to the provisions of the privileged enterprise is entitledInvestment Law as amended in 2011. Our Israeli subsidiaries did not file a request to tax benefits (for example income generated fromapply the sale of products that were manufactured by the privileged enterprise, income generated from usage right with respect to know-how developed by the privileged enterprise, etc.).

We cannot assure you that we will comply with the above conditions in the future or that we will be entitled to any additionalnew benefits under the amended Investments Law.2011 Amendment.

70
In addition, the amended Investments Law changed the definition of “foreign investment” according to the Investments Law so that the definition, instead of a foreign currency investment, now requires a minimal investment of NIS 5 million by foreign investors. Furthermore, such definition now also includes the purchase of shares of a company from another shareholder (secondary market purchase), provided that the company’s outstanding and paid-up share capital exceed NIS 5 million. Such changes to the aforementioned definition will take effect retroactively from 2003.
To date, we have not utilized the benefits of the Investments Law, as amended subsequent to April 1, 2005, since we are in a loss position for tax purposes.

Special Provisions Relating to Taxation Underunder Inflationary Conditions


The Inflationary Adjustments Law represents an attempt to overcome the problems presented to a traditional tax system by an economy with high inflation rates. Under the Income Tax (Inflationary Adjustments) Law, of 1985, or theInflationary Adjustments Law, taxable results for tax purposes areof Israeli companies through, and including, the year 2007 were measured inon a real terms, in accordance withbasis, taking into account the changesrate of change in the Israeli Consumer Price Index (“Israeli CPI”). Accordingly, until 2004, results for tax purposes were measured in termsconsumer price index, or CPI. Subject to certain transitional provisions, the Inflationary Adjustments Law was repealed as of earnings in NIS after certain adjustments for increases in the Israeli CPI. Commencing in taxable yearJanuary 1, 2008.

As of tax-year 2005, our Israeli subsidiaries in Israel elected to measure their taxable income and file their tax returns under the Israeli Income Tax Regulations (Principles Regarding the Management of Books of Account of Foreign Invested Companies and Certain Partnerships and the Determination of Their Taxable Income), 1986. Such an election obligates ourTherefore, as of tax-year 2005, taxable income of each Israeli subsidiaries for three years. Accordingly, commencing taxable year 2005, results for tax purposes are me asuredsubsidiary is measured in terms of earnings in dollar. We have submittedEach year we submit a request to the Israeli tax authoritiesauthority to extend the effect of the above tax regulations on our company for 2008.


an additional year.

Tax Benefits for Research and Development


Israeli tax law allows, under specified conditions, a tax deduction for research and development expenditures, including capital expenditures, for the year in which they are incurred.  These expensesSuch expenditures must relate to scientific research and development projects, and must be approved by the relevant Israeli government ministry, determined by the field of research.  Furthermore, the research and development must be for the promotion of the company’s business and carried out by or on behalf of the company seeking such tax deduction.  However, the amount of such deductible expenses is reduced by the sum of any funds received through government grants for the finance of such scientific research and development projects.  Expenditures not so approved by the relevant Israeli government ministry, but otherwise qualifying for deduction, are deductible over a three-year period.

49

Transfer Pricing

As part of the Israeli 2003 tax reform, the Israeli Tax Ordinance was amended to include section 85A, dealing with international transactions transfer pricing. Section 85A provides that regardless of the actual conditions of an international transaction between related parties, the transaction shall be reported and taxed, based on the arm’s length standard,i.e., based on market conditions in similar transactions between unrelated parties. On October 30, 2006, the Income Tax Regulations (Determination of Market Conditions) (the “Regulations”), hereinafter referred to as the Regulations, which provide instructions for the implementation of section 85A, came into effect.

In accordance with the Regulations, a transaction shall be considered an international transaction if one of the parties is a “foreign resident” as defined thereunder or if the income generated from such transaction, in all or in part, is taxed both in and outside of Israel. The Regulations establish acceptable methods for comparison between transactions, and methods for calculating the price range against which the transaction is measured.

Taxpayers are required to include in their yearly income tax returns a report regarding their international transactions at arm’s length prices. The transfer pricing regulations have not had a material effect on the Company.

Israeli Taxation Considerations for Our Shareholders

The following is a short summary of the material provisions of the tax environment to which shareholders may be subject. This summary is based on the current provisions of tax law. To the extent that the discussion is based on new tax legislation that has not been subject to judicial or administrative interpretation, we cannot assure you that the views expressed in the discussion will be accepted by the appropriate tax authorities or the courts.

The summary does not address all of the tax consequences that may be relevant to all purchasers of our common shares in light of each purchaser’s particular circumstances and specific tax treatment. For example, the summary below does not address the tax treatment of residents of Israel and traders in securities who are subject to specific tax regimes. As individual circumstances may differ, holders of our common shares should consult their own tax adviser as to the United States, Israeli or other tax consequences of the purchase, ownership and disposition of common shares. The following is not intended, and should not be construed, as legal or professional tax advice and is not exhaustive of all possible tax considerations. Each individual should consult his or her own tax or legal adviser.

Tax Consequences Regarding Disposition of Our Common Shares

Overview

Israeli law generally imposes a capital gains tax on the sale of capital assets by residents of Israel, as defined for Israeli tax purposes, and on the sale of assets located in Israel, including shares in Israeli companies, by both residents and non-residents of Israel, unless a specific exemption is available or unless a tax treaty between Israel and the shareholder’s country of residence provides otherwise. The Ordinance distinguishes between the “Real Capital Gain” and the “Inflationary Surplus”. The Inflationary Surplus is a portion of the total capital gain which is equivalent to the increase of the relevant asset’s purchase price which is attributable to the increase in the Israeli consumer price index (CPI) or, in certain circumstances, a foreign currency exchange rate, between the date of purchase and the date of sale. The Real Capital Gain is the excess of the total capital gain over the Inflationary Surplus.

Israeli Resident Shareholders

Israeli Resident Individuals.Beginning as of January 1, 2006, the tax rate applicable to Real Capital Gain derived by Israeli individuals from the sale of shares which had been purchased on or after January 1, 2003, whether or not listed on a stock exchange, is 20%. However, if such a shareholder is considered a Substantial Shareholder (i.e., a person who holds, directly or indirectly, alone or together with another, 10% or more of any of the company’s “means of control” (including, among other things, the right to receive profits of the company, voting rights, the right to receive the company’s liquidation proceeds and the right to appoint a director)) at the time of sale or at any time during the preceding 12-month period, such gain will be taxed at the rate of 25%. Individual shareholders dealing with securities in Israel are taxed at their marginal tax rates applicable to business income (up to 45% in 2011, and up to 48% in 2012).

Notwithstanding the foregoing, pursuant to the Tax Burden Law, the capital gain tax rate applicable to individuals was raised from 20% to 25% from 2012 and onwards (or from 25% to 30% if the selling individual shareholder isa Substantial Shareholderat any time during the 12-month period preceding the sale). With respect to assets (not shares that are listedon a stock exchange) purchased on or after January 1, 2003, the portion of the gain generated from the date of acquisition until December 31, 2011 will be subject to the previous capital gains tax rates (20% or 25%) and the portion of the gain generated from January 1, 2012 until the date of sale will be subject to the new tax rates (25% or 30%).

Israeli Resident Corporations.Under present Israeli tax legislation, the tax rate applicable to Real Capital Gain derived by Israeli resident corporations from the sale of shares of an Israeli company is the general corporate tax rate. As described above, recent changes in the lawabolished the scheduled progressive reduction of the corporate tax rate and set the corporate tax rate at 25% from 2012 and onwards..

Non-Israeli Residents Shareholders

Israeli capital gain tax is imposed on the disposal of capital assets by a non-Israeli resident if such assets are either (i) located in Israel; (ii) shares or rights to shares in an Israeli resident company; or (iii) represent, directly or indirectly, rights to assets located in Israel, unless a tax treaty between Israel and the seller’s country of residence provides otherwise. As mentioned above, Real Capital Gain derived by a company is generally subject to tax at the corporate tax rate (24% in 2011 and 25% as of 2012) or, if derived by an individual, at the rate of 20% (25% as of 2012), or 25% (30% as of 2012), if generated from an asset purchased on or after January 1, 2003. Individual and corporate shareholders dealing in securities in Israel are taxed at the tax rates applicable to business income (a corporate tax rate for a corporation and a marginal tax rateof up to 45% for an individual in 2011).

Notwithstanding the foregoing, shareholders who are non-Israeli residents (individuals and corporations) are generally exempt from Israeli capital gain tax on any gains derived from the sale, exchange or disposition of shares publicly traded on the Tel Aviv Stock Exchange or on a recognized stock exchange outside of Israel, provided, among other things, that (i) such gains are not generated through a permanent establishment that the non-Israeli resident maintains in Israel, (ii) the shares were purchased after being listed on a recognized stock exchange, and (iii) with respect to shares listed on a recognized stock exchange outside of Israel, such shareholders are not subject to the Inflationary Adjustments Law. However, non-Israeli corporations will not be entitled to the foregoing exemptions if an Israeli resident (a) has a controlling interest of 25% or more in such non-Israeli corporation, or (b) is the beneficiary of or is entitled to 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly. Such exemption is not applicable to a person whose gains from selling or otherwise disposing of the shares are deemed to be business income.

In addition, a sale of securities may be exempt from Israeli capital gain tax under the provisions of an applicable tax treaty. For example, under the U.S.-Israel Tax Treaty, which we refer to as the U.S-Israel Treaty, the sale, exchange or disposition of shares of an Israeli company by a shareholder who is a U.S. resident (for purposes of the U.S.-Israel Treaty) holding the shares as a capital asset is exempt from Israeli capital gains tax unless either (i) the shareholder holds, directly or indirectly, shares representing 10% or more of the voting capital during any part of the 12-month period preceding such sale, exchange or disposition; (ii) the shareholder, being an individual, has been present in Israel for a period or periods of 183 days or more in the aggregate during the applicable taxable year; or (iii) the capital gains arising from such sale are attributable to a permanent establishment of the shareholder which is maintained in Israel. In either case, the sale, exchange or disposition of such shares would be subject to Israeli tax, to the extent applicable; however, under the U.S.-Israel Treaty, a U.S. resident would be permitted to claim a credit for the Israeli tax against the U.S. federal income tax imposed with respect to the sale, exchange or disposition, subject to the limitations in U.S. laws applicable to foreign tax credits. The U.S-Israel Treaty does not provide such credit against any U.S. state or local taxes.

Payors of consideration for traded securities, like our common shares, including the purchaser, the Israeli stockbroker effectuating the transaction, or the financial institution through which the sold securities are held, are required, subject to any of the foregoing exemptions and the demonstration of a shareholder regarding his, her or its foreign residency, to withhold tax upon the sale of publicly traded securities from the consideration or from the Real Capital Gain derived from such sale, as applicable, at the rate of 25%.

Taxes Applicable to Dividends

Israeli Resident Shareholders

Israeli Resident Individuals.Israeli residents who are individuals are generally subject to Israeli income tax for dividends paid on our common shares (other than bonus shares or share dividends) at 20%, or 25% if the recipient of such dividend is a Substantial Shareholder at the time of distribution or at any time during the preceding 12-month period. Pursuant to the Tax Burden Law, as of 2012 such tax rate is 25%, or 30% if the dividend recipientis a Substantial Shareholder at the time of distribution or at any time during the preceding 12-month period. However, dividends distributed from taxable income accrued during the period of benefit of an Approved Enterprise, Benefited Enterprise or Preferred Enterprise are subject to withholding tax at the rate of 15%, if the dividend is distributed during the tax benefit period under the Investment Law or within 12 years after that period. An average rate will be set in case the dividend is distributed from mixed types of income (regular and Approved/ Benefited/ Preferred income).

Israeli Resident Corporations.Israeli resident corporations are generally exempt from Israeli corporate tax for dividends paid on our common shares.

Non-Israeli Resident Shareholders

Non-Israeli residents (whether individuals or corporations) are generally subject to Israeli withholding tax on the receipt of dividends paid for publicly traded shares, like our common shares, at the rate of 20% (25% as of 2012, so long as the shares are registered with a Nominee Company) or 15% if the dividend is distributed from income attributed to our Approved Enterprises, unless a reduced rate is provided under an applicable tax treaty. For example, under the U.S-Israel Treaty, the maximum rate of tax withheld in Israel on dividends paid to a holder of our common shares who is a U.S. resident (for purposes of the U.S.-Israel Treaty) is 25%. However, generally, the maximum rate of withholding tax on dividends that are paid to a U.S. corporation holding at least 10% or more of our outstanding voting capital from the start of the tax year preceding the distribution of the dividend through (and including) the distribution of the dividend, is 12.5%, provided that no more than 25% of our gross income for such preceding year consists of certain types of dividends and interest.Notwithstanding the foregoing, dividends distributed from income attributed to an Approved Enterprise, a Benefited Enterprise or a Preferred Enterprise are subject to a withholding tax rate of 15% for such a U.S. corporation shareholder, provided that the condition related to our gross income for the previous year (as set forth in the previous sentence) is met. If the dividend is attributable partly to income derived from an Approved Enterprise, a Benefitted Enterprise or a Preferred Enterprise, and partly to other sources of income, the withholding rate will be a blended rate reflecting the relative portions of the two types of income.U.S residents who are subject to Israeli withholding tax on a dividend may be entitled to a credit or deduction for U.S. federal income tax purposes in the amount of the taxes withheld, subject to detailed rules contained in United States tax legislation.

A non-Israeli resident who receives dividends from which tax was withheld is generally exempt from the obligation to file tax returns in Israel with respect to such income, provided that (i) such income was not generated from business conducted in Israel by the taxpayer, and (ii) the taxpayer has no other taxable sources of income in Israel with respect to which a tax return is required to be filed.

Payors of dividend on our common shares, including the Israeli stockbroker effectuating the transaction, or the financial institution through which the securities are held, are required, subject to any of the foregoing exemptions and the demonstration of a shareholder regarding his, her or its foreign residency, to withhold tax upon the distribution of dividend at the rate of 25%, so long as the shares are registered with a Nominee Company (for corporations and individuals).

Taxation of Investments

The following discussion is a summary of certain anticipated tax consequences of an investment in the Common Shares under Netherlands AntillesCuraçao tax laws, US federal income tax laws and Israeli laws. The discussion does not deal with all possible tax consequences relating to an investment in the Common Shares. In particular, the discussion does not address the tax consequences under state, local and other (e.g., non-US, non-Netherlands Antilles, non-Israel) tax laws. Accordingly, each prospective investor should consult its tax advisor regarding the tax consequences of an investment in the Common Shares. The discussion is based upon laws and relevant interpretations thereof in effect as of the date of this annual report on Form 20-F, all of which are subject to change.

Netherlands Antilles

Curaçao Taxation

Under the laws of the Netherlands AntillesCuraçao as currently in effect, a holder of Common Shares who is not a resident of, and during the taxable year has not engaged in trade or business through a permanent establishment in, the Netherlands AntillesCuraçao, will not be subject to Netherlands AntillesCuraçao income tax on dividends paid with respect to the Common Shares or on gains realized during that year on sale or disposal of such shares; the Netherlands AntillesCuraçao does not impose a withholding tax on dividends paid by the Company. Under Netherlands AntillesCuraçao law, no gift or inheritance taxes are levied if, at the time of such gift or at the time of death, the relevant holder of Common Shares was not domiciled in the Netherlands Antilles.

Curaçao.

U.S. Federal Income Tax Considerations

Subject to the limitations described herein, this discussion summarizes certain U.S. federal income tax consequences of the purchase, ownership and disposition of our Common Shares to a U.S. holder. A U.S. holder is a holder of our Common Shares who is:

·
an individual who is a citizen or resident of the U.S. for U.S. federal income tax purposes;
50

·
a corporation (or another entity taxable as a corporation for U.S. federal income tax purposes) created or organized under the laws of the United States, any political subdivision thereof, or the District of Columbia;

·
an estate, the income of which may be included in gross income for U.S. federal income tax purposes regardless of its source; or

·
a trust (i) if, in general, a U.S. court is able to exercise primary supervision over its administration and one or more U.S. persons have the authority to control all of its substantial decisions or (ii) an electing trust that haswas in effect a valid election under applicable U.S. Treasury Regulations to beexistence on August 19, 1996 and was treated as a U.S. person.domestic trust on that date.

Unless otherwise specifically indicated, this discussion does not consider the U.S. tax consequences to a person that is not a U.S. holder (a “non-U.S. holder”) and considers only U.S. holders that will own our Common Shares as capital assets (generally, for investment).

This discussion is based on current provisions of the Internal Revenue Code of 1986, as amended (the “Code”), current and proposed Treasury Regulations promulgated under the Code and administrative and judicial interpretations of the Code, all as currently in effect and all of which are subject to change, possibly with a retroactive effect. This discussion does not address all aspects of U.S. federal income taxation that may be relevant to any particular U.S. holder based on the U.S. holder’s particular circumstances. In particular, this discussion does not address the U.S. federal income tax consequences to U.S. holders who are broker-dealers, insurance companies, real estate investment trusts, regulated investment companies, grantor trusts, individual retirement and tax-deferred accounts, certain former citizens or long-term residen tsresidents of the U.S., tax-exempt organizations, financial institutions , “financial service entities”or who own, directly, indirectly or constructively, 10% or more of our outstanding voting shares, U.S. holders holding our Common Shares as part of a hedging, straddle or conversion transaction, U.S. holders whose functional currency is not the U.S. dollar, U.S. holders that acquired our Common Shares upon the exercise of employee stock options or otherwise as compensation, and U.S holders who are persons subject to the alternative minimum tax, who may be subject to special rules not discussed below.

Additionally, the tax treatment of persons who are, or hold our Common Shares through a partnership or other pass-through entity is not considered, nor is the possible application of U.S. federal estate or gift taxes or any aspect of state, local or non-U.S. tax laws.

You are advised to consult your tax advisor with respect to the specific U.S. federal, state, local and foreign tax consequences of purchasing, holding or disposing of our Common Shares.

Taxation of Distributions on Common Shares

Subject to the discussion below under “Tax Consequences if We Are a Passive Foreign Investment Company,” a distribution paid by us with respect to our Common Shares to a U.S. holder will be treated as dividend income to the extent that the distribution does not exceed our current and accumulated earnings and profits, as determined for U.S. federal income tax purposes.  Dividends

For the taxable years of 2011 and 2012, dividends that are received by U.S. holders that are individuals, estates or trusts will be taxed at thegenerally qualify for a 15% reduced maximum tax rate, applicable to long-term capital gains (currently a maximum rate of 15% through taxable years beginning on or before December 31, 2010), provided that such dividends meet the requirements of “qualified dividend income.” Unless the reduced rate provision is extended or made permanent or other changes are made by subsequent legislation, for tax years beginning on or after January 1, 2013, dividends will be taxed at regular ordinary income rates.” For this purpose, qualified dividend income generally includes dividends paid by a foreign corporation if certain holding period and other requirements are met and either (a) the stock of the foreign corporation with respect to which the dividends are paid is “readily tradable” on an established securities market in the U.S. (e.g., the NASDAQ Capital Market) or (b) the foreign corporation is eligible for benefits of a comprehensive income tax treaty with the U.S. which includes an information exchange program and is determined to be satisfactory by the U.S. Secretary of the Treasury. The United States Internal Revenue Service (“IRS”) has determined that the U.S.-Netherlands Antilles income tax treaty is not a comprehensive income tax treaty for this purpose. Dividends that fail to meet such requirements and dividends received by corporate U.S. holders are taxed at ordinary income rates. No dividend received by a U.S. holder will be a qualified dividend (i) if the U.S. holder held the Common Share with respect to which the dividend was paid for less than 61 days during the 121-day period beginning on the date th atthat is 60 days before the ex-dividend date with respect to such dividend, excluding for this purpose, under the rules of Code Section 246(c), any period during which the U.S. holder has an option to sell, is under a contractual obligation to sell, has made (and not closed) a short sale of, is the grantor of a deep-in-the-money or otherwise nonqualified option to buy, or has otherwise diminished its risk of loss by holding other positions with respect to, such Common Share (or substantially identical securities); or (ii) to the extent that the U.S. holder is under an obligation (pursuant to a short sale or otherwise) to make related payments with respect to positions in property substantially similar or related to the Common Share with respect to which the dividend is paid. If we were to be a “passive foreign investment company” (as such term is defined in the Code), or “PFIC”, for any taxable year, dividends paid on our Common Shares in such year or in the following taxable year would not be qualified dividends. See the discussion below regarding our PFIC status under “Tax Consequences if We Are a Passive Foreign Investment Company.” In addition, a non-corporate U.S. holder will be able to take qualified dividend income into account in determining its deductible investment interest (which is generally limited to its net investment income) only if it elects to do so; in such case the dividend income will be taxed at ordinary income rates.

51

The amount of any distribution which exceeds the amount treated as a dividend will be treated first as a non-taxable return of capital, reducing the U.S. holder’s tax basis in our Common Shares to the extent thereof, and then as capital gain from the deemed disposition of the Common Shares. Corporate holders will not be allowed a deduction for dividends received in respect of the Common Shares.

Distributions of current or accumulated earnings and profits paid in foreign currency to a U.S. holder will be includible in the income of a U.S. holder in a U.S. dollar amount calculated by reference to the exchange rate on the day the distribution is received. A U.S. holder that receives a foreign currency distribution and converts the foreign currency into U.S. dollars subsequent to receipt may have foreign exchange gain or loss based on any appreciation or depreciation in the value of the foreign currency against the U.S. dollar, which will generally be U.S. source ordinary income or loss.

Taxation of the Disposition of Common Shares

Subject to the discussion below under “Tax Consequences if We Are a Passive Foreign Investment Company,” upon the sale, exchange or other disposition of our Common Shares, a U.S. holder will recognize capital gain or loss in an amount equal to the difference between the amount realized on the disposition and the U.S. holder’s tax basis in our Common Shares. The gain or loss recognized on the disposition of the Common Shares will be long-term capital gain or loss if the U.S. holder held the Common Shares for more than one year at the time of the disposition and would be eligible for a reduced rate of taxation for certain non-corporate U.S. holders (currently a maximum rate of 15% for taxable years for a holding period ending in taxable years beginning on or before December 31, 2010).January 1, 2013 and a maximum rate of 20% thereafter. Capital gain from the sale, exchange or other disposition of Common Shares held for one year or l essless is short-term capital gain and taxed as ordinary income. Gain or loss recognized by a U.S. holder on a sale, exchange or other disposition of our Common Shares generally will be treated as U.S. source income or loss. The deductibility of capital losses is subject to certain limitations.

A U.S. holder that uses the cash method of accounting calculates the dollar value of the proceeds received on the sale as of the date that the sale settles. However, a U.S. holder that uses the accrual method of accounting is required to calculate the value of the proceeds of the sale as of the trade date and may therefore realize foreign currency gain or loss. A U.S. holder that uses the accrual method may avoid realizing foreign currency gain or loss by electing to use the settlement date to determine the proceeds of sale for purposes of calculating the foreign currency gain or loss. In addition, a U.S. holder that receives foreign currency upon disposition of its Common Shares and converts the foreign currency into dollars after the settlement date or trade date (whichever date the U.S. holder is required to use to calculate the value of the proceed sproceeds of sale) may have foreign exchange gain or loss based on any appreciation or depreciation in the value of the foreign currency against the dollar, which will generally be U.S. source ordinary income or loss.

Tax Consequences if We Are a Passive Foreign Investment Company

We would be a passive foreign investment company, or PFIC, for a taxable year if (taking into account certain “look-through” rules with respect to the income and assets of our corporate subsidiaries) either (i)(1) 75% or more of our gross income forin the taxable year wasis passive income,income; or (ii)(2) the average percentage (by value determined on a quarterly basis) in a taxable year of our assets that produce, or are held for the production of, passive assets during the taxable year wasincome is at least 50%. Passive income for this purpose generally includes, among other things, certain dividends, interest, royalties, rents and gains from commodities and securities transactions and from the sale or exchange of property that gives rise to passive income. If we own (directly or indirectly) at least 25% by value of the stock of another corporation, we would be treated for purposes of the foregoing tests as owning our proportionate share of the other corporation’s assets and as directly earning our proportionate share of the other corporation’s income. As discussed below, we believe that we were not a PFIC for 2009.

52

2010.

If we were a PFIC, each U.S. holder would (unless it made one of the elections discussed below on a timely basis) be taxable on gain recognized from the disposition of our Common Shares (including gain deemed recognized if our Common Shares are used as security for a loan) and upon receipt of certain excess distributions (generally, distributions that exceed 125% of the average amount of distributions in respect to such shares received during the preceding three taxable years or, if shorter, during the U.S. holder’s holding period prior to the distribution year) with respect to our Common Shares as if such income had been recognized ratably over the U.S. holder’s holding period for the shares. The U.S. holder’s income for the current taxable year would include (as ordinary income) amounts allocated to the current taxable ye aryear and to any taxable year prior to the first day of the first taxable year for which we were a PFIC. Tax would also be computed at the highest ordinary income tax rate in effect for each other taxable year to which income is allocated, and an interest charge on the tax as so computed would also apply. The tax liability with respect to the amount allocated to the taxable year prior to the taxable year of the distribution or disposition cannot be offset by any net operating losses. Additionally, if we were a PFIC, U.S. holders who acquire our Common Shares from decedents (other than nonresident aliens) dying before 2010 would be denied the normally-available step-up in basis for such shares to fair market value at the date of death and, instead, would have a tax basis in such shares equal to the lessorlesser of the decedent’s basis or the fair market value of such shares on the decedent's date of death.

.

As an alternative to the tax treatment described above, a U.S. holder could elect to treat us as a “qualified electing fund” (a “QEF”), in which case the U.S. holder would be taxed, for each taxable year that we are a PFIC, on its pro rata share of our ordinary earnings and net capital gain (subject to a separate election to defer payment of taxes, which deferral is subject to an interest charge). Special rules apply if a U.S. holder makes a QEF election after the first taxable year in its holding period in which we are a PFIC. We have agreed to supply U.S. holders with the information needed to report income and gain under a QEF election if we were a PFIC. Amounts includable in income as a result of a QEF election will be determined without regard to our prior year losses or the amount of cash d istributions,distributions, if any, received from us. A U.S. holder’s basis in its Common Shares will increase by any amount included in income and decrease by any amounts not included in income when distributed because such amounts were previously taxed under the QEF rules. So long as a U.S. holder’s QEF election is in effect with respect to the entire holding period for its Common Shares, any gain or loss realized by such holder on the disposition of its Common Shares held as a capital asset generally will be capital gain or loss. Such capital gain or loss ordinarily would be long-term if such U.S. holder had held such Common Shares for more than one year at the time of the disposition.  Fordisposition and would be eligible for a reduced rate of taxation for certain non-corporate U.S. holders long-term capital gain is generally subject to(currently a maximum federal income tax rate of 15% for a holding period ending in taxable years beginning on or before December 31, 2010.January 1, 2013 and a maximum rate of 20% thereafter). The QEF election is made on a shareholder-by-shareholder basis, applies to all Common Shares held or subsequently acquired by an electing U.S. holder and can be revoked only with the consent of the IRS.

As an alternative to making a QEF election, a U.S. holder of PFIC stock that is “marketable stock” (e.g., “regularly traded” on the NASDAQ Capital Market) may, in certain circumstances, avoid certain of the tax consequences generally applicable to holders of stock in a PFIC by electing to mark the stock to market as of the beginning of such U.S. holder’s holding period for our Common Shares. Special rules apply if a U.S. holder makes a mark-to-market election after the first year in its holding period in which we are a PFIC. As a result of such an election, in any taxable year that we are a PFIC, a U.S. holder would generally be required to report gain or loss to the extent of the difference between the fair market value of the Common Shares at the end of the taxable year and such U.S. holder’s tax basis i nin such shares at that time. Any gain under this computation, and any gain on an actual disposition of our Common Shares in a taxable year in which we are PFIC, would be treated as ordinary income. Any loss under this computation, and any loss on an actual disposition of our Common Shares in a taxable year in which we are PFIC, would be treated as ordinary loss to the extent of the cumulative net-mark-to-market gain previously included. Any remaining loss from marking our Common Shares to market will not be allowed, and any remaining loss from an actual disposition of our Common Shares generally would be capital loss. A U.S. holder’s tax basis in its Common Shares is adjusted annually for any gain or loss recognized under the mark-to-market election. There can be no assurances that there will be sufficient trading volume with respect to our Common Shares for the Common Shares to be considered “regularly traded” or that our Common Shares will continue to trade on the NASDAQ Capital Market. Accordingly, there are no assurances that our Common Shares will be marketable stock for these purposes. As with a QEF election, a mark-to-market election is made on a shareholder-by-shareholder basis, applies to all Common Shares held or subsequently acquired by an electing U.S. holder and can only be revoked with consent of the IRS (except to the extent our Common Shares no longer constitute “marketable stock”).

53

Based on an analysis of our assets and income, we believe that we were not a PFIC for 2008.2010. We currently expect that we will not be a PFIC in 2010.2011. The tests for determining PFIC status are applied annually and it is difficult to make accurate predictions of future income and assets, which are relevant to this determination. Accordingly, there can be no assurance that we will not become a PFIC in any future taxable years. U.S. holders who hold our Common Shares during a period when we are a PFIC will be subject to the foregoing rules, even if we cease to be a PFIC, subject to certain exceptions for U.S. holders who made QEF, mark-to-market or certain other special elections. U.S. holders are urged to consult their tax advisors about the PFIC rules, including the consequences to them of making a mark-to-market or QEF election with respect to our Common Shares in the event that we qualify as a PFIC.

80

Non-U.S. holders of Common Shares

Except as provided below, a non-U.S. holder of our Common Shares will not be subject to U.S. federal income or withholding tax on the receipt of dividends on, or the proceeds from the disposition of, our Common Shares, unless, in the case of U.S. federal income taxes, that item is effectively connected with the conduct by the non-U.S. holder of a trade or business in the United States and, in the case of a resident of a country which has an income tax treaty with the United States, such item is attributable to a permanent establishment in the United States or, in the case of an individual, a fixed place of business in the United States. In addition, gain recognized on the disposition of our Common Shares by an individual non-U.S. holder will be subject to tax in the United States if the non-U.S. holder is present in the United States for 183 days or mo remore in the taxable year of the sale and certain other conditions are met.

Information Reporting and Backup Withholding

A U.S. holder generally is subject to information reporting and may be subject to backup withholding at a rate of up to 28% (through 2010) with respect to dividend payments on, or receipt of the proceeds from the disposition of, our Common Shares. Backup withholding will not apply with respect to payments made to exempt recipients, including corporations and tax-exempt organizations, or if a U.S. holder provides a correct taxpayer identification number, certifies that such holder is not subject to backup withholding or otherwise establishes an exemption. Non-U.S. holders are not subject to information reporting or backup withholding with respect to dividend payments on, or receipt of the proceeds from the disposition of, our Common Shares in the U.S., or by a U.S. payor or U.S. middleman, provided that such non-U.S. holder provides a taxpayer identific ationidentification number, certifies to its foreign status, or otherwise establishes an exemption. Backup withholding is not an additional tax and may be claimed as a credit against the U.S. federal income tax liability of a holder, or alternatively, the holder may be eligible for a refund of any excess amounts withheld under the backup withholding rules, in either case, provided that the required information is furnished to the IRS.

Israeli Tax Considerations

Israeli Holders of Common Shares

Capital Gains From the Sale of Shares

Israeli law generally imposes a capital gains tax on the sale of capital assets by residents of Israel, as defined for Israeli tax purposes, and on the sale of assets located in Israel, including shares in Israeli companies, by both residents and non-residents of Israel, unless a specific exemption is available or unless a tax treaty between Israel and the shareholder’s country of residence provides otherwise. The law distinguishes between the “Real Gain” and the “Inflationary Surplus”. The Inflationary Surplus is a portion of the total capital gain which is equivalent to the increase of the relevant asset’s purchase price which is attributable to the increase in the Israeli CPI or, in certain circumstances, a foreign currency exchange rate, between the date of purchase and the date of sale. The Real Gain is the excess of the total capital gain over the Inflationary Su rplus.
54

As of January 1, 2006, the Israeli Income Tax Ordinance was amended (via the Law for Amendment of the Income Tax Ordinance (No. 147), 5765-2005) to provide that an individual is subject to a 20% tax rate on real capital gains derived from the sale of shares, as long as the individual has not demanded a deduction of interest and linkage differences in connection with the purchase and holding of the securities; and as long as the individual is not considered as a "substantial shareholder" of the company issuing the shares, i.e., a shareholder who holds directly or indirectly, including with others, at least 10% of any means of control in the company. A substantial shareholder (or a shareholder who has demanded a deduction of interest and linkage differences) will be subject to tax at a rate of 25% on real capital gains derived from the sale of shares iss ued by the company. The determination of whether the individual is a substantial shareholder will be made on the date that the securities are sold. In addition, the individual will be deemed to be a substantial shareholder if at any time during the twelve months preceding such date he or she had been a substantial shareholder. Israeli companies are subject to the corporate tax rate on capital gains derived from the sale of shares, unless such companies were not subject to the Income Tax Law (Adjustment for Inflation) 1985 (the "Adjustments Law") (or certain regulations) at the time of publication of the aforementioned Law for Amendment of the Income Tax Ordinance (No. 147), 5765-2005, in which case the applicable tax rate is 25%. The foregoing tax rates, however, will not apply to (i) dealers in securities; and (ii) shareholders who acquired their shares prior to an initial public offering (which shares may be subject to a different tax arrangement).
The tax basis of shares acquired prior to January 1, 2003 will be determined in accordance with the average closing share price in the three trading days preceding January 1, 2003. However, a request may be made to the tax authorities to consider the actual adjusted cost of the shares as the tax basis if it is higher than such average price.
According to the tax reform legislation, non-residents of Israel are exempt from any capital gains tax on any gains derived from the sale of shares of Israeli companies publicly traded on a recognized stock exchange or regulated market outside of Israel (including from the sale of our Common Shares), provided however that (i) such capital gains are not derived through a permanent establishment in Israel; (ii) such shareholders are not subject to the Adjustments Law; (iii) such shareholders did not acquire their shares prior to an initial public offering; and (iv) so long as our Common Shares remain listed for trading as described above. However, non-Israeli corporations will not be entitled to such exemption if an Israeli resident (x) has a controlling interest of 25% or more in such non-Israeli corporation, or (y) is the beneficiary or is entitled to 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly.
In some instances where our shareholders may be liable for Israeli tax on the sale of our Common Shares, the payment of the consideration may be subject to the withholding of Israeli tax at the source.
Rate of Tax Applicable to Income from Dividends on Shares

In general, those individuals who are residents of Israel will owe tax at a rate of 20% on dividends received in connection with our Common Shares. Yet, individuals who are “significant shareholders” (see above) at the time of receiving the dividend, or at any time during the 12-month period preceding the receipt of dividend, will be subject to a tax rate of 25%. The tax rate in respect of dividends received by Israeli companies is, in general, 0%, but dividends that are derived from sources outside of Israel or that are generated or produced outside of Israel will be taxed at a rate of 25%. Dividends received by a taxable mutual fund will be subject to the 20% tax rate of an Israeli resident individual (for whom the income is not classified as “business” income). Generally, exempt mutual funds, pension funds and other entities that are exempt from tax under Section 9(2) of the Israeli Tax Ordinance are exempt from tax on such dividends. A “taxable mutual fund” is defined in the Israeli Tax Ordinance as a mutual fund whose agreement or prospectus irrevocably states that the fund is a mutual fund subject to tax. An “exempt mutual fund” is defined as a mutual fund whose agreement or prospectus irrevocably states that the fund is a mutual fund exempt from tax.

Non- Israeli Holders

Generally, Israeli income tax will not apply to income, including capital gains dividends, which is realized by a non-Israeli resident who has purchased securities from a non-Israeli resident corporation, provided that (i) the non-Israeli resident corporation is not deemed an Israeli resident corporation for tax purposes;  (ii) the securities are not deemed as a right to assets in Israel (i.e., the consolidated assets of the corporation are substantially located in Israel); and (iii) the income is not derived from a permanent establishment of the non-Israeli resident purchaser in Israel.
55


Although we are not registered and/or incorporated in Israel, the Israeli Tax Authority may contend that the "control and management" of our business is exercised in Israel and, therefore, we are considered a resident of Israel for tax purposes. In general, the test of “control and management” seeks to determine where the company’s policy is set and where its strategic resolutions are accepted. Accordingly, what is examined is the place in which the ability to direct and determine the business policy of the company is realized and the place in which the resolutions allowing the business of the company to be carried-out are accepted. The test of “control and management” is determined every tax year. Furthermore, since a substantial portion of our assets are located in Israel, our shares may be deemed by the Israeli Tax Auth ority as a right to assets in Israel. It should be noted that Israeli tax law does not provide clear guidelines regarding the manner in which the Israeli and non-Israeli assets of a non-Israeli company should be measured for purposes of determining whether the assets of such company are substantially located in Israel and whether its shares are deemed a right to assets in Israel. Therefore, it is uncertain whether our shares would be considered a right to assets in Israel.

In the event that we are classified as an Israeli resident corporation or our shares are deemed a right to assets in Israel, the following tax consequences would be applicable to non-Israeli residents who purchased our securities.

Capital Gains From the Sale of Shares

Non-Israeli residents, including U.S. resident purchasers, are generally exempt from Israeli capital gains tax on any gains derived from the sale of securities publicly traded on NASDAQ, whether such sold securities are of an Israeli resident corporation or of a non-Israeli resident corporation, provided such gains are not derived from a permanent establishment of such shareholders in Israel. However, non-Israeli corporations selling such securities, including U.S. resident corporations, will not be entitled to such an exemption if an Israeli resident (i) has a controlling interest of 25% or more in the non-Israeli corporation, or (ii) if the beneficiary is directly or indirectly entitled to 25% or more of the revenues or profits of the non-Israeli corporation.
In addition, pursuant to certain treaties to which the Government of Israel is a party, the sale, exchange or disposition of common shares may not be subject to Israeli capital gains tax, in according with the terms of such treaties.
For example, pursuant to the Convention between the Government of the United States of America and the Government of Israel with respect to Taxes on Income, or U.S.-Israel Tax Treaty, the sale, exchange or disposition of common shares by a person who qualifies as a “resident of the United States” within its meaning under the U.S.-Israel Tax Treaty and who is entitled to claim the benefits afforded to such person by the U.S.-Israel Tax Treaty, which person is referred to for purposes of this tax discussion as “Treaty U.S. Resident,” generally will not be subject to Israeli capital gains tax unless such Treaty U.S. Resident holds, directly or indirectly, shares representing 10% or more of the voting power during any part of the 12-month period preceding such sale, exchange or disposition. Moreover, subject to particular conditions , the capital gains from such sale, exchange or disposition can be allocated to a permanent establishment of such Treaty U.S. Resident in Israel. In such cases, subject to the limitations of U.S. laws applicable to foreign tax credits, the Treaty U.S. Resident would be subject to Israeli tax, to the extent applicable; however, under the U.S.-Israel Tax Treaty, such Treaty U.S. Resident would be permitted to claim a credit for such taxes against the U.S. federal income tax imposed with respect to such sale, exchange or disposition.
Therefore, the exemption under the Israeli Tax Ordinance may be the only exemption from Israeli tax available to non-Israeli shareholders. Accordingly, non-Israeli resident purchasers who, in light of the existence or lack of existence of certain conditions, are unable to benefit from a treaty, may wish to utilize a recently introduced special exemption on capital gains arising from the sale of shares in an Israeli company (including companies which are deemed an Israeli resident corporation for tax purposes) between July 1, 2005 and December 31, 2008.  In order for this exemption to apply, the following conditions must be met:

(a)an application is to be submitted to the Israeli Tax Authority at the same time as the reporting of the saleF.Dividends and capital gain;Paying Agents.

Not applicable.

(b)the capital gain does not derive from a permanent establishment of the seller in Israel;G.Statement by Experts.
56

Not applicable.

(c)the seller is an individual and has been a resident of a country with which Israel has a tax treaty (e.g., the U.S.) during the ten continuous years prior to the acquisition or is an entity where at least 75% of the means of control of the entity are ultimately held, directly or indirectly, by individual shareholders who are residents of a country with which Israel has a tax treaty (e.g., the U.S.) during the ten continuous years prior to the acquisition. Unless it can be proved otherwise, where the entity is listed on a non-Israel stock exchange, this condition is deemed to be met automatically in respect of “non-material” shareholders. “Material” is defined as a 10% or more holding, directly or indirectly, of any means of control, together with related parties;

(d)the shares were not purchased from a “related party” (as defined in the Israeli Tax Ordinance) and Chapter E-2 of the Israeli Tax Ordinance did not apply to such purchase of shares;

(e)the sale was reported to the tax authority in the country of the seller’s residence; and

(f)within 30 days of the acquisition, the transaction was disclosed in full to the Israeli Tax Authority.

Shareholders who wish to benefit from this additional exemption would therefore be advised to approach the Israeli Tax Authority within 30 days of the purchase of shares in the Company.
In the event that the exceptions to the capital gains tax do not apply to a non-Israeli resident purchaser, upon the realization of gain from the sale of our shares, such non-Israeli resident purchaser will be subject to the tax rates described above under “Israeli Holders - Capital Gains From the Sale of Shares.”

Rate of Tax Applicable to Income from Dividends on Shares

Non-residents of Israel are subject to income tax on income accrued or derived from sources in Israel. Such sources of income include passive income, such as dividends on shares of an Israeli resident corporation.

Under Israeli tax law, distributions of dividends are generally subject to withholding tax at the rates indicated above under “Israeli Holders - Rate of Tax Applicable to Income from Dividends on Shares.” However, the tax rates in the event of a distribution of dividends to a foreign resident are subject to relevant provisions of the applicable treaty for the avoidance of double taxation between Israel and the country of residency of the foreign resident. For U.S. resident purchasers, who qualify as Treaty U.S. Residents under the U.S.-Israel Tax Treaty, the maximum rate of tax on dividends paid to a holder of common shares is 25%; however, the tax rate is generally reduced to 12.5% if the shareholder is a U.S. corporation and holds at least 10% of the issued voting power during the whole of its prior tax year, as well as during the part of the tax year that precedes the date of payment of the dividend, and not more than 25% of the gross income consists of interest or dividends.

F.           Dividends and Paying Agents.
Not applicable.
G.           Statement by Experts.
Not applicable.
57

H.Documents on Display.

We are currently subject to the information and periodic reporting requirements of the Exchange Act that are applicable to foreign private issuers. Although as a foreign private issuer we are not required to file periodic information as frequently or as promptly as United States companies, we generally do publicly announce our quarterly and year-end results promptly and file periodic information with the United States Securities and Exchange Commission under cover of Form 6-K. As a foreign private issuer, we are also exempt from the rules under the Exchange Act prescribing the furnishing and content of proxy statements and our officers, directors and principal shareholders are exempt from the reporting and other provisions in Section 16 of the Exchange Act. Our SEC filings are filed electronically on the EDGAR reporting system and may be obtained through that medium. You may inspect without charge and copy at prescribed rates such filings, including any exhibits and schedules, at the public reference facilities maintained by the SEC, 100 F Street, N.E., Washington, D.C. 20549. You may also obtain copies of such materials from the SEC at prescribed rates. The SEC also maintains a web site that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. The address of this web site is http://www.sec.gov. You may call the SEC at 1-800-SEC-0330 for further information on the public reference rooms. The Exchange Act file number for our Securities and Exchange Commission filings is 000-20181.

Information about Sapiens is also available on itsour website at http://www.sapiens.com. Such information on our website is not part of this annual report.

I.           Subsidiary Information.

I.Subsidiary Information.

Not applicable.

Item 11.QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.Quantitative and Qualitative Disclosure about Market Risk.

Market risks relating to our operations result primarily from changes in exchange rates, interest rates or weak economic conditions in the markets in which we sell our products and services. We have been and we are actively monitoring these potential exposures. To manage the volatility relating to these exposures, we may enter into various forward contracts or other hedging instruments. Our objective is to reduce, where it is deemed appropriate to do so, fluctuations in earnings and cash flows associated with changes in foreign currency rates and interest rates.

Foreign Currency Risk.We conduct our business in various foreign currencies, primarily those of Israel and the UK,United Kingdom, and to a lesser extent of Japan, Europe and Canada. A devaluation of the NIS, GBP, Euro and the Japanese Yen in relation to the US dollarDollar has the effect of reducing the US dollarDollar amount of any of our expenses or liabilities which are payable in those currencies (unless such expenses or payables are linked to the US dollar) while reducing the US Dollar amount of any of our revenues which are payable to us in those currencies.


Because exchange rates between the NIS, GBP, Euro and the Japanese Yen against the US dollar fluctuate continuously, exchange rate fluctuations and especially larger periodic devaluations will have an impact on our profitability and period-to-period comparisons of our results. The effects of foreign currency re-measurements are reflected as financial expenses in our consolidated financial statements. A hypothetical 10% movement in foreign currency rates (primarily the NIS, GBP, Euro and Japanese Yen) against the US dollar, with all other variables held constant on the expected sales, would result in a decrease or increase in expected 20102011 sales revenues of approximately $3.6$5.0 million.


We monitor our foreign currency exposure and, from time to time, may enter into currency forward contracts or put/call currency options to hedge balance sheet exposure. We may use such contracts to hedge exposure to changes in foreign currency exchange rates associated with balance sheet balances denominated in a foreign currency and anticipated costs to be incurred in a foreign currency. In 2009, we entered into hedging transactions, by purchasing put options in the total amountSee Item 5E for details of $5.8 million, to protect against the devaluation of the US Dollar, in the range of NIS 3.80 – 4.00 per US dollar (i.e., pursuant to which we could sell up to such aggregate amount of US dollars in exchange for such number of Israeli shekels per US dollar. As of December 31, 2009, we did not have any put option contracts outstanding.

Except for the abovementioned put option contracts, as of December 31, 2009, we had no foreign exchange contracts, options contracts or other foreign hedging arrangements.
arrangements entered into during 2011.

Market Risk.We currently do not invest in, or otherwise hold, for trading or other purposes, any financial instruments subject to market risk.

58

Interest Rate Risk. We pay interest on our credit facilities convertible notes and short-term loans based on LIBOR, for dollar-denominated loans, and the prime interest rate in Israel for some of our NIS-denominated loans. As a result, changes in the general level of interest rates directly affect the amount of interest payable by us under these facilities. However, we expect our exposure to risk from changes in interest rates to be minimal and not material. Therefore, no quantitative tabular disclosures are required.

Item 12.DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES.Description of Securities Other than Equity Securities.

Not applicable.

Item 13.DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES.Defaults, Dividend Arrearages and Delinquencies.

Not applicable.

Item 14.MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS.Material Modifications to the Rights of Security Holders and Use of Proceeds.

None.

CONTROLS AND PROCEDURESItem 15.Controls and Procedures

A.Disclosure Controls and Procedures. TheOur management, including our President and Chief Executive Officer of the Company and the Chief Financial Officer of the Company have evaluated the effectiveness of the Company’sour disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this annual report (the “Evaluation Date”). Based on such evaluation, the President and Chief Executive Officer and the Chief Financial Officer have con cludedconcluded that, as of the Evaluation Date, the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports that the Company files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including the President and Chief Executive Officer and the Chief Financial Officer, to allow for timely decisions regarding required disclosure and that such information is recorded, processed, summarized and reported within the periods specified by the SEC’s rules and forms.effective.

B.Management's Annual Report on Internal Control Over Financial Reporting.Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Under the supervision and with the participation of ourOur management, including our President and Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporti ngreporting based principally on the framework and criteria established in Internal Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) as of the end of the period covered by this report. Based on that evaluation, our management has concluded that our internal control over financial reporting was effective as of December 31, 2009.2011. Our management’s assessment of, and conclusion on, the effectiveness of internal control over financial reporting did not include the internal control over financial reporting of IDIT and FIS, which were acquired on August 21, 2011, and are included in the 2011 consolidated financial statements of Sapiens and its subsidiaries. Notwithstanding the foregoing, there can be no assurance that the Company’sour internal control over financial reporting will detect or uncover all failures of persons within the Company to comply with our internal procedures, as all internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective may not prevent or detect misstatements and can provide only reasonable assurance with respect to the ability to detect or uncover all failures of persons within the Company to disclose material information required to be set forth in our reports.misstatements.


This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by our registered public accounting firm pursuant to temporary rulesC.          Attestation Report of the Securities and Exchange Commission that permit us to provide only management's report in this annual report.Registered Public Accounting Firm.

59

Not applicable.

C.D.Changes in Internal Control Over Financial Reporting.Based on the evaluation conducted by our President and Chief Executive Officer and our Chief Financial Officer pursuant to Rules 13a-1513a-15(d) and 15d-1515d-15(d) under the Exchange Act, we haveour management has concluded that there werewas no changeschange in our internal control over financial reporting that occurred during the year ended December 31, 20092011 that have materially affected, or areis reasonably likely to materially affect, our internal control over financial reporting.

ITEM 16.  RESERVED

RESERVEDItem 16A.Audit Committee Financial Expert.
AUDIT COMMITTEE FINANCIAL EXPERT.

Our Board of Directors has determined that Mr. Yacov Elinav, a member of our Audit Committee, meets the definition of an “audit committee financial expert,” as defined under the applicable rules promulgated by the SEC. All members of our Audit Committee, including Mr. Elinav, are "independent", as defined under the NASDAQ Listing Rules.

Item 16B.CODE OF ETHICS.Code of Ethics.

We have adopted a Code of Ethics that applies to our principal executive officer, principal financial officer and corporate controller, as well as to our directors and other employees. The Code of Ethics is publicly available on our website at www.sapiens.com. Written copies are available upon request. If we make any substantive amendments to the Code of Ethics or grant any waivers, including any implicit waiver, from a provision of such Code to our principal executive officer, principal financial officer or corporate controller, we will disclose the nature of such amendment or waiver on our website.

ITEM 16C.PRINCIPAL ACCOUNTANT FEES AND SERVICES.

Policies and Procedures

Our Audit Committee has adopted policies and procedures for the pre-approval of audit and non-audit services rendered by our independent auditors, Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global. The policies generally require the Audit Committee’s pre-approval of the scope of the engagement of our independent auditors or additional work performed on an individual basis. The policy prohibits retention of the independent auditors to perform the prohibited non-audit functions defined in Section 201 of the Sarbanes-Oxley Act of 2002 or the rules of the SEC and also considersprovides that the Audit Committee consider whether proposed services are compatible with the independence of the public auditors. During 20082010 and 2009,2011, 100% of the fees for services rendered by the Company’s independent auditors were pre-approved by the Audit Committee, in accordance with th esethese procedures.

Fees Paid to Independent Auditors

The following table sets forth, for each of the years indicated, the aggregate fees billed by our independent auditors for types of services indicated:

  Year ended December 31, 
  2009  2008 
  (in thousands) 
Audit Fees (1) $202  $144 
Audit Related Fees (2)  -  $40 
Tax Fees (3) $33  $28 
All Other Fees (4) $8  $26 
         
Total $243  $238 
60

  Year ended December 31, 
  2011  2010 
  (in thousands) 
Audit Fees (1) $195  $212 
Tax Fees (2) $83  $64 
All Other Fees (3) $72  $17 
         
Total $350  $293 

(1)Audit Fees consist of fees billed for the annual audit and the quarterly reviews of the Company’s consolidated financial statements and consist of services that would normally be provided in connection with statutory and regulatory filings or engagements, including services that generally only the independent auditors can reasonably provide.

(2)Audit Related Fees consist of fees billed for assurance and related services that traditionally were only performed by the independent auditor, and include the review of documents filed with the SEC, accounting consultation and consultation concerning financial accounting and reporting standards.
(3)(2)Tax Fees relate to tax compliance, planning and advice.

(4)(3)All Other Fees consist of services related to stock options and value added tax (VAT) related matters.

Item 16D.Exemptions from the Listing Standards for Audit Committees

Not applicable.

Item 16E.Purchase of Equity Securities by the Issuer and Affiliated Purchasers

None.

ITEM 16F.CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT.

Not applicable.

85
EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES
Not applicable.

ITEM 16E.16G.PURCHASE OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERSCORPORATE GOVERNANCE.

We did not effect any repurchasesare exempt from a number of the requirements under the Nasdaq Listing Rules based on our Common Shares during the 2009 fiscal year covered by this annual report.

Our controlling shareholder, Formula, conducted purchases of 12,108 of our Common Shares in the open market during such period.
None
status as a "controlled company." See Item 6.C below “Board Practices— NASDAQ Exemptions for a Controlled Company.”

We have elected to follow our home country practice in lieu of the requirements set forth in NASDAQ Listing Rule 5250(d)(1) which require a domestic United States company to make available to its shareholders a copy of its annual report containing its audited financial statements in one of three specific ways. Instead of distributing copies of our annual report by mail, furnishing an annual report in accordance with Rule 14a-16 under the Exchange Act or posting our annual report on our website and undertaking to provide a hard copy thereof free of charge upon request, we simply make our annual report available to shareholders via our website (http://www.sapiens.com/AnnualReports/Annual-Reports/).

We have also elected to follow our home country practice in lieu of the requirements of NASDAQ Listing Rules 5605(b), (d) and (e) which require:

•          The majority of the company’s board of directors must qualify as independent directors, as defined under NASDAQ Listing Rule 5605(a)(2) and that the independent directors have regularly scheduled meetings at which only independent directors are present.

•          The compensation of the chief executive officer and all other executive officers must be determined, or recommended to the board of directors for determination, either by (i) a majority of the independent directors or (ii) a compensation committee comprised solely of independent directors (subject to limited exceptions).

•          Director nominees must either be selected or recommended for the board of directors’ selection, either by (a) a majority of independent directors or (b) a nominations committee comprised solely of independent directors (subject to limited exceptions).

•          The company must certify that it has adopted a formal written charter or board resolution, as applicable, addressing the nominations process and such related matters as may be required under US federal securities laws.

We have also elected to follow our home country practice in lieu of the requirements set forth in of NASDAQ Listing Rule 5635 which require a domestic United States Company to obtain shareholder approval for certain dilutive events, such as for the establishment or amendment of certain equity based compensation plans and arrangements, an issuance that will result in a change of control of the company, certain transactions other than a public offering involving issuances of a 20% or more interest in the company and certain acquisitions of the stock or assets of another company.

We have submitted to NASDAQ a written statement from our independent Netherlands AntillesCuraçao counsel which certified that our practice of not making the annual report available in accordance with NASDAQ rules, but rather making it available on our website, isour not complying with the requirements of NASDAQ Listing Rules 5605(b), (d) and (e) and not obtaining the shareholder approvals required under NASDAQ Listing Rule 5635 are not prohibited by Netherlands AntillesCuraçao law.

61

Item 17.FINANCIAL STATEMENTS.Financial Statements.

We have elected to provide financial statements and related information pursuant to Item 18.

Item 18.FINANCIAL STATEMENTS.Financial Statements.

The Consolidated Financial Statements and related notes required by this Item are contained on pages F-1 through F-40 hereof.

INDEX TO 20092011 CONSOLIDATED FINANCIAL STATEMENTS

 Page
Report of Independent Registered Public Accounting FirmF-2
Consolidated Balance SheetsF-3 – F-4
Consolidated Statements of OperationsF-5
Consolidated Statements of Changes in Shareholders’ EquityF-6 – F-8
Consolidated Statements of Cash FlowF-9 – F-10
Notes to the Consolidated Financial StatementsF-11 – F-35F-41

87
62

ITEM 19.EXHIBITS

The exhibits filed with or incorporated into this annual report are listed immediately below.

1.1Articles of Association of Sapiens International Corporation N.V., as amended on March 17, 2005 – incorporated by reference to Exhibit 1.1 to the Company’s Annual Report on Form 20-F, filed with the SEC on June 29, 2005.

4(a)1Sapiens International Corporation N.V. 1992 Stock Option and Incentive Plan, as amended and restated – incorporated by reference to Exhibit 28.1 to the Company’s Registration Statement on Form S-8 (No. 33-64208), filed with the SEC on June 9, 1993, and to the Company's Registration Statement on Form S-8 (No. 333-10622), filed with the SEC on July 22, 1999.

4(a)2Sapiens International Corporation N.V. 2003 Share Option Plan - incorporated by reference to Exhibit 4(c)2 to the Company’s Annual Report on Form 20-F, filed with the SEC on June 28, 2007.

4(a)3Sapiens International Corporation N.V. 2005 Special Incentive Share Option Plan - incorporated by reference to Exhibit 4(c)3 to the Company’s Annual Report on Form 20-F, filed with the SEC on June 28, 2007.

4(a)4Sapiens International Corporation N.V. 2011 Share Incentive Plan - incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-8 (No. 333-177834), filed with the SEC on November 9, 2011.

4(b)Share Purchase Agreement, dated as of July 21, 2011, by and among Sapiens, Sapiens Technologies (1982) Ltd., IDIT I.D.I. Technologies Ltd., the shareholders of IDIT I.D.I. Technologies Ltd., Amit Ben-Yehuda, as the IDIT Shareholder Representative, FIS Software Ltd., the shareholders of FIS Software Ltd. and Dan Goldstein, as the FIS Shareholder Representative.

8.1List of Subsidiaries

10.1Consent of Kost Forer Gabbay & Kasierer, Independent Registered Public Accounting FirmFirm.

12.1Certification by Chief Executive Officer pursuant to Rule 13a-14(a)/Rule 15d-14(a) under the Exchange Act.

12.2Certification by Chief Financial Officer pursuant to Rule 13a-14(a)/Rule 15d-14(a) under the Exchange Act.
13.1Certification of Chief Executive Officer pursuant to Rule 13a-14(b)/Rule 15d-14(b) under the Exchange Act and 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 20022002.

13.2Certification of Chief Financial Officer pursuant to Rule 13a-14(b)/Rule 15d-14(b) under the Exchange Act and 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 20022002.
63

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

SAPIENS INTERNATIONAL CORPORATION N.V.
   
 By:/s/ Roni Al Dor 
  Roni Al Dor
  President & Chief Executive Officer

Date: April 3, 2012

Date: April 28, 2010
90
64

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES


CONSOLIDATED FINANCIAL STATEMENTS


AS OF DECEMBER 31, 2009


2011

IN U.S. DOLLARS


INDEX


 Page
  
F - 2
  
F - 3 - F - 4
  
IncomeF - 5
  
and Comprehensive IncomeF – 6
Consolidated Statements of Cash FlowsF - 67 - F - 8
  
F - 9 - F - 10– 41

- - - - - - - -



  

Kost Forer Gabbay & Kasierer

3 Aminadav St.


Tel-Aviv 67067, Israel

Tel:972 (3)6232525

Fax: 972 (3)5622555

www.ey.com/il

www.ey.com

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the Board of Directors and Shareholders of


SAPIENS INTERNATIONAL CORPORATION N.V.


We have audited the accompanying consolidated balance sheets of Sapiens International Corporation N.V. ("the Company") and its subsidiaries as of December 31, 20082010 and 20092011, and the related consolidated statements of operations,income, changes in equity and comprehensive income, and cash flows for each of the three years in the period ended December 31, 2009.2011. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.


We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Company's internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statemen ts,statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.


In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Sapiens International Corporation N.V.the Company and its subsidiaries as of December 31, 20082010 and 20092011, and the consolidated results of their operations and their cash flows for each of the three years in the period ended December 31, 2009,2011, in conformity with U.S. generally accepted accounting principles.


Tel-Aviv, Israel
/s/ Kost Forer Gabbay & Kasierer
KOST FORER GABBAY & KASIERER
Tel-Aviv, IsraelKOST FORER GABBAY & KASIERER
April 28 , 20104, 2012A Member of Ernst & Young Global
F - 2


SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS


U.S. dollars in thousands


  December 31, 
  2008  2009 
ASSETS      
       
CURRENT ASSETS:      
Cash and cash equivalents $7,938  $11,172 
Trade receivables (net of allowance for doubtful accounts of $ 881 and $ 904 at December 31, 2008 and 2009, respectively) (Note 3)  6,860   5,132 
Other receivables and prepaid expenses (Note 4)  2,565   3,008 
         
Total current assets
  17,363   19,312 
         
PROPERTY AND EQUIPMENT, NET (Note 5)  1,055   897 
         
OTHER ASSETS:        
Capitalized software development costs, net of accumulated amortization of $ 20,193 and $ 25,216 at December 31, 2008 and 2009, respectively (Note 6a)  14,391   13,540 
Goodwill  8,621   8,621 
Deferred income taxes (Note 11h)  2,159   1,806 
Other, net (Note 6b)  1,588   1,598 
         
Total other assets
  26,759   25,565 
         
Total assets
 $45,177  $45,774 

  December 31, 
  2010  2011 
       
ASSETS        
         
CURRENT ASSETS:        
Cash and cash equivalents $16,182  $21,460 
Restricted cash  -   456 
Trade receivables (net of allowance for doubtful accounts of $ 145 and
$ 226 at December 31, 2010 and 2011, respectively)
  5,511   14,484 
Other receivables and prepaid expenses  1,350   1,823 
Deferred tax assets  1,681   1,406 
         
Total current assets  24,724   39,629 
         
         
LONG-TERM ASSETS:        
Other long-term assets  2,955   3,546 
Severance pay fund  4,908   10,172 
Capitalized software development costs, net  13,822   17,399 
Other intangible assets, net  1,545   14,193 
Goodwill  9,604   66,715 
Property and equipment, net  1,161   1,814 
         
Total long-term assets  33,995   113,839 
         
Total assets $58,719  $153,468 

The accompanying notes are an integral part of the consolidated financial statements.

F - 3

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS


U.S. dollars in thousands (except share and per share data)



  December 31, 
  2008  2009 
LIABILITIES AND EQUITY      
       
CURRENT LIABILITIES:      
Current maturities of long-term liabilities and convertible debt (Notes 8 and 9) $5,745  $- 
Trade payables  1,500   1,197 
Other liabilities and accrued expenses (Note 7)  9,716   10,199 
Deferred revenues  4,908   6,991 
         
Total current liabilities
  21,869   18,387 
         
LONG-TERM LIABILITIES:        
Other long-term liabilities (Note 9)  1,432   972 
         
Total long-term liabilities
  1,432   972 
         
COMMITMENTS AND CONTINGENT LIABILITIES (Note 10)        
         
EQUITY (Note 12):        
        Sapiens shareholders' equity:        
Share capital:        
Preferred shares: Authorized - 1,000,000 of € 0.01 par value at December 31, 2008 and 2009; Issued and outstanding: None at December 31, 2008 and 2009  -   - 
Common shares: Authorized - 30,000,000 of € 0.01 par value at December 31, 2008 and 2009; Issued - 21,941,882 shares at December 31, 2008 and 2009; Outstanding: 21,591,088 shares at December 31, 2008 and 2009  276   276 
Additional paid-in capital  132,286   132,545 
Treasury shares, at cost (350,794 shares at December 31, 2008 and 2009)  (2,423)  (2,423)
Accumulated other comprehensive loss  (1,669)  (1,590)
Accumulated deficit  (106,727)  (102,526)
         
Total Sapiens shareholders' equity  21,743   26,282 
Non-controlling interest *)  133   133 
         
Total equity
  21,876   26,415 
         
Total liabilities and equity
 $45,177  $45,774 

*)Effective January 1, 2009, the Company reclassified non-controlling interest in equity, see also Note 2v for the adoption of ASC 810, "Consolidation - an Amendment of ARB No. 51".

  December 31, 
  2010  2011 
       
LIABILITIES AND EQUITY        
         
CURRENT LIABILITIES:        
Trade payables $1,693  $2,559 
Employees and payroll accruals  3,321   8,957 
Accrued expenses and other liabilities  8,325   10,774 
Deferred revenues  6,517   9,603 
         
Total current liabilities  19,856   31,893 
         
LONG-TERM LIABILITIES:        
Other long-term liabilities  299   617 
Accrued severance pay  4,446   10,711 
         
Total long-term liabilities  4,745   11,328 
         
COMMITMENTS AND CONTINGENT LIABILITIES        
         
EQUITY:        
Sapiens International Corporation N.V. Shareholders' equity:        
Share capital:        
Preferred shares of € 0.01 par value:
Authorized - 1,000,000 shares at December 31, 2011;
Issued and outstanding: None at December 31, 2011
        
Common shares of € 0.01 par value:
Authorized: 54,000,000 shares at December 31, 2011;
Issued: 22,373,130 and 40,008,926 shares at December 31, 2010 and 2011, respectively;
Outstanding: 22,044,834 and 39,680,630 shares at December 31, 2010 and 2011, respectively
  282   534 
Additional paid-in capital  133,136   207,930 
Treasury shares, at cost - 328,296 common shares at December 31, 2011 and 2010  (2,423)  (2,423)
Foreign currency translation adjustments  (657)  (6,277)
Accumulated deficit  (96,374)  (90,477)
         
Total Sapiens International Corporation N.V. shareholders' equity  33,964   109,287 
Non-controlling interests  154   960 
         
Total equity  34,118   110,247 
         
Total liabilities and equity $58,719  $153,468 

The accompanying notes are an integral part of the consolidated financial statements.

F - 4

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS


INCOME

U.S. dollars in thousands (except share and per share data)


  Year ended December 31, 
  2007  2008  2009 
Revenues:         
Products $5,632  $4,137  $3,123 
Consulting and other services  36,763   39,397   42,572 
             
Total revenues
  42,395   43,534   45,695 
             
Cost of revenues:            
Products  3,277   2,482   1,874 
Consulting and other services  22,306   23,975   24,697 
             
Total cost of revenues
  25,583   26,457   26,571 
             
Gross profit  16,812   17,077   19,124 
             
Operating expenses:            
Research and development, net (Note 14a)  3,502   3,884   2,735 
Selling, marketing, general and administrative  12,513   10,708   11,048 
             
Total operating expenses
  16,015   14,592   13,783 
             
Operating income  797   2,485   5,341 
             
Financial expenses, net (Note 14b)  2,798   2,236   880 
Other expenses (income), net  109   (32)  - 
             
Income (loss) before taxes on income  (2,110)  281   4,461 
             
Taxes on income (Note 11)  338   584   260 
             
Net income (loss)  (2,448)  (303)  4,201 
             
Attributable to non-controlling interest  (96)  (41)  - 
             
Net income (loss) attributable to Sapiens $(2,544) $(344) $4,201 
             
Basic net earnings (loss) per share attributable to Sapiens' shareholders (Note 2r) $(0.14) $(0.02) $0.19 
Diluted net earnings (loss) per share attributable to Sapiens' shareholders (Note 2r) $(0.14) $(0.02) $0.19 
             
Weighted-average number of shares used in computing basic net earnings (loss) per share  18,218   21,550   21,591 
    Weighted-average number of shares used in computing diluted net earnings (loss) per share  18,218   21,550   21,592 

  Year ended December 31, 
  2009  2010  2011 
          
          
Revenues $45,695  $52,235  $69,927 
Cost of revenues  26,571   29,921   40,067 
             
Gross profit  19,124   22,314   29,860 
             
Operating expenses:            
Research and development, net  2,735   3,293   5,008 
Selling, marketing, general and administrative  11,048   12,310   18,113 
Acquisitions-related and restructuring costs  -   -   1,115 
             
Total operating expenses  13,783   15,603   24,236 
             
Operating income  5,341   6,711   5,624 
Financial income (expenses), net  (880)  (364)  104 
             
Income before taxes on income  4,461   6,347   5,728 
Taxes on income (tax benefit)  260   177   (230)
             
Net income  4,201   6,170   5,958 
             
Attributable to non-controlling interests  -   18   61 
             
Net income attributable to Sapiens' shareholders $4,201  $6,152  $5,897 
             
Net earnings per share attributable to Sapiens' shareholders            
             
Basic $0.19  $0.28  $0.21 
             
Diluted $0.19  $0.28  $0.19 
             

The accompanying notes are an integral part of the consolidated financial statements.

F - 5

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY


AND COMPREHNSIVE INCOME

U.S. dollars in thousands (except share and per share data)

    Sapiens International Corporation N.V. shareholders     
      Additional   Note 
Accumulated
other
   Non   
  Common shares paid-in Treasury receivable comprehensive Accumulated controlling Total 
  Shares Amount capital shares - shareholder loss deficit interest *) equity 
                    
Balance as of January 1, 2007  15,144,852 $185 $113,498 $(2,423)$(975)$(2,817)$(103,539)$78 $4,007 
                             
Net loss  -  -  -  -  -  -  (2,544) 96  (2,448)
Other comprehensive income:                            
Unrealized losses on available-for-sale marketable securities, net  -  -  -  -  -  (20) -     (20)
Foreign currency translation adjustments  -  -  -  -  -  1,183  -  (81) 1,102 
Other comprehensive income  -  -  -  -  -  -  -     1,082 
Cumulative impact of change in accounting for uncertainties in income taxes  -  -  -  -  -  -  (300)    (300)
Exercise of options  29,569  **)   -  69  -  -  -  -     69 
Stock-based compensation  -  -  118  -  -  -  -     118 
Loan settlement - Red Coral  (300,000) **)   -  (975) -  975  -  -     - 
Shares issued, net ***)  6,666,667  90  19,325  -  -  -  -     19,415 
                             
Balance as of December 31, 2007  21,541,088 $275 $132,035 $(2,423)$- $(1,654)$(106,383)$93 $21,943 
                             
Accumulated foreign currency translation adjustments                $(1,654)         
*)           Effective January 1, 2009, the Company reclassified non-controlling interest in equity.
**)         Less than $ 1.
***)       Net of issuance expenses of $ 585.

  Common stock  Additional paid-in  Treasury  Foreign currency translation  Accumulated  Total comprehensive  Non-controlling  

Total

shareholders'

 
  Shares  Amount  capital  shares  adjustments  deficit  income  interests  equity 
                                     
Balance as of January 1, 2009  21,573,006  $276  $132,286  $(2,423) $(1,669) $(106,727)     $133  $21,876 
Stock-based compensation  -   -   259   -   -   -       -   259 
Foreign currency translation adjustments  -   -   -   -   79   -  $79   -   79 
Net income  -   -   -   -   -   4,201   4,201   -   4,201 
                                     
Totalcomprehensive income                         $4,280         
                                     
Balance as of December 31, 2009  21,573,006   276   132,545   (2,423)  (1,590)  (102,526)      133   26,415 
                                     
Stock-based compensation  -   -   412   -   -   -       -   412 
Stock-based compensation with respect to Harcase acquisition  454,546   6   155   -   -   -       -   161 
Employee stock options exercised  17,282   -   24   -   -   -       -   24 
Foreign currency translation adjustments  -   -   -   -   933   -  $933   3   936 
Net income  -   -   -   -   -   6,152   6,152   18   6,170 
                                     
Totalcomprehensive income                         $7,085         
                                     
Balance as of December 31, 2010  22,044,834   282   133,136   (2,423)  (657)  (96,374)      154   34,118 
                                     
Stock-based compensation  -   -   336   -   -   -       -   336 
Stock-based compensation with respect to Harcase acquisition  -   -   240   -   -   -       -   240 
Issuance of shares and options  upon the acquisition of IDIT  7,483,125   108   31,336   -   -   -       -   31,444 
Issuance of shares, options and assumption of non controlling interest upon the acquisition of FIS  10,016,875   143   42,778   -   -   -       882   43,803 
Issuance expenses relating to FIS and IDIT acquisition          (102)                      (102)
Employee stock options exercised  135,796   1   206   -   -   -       -   207 
Dividend to non-controlling interests  -   -   -   -   -   -       (134)  (134)
Foreign currency translation adjustments  -   -   -   -   (5,620)  -  $(5,620)  (3  (5,623)
Net income  -   -   -   -   -   5,897   5,897   (61)  5,958 
                                     
Totalcomprehensive income                         $277         
                                     
Balance as of December 31, 2011  39,680,630  $534  $207,930  $(2,423) $(6,277) $(90,477)     $960  $110,247 

The accompanying notes are an integral part of the consolidated financial statements.


F - 6

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY


CASH FLOWS

U.S. dollars in thousands (except share and per share data)


     Sapiens International Corporation N.V. shareholders       
              Accumulated          
     Additional     other     Non    
   Common shares  paid-in  Treasury  comprehensive  Accumulated  controlling  Total 
  Shares  Amount  capital  shares  loss  deficit  interest *)  equity 
                         
Balance as of January 1, 2008  21,541,088  $275  $132,035  $(2,423) $(1,654) $(106,383) $93  $21,943 
                                 
Net loss  -   -   -   -   -   (344)  41   (303)
Foreign currency translation adjustments  -   -   -   -   (15)  -   (1)  (16)
Exercise of options  50,000   1   86   -   -   -   -   87 
Stock-based compensation  -   -   165   -   -   -   -   165 
                                 
Balance as of December 31, 2008  21,591,088  $276  $132,286  $(2,423) $(1,669) $(106,727) $133  $21,876 
                                 
Accumulated foreign currency translation adjustments                 $(1,669)            
*)           Effective January 1, 2009, the Company reclassified non-controlling interest in equity.

  Year ended December 31, 
  2009  2010  2011 
Cash flows from operating activities:            
             
Net income $4,201  $6,170  $5,958 
Reconciliation of net income to net cash provided by operating activities:            
Depreciation and amortization  5,098   6,649   7,776 
Amortization and loss from convertible debt  686   -   - 
Re-measurement of earn-out payment  -   106   - 
Stock-based compensation  259   724   803 
             
Net changes in operating assets and liabilities, net of amount acquired:            
Trade receivables, net  1,932   267   (3,333)
Other operating assets  228   (285)  (480)
Deferred tax assets, net  (34)  (304)  222 
Trade payables  (295)  195   (1,279)
Other operating liabilities  164   (635)  (1,544)
Deferred revenues  1,778   (690)  (408)
Accrued severance pay, net  (479)  (172)  698 
             
Net cash provided by operating activities  13,538   12,025   8,413 
             
Cash flows from investing activities:            
             
Purchase of property and equipment  (324)  (662)  (482)
Capitalized software development costs  (3,692)  (5,387)  (4,735)
Issuance expenses relating to FIS and IDIT acquisition  -   -   (102)
Earn-out payment with respect to Harcase acquisition  -   -   (952)
Payments for business acquisitions, net of cash acquired  -   (1,416)  3,741 
             
Net cash used in investing activities  (4,016)  (7,465)  (2,530)

The accompanying notes are an integral part of the consolidated financial statements.

F - 7


SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY


CASH FLOWS

U.S. dollars in thousands (except share and per share data)




     Sapiens International Corporation N.V. shareholders       
              Accumulated          
        Additional     other     Non    
  Common shares  paid-in  Treasury  comprehensive  Accumulated  controlling  Total 
  Shares  Amount  capital  shares  loss  deficit  interest *)  equity 
                         
Balance as of January 1, 2009  21,591,088  $276  $132,286  $(2,423) $(1,669) $(106,727) $133  $21,876 
                                 
Net income  -   -   -   -   -   4,201   -   4,201 
Foreign currency translation adjustments  -   -   -   -   79   -   -   79 
Stock-based compensation  -   -   259   -   -   -   -   259 
                                 
Balance as of December 31, 2009  21,591,088  $276  $132,545  $(2,423) $(1,590) $(102,526) $133  $26,415 
                                 
Accumulated foreign currency translation adjustments                 $(1,590)            
                                 
*)           Effective January 1, 2009, the Company reclassified non-controlling interest in equity.

  Year ended December 31, 
  2009  2010  2011 
Cash flows from financing activities:            
             
Proceeds from employee stock options exercised  -   24   207 
Dividend to non-controlling interests  -   -   (134)
Principal payments and repurchase of convertible debt  (5,824)  -   - 
Payments of long-term loans  (627)  (15)  - 
             
Net cash provided by (used in) financing activities  (6,451)  9   73 
             
Effect of exchange rate changes on cash  163   441   (678)
             
Increase in cash and cash equivalents  3,234   5,010   5,278 
Cash and cash equivalents at beginning of year  7,938   11,172   16,182 
             
Cash and cash equivalents at end of year $11,172  $16,182  $21,460 
             
(a)Supplemental cash flow activities:            
             
Cash paid during the year for:            
             
Interest $454  $115  $16 
             
Income taxes $227  $494  $162 

The accompanying notes are an integral part of the consolidated financial statements.

F - 8

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS OF CASH FLOWS


U.S. dollars in thousands



  Year ended December 31, 
  2007  2008  2009 
Cash flows from operating activities:         
          
Net income (loss) $(2,448) $(303) $4,201 
Adjustments to reconcile net income (loss) to net cash provided by operating activities:            
Depreciation and amortization  4,037   5,122   5,365 
Re-evaluation of warrants (series 1)  (71)  -   - 
Amortization of convertible debt issuance expenses  228   268   226 
Amortization of convertible debt discount and changes in embedded derivative  1,653   699   458 
Loss on repurchase of convertible debt  109   314   2 
Gain on disposal of property and equipment  -   (32)  - 
Stock-based compensation  118   165   259 
Gain on marketable securities and bonds  (29)  -   - 
Decrease (increase) in trade receivables, net  4,090   (127)  1,932 
Decrease (increase) in other receivables and prepaid expenses  259   (817)  (39)
Decrease (increase) in deferred income taxes and reserves  103   330   (34)
Increase (decrease) in trade payables  (1,038)  382   (295)
Increase (decrease) in other liabilities and accrued expenses  (385)  2,533   (315)
Increase in deferred revenues  493   1,235   1,778 
             
Net cash provided by operating activities  7,119   9,769   13,538 
             
Cash flows from investing activities:            
             
Purchase of property and equipment  (190)  (768)  (324)
Increase in capitalized software development costs  (3,169)  (3,496)  (3,692)
Purchase of marketable securities and short-term deposits  -   (23)  - 
    Proceeds from sale of marketable securities and short-term deposits  41   -   - 
Proceeds from sale of property and equipment  -   429   - 
             
Net cash used in investing activities  (3,318)  (3,858)  (4,016)
The accompanying notes are an integral part of the consolidated financial statements.
F - 9

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS

U.S. dollars in thousands

  Year ended December 31, 
  2007  2008  2009 
Cash flows from financing activities:         
          
Decrease in short-term bank credit, net  (4,610)  (5,033)  - 
Proceeds from employee stock options exercised  69   87   - 
Proceeds from issuance of Common shares, net  19,415   -   - 
Principal payments and repurchase of convertible debt  (7,818)  (5,495)  (5,824)
Principal payments of long-term loans  (1,000)  (487)  (627)
             
Net cash provided by (used in) financing activities  6,056   (10,928)  (6,451)
             
Effect of exchange rate changes on cash and cash equivalents  160   (170)  163 
             
Increase (decrease) in cash and cash equivalents  10,017   (5,187)  3,234 
Cash and cash equivalents at beginning of year  3,108   13,125   7,938 
             
Cash and cash equivalents at end of year $13,125  $7,938  $11,172 
             
Supplemental cash flow activities:            
             
Cash paid during the year for:            
             
Interest $1,992  $741  $454 
             
Income taxes $120  $159  $227 
The accompanying notes are an integral part of the consolidated financial statements.
F - 10

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands
(except share and per share data)

NOTE 1:GENERAL

a.
Sapiens International Corporation N.V. ("theGeneral:

Sapiens International Corporation N.V. ("Sapiens") and subsidiaries (collectively - "the Company"), a member of the Formula Systems (1985) Ltd. Group, is a global provider of innovative software solutions for the financial services industry with a focus on insurance. The Company offers end-to-end solutions for the Life, Pension and Annuities ("L&P") and Property & Casualty/General Insurance ("P&C") markets. The Company's offerings include a portfolio of software solutions and delivery, implementation and support and maintenance services. These products and services enable its customers to modernize business processes, rapidly launch new products, build multiple distribution channels, adhere with new regulations and respond quickly to changes in the industry.

On August 21, 2011 Sapiens completed the acquisition ofFIS Software Ltd. ("FIS") andIDIT I.D.I. TechnologiesLtd. ("IDIT") (See note 1(b) and 1(c) for further information).

The Company's target markets are primarily North America, Israel, Europe, and Asia Pacific.

Revenues from a major customer accounted for 23%, 26% and 20% of total revenues for the years ended December 31, 2009, 2010 and 2011, respectively. A loss of a major customer, or any event negatively affecting such customer's financial condition, could have a material adverse effect on the Company's results of operations and financial position.

b.Acquisition of FIS:

On August 21, 2011, the Companycompleted the acquisition ofall of the outstanding shares of FIS, a provider of insurance software solutions for L&P, in consideration for $ 49,671, composed of the following:

Sapiens' common shares $38,987 
Cash paid  6,750 
Warrants (i)  2,031 
Options (ii)  1,903 
     
Total purchase price $49,671 

(i)Sapiens issued 1,000,000 warrants. (See Note 11(e))

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 1:GENERAL (Cont.)

(ii)Represents the fair value of the Formula Group, is a global providervested portion of information technology ("IT") solutions that modernize business processes to enable insurance and other leading companies to quickly adapt to change. The Company's solutions, sold as customizable software modules, align IT with business demands for speed, flexibility and efficiency. The Company's solutions are supplemented by934,970 options of Sapiens granted upon consummation of the Company's technology, methodology and consulting services, which address the complex issues relatedacquisition to the life-cycleholders of enterprise business applications.partially vested options of FIS originally granted under the FIS Employee Share Option Plan. The fair value of these options was determined using a Binomial valuation model with the following assumptions: stock price of $ 4.1, early exercise of 1.5-11, risk-free interest rate of 0.10%-2.07%, expected volatility of 70% and no dividend yield.

The acquisition of FIS allows Sapiens to offer an enhanced solution for the L&P market. In addition, the acquisition of FIS has grown Sapiens' customer base in the insurance market world-wide. The value of goodwill is attributed to synergies between Sapiens solutions and services and FIS’s solutions and services which strengthen the Company's position in the market as a leading provider of L&P core software solutions. The entire goodwill was assigned to Sapiens' reporting unit.

The acquisition was accounted for by the acquisition method and accordingly, the purchase price has been allocated according to the estimated fair value of the assets acquired and liabilities assumed of FIS. The results of FIS operations have been included in the consolidated financial statements since August 21, 2011.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed based on a third party valuation:

Cash and cash equivalents $8,349 
Restricted cash  239 
Trade receivables  5,152 
Other receivables and prepaid expenses  632 
Property and equipment  451 
Severance pay fund  4,182 
Other intangible assets  11,724 
Goodwill  35,523 
     
Total assets acquired  66,252 
     
Trade payables  (1,486)
Employees and payroll accruals  (3,461)
Deferred revenues  (1,706)
Accrued expenses and other liabilities  (1,914)
Deferred tax liabilities  (406)
Accrued severance pay  (4,487)
Long-term contracts  (2,239)
Non-controlling interest  (882)
     
Total liabilities assumed  (16,581)
     
Total assets acquired, net $49,671 

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 1:GENERAL (Cont.)

In performing the purchase price allocation, management considered, among other factors, analyses of historical financial performance, highest and best use of the acquired assets and estimates of future performance of FIS's business. In performing the purchase price allocation the fair value of intangible assets such as customer relationship was based on the income approach, core technology was valuated using the relief from royalty method and long-term contracts were valuated based on an exit price that would be paid or received in a transfer of all the rights and obligations of the contractor to a market participant.

The following table sets forth the components of intangible assets and liabilities associated with the acquisition and their annual amortization rates:

  Fair value  Weighted average rate
       
Core technology $4,206  13%
Customer relationships  7,518  14%
Long-term contracts  (2,239) 67%
       
Total $9,485  22%

Revenues of FIS for the period since the acquisition date through December 31, 2011, which are included in the consolidated financial statements, amounted to $ 11,207.

c.Acquisition of IDIT:

On August 21, 2011, the Companycompleted the acquisition ofall of the outstanding shares of IDIT, a provider of insurance software solutions which focuses on the P&C market in consideration for $ 31,444, composed as follows:

Sapiens' common shares $29,052 
Options (i)  2,392 
     
Total purchase price $31,444 

(i)Represents the fair value of the vested portion of 1,003,874 options of Sapiens INSIGHT™ suitegranted upon consummation of solutions includes scalable insurance applications that the Company has developed for leading insurance organizations.acquisition to the holders of partially vested options of IDIT originally granted under the IDIT Employee Share Option Scheme. The Company's service offerings includefair value of these options was determined using a standard consulting offering that helps cus tomers make better useBinomial valuation model with the following assumptions: stock price of IT in order to achieve its business objectives. The Company's core technology, Sapiens eMerge™$ 4.1, early exercise factor of 1.5-11, risk-free interest rate of 0.10%-2.07%, is a rules-based application development suite which enables rapid solution development for complex mission-critical enterprises to deliver new functionality, achieve legacy modernizationexpected volatility of 70% and enterprise application integration.no dividend yield.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

b.NOTE 1:
Revenues from a major customer accounted for 20%, 26% and 23% of total revenues for the years ended December 31, 2007, 2008 and 2009, respectively.
GENERAL (Cont.)

The acquisition of IDIT allows the Company to offer its customers and partners a more extensive product portfolio in the industry. Acquiring IDIT is expected to strengthen Sapiens' presence in the P&C insurance market by increasing its customer base. IDIT is considered as a separate reporting unit.

The acquisition was accounted for by the acquisition method and accordingly, the purchase price has been allocated according to the estimated fair value of the assets acquired and liabilities assumed of IDIT. The results of IDIT's operations have been included in the consolidated financial statements since August 21, 2011.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed based on a third party valuation:

Cash and cash equivalents $2,143 
Restricted cash  216 
Trade receivables  1,194 
Other receivables and prepaid expenses  302 
Other long term assets  90 
Property and equipment  482 
Severance pay fund  1,800 
Other intangible assets  7,918 
Goodwill  25,355 
     
Total assets acquired  39,500 
     
Trade payables  (807)
Employees and payroll accruals  (2,328)
Accrued expenses and other liabilities  (1,012)
 Deferred revenues  (1,769)
Accrued severance pay  (2,140)
     
Total liabilities assumed  (8,056)
     
Total purchase price  31,444 

In performing the purchase price allocation, management considered, among other factors, analyses of historical financial performance, highest and best use of the acquired assets and estimates of future performance of IDIT's business. In performing the purchase price allocation the fair value of intangible assets such as customer relationship was determined based on the income approach, core technology was valued using the relief from royalty method and long-term contracts were valued based on an exit price that would be paid or received in a transfer of all the rights and obligations of the contractor to a market participant.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 1:GENERAL (Cont.)

The following table sets forth the components of intangible assets associated with the acquisition and their annual amortization rates:

  Fair value  Weighted average rate 
         
Core technology $5,548   14% 
Customer relationships  1,389   16% 
Long-term contracts  981   74% 
         
Total intangible assets $7,918   22% 

Revenues of IDIT for the period since the acquisition date through December 31, 2011, which are included in the consolidated financial statements, amounted to $ 5,105.

d.Acquisition of Harcase Software Ltd.

On April 27, 2010, the Company completed the acquisition of Harcase Software Ltd. ("Harcase"). The total fair value of the purchase consideration for the acquisition was $3,092, which includes cash paid for common stock and estimated fair value of earn-out payment. In connection with this acquisition, the Company recorded intangibles and goodwill in the amounts of $ 1,732 and $ 981, respectively. In 2011, the Company paid an amount of $ 953 with respect to earn out.

As part of the acquisition, the Company is obligated to pay additional consideration to the selling shareholders in consideration for their continued employment of two to three years, as defined in the agreement pursuant to which the Company acquired Harcase ("the Additional Consideration"). The Additional Consideration includes the following: (1) $ 750 in cash to be held in escrow until released upon certain conditions, as described in the agreement, (2) issuance of 454,546 Common shares of the Company to be held in escrow, as described in the agreement, (3) put options on the Company's shares described in (2) above for a price of $ 1.54 per share, exercisable during a period of six months from the date the shares are released from escrow. The cash portion of the Additional Consideration is recognized over the employment period of the respective shareholders. The shares and the respective put options are accounted for in accordance with ASC 718 as an award with a liability and equity component. The compensation is measured based on the combined value of the shares and the respective put options in accordance with ASC 718. The total compensation costs related to the shares and the put options at the grant date was $ 1,302, recognized over the employment period of the respective former shareholders of Harcase.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 1:GENERAL (Cont.)

For the period from April 27, 2010 (the acquisition date) until December 31, 2010 and for the year ended December 31, 2011, the Company recorded an amount of $502 and $754, respectively of compensation expense in respect of the above Additional Consideration. Included within the above amounts are $311 and $467 respectively, which are considered as stock based compensation.

In addition, the Company is obligated to pay commissions to the former shareholders for new customers obtained during the five-year period following the closing date, based on rates and conditions described in the agreement. As of December 31, 2011, no provision was recorded in respect of the above-mentioned commissions.

e.Pro Forma information:

The following represents the unaudited pro forma condensed results of operations for the years ended December 31, 2010 and 2011, assuming that the acquisitions of FIS and IDIT occurred on January 1, 2010. The pro forma information is not necessarily indicative of the results of operations, which actually would have occurred had the acquisitions been consummated on those dates, nor does it purport to represent the results of operations for future periods.

  December 31, 
  2010  2011 
  Unaudited  Unaudited 
       
Revenues $95,289  $97,679 
Net income (loss) $1,775  $(414)
         
Basic net earnings (losses) per share $0.05  $(0.01)
Diluted net earnings (losses) per share $0.04  $(0.01)

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in United States ("U.S. GAAP").

a.Use of estimates:

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

b.Financial statements in United States ("U.S. GAAP").dollars:

The currency of the primary economic environment in which the operations of Sapiens and certain subsidiaries are conducted is the U.S. dollar ("dollar"); thus, the dollar is the functional currency of Sapiens and certain subsidiaries.

Sapiens and certain subsidiaries' transactions and balances denominated in dollars are presented at their original amounts. Non-dollar transactions and balances have been remeasured to dollars in accordance with ASC 830, "Foreign Currency Matters". All transaction gains and losses from remeasurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statements of income as financial income or expenses, as appropriate.

For those subsidiaries whose functional currency has been determined to be their local currency, assets and liabilities are translated at year-end exchange rates and statement of income items are translated at average exchange rates prevailing during the year. Such translation adjustments are recorded as a separate component of accumulated other comprehensive income in shareholders' equity.

a.c.
UsePrinciples of estimates:
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
consolidation:

The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.

b.d.
Financial statements in U.S. dollars:
A substantial portion of the financing of the Company's activities is made in U.S. dollars ("dollar"). In addition, a substantial portion of the Company's and certain of its subsidiaries' costs are incurred in dollars. A majority of the revenues of the Company and certain of its subsidiaries is generated in dollars. The Company's management believes that the dollar is the primary currency of the economic environment in which the Company and those subsidiaries operate. Thus, the functional and reporting currency of the Company and these subsidiaries is the dollar.
Cash equivalents:

F - 11

Cash equivalents are short-term highly liquid investments that are readily convertible to cash, with original maturities of three months or less at acquisition.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands

(except share and per share data)

NOTE 2:-SIGNIFICANT ACCOUNTING POLICIES (Cont.)

e.Restricted cash:

The Company maintains certain cash amounts restricted as to withdrawal or use. On December 31, 2011, the Company maintained a balance of $ 456 that represents security deposits with respect to leases, restricted due to the lease agreement and security deposits for credit lines from banks.

f.Property and equipment, net:

Property and equipment are stated at cost, net of accumulated depreciation using the straight-line method over the estimated useful lives of the assets, at the following annual rates:

  
Accordingly, monetary accounts maintained in currencies other than the dollar are re-measured into dollars in accordance with Accounting Codification Statement ("ASC") 830 (formerly SFAS No. 52), "Foreign Currency Matters". All transaction gains and losses of the re-measurement of monetary balance sheet items are reflected in the consolidated statements of operations as financial expenses, net.

The financial statements of foreign subsidiaries, whose functional currency is not the dollar, have been translated into dollars. All balance sheet accounts have been translated using the exchange rates in effect at the balance sheet date. Statements of operations amounts have been translated using the average exchange rate for the period. The resulting translation adjustments are reported as accumulated other comprehensive income (loss) in equity.

Foreign currency translation differences included in financial expenses (income), net, amounted to approximately $ 663, $ 336 and $ 247 for the years ended December 31, 2007, 2008 and 2009, respectively. See Note 14b for finance expenses.
%
 c.
Principles of consolidation:
The consolidated financial statements include the accounts of the Company
Computers and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.peripheral equipment
 d.
Cash equivalents:
Cash equivalents are short-term highly liquid investments that are readily convertible to cash, with maturities of three months or less at the date of acquisition.
33
Office furniture and equipment e.
Allowance for doubtful accounts:
The allowance is determined based on management's evaluation of receivables doubtful of collection on a specific basis.
f.
Property and equipment, net:
Property and equipment are stated at cost, net of accumulated depreciation using the straight-line method over the estimated useful lives of the assets as follows:
Equipment and furniture46 - 15 years
Computer equipment and software3 years
Motor vehicles7 years
Leasehold improvements
Over the shorter of the term of the lease
 or the estimated useful life of the asset
14


F

Leasehold improvements are amortized by the straight-line method over the term of the lease (including option terms) or the estimated useful life of the improvements, whichever is shorter.

g.Research and development costs:

Research and development costs incurred in the process of software production before establishment of technological feasibility are charged to expenses as incurred. Costs incurred to develop software to be sold are capitalized after technological feasibility is established in accordance with ASC 985-20, "Software - 12


Costs of Software to be Sold, Leased, or Marketed". Based on the Company's product development process, technological feasibility is established upon completion of a detailed program design.

Costs incurred by the Company between completion of the detailed program design and the point at which the product is ready for general release, have been capitalized.

Capitalized software development costs are amortized commencing with general product release by the straight-line method over the estimated useful life of the software product (between 3-7 years).

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands

NOTE 2:            SIGNIFICANT ACCOUNTING POLICIES (Cont.)

(except share and per share data)

g.NOTE 2:
Impairment of long-lived assets:
The Company's long-lived assets and certain identifiable intangibles are reviewed for impairment in accordance with ASC 360 (formerly SFAS No. 144), "Property, Plant, and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During 2007, 2008 and 2009, no impairment losses have been identified.
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

h.
Capitalized software development costs:
Research and development costs incurred in the process of developing new products or product improvements, are charged to expense as incurred.

ASC 985 (formerly SFAS No. 86), "Software", requires capitalization of certain software development costs subsequent to the establishment of technological feasibility. Based on the Company's product development process, technological feasibility is generally established upon completion of a detailed program design.

Significant costs incurred by the Company and its subsidiaries between the establishment of technological feasibility and the point at which the product is ready for general release, have been capitalized, net of participation by the OCS.

The changes in capitalized software development costs during the year ended December 31, 2009 were as follows:
Other intangible assets, net:
  Capitalized software development costs 
    
Balance as of January 1, 2009 $14,391 
Capitalized software development costs  3,692 
Amortization of software development costs  (4,623)
Effect of exchange rate differences  80 
     
Balance as of December 31, 2009 $13,540 

Technology is amortized over its estimated useful life on a straight-line basis. The acquired customer relationships are amortized over their estimated useful lives in proportion to the economic benefits realized or the straight-linemethod. The weighted averageannual rates for other intangible assets are as follows:

  
As for finance expense capitalization, see Note 6a.

Capitalized software costs are amortized by the greater%
Technology15%
Customer relationships14%

i.Impairment of the amount computed using: (i) the ratio that current gross revenues from sales of the software bear to the total of current and anticipated future gross revenues from sales of that software, or (ii) the straight-line method between three to five years, which is the estimated useful life of the respective software product. The Company assesses the recoverability of this intangible asset on an annual basis by determining whether the amortization of the asset over its remaining life can be recovered through undiscounted future operating cash flows from the specific software product sold.

For the years ended December 31, 2007, 2008 and 2009, no impairment of capitalized software development costs exists.
long-lived assets:

F - 13

The Company's long-lived assets and identifiable intangibles that are subject to amortization are reviewed for impairment in accordance with ASC 360 "Property, Plant, and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During 2009, 2010 and 2011, no impairment losses have been identified.

j.Goodwill:

Goodwill represents the excess of the purchase price in a business combination over the fair value of the net tangible and intangible assets acquired. Under ASC 350," Intangibles—Goodwill and Other" goodwill is subject to an annual impairment test or more frequently if impairment indicators are present. Goodwill impairment is deemed to exist if the net book value of a reporting unit exceeds its estimated fair value. Following the acquisition of FIS and IDIT, the Company operates in two reporting units: Sapiens and IDIT.

In September 2011, the FASB issued ASU 2011-08 which amends the rules for testing goodwill for impairment. Under the new rules, an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is unnecessary.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands

NOTE 2:            SIGNIFICANT ACCOUNTING POLICIES (Cont.)

(except share and per share data)

i.NOTE 2:
Goodwill:
Goodwill represents excess of the costs over the net assets of businesses acquired. Under ASC 350 (formerly SFAS No. 142), "Intangibles - Goodwill and Other", goodwill acquired in a business combination should not be amortized. ASC 350 requires goodwill to be tested for impairment at least annually or between annual tests in certain circumstances, and written down when impaired, rather than being amortized as previous accounting standards required. Goodwill is allocated to one reporting unit and fair values are determined using market capitalization. Through 2009, no impairment losses were identified.
SIGNIFICANT ACCOUNTING POLICIES (Cont.)

The Company early adopted the provisions of ASU 2011-08 for the Company's annual impairment test on the fourth quarter of 2011. This analysis determined that no indicators of impairment existed primarily because (1) the Company's market capitalization has consistently exceeded the Company's book value by a sufficient margin, (2) the acquisition of one of the Company's reporting units was on August 21, 2011 and no significant changes in the reporting unit's operational business occurred since the acquisition (3) the Company's overall financial performance has been stable since the acquisition, and (4) forecasts of operating income and cash flows generated by the Company's reporting units appear sufficient to support the book values of the net assets of each reporting unit.

However, it is possible that the Company's determination that goodwill for a reporting unit is not impaired could change in the future if current economic conditions deteriorate or remain difficult for an extended period of time. The Company will continue to monitor the relationship between the Company’s market capitalization and book value, as well as the ability of our reporting units to deliver current income and cash flows sufficient to support the book values of the net assets of their respective businesses.

The Company performed annual impairment tests during the fourth quarter of each of 2009, 2010 and 2011 and did not identify any impairment losses.

j.  
Intangible assets:
Intangible assets are stated at cost less accumulated amortization. Amortization is computed using the straight-line method as follows:
Prepaid royalties15 years
Technologies, usage rights and other intangible assets4-8 years
During 2007, 2008 and 2009, no impairment losses have been identified.

As of December 31, 2009, all the intangible assets were fully amortized. See Note 6b.
k.
Revenue recognition:
Product revenues include software license sales and may also include implementation and customization services with respect to such software license sales. In addition, the Company also provides consulting services that are not deemed essential to the functionality of the license, as well as outsourcing IT services.

The Company recognizes revenue from software license sales in accordance with ASC 985-605 (formerly SOP 97-2), "Software Revenue Recognition", with respect to certain transactions. Under ASC 985-605, revenues from software product licenses are recognized upon delivery of the software provided there is

The Company generates revenues from sales of software licenses which normally include significant implementation services that are considered essential to the functionality of the software license. In addition, the Company generates revenues from post implementation consulting services and maintenance services.

Sales of software licenses are recognized when persuasive evidence of an agreement exists, delivery of the product has occurred, the fee is fixed or determinable, and collectability is probable. The Company considers all arrangements with payment terms extending beyond six months from the delivery of the elements not to be fixed or determinable. If the fee is not fixed or determinable, collection of the related receivable is probable and no further obligations exist. Revenues under multiple-element arrangements, which may include software licenses, support and maintenance, and training and consulting services, are allocated to each element under the "residual method" when Vendor Specific Objective Evidence ("VSOE") of fair value exists for all undelivered elements and VSOE does not exist for all of the delivered elements. VSOE is determined for support and maintenance, training and consulting services based on the price charged when the respective elements are sold separately or renewed. The Company charges support an d maintenance renewals at a fixed percentage of the total price of the licensed software products purchased by the customer. Under the residual method, the Company defers revenues related to the undelivered elements based on their VSOE of fair value and recognizes the remaining arrangement fee for the delivered elements.


When VSOE of fair value for undelivered elements does not exist, revenues from the entire arrangement are recognized over the term of the agreement.

Revenues from support and maintenance agreements are recognized ratably over the term of the agreement, which is typically one year. Revenues from training arrangements are recognized as the services are performed.

F - 14

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands
NOTE 2:            SIGNIFICANT ACCOUNTING POLICIES (Cont.)

The Company generally does not grant a right of return to its customers. When a right of return exists, revenue is deferred until the right of return expires, at which time revenue is recognized as payments become due from the customer, provided that all other revenue recognition criteria arehave been met.

Amounts collected prior to satisfying the above revenue recognition criteria are reflected

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

The Company usually sells its software licenses as deferred revenue. Deferred revenue represents deferred maintenance revenue, andpart of an overall solution offered to a lesser extent, deferredcustomer that combines the sale of software license revenues.


Under certain circumstances, license revenue consists of license fees received, whereby underlicenses which normally include significant implementation that is considered essential to the terms of these license agreements the Company's software is modified to a customer's specific requirements. Each license is designed to meet the specific requirementsfunctionality of the particular customer. Fees are payable upon completion of agreed-upon milestones, such as delivery of specificationslicense. The Company accounts for revenues from the services (either fixed price or Time and technical documentation.

Revenues from license fees that involve implementation and customization ofMaterials (T&M)) together with the Company's software to customer specific requirements are generated from fixed-price or time-and-materials contracts. Such revenues generated from fixed-price contracts are recognizedunder contract accounting using the percentage-of-completion method in accordance with ASC 605-35, (formerly SOP 81-1), "Revenue Recognition - Construction-Type"Construction-Type and Production-Type Contracts". Fixed-price contracts revenues are recognized using contract accounting on a percentage-of-completion method, over the period from signing of the license through to customer acceptance, in accordance with the "Input Method" or "Output Method". The amounts of revenues recognized are based on the total license fees under the license agreement and the percentage to completion achieved. According to the "Input Method", the percentage to completion is measured by monitoring progress using records of actual time incurred to date in the project compared to the total estimated project requirement, which corresponds to the costs related to earned revenues. According to the "Output Method", the percentage to completion is determined by using technological or time-based milestones methods. The Company uses the "Input Method" when it has an enforceable right to services performed between milestones during the project.

The Company believes that the use of the percentage of completion method is appropriateused when the required services are quantifiable, based on the estimated number of labor hours necessary to complete the project, and under that method revenues are recognized using labor hours incurred as the Company has the ability to make reasonably dependable estimates of the extentmeasure of progress towards completion, contract revenues and contract costs. completion. 

In addition, contracts executed include provisions that clearly specify the enforceable rights regarding services to be provided and received by the parties to the contracts, the consideration to be exchanged and the manner and the terms of settlement, including in cases of termination for convenience. In all cases,accordance with ASC 985-605, the Company expects to perform its contractual obligations and its customers are expected to satisfy their obligations under the contract.


Estimatesestablishes Vendor Specific Objective Evidence ("VSOE") of total project requirements arefair value of maintenance services (PCS) based on prior experiencethe Bell-Shaped approach and determined VSOE for PCS, based on the price charged when the element is sold separately (that is, the renewal rate). The Company's process for establishing VSOE of customization, delivery and acceptancefair value of PCS is through performance of VSOE compliance test which is an analysis of the same or similar technology, and are reviewed and updated regularly by management. After delivery, if uncertainty exists about customer acceptanceentire population of the software, license revenue is not recognized until acceptance. PCS renewal activity for its installed base of customers.

Provisions for estimated losses on uncompleted contracts in progress are made in the period in which such lossesthey are first determined, in the amount of the estimated loss on the entire contract. As of December 31, 2009, nocontact. Provisions for estimated losses were identified. Under time-and-materials contracts,are presented in accrued expenses and other liabilities.  

Maintenance revenue is recognized ratably over the term of the maintenance agreement. Deferred revenues include unearned amounts received under maintenance and support agreements and amounts received from customers, for which revenues have not yet been recognized.

In addition, the Company is reimbursedderives significant portion of its revenues from post implementation consulting services provided on a "Time and Materials" ("T&M") basis which are recognized as services are performed.

l.Income taxes:

The Company accounts for labor hours at fixed hourly billingincome taxes in accordance with ASC 740, "Income Taxes". This topic prescribes the use of the asset and liability method, whereby deferred tax asset and liability account balances are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and recognizes revenues aslaws that will be in effect when the servicesdifferences are provided.



F - 15

expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands

(except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

The Company implements a two-step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement.

The Company classifies interest as financial expenses and penalties as selling, marketing, general and administration expenses.

m.Concentrations of credit risk:

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, trade receivables and foreign currency derivative contracts.

The Company's cash and cash equivalents and restricted cash are invested in bank deposits mainly in NIS and dollars. Deposits in the U.S. may be in excess of insured limits and are not insured in other jurisdictions. Generally, these banks deposits may be redeemed upon demand and therefore bear minimal risk.

The Company's trade receivables are generally derived from sales to large and solid organizations located mainly in Israel, Europe, North America and Asia Pacific. The Company performs ongoing credit evaluations of its customers and to date has not experienced any material losses. In certain circumstances, the Company may require prepayment. An allowance for doubtful accounts is determined with respect to those amounts that the Company has determined to be doubtful of collection. Provisions for doubtful accounts were recorded in general and administrative expenses.

The Company entered into forward contracts, and option contracts intended to protect against the increase in value of forecasted non-dollar currency cash flows. The derivative instruments hedge a portion of the Company's non-dollar currency exposure.

No off-balance sheet concentrations of credit risk exist.

F-20

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

n.Accrued severance pay:

The Company's liability for severance pay for its Israeli employees is calculated pursuant to Israel's Severance Pay Law based on the most recent monthly salary of the employees multiplied by the number of years of employment as of the balance sheet date. Employees are entitled to one month's salary for each year of employment, or a portion thereof. The Company's liability is fully provided by monthly deposits with insurance policies and severance pay funds and by an accrual.

The deposited funds include profits (losses) accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israel's Severance Pay Law or employment agreements. The value of the deposited funds is based on the cash surrendered value of these policies and recorded as an asset in the Company's consolidated balance sheet

In addition, the Company signed on a collective agreement with some of its employees, according to which the Company's contributions for severance pay shall be instead of severance compensation and that upon release of the policy to the employee, no additional payments shall be made by the Company to the employee. Generally, the Company, under its sole discretion, pays to these employees the entire liability, irrespective of the collective agreement described per above. Therefore, the net obligation related to those employees is stated on the balance sheet as accrued severance pay.

The Company's agreements with certain employees in Israel are in accordance with Section 14 of the Severance Pay Law, 1963, whereas, the Company's contributions for severance pay shall be instead of its severance liability. Upon contribution of the full amount of the employee's monthly salary, and release of the policy to the employee, no additional calculations shall be conducted between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of such obligation are not stated on the balance sheet, as they are legally released from obligation to employees once the deposit amounts have been paid.

Severance expense for the years 2009, 2010 and 2011 amounted to $ 307, $ 790 and $ 1,514, respectively.

o.Basic and diluted net earnings per share:

Basic net earnings per share are computed based on the weighted average number of common shares outstanding during each year. Diluted net earnings per share are computed based on the weighted average number of common shares outstanding during each year plus dilutive potential equivalent common shares considered outstanding during the year, in accordance with ASC 260, "Earnings Per Share".

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

p.Stock-based compensation:

The Company accounts for stock-based compensation in accordance with ASC 718, "Compensation - Stock Compensation", which requires the measurement and recognition of compensation expense based on estimated fair values for all share-based payment awards made. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated income statements.

The Company recognizes compensation expenses for the value of its awards, which have graded vesting, based on the straight-line basis over the requisite service period of the award, net of estimated forfeitures. Estimated forfeitures are based on actual historical pre-vesting forfeitures.

The Company used the Black-Scholes option-pricing model to estimate the fair value for any options granted until December 31, 2009. In 2010, the Company changed the option-pricing model to the Binomial Lattice ("Binomial model") option-pricing model. The Binomial model considers characteristics of fair value option pricing that are not available under the Black-Scholes model. Similar to the Black-Scholes model, the Binomial model takes into account variables such as volatility, dividend yield rate, and risk free interest rate. However, the Binomial model allows for the use of dynamic assumptions and also considers the contractual term of the option, the probability that the option will be exercised prior to the end of its contractual life, and the probability of termination or retirement of the option holder in computing the value of the option. For these reasons, the Company believes that the Binomial model provides a better estimate of an employee stock options fair value than that calculated using the Black-Scholes model.

The fair value of each option granted in 2010 and 2011 using the Binomial model, is estimated on the date of grant with the following weighted average assumptions:

  Year ended December 31,
  2010 2011
     
Contractual life 6 years 6 years
Expected exercise factor 2.5 2.5
Dividend yield 0% 0%
Expected volatility 66% 70%
Risk-free interest rate 2.3%-2.8% 0.1%-1.2%

F-22
NOTE 2:            SIGNIFICANT ACCOUNTING POLICIES (Cont.)

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

The risk-free interest rate assumption is based on the yield from U.S. Treasury zero-coupon bonds with an equivalent term as of the Company's employee stock options. The dividend yield assumption is based on the Company's historical and expectation of future dividend payouts. The expected life of options granted is derived from the output of the option valuation model and represents the period of time the options are expected to be outstanding. The expected exercise factor is based on industry acceptable rates since no actual historical behavior by option holders exists. Expected volatility is based on the historical volatility of the Company.

For options granted prior to January 1, 2010, the fair value of each option granted was estimated at the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:

  
Estimated gross profit or loss from long-term contracts may change due to changes in estimates resulting from differences between actual performance and original forecasts. Such changes in estimated gross profit are recorded in results of operations when they are reasonably determinable by management, on a cumulative catch-up basis.

Consulting services that are not deemed essential to the functionality of the license provided on a "time and materials" basis are recognized as services are performed.

IT outsourcing services that mainly include maintenance of customers' applications integrated on the Company's license performed on a fixed fee basis are recognized on a straight line basis over the contractual period that the services are rendered, since no other pattern of outputs is discernible. Revenues from IT outsourcing services that are performed on a "time and materials" basis are recognized as services are performed.
Year ended December 31,
 l.
Investment in affiliate:
For the purposes of these financial statements, an affiliated company is a company held to the extent of 20% or more, or a company less than 20% held, in which the Company can exercise significant influence over operating and financial policy of the affiliate. If the Company lacks the ability to exercise significant influence over operating and financial policies of its affiliated company, the investment should be accounted for on a cost basis.

The Company's investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an investment may not be recoverable. As of December 31, 2009 the Company's investments are accounted for on a cost basis and no impairment losses have been identified.
 m.
Advertising expenses:
Advertising expenses are charged to the statement of operations as incurred.
Expected term n.
Income taxes:
The Company and its subsidiaries account for income taxes in accordance with ASC 740 (formerly SFAS 109), "Income Taxes". This Statement prescribes the use of the asset and liability method, whereby deferred tax assets and liability account balances are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company and its subsidiaries provide a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.

ASC 740 (formerly FIN 48) addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC 740, a company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement.
4.25 years

F - 16

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands
NOTE 2:            SIGNIFICANT ACCOUNTING POLICIES (Cont.)

Dividend yield o.
Concentrations of credit risk:
Financial instruments that potentially subject the Company and certain of its subsidiaries to concentrations of credit risk consist principally of cash and cash equivalents, and trade receivables.

The Company's cash and cash equivalents are invested in deposits with major international financial institutions. Such deposits in the United States may be in excess of insured limits and are not insured in other jurisdictions. Generally, these deposits may be redeemed upon demand and, therefore, bear minimal risk.  Management believes that the financial institutions that hold the Company's investments are institutions with high credit standing, and accordingly, minimal credit risk exists with respect to these investments.

The Company's trade receivables are generally derived from sales to large and solid organizations located mainly in Europe, North America and Israel. The Company performs ongoing credit evaluations of its customers and has established an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers and other information. In certain circumstances, the Company may require letters of credit, other collateral or additional guarantees.

No off-balance sheet concentrations of credit risk exist.
0%
Expected volatility p.90%
Risk-free interest rate
1.8% - 2.5%

Stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the requisite service period for each of the awards.

q.Fair value of financial instruments:
The carrying amounts of our financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate fair value because of their generally short-term maturities.

Effective January 1, 2008, the Company adopted ASC 820 (formerly SFAS 157), "Fair Value Measurements and Disclosures". ASC 820 clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:
Level 1-
Level 2-  
Level 3-  
Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Include other inputs that are directly or indirectly observable in the marketplace.
Unobservable inputs which are supported by little or no market activity.

ASC 820, "Fair Value Measurements and Disclosures", defines fair value as the price that would be received to sell an asset or paid to transfer a liability (i.e., the "exit price") in an orderly transaction between market participants at the measurement date.

In determining fair value, the Company uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company's assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances.

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

F-23
F - 17

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands

(except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

Level 1 -Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.
Level 2 - Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly. 
Level 3 -Valuations based on inputs that are unobservable and significant to the overall fair value measurement. 

Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments.

The carrying amounts of cash and cash equivalents, restricted cash, accounts receivable, and accounts payable approximate fair value due to the short-term maturities of such instruments.

r.Derivatives and hedging:

The Company enters into option contracts and forward contracts to hedge certain transactions denominated in foreign currencies. The purpose of the Company's foreign currency hedging activities is to protect the Company from risk that the eventual dollar cash flows from international activities will be adversely affected by changes in the exchange rates. The Company's option and forward contracts do not qualify as hedging instruments under ASC 815. Changes in the fair value of option strategies are reflected in the consolidated statements of income as financial income or expense.

In 2009, 2010 and 2011, the Company entered into option strategies contracts in the notional amounts of $ 5,800, $ 1,409 and $ 1,450, respectively that converted a portion of its floating currency liabilities to a fixed rate basis for a twelve-month period, thus reducing the impact of the currency changes on the Company's cash flow. In addition, in 2010 and 2011 the Company entered into forward contracts in the notional amounts of $ 2,020 and $ 5,750, respectively, that converted a portion of its floating currency liabilities to a fixed rate basis for a twelve-month period, thus reducing the impact of the currency changes on the Company's cash flow.

In 2009, 2010 and 2011, the Company recorded a loss of $ 28, $ 67 and income of $ 27, respectively, with respect to the above transactions, presented in the statements of income as financial income or expense, net.

NOTE 2:            SIGNIFICANT ACCOUNTING POLICIES (Cont.)

F-24
 q. 
Derivatives and hedging:
Accounting Codification Statement No. 815 (formerly SFAS No. 133), "Derivatives and Hedging", as amended, requires the Company to recognize all derivatives on the balance sheet at fair value. Derivatives that are not hedges must be adjusted to fair value through income. If the derivative is a hedge, depending on the nature of the hedge, changes in the fair value of derivatives are either offset against the change in fair value of the hedged assets, liabilities, or firm commitments through earnings or recognized in other comprehensive income until the hedged item is recognized in earnings. The ineffective portion of a derivative's change in fair value is immediately recognized in earnings. The Company uses derivatives to hedge certain cash flow foreign currency exposures in order to further reduce the Company's exposure to foreign currency risks.
The Company enters into put option contracts to hedge certain transactions denominated in foreign currencies. The purpose of the Company's foreign currency hedging activities is to protect the Company from risk that the eventual dollar cash flows from international activities will be adversely affected by changes in the exchange rates. The Company's put option contracts did not qualify as hedging instruments under ASC 815.

Changes in the fair value of put option contracts are reflected in the consolidated statements of operations as financial income or expense.

In 2007, 2008 and 2009, the Company entered into put option contracts in the amount of $ 2,500, $ 10,800 and $ 5,800, respectively that converted a portion of its floating currency liabilities to a fixed rate basis for a six month period, thus reducing the impact of the currency changes on the Company's cash flow. In 2007, 2008 and 2009, the Company recorded a gain of $ 158, $ 106 and $ 135, respectively, with respect to the above transactions, presented in the statements of operations as financial income.
r.
Basic and diluted net earnings (loss) per share:
Basic and diluted net earnings (loss) per share are presented in accordance with ASC Topic 260, "Earnings per Share", for all periods presented.
Basic net earnings (loss) per share have been computed using the weighted-average number of Ordinary shares outstanding during the year. Diluted net earnings (loss) per share are computed based on the weighted average number of Ordinary shares outstanding during each year, plus the weighted average number of dilutive potential Ordinary shares considered outstanding during the year.

For the years ended December 31, 2007 and 2008, all the outstanding options, convertible notes and warrants have been excluded from the computation of diluted net loss per share, since their effect is anti-dilutive.

For the year ended December 31, 2009, 2,878,792 options as well as all convertible notes and warrants have been excluded from the computation of diluted earnings per share, since their effect is anti-dilutive. 472 options were included in the computation of diluted earnings per share.

F - 18

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands

NOTE 2:            SIGNIFICANT ACCOUNTING POLICIES (Cont.)

(except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

s.
Stock-based compensation:
The Company applies ASC 718, and ASC 505-50, "Equity-Based Payments to Non-Employees", with respect to options and warrants issued to non-employees. ASC 718 requires the use of an option valuation model to measure the fair value of the options and warrants at the measurement date as defined in ASC 505-50.

ASC 718 requires companies to estimate the fair value of share-based awards on the date of grant using an option-pricing model, where applicable. Share-based compensation expense recognized in the Company's consolidated statements of operations for 2007, 2008 and 2009 includes compensation expense for share-based awards granted (i) prior to, but not yet vested as of, January 1, 2006, based on the grant date fair value estimated in accordance with the original provisions of ASC 718, and (ii) subsequent to January 1, 2006, based on the grant date fair value estimated in accordance with the provisions of ASC 718.

The Company recognizes these compensation costs net of a forfeiture rate and recognizes the compensation costs for only those shares expected to vest on a straight-line basis over the requisite service period of the award, which is the option vesting term of four years. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

The Company estimates the fair value of stock options on the grant date using the Black-Scholes option-pricing model with the following weighted average assumptions:
Treasury shares:
  Year ended December 31,
  2007 2008 2009
       
Expected term 6.25 years 4.25 years 4.25 years
Dividend yield 0% 0% 0%
Expected volatility 89% 78% 90%- 93%
Risk-free interest rate 4.2% 2.95% 1.79% - 2.46%

In prior years, the Company repurchased certain of its common shares and holds such shares as treasury shares. The Company presents the cost to repurchase treasury stock as a reduction of shareholders’ equity.

The risk-free interest rate assumption is based on the yield from U.S. Treasury zero-coupon bonds with an equivalent term as of the Company's employee stock options. The dividend yield assumption is based on the Company's historical and expectation of future dividend payouts. The expected term of the options represents the period of time that the options are expected to be outstanding and is based on the simplified method, as allowed under Staff Accounting Bulletin 110, which is the midpoint between the vesting date and the end of the contractual term of the options. It should be noted that in 2008 and 2009, the Company granted options with contractual term of six years (ten years in 2007). The Company used its historical volatility for calculating volatility in accordance with ASC 718.

The Company estimates the fair value of stock options with market conditions using the Binominal option-pricing model.

Stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the requisite service period for each of the awards. In 2008 and 2009, the Company granted 244,000 and 292,012 stock options to employees, respectively.

In 2008 and 2009, there were no options and warrants granted to non-employees.

F - 19

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands
NOTE 2:            SIGNIFICANT ACCOUNTING POLICIES (Cont.)

t.
Accrued severance pay:
The liability of the Company's subsidiaries in Israel for severance pay is calculated pursuant to Israeli Severance Pay Law based on the most recent salary of the employees multiplied by the number of years of employment as of the balance sheet date. Employees are entitled to one month's salary for each year of employment or a portion thereof. The liability for its employees in Israel is fully provided by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset in the Company's consolidated balance sheet.

In addition, the Company signed collective agreements with few of its employees, according to which the Company's contributions for severance pay shall be instead of severance compensation and that upon release of the policy to the employee, no additional payments shall be made by the Company to the employee. Generally, the Company pays to all its employees the entire liability, irrespective of the collective agreements described per above. Therefore, the net obligation related to the employees is stated on the balance sheet as accrued severance pay.

In addition, some of the Company's agreements with its employees are in accordance with section 14 of the Severance Pay Law, 1963, under which the Company's contributions for severance pay shall be in lieu of severance compensation and upon release of the policy to the employee, no additional liability exists between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee.
The deposited funds include profits and losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israeli severance pay law or labor agreements. The value of the deposited funds is based on the cash surrendered value of these policies.

Severance expense for the years 2007, 2008 and 2009 amounted to approximately $ 502, $ 1,588 and $ 307, respectively.

In addition, the Company has various defined contribution plans for employees of its subsidiaries around the world. Most of the plans are those required according to the laws of the country in which the subsidiary operates. Contributions made under the plans are invested with financial institutions. Benefits under the plans are based on contributions from employees and the Company, and earnings on insurance contracts or other investment instruments in which the contributions are invested.

Expense for contributions made to these plans was $ 178, $ 154 and $ 110 for 2007, 2008 and 2009, respectively.

F - 20


SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands

NOTE 2:            SIGNIFICANT ACCOUNTING POLICIES (Cont.)

u.
Impact of recently issued accounting standards:
In October 2009, the FASB

In September 2011, the Financial Accounting Standards Board, (the "FASB") issued ASU 2011-08, Testing Goodwill for Impairment, codified in ASC 350 "Intangibles – Goodwill and Other". The revised accounting standard update is intended to simplify how an entity tests goodwill for impairment. The amendment allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. An entity is no longer required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. This accounting standard update is effective for the Company beginning January 1, 2012. The Company early adopted the provisions of ASU 2011-08 in 2011 in the performance of the Company's annual impairment test of goodwill and determined that no indicators of impairment exist.

u.Recently issued ASU 2009-13, "Revenue Recognition (ASC Topic 605)-Multiple-Deliverable Revenue Arrangements" ("ASU 2009-13"). ASU 2009-13 amends the criteria in ASC Subtopic 605-25, "Revenue Recognition-Multiple-Element Arrangements", for separating consideration in multiple-deliverable arrangements. This Update addresses the accounting for multiple-deliverable arrangements to enable vendors to account for products or services (deliverables) separately rather than as a combined unit. ASU 2009-13 modifies the requirements for determining whether a deliverable can be treated as a separate unit of accounting by removing the criteria that verifiable and objective evidence of fair value exists for the undelivered elements. This guidance eliminates the residual method of allocation and requires that arrangement consideration be allocated at the inception of the arrangement to all deliverables using the relative selling price method. This guidance establishes a selling price hierarchy for dete rmining the selling price of a deliverable, which is based on: a) vendor-specific objective evidence; b) third-party evidence; or c) estimates. In addition, this guidance significantly expands required disclosures related to a vendor's multiple-deliverable revenue arrangements. ASU 2009-13 is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010, with early adoption permitted. The Company has chosen not to early adopt ASU 2009-13. The Company is currently evaluating the potential impact, if any, of the adoption of the Standard on its consolidated financial statements.

In October 2009, the FASB also issued an update to ASC Topic 985-605, "Software Revenue Recognition", which changes revenue recognition for tangible products containing software and hardware elements. Specifically, tangible products containing software and hardware that function together to deliver the tangible products' essential functionality are scoped out of the existing software revenue recognition guidance and will be accounted for under the multiple-element arrangements revenue recognition guidance discussed above. The Standard will be effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010, with early adoption permitted. The Company has chosen not to early adopt the standard. The Company is currently evaluating the potential impact, if any, of the adoption of the Standard on its consolidated financial statement.
standards:
v. 
Adoption of new accounting standards:
In June 2009, the FASB issued ASU No. 2009-01, Topic 105, "Generally Accepted Accounting Principles Amendments" based upon Statement of Financial Accounting Standards No. 168, "The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles - a Replacement of FASB Statement 162" ("ASU 2009-01"). ASU 2009-01 establishes the FASB ASC as the single source of authoritative accounting principles to be applied to financial statements of nongovernmental entities in conformity with U.S. GAAP. ASU 2009-01 was effective for financial statements issued for interim and annual periods ending after September 15, 2009. The Company's adoption of ASU 2009-01 did not affect its consolidated results of operations or financial condition.


F - 21

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands
NOTE 2:            SIGNIFICANT ACCOUNTING POLICIES (Cont.)

In December 2007,June 2011, the FASB issued new authoritative accountingASU 2011-05 Presentation of Comprehensive Income, codified in ASC 220 "Comprehensive Income". The guidance underrequires an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. The guidance also eliminates the option to present the components of other comprehensive income as part of the statement of equity. In December 2011, the FASB issued ASU 2011-12, deferring the effective date for amendments outlined in ASU 2011-05. The Company is still evaluating whether to present other comprehensive income in a single continuous statement of comprehensive income or in two separate but consecutive statements.

In May 2011, the FASB issued ASU 2011-04 Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS, codified in ASC Topic 810 (formerly SFAS No. 160) which establishes accounting820 "Fair Value Measurement". The guidance requires an entity to provide a consistent definition of fair value to ensure that the fair value measurement and reporting standardsdisclosure requirements are similar between U.S. GAAP and International Financial Reporting Standards. The guidance changes certain fair value measurement principles and enhances the disclosure requirements particularly for Level 3 fair value measurements, and will become effective for the non-controlling interest in a subsidiary and forCompany beginning January 1, 2012. The Company does not expect the deconsolidation of a subsidiary. ASC Topic 810 clarifies that a non-controlling interest in a subsidiary, which is sometimes referred to as minority interest, is an ownership interest in the consolidated entity that should be reported as a component of equity in the consolidated financial statements. Among other requirements, ASC Topic 810 requires consolidated net income to be reported at amounts that include the amounts attributable to both the parent and the non-controlling interest. It also requires disclosure, on the face of the consolidated income statement, of the amounts of consolidated net incom e attributable to the parent and to the non-controlling interest. ASC Topic 810 is effective for fiscal years beginning on or after December 15, 2008. The adoption of ASC Topic 810 on January 1, 2009 did notthis new guidance to have a material impact on the Company'sits financial position or results of operations.


statements.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 3:TRADE RECEIVABLESOTHER LONG TERM ASSETS

The Company's net trade receivables are composed of accounts receivable in the amounts of $ 6,677 and $ 5,062 as of December 31, 2008 and 2009, respectively and unbilled receivables in the amounts of $ 183 and $ 70 as of December 31, 2008 and 2009, respectively.

Bad debt expense totaled $ 195, $ 411 and $ 32 for the years ended December 31, 2007, 2008 and 2009, respectively.

NOTE 4:OTHER RECEIVABLES AND PREPAID EXPENSES

  December 31, 
  2008  2009 
       
Prepaid expenses $983  $1,169 
Deferred income taxes  1,061   1,448 
Others  521   391 
         
  $2,565  $3,008 

  December 31, 
  2010  2011 
       
Deferred tax assets $1,824  $1,782 
Government authorities  -   883 
Other  1,131   881 
         
  $2,955  $3,546 

NOTE 5:             PROPERTY AND EQUIPMENT, NET

  Cost  Accumulated depreciation 
  December 31, 
  2008  2009  2008  2009 
             
Equipment and furniture $2,057  $2,055  $1,688  $1,759 
Computer equipment and software  13,117   13,529   12,501   13,030 
Motor vehicles  85   147   63   75 
Leasehold improvements  1,583   1,638   1,535   1,608 
                 
  $16,842  $17,369  $15,787  $16,472 
NOTE 4:PROPERTY AND EQUIPMENT, NET

  December 31, 
  2010  2011 
       
Cost:        
Computers and peripheral equipment $14,857  $17,330 
Office furniture and equipment  2,362   3,842 
Motor vehicles  160   176 
Leasehold improvements  1,735   1,275 
         
   19,114   22,623 
Accumulated depreciation:        
Computers and peripheral equipment  14,195   16,466 
Office furniture and equipment  1,969   3,038 
Motor vehicles  111   140 
Leasehold improvements  1,678   1,165 
         
   17,953   20,809 
         
Depreciated cost $1,161  $1,814 

Depreciation expense totaled $ 583,475,550593 and $ 475755 for the years 2007, 20082009, 2010 and 2009,2011, respectively.

As for pledges, see Note 10.


F - 22

9.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands
NOTE 6:OTHER ASSETS

a.
Amortization expense for capitalized software development costs for 2007, 2008 and 2009, was $ 3,035, $ 4,224 and $ 4,623, respectively. Amortization expense is included in cost of revenues.
In 2008 and 2009, $ 62 and $ 65, respectively, of interest expense was capitalized in respect of software development costs.
b.Other assets, net, are comprised of the following:

  Cost  
Accumulated
amortization
  Other assets, net 
  December 31, 
  2008  2009  2008  2009  2008  2009 
                   
Prepaid royalties $2,074  $2,074  $2,074  $2,074  $-  $- 
Technologies and usage rights  1,701   1,701   1,701   1,701   -   - 
Deferred debt issuance costs (1)  1,528   -   1,287   -   241   - 
                         
  $5,303  $3,775  $5,062  $3,775   241   - 
In addition, other assets include:                        
                         
Severance pay fund                  900   1,104 
Long-term deposits                  250   254 
Other                  197   240 
                         
                   1,347   1,598 
                         
                  $1,588  $1,598 
(1)As to the issuance of debentures, options (series A) and warrants (series 1), see Note 8.
                                     Amortization of other assets charged to expenses was $ 647, $ 618 and $ 493 for 2007, 2008 and 2009, respectively.

NOTE 7:OTHER LIABILITIES AND ACCRUED EXPENSES

  December 31, 
  2008  2009 
       
Employees and related payroll accruals *) $3,330  $2,837 
Sales and other taxes payable  926   1,242 
Accrued royalties to the OCS (Note 10a)  3,377   3,114 
Accrued expenses and other liabilities  2,083   3,006 
         
  $9,716  $10,199 
         
*)      Including accrual for vacation $1,089  $1,033 


F - 23

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 8:             CONVERTIBLE DEBT

During December 2003,

NOTE 5:CAPITALIZED SOFTWARE DEVELOPMENT COSTS

The changes in capitalized software development costs during the Company completed an offering of securities on the Tel-Aviv Stock Exchange ("TASE") in Israel, resulting in gross proceeds of NIS 75.2 million (approximately $ 17,100). The price per unit was NIS 752 (approximately $ 171.14) with 100,000 units sold. Each of the units consists of 800 debentures (series A), two options (series A) exercisable into debentures (series A) and six warrants (series 1) exercisable into Common shares of the Company.


The debentures (series A) were linked to the U.S. dollar with a floor exchange rate of NIS 4.394 to the dollar, and bear annual interest at the rate of 6.0%, payable twice a year commencing on June 5, 2004 and ending on December 5, 2009. Principal is payable in four installments on December 5 of the years 2006-2009. The debentures (series A) were convertible into Common shares at a conversion rate of one Common share per each NIS 27 (approximately $ 6.14) amount of the debentures, linked to the NIS/dollar exchange rate, with a floor exchange rate of NIS 4.394 to the dollar.

Each option (series A) was exercisable into 100 debentures (series A) no later than March 3, 2004 at an exercise price of NIS 96 (approximately $ 21.85), of which 179,663 options (series A) were exercised into debentures (series A) in 2004, with a total exercise price of approximately $ 3,800. 105,225 of the options (series A) were exercised by one of the Company's subsidiaries in Israel. The remaining options expired. All the warrants (series 1) that were exercisable into Common shares of the Company expired on November 21, 2007, without being exercised.

The debentures (series A), options (series A) and warrants (series 1) were, traded on TASE only. Any Common shares issued upon conversion of the debentures (series A) will be traded on both TASE and NASDAQ.

The conversion feature and the floor rate to the dollar payments were evaluated and determined under ASC 815 to have characteristics of liabilities and therefore, accounted for as derivative liabilities. Each reporting period, these derivative liabilities were marked to fair value with the non-cash gain or loss recorded in the period. Atended December 31, 2010 and 2011 were as follows:

  Year ended December 31, 
  2010  2011 
       
Balance at the beginning of the year $13,540  $13,822 
         
Acquisition of core technology which considered as software development  -   4,659 
Capitalization  5,387   4,735 
Amortization  (5,869)  (4,544)
Functional currency translation adjustments  764   (1,273)
         
Balance at the year end $13,822  $17,399 

Amortization of capitalized software development costs for 2009, 2010 and 2008, the aggregate derivative liabilities were2011, was04,623, $ 5,869 and $ 900, respectively classified on the balance sheet as "convertible debentures". The valuation of the embedded derivatives was determined by the Black and Scholes model and the Lattice model.


During the years 2007, 2008 and 2009, the Company re-purchased an aggregate amount of NIS 15,000, NIS 7,600 and NIS 1,600  nominal value, respectively, representing $ 3,500, $ 2,090 and $ 400 of the outstanding debentures (series A) that were retired and removed from circulation on the TASE.

On December 5, 2009, the Company repaid the fourth and final payment of the principal of the debentures (series A).

As of December 31, 2008 and 2009, the net balance of the convertible debt was $ 5,380 and $ 0,4,544, respectively. Amortization expense is included in cost of the deemed discount and the changes in the fair value of the embedded derivatives charged to expenses were $ 308 and $ 459 for 2008 and 2009, respectively. The debt issuance expenses, which are classified as other assets (Note 6b), and the deemed discount, are amortized over the term of the debentures (series A), using the effective interest rate method.

F - 24

revenues.

NOTE 6:OTHER INTANGIBLE ASSETS, NET

a.Other intangible assets, net, are comprised of the following:

  December 31, 
  2010  2011 
       
Original amounts:        
         
Customer relationship $789  $9,130 
Technology  943   5,705 
Long-term contracts  -   921 
         
   1,732   15,756 
         
Accumulated amortization:        
         
Customer relationship  78   763 
Technology  109   513 
Long-term contracts  -   287 
         
   187   1,563 
         
Other intangible assets, net $1,545  $14,193 

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands

(except share and per share data)

NOTE 9:6:OTHER LONG-TERMINTANGIBLE ASSETS, NET (cont.)

c.Amortization of other intangible assets was $ 493, $ 506 and $ 1,449 for 2009, 2010 and 2011, respectively.

d.Estimated amortization expense for future periods:

For the year ended December 31,   
     
2012 $2,628 
2013  2,047 
2014  2,111 
2015  1,986 
2016  1,606 
2017 and thereafter  3,815 
     
  $14,193 

NOTE 7:-GOODWILL

The changes in the carrying amount of goodwill for the year ended December 31, 2010 and 2011 are as follows:

  Year ended December 31, 
  2010  2011 
       
Balance at the beginning of the year $8,621  $9,604 
         
Acquisitions  981   60,878 
Functional currency translation adjustments  2   (3,767)
         
Balance at the year end $9,604  $66,715 

NOTE 8:ACCRUED EXPENSES AND OTHER LIABILITIES

         December 31, 
 Linkage Interest  Maturity  2008  2009 
   %          
              
Other long-term liability *)GBP  -  Through 12/2008  $365  $- 
Other long-term debtJapanese Yen  1.47   2/2011   174   15 
                  
            539   15 
Less - current maturities of long-term liabilities           (365)  - 
                  
            174   15 
Accrued severance pay           1,136   938 
Others           122   19 
                  
           $1,432  $972 

*)See Note 6b(1).

Interest expense

  December 31, 
  2010  2011 
       
Government authorities $1,216  $2,543 
Accrued royalties to the OCS (Note 9a)  2,669   1,591 
Accrued contract costs  -   1,541 
Earn-out payment (Note 1d)  952   - 
Accrued expenses  3,488   5,099 
         
  $8,325  $10,774 

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in respect of the above liabilities was approximately $ 60, $ 5thousands (except share and $ 1 for 2007, 2008 and 2009, respectively.

per share data)

NOTE 10:9:COMMITMENTS AND CONTINGENT LIABILITIES

a.
Sapiens Technologies (1982) Ltd. ("Sapiens Technologies"), a subsidiary incorporated in Israel, was partially financed its research and development expenditures under programs sponsored by the Office of Chief Scientist ("OCS") for the support of certain research and development activities conducted in Israel.

In exchange for participation in the programs by the OCS, the Company agreed to pay 3%-3.5% of total net consolidated license and maintenance revenue and 0.35% of the net consolidated consulting services revenue related to the software developed within the framework of these programs based on an understanding with the OCS reached in January 2012. The understanding reached with the OCS resulted in a reversal of an accrual in the amount of $ 922 which was recorded as a reduction of cost of revenues in 2011.

The royalties will be paid up to a maximum amount equaling 100%-150% of the grants provided by the OCS, linked to the dollar, and for grants received after January 1, 1999, bear annual interest at a rate based on LIBOR.

Royalties expenses amounted to $ 577, $ 614 and $ 510 in 2009, 2010 and 2011, respectively, and are included in cost of revenues. During 2011, the Company paid to the OCS, royalties in the amount of $ 1,184.

As of December 31, 2011, the Company had a contingent liability to pay royalties of approximately $ 6,300.

b.Lease commitments:

The Company leases office space, office equipment and various motor vehicles under operating leases.

1.The Company's office space and office equipment are rented under several operating leases. Future minimum lease commitments under non-cancelable operating leases for participation in the programs by the OCS, the Company agreed to pay 3%-3.5% of total net consolidated license and maintenance revenue and 0.35% of the net consolidated consulting services revenue related to the software developed within the framework of these programs. The royalties will be paid up to a maximum amount equaling 100%-150% of the grants provided by the OCS, linked to the dollar, and for grants received after January 1, 1999, bear annual interest at a rate based on LIBOR. Repayment of such grants is not required in the event that there are no sales of products developed within the framework of such funded programs.

Royalties accrued amounted to approximately $ 930, $ 760 and $ 577 in 2007, 2008 and 2009, respectively, and are included in cost of revenues.

During 2009, the Company paid an amount of $ 1,100 with respect to royalties payable to the OCS. In addition, subsequent to balance sheet date, the Company paid an additional amount of $ 540 with respect to royalties payable to the OCS. As ofyears ended December 31, 2009, the Company had a contingent liability to pay royalties of approximately $ 6,400. The total amount of the contingent liability due to royalties is currently negotiated by the Company with the OCS.
were as follows:

F - 25

2012 $2,487 
2013  1,863 
2014  1,636 
2015  657 
     
  $6,643 

Rent expense for the years ended December 31, 2009, 2010 and 2011 was $ 1,556, $ 1,811 and $ 2,399, respectively.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands

(except share and per share data)

NOTE 10:9:COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)

b.2.The Company andleases its subsidiaries lease various office equipment, computers, office space, and motor vehicles throughunder cancelable operating leases. Office lease agreements expire in the years 2010 to 2011 (some with renewal options). Future minimum lease payments for the next five years and thereafter are as follows:agreements.

  Operating leases 
    
2010 $2,105 
2011  925 
2012  117 
2013  117 
2014 and thereafter  64 
     
Total future minimum lease payments
 $3,328 

The minimum payment under these operating leases, upon cancellation of these lease agreements was $ 203 as of December 31, 2011.

Rent expense for the years 2007, 2008 and 2009 was $ 1,820, $ 1,763 and $ 1,556, respectively.
c.
In February 2008, a former employee filed a claim against the Company for the amount that such employee was required to pay to the Israel Tax Authorities of approximately NIS 4,562 thousand (approximately $ 1,208 as of December 31, 2009) as a result of his exercise of stock options. The Company believes that such claim lacks merit and the Company, based on the advice of its legal counsel, believes that it has a reasonable defense.
In addition, the Company is a party to various other legal proceedings and claims that arise in the ordinary course of business. The total aggregate amount of exposure of such proceedings and claims, except for the above mentioned claim, is approximately $ 157.
The Company has provided an amount which it believes is sufficient to cover damages, if any, which may result from these claims, in accordance with ASC 450, "Contingencies".
Legal settlement:

In 2010, a former customer of the Company filed a claim in the arbitration court in Warsaw, Poland against the Company for damages allegedly caused by the Company with respect to a license and services contract with such former customer signed a number of years ago. A settlement was reached in October 2011 under which the Company paid 1,100 Euro ($1,509) and recovered an amount of $ 1,200 from the insurance company and reversed a provision provided for this claim in the amount of $ 501. The Company recorded income in the amount of $ 192 which was deducted from selling, marketing, general and administrative.

d.As for tax assessments, see Note 11d.

e.
The Company's leased assets are pledged to the finance companies that provided the lease financing and the banks providing credit lines.financing. The pledges are for various terms depending on the asset leased.

The Company has provided bank guarantees in the amount of $ 704 as security for the rent to be paid for its leased offices. The lease is valid for approximately four years ending in July 2015.

As of December 31, 2011, the Company has provided bank guarantees in the amount of $ 109 as security for the performance of various contracts with customers and suppliers.

e.According to the amount of approximately $ 398 as security foragreement with the rent to be paid for its leased offices in Israel. The lease is valid for approximately six years ending in 2010. IfCompany's major customer, the Company wereis obligated to breach certain termspay sales commission to this customer of its lease, the lessor could demand thathigher between 15% on future license sales or 5% of future total project sales of one of the banks providing the guarantees pay amounts claimedCompany's products to be due.

third parties. As of December 31, 2009,2011, the Company has provided bank guaranteesrecorded an accrual in the amount of approximately $ 162 as security for234 with respect to the performance of various contracts with customers and suppliers. If the Company were to breach certain terms of such contracts, the customers or the suppliers could demand that the banks providing the guarantees pay amounts claimed to be due.
licenses sold.

F - 26


SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands

(except share and per share data)

NOTE 11:10:TAXES ON INCOME

a.
Net operating losses carryforwards:
At December 31, 2009, the Company's subsidiary in the U.S. had net operating loss carryforwards for U.S. federal income tax purposes of approximately $ 3,000. The losses are to be used and will expire between 2010 and 2020. 

Utilization of U.S. net operating losses may be subject to substantial annual limitation due to the "change in ownership" provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitations may result in the expiration of net operating losses before utilization.

In addition, the Company had net operating losses carryforwards relating to non-U.S. subsidiaries totaling approximately $ 47,000 which are available to offset future taxable income. Generally, a majority of such amounts have no expiration date.
Parent taxation:

Organized and existing under the laws of the Curaçao.

b.
Israeli corporatetaxation:

1.Corporate tax structure:
Therates in Israel:

Taxable income of Israeli companies is subject to tax at the rate of 26% in 2009, 25% in 2010, 24% in 2011 and 25% in 2012 and onwards.

2.Tax benefits under the Israeli corporate tax is as follows: 2007 - 29%, 2008 - 27%, 2009 - 26%, 2010 - 25%.  Tax at a reduced rate of 25% applies on capital gains arising after January 1, 2003, instead of the regular tax rate.  In July 2009, the "Knesset" (Israeli Parliament) passed theIsrael Law for Economic Efficiency (Amended Legislation for Implementing the Economic Plan for 2009 and 2010), which prescribes, among others, an additional gradual reduction in Encouragement of Capital Investments, 1959 ("the rates of the Israeli corporate tax and real capital gains tax starting in 2011 to the following tax rates: 2011 - 24%, 2012 - 23%, 2013 - 22%, 2014 - 21%, 2015 - 20%, 2016 and thereafter - 18%.Law"):

Certain of the Company's Israeli subsidiaries have been granted "Approved Enterprise" and "Privileged Enterprise" status, which provides certain benefits, including tax exemptions and reduced tax rates. Income not eligible for Approved Enterprise and Privileged Enterprise benefits is taxed at regular rates.

In the event of distribution of dividends from the said tax-exempt income, the amount distributed will be subject to corporate tax at the rate ordinarily applicable to the Approved Enterprise's income. The tax-exempt income attributable to the Approved Enterprise programs mentioned above can be distributed to shareholders without subjecting the Company to taxes, only upon the complete liquidation of the applicable Israeli subsidiary. Tax-exempt income generated under the Privileged Enterprise program will be subject to taxes upon dividend distribution (which includes the repurchase of the Company's shares) or liquidation.

The entitlement to the above benefits is conditional upon the fulfilling of the conditions stipulated by the Laws and regulations (see below). Should they fail to meet such requirements in the future, income attributable to its Approved Enterprise and Privileged Enterprise programs could be subject to the statutory Israeli corporate tax rate and they could be required to refund a portion of the tax benefits already received, with respect to such programs. As of December 31, 2011, management believes that the Company's Israeli subsidiaries are in compliance with all the conditions required by the Law.

The Company does not intend to distribute any of its undistributed tax-exempt income as dividends, as it intends to reinvest this within the Company. Accordingly, no deferred income taxes have been provided on income attributable to the Company's Approved or Privileged Enterprise programs as the undistributed tax-exempt income is essentially permanent in duration.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

c. 
NOTE 10:
Israeli corporate tax structure:
TAXES ON INCOME (Cont.)

Effective January 1, 2011, the Knesset enacted the Law for Economic Policy for 2011 and 2012 (Amended Legislation), and among other things, amended the Law, ("the Amendment"). According to the Amendment, the benefit tracks in the Investment Law were modified and a flat tax rate applies to the Company's entire preferred income. The Company will be able to opt to apply (the waiver is non-recourse) the Amendment and from then on it will be subject to the amended tax rates as follows: 2011 and 2012 - 15%, 2013 and 2014 - 12.5% and in 2015 and thereafter - 12%.

3.Tax benefits under the Law for the Encouragement of Capital Investments, 1959:
Sapiens Technologies has been granted "Approved Enterprise" status for a number of investment programs approved by the Israeli Government under the Law for Encouragement of Capital Investments, 1959 ("the Capital Investments Law").

According to the provisions of the Capital Investments Law, Sapiens Technologies has elected the "alternative benefits track" - the waiver of grants in return for tax exemption and, accordingly, it is tax-exempt for a period of two to four years commencing from the year it first earns taxable income and to a reduced corporate tax rate of 10% - 25% for an additional period of three to eight years (depending on the level of foreign-investment in Technologies). These tax benefits are subject to a limitation of the earlier of twelve years from commencement of operations, or fourteen years from receipt of the approval. This limitation does not apply for the years of tax exemption. The Capital Investments Law also grants entitlement to claim accelerated depreciation on machinery and equipment used by the "Approved Enterprise"Industry (Taxation), during the firs t five years, which the Company claims.

Income from sources other than the "Approved Enterprise" during the benefit period is subject to tax at the regular corporate tax rate of 26% in 2009, 25% in 2010, 24% in 2011, 23% in 2012, 22% in 2013, 21% in 2014, 20% in 2015 and 18% in 2016 and thereafter.

The entitlement to the above benefits is conditional upon the Company fulfilling the conditions stipulated by the Capital Investments Law, regulations published thereunder and the instruments of approval for the specific investments in "Approved Enterprises".
1969:

F - 27

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars

Management believes that Sapiens Technologies currently qualifies as an "industrial company" under the above law and as such, is entitled to certain tax benefits including accelerated depreciation, deduction of public offering expenses in thousands

three equal annual installments and amortization of other intangible property rights for tax purposes.

NOTE 11:TAXES ON INCOME (Cont.)
In the event of failure to comply with these conditions, the benefits may be cancelled and the Company may be required to refund the amount of the benefits, in whole or in part, plus a consumer price index linkage adjustment and interest.

In the event Sapiens Technologies distributes a dividend out of the retained tax exempt profits, such profits will be subject to corporate tax in the year the dividend is distributed, in respect of the gross amount of the dividend distributed and at a rate that would have been applicable had the Company not elected the "alternative benefits track" (10%-25%, depending on the level of foreign investment in the Company). In addition, the dividend recipient is subject to tax at a reduced rate of 15% applicable to dividends from "Approved Enterprises" if the dividend is distributed during the exemption period or within 12 years thereafter.  This tax must be withheld by Sapiens at the source. However, in the event that the Company qualifies as a Foreign Investors Company, there would be no such limitation.

On April 1, 2005, an amendment to the Investment Law came into effect ("the Amendment") and has significantly changed the provisions of the Investment Law. The Amendment sets forth the scope of enterprises which may qualify as a Privileged Enterprise (under the Amendment, the designation is Beneficiary Enterprise rather than Approved Enterprise) by setting forth criteria for qualification of a company, such as provisions generally requiring that at least 25% of the Beneficiary Enterprise's income will be derived from export and that minimum qualifying investments in productive assets be made. Additionally, the Amendment enacted major changes in the manner in which tax benefits are awarded under the Investment Law so that companies no longer require Investment Center approval in order to qualify for tax benefits.

Under the Amendment, the year in which the company elects to commence its tax benefits is designated as the year of election ("Year of Election"). A company may choose its Year of Election by notifying the Israeli Tax authorities in connection with filings its annual tax return or within 12 months after the end of the Year of Election, whichever is earlier, or by requesting a pre-ruling ruling from the Israeli tax authorities no later than within 6 months after the end of the Year of Election. As a result of the Amendment among others, tax-exempt income generated under the provisions of the new law, will subject the Company to taxes upon distribution or liquidation and the Company may be required to record deferred tax liability with respect to such tax-exempt income. As of December 31, 2009, the Company did not generate income under th e Amendment.
d.4.Commencing 2005, some of the Company's Israeli subsidiaries have elected to file their tax returns under the Israeli Income Tax Regulations 1986 (Principles Regarding the Management of Books of Account of Foreign Invested Companies and Certain Partnerships and the Determination of Their Taxable Income). Accordingly, commencing 2005, results for tax purposes are measured in terms of U.S. dollars.

F - 28

c.Income taxes on non-Israeli subsidiaries:

Non-Israeli subsidiaries are taxed according to the tax laws in their respective country of residence. Neither Israeli income taxes, foreign withholding taxes nor deferred income taxes were provided in relation to undistributed earnings of the non-Israelis subsidiaries. This is because the Company intends to permanently reinvest undistributed earnings in the foreign subsidiaries in which those earnings arose. If these earnings were distributed in the form of dividends or otherwise, the Company would be subject to additional Israeli income taxes (subject to an adjustment for foreign tax credits) and non-Israeli withholding taxes.

d.Net operating losses carryforward:

As of December 31, 2011, certain subsidiaries had tax loss carry-forwards totaling approximately $ 61,100 which can be carried forward and offset against taxable income with expiration dates ranging from 2012 and onwards. Most of these carry-forward tax losses have no expiration date.

Utilization of U.S. net operating losses may be subject to substantial annual limitation due to the "change in ownership" provisions of the Internal Revenue Code of 1986 and similar state provisions. The annual limitations may result in the expiration of net operating losses before utilization.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands

(except share and per share data)

NOTE 11:10:TAXES ON INCOME (Cont.)

e.
Tax benefits under the Law for the Encouragement of Industry (Taxation), 1969:
Management believes that Sapiens Technologies is currently qualified as an "industrial company" under the above law and as such, enjoysDeferred tax benefits, including:
(1)
Deduction of purchase of know-how and patents and/or right to use a patent over an eight-year period;
(2)The right to elect, under specified conditions, to file a consolidated tax return with additional related Israeli industrial companies and an industrial holding company;
(3)Accelerated depreciation rates on equipment and buildings; and
(4)Expenses related to a public offering on the Tel-Aviv Stock Exchange and as of 1.1.2003 on recognized stock markets outside of Israel, are deductible in equal amounts over three years.

f.
Income taxes on non-Israeli subsidiaries:
Non-Israeli subsidiaries are taxed according to the tax laws in their respective country of residence.
g.
Tax positions:
Technologies and some of the Company's group entities have final tax assessments through the year 2004. At December 31, 2009, the Company had a liability for unrecognized tax benefits of $ 300. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
  December 31, 
  2008  2009 
       
Balance at the beginning of the year $150  $160 
Additions based on tax positions taken during the current period  -   130 
Addition of interest related to the unrecognized tax liabilities from previous years  10   10 
         
Balance at the end of the year $160  $300 
h.
Deferred income taxes:
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company and its subsidiaries' deferred tax assets are as follows:
liabilities:
  December 31, 2008  December 31, 2009 
  Current  
Non-
current
  Current  
Non-
current
 
             
Tax loss carryforwards $1,159  $14,347  $1,472  $11,477 
Temporary differences  331   (1,742)  485   (2,143)
                 
Gross deferred tax assets  1,490   12,605   1,957   9,334 
Less - valuation allowance  (429)  (10,446)  (509)  (7,528)
                 
Net deferred tax asset $1,061  $2,159  $1,448  $1,806 

F - 29

Deferred taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for tax purposes. Significant components of the Company deferred tax assets are as follows:

  December 31, 
  2010  2011 
       
Deferred tax assets:        
Net operating losses carryforward $10,851  $15,620 
Research and Development assets for Israeli Tax Authorities  1,534   2,809 
Other  179   816 
         
Deferred tax assets before valuation allowance  12,564   19,245 
Valuation allowance  (5,975)  (8,881)
         
Deferred tax assets  6,589   10,364 
         
Deferred tax liabilities:        
Research and Development capitalization  (3,084)  (3,234)
Acquired intangibles  (410)  (4,624)
         
Deferred tax assets, net $3,095  $2,506 

  December 31, 
  2010  2011 
       
Current deferred tax assets $1,681  $1,406 
Long-term deferred tax assets  1,824   1,782 
Current deferred tax liabilities  (410)  (145)
 Long-term deferred tax liabilities  -   (537)
         
Deferred tax assets, net $3,095  $2,506 

Current and long-term deferred tax liabilities are included within other liabilities and other long-term liabilities, respectively, in the balance sheets. Long-term deferred tax assets are included within other long term assets.

The Company has provided valuation allowances in respect of certain deferred tax assets resulting from tax loss carry forwards and other reserves and allowances due to uncertainty concerning realization of these deferred tax assets.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands

(except share and per share data)

NOTE 11:10:TAXES ON INCOME (Cont.)

f.
During the year ended December 31, 2009, the Company and its subsidiaries have decreased the deferred income taxes assets resulting from tax loss carryforwards and temporary differences by $ 2,804 and decreased the related valuation by $ 2,838. Management currently believes that it is more likely than not that the deferred income taxes regarding the loss carryforwards and other temporary differences, on which a valuation allowance has been provided, will not be realized in the foreseeable future.

Provisions for income tax expense are comprised of the following:
  Year ended December 31, 
  2007  2008  2009 
          
Current (foreign) $235  $253  $294 
Deferred (foreign)  103   331   (34)
             
  $338  $584  $260 

The Company's entire provision forIncome before taxes on income relates to operations in jurisdictions other than the Netherlands Antilles. The effective income tax rate varies from period to period because each jurisdiction in which the Company and its subsidiaries operate has its own system of taxation (not only with respect to the nominal rate, but also with respect to the allowance of deductions, credits and other benefits).is comprised as follows:

  Year ended December 31, 
  2009  2010  2011 
          
Domestic (Curaçao) $(930) $(13) $(236)
Foreign  5,391   6,360   5,964 
             
  $4,461  $6,347  $5,728 

i.g.A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Companyfor an Israeli company, and the actual tax expense as reported in the statements of operations,income is as follows:

  Year ended December 31, 
  2007  2008  2009 
Income (loss) before taxes on income, as reported in the statements of operations $(2,110) $281  $4,461 
             
Tax rates  29%  27%  26%
             
Theoretical taxes on income (tax benefit) $(612) $76  $1,160 
Increase in taxes resulting from:            
Effect of different tax rates  55   77   77 
Utilization of carryforwards tax loss for which valuation allowance was provided  (419)  (391)  (32)
Non-deductible expenses and tax exempt income  39   43   (97)
Taxes and deferred taxes in respect of previous years  105   34   53 
Change in deferred taxes during the year  (374)  (437)  (1,618)
Deferred taxes for which valuation allowance was provided  1,527   1,157   691 
Others  17   25   26 
Taxes on income, as reported in the statements of operations $338  $584  $260 


F - 30

  Year ended December 31, 
  2009  2010  2011 
          
Income before taxes on income, as reported in the statements of income $4,461  $6,347  $5,728 
             
Statutory tax rate in Israel  26%  25%  24%
             
Theoretical taxes on income $1,160  $1,587  $1,375 
Increase (decrease) in taxes resulting from:            
Effect of different tax rates  77   106   75 
Utilization of carryforward tax losses for which valuation allowance was provided  (32)  (186)  (66)
Non-deductible expenses and tax exempt income  (97)  (302)  68 
Taxes in respect of previous years  53   236   21 
Recognition of deferred taxes during the year for which valuation allowance was provided  (1,618)  (1,471)  (2,040)
Losses and temporary differences for which valuation allowance was provided  691   172   244 
Others  26   35   93 
Taxes on income, as reported in the statements of operations $260  $177  $(230)

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except(except share and per share data)

NOTE 11:10:TAXES ON INCOME (Cont.)

j.h.Income (loss) before taxesTaxes on income is(benefit) are comprised as follows:

  Year ended December 31, 
  2007  2008  2009 
          
Domestic $(4,471) $(3,678) $(930)
Foreign  2,361   3,959   5,391 
             
  $(2,110) $281  $4,461 

  Year ended December 31, 
  2009  2010  2011 
          
Current (foreign) $294  $427  $470 
Deferred (foreign)  (34)  (250)  (700)
             
  $260  $177  $(230)

The Company's entire provision for taxes on income relates to operations in jurisdictions other than Curaçao.

NOTE 12:EQUITYi.Uncertain tax positions:

a.Common shares confer upon their holders voting rights, the right to receive cash dividends and the right to share in excess assets upon liquidation of the Company.

b.In June 2007, the Company entered into a private placement investment transaction with several institutional investors, private investors, and Formula for an aggregate gross investment amount of $ 19,415 (net of issuance expenses of $ 585). The Company issued the investors an aggregate of 6,666,667 Common shares at a price per share of $ 3.00. 
c.  
Stock option plan:
Stock options granted under the Company's 1992 Stock Option and Incentive Plan ("the 1992 Stock Plan") to employees, directors and service providers are exercisable at the fair market value of the Company's Common shares on the date of grant and, subject to termination of employment, expire ten years from the date of grant and are generally exercisable in four equal annual installments commencing one year from the date of grant, unless otherwise determined by the Compensation Committee of the Company's Board of Directors.

In 2003, the Company's Board of Directors and shareholders authorized the extension of the 1992 Stock Plan until April 2012. Also in 2003, the Company's Board of Directors and shareholders approved the 2003 Share Option Plan ("the 2003 Option Plan"), including the reservation of 500,000 Common shares for grant pursuant to such plan. The 1992 Stock Plan and the 2003 Option Plan are referred to together as "the Plan". In August 2004, the Company's shareholders approved an increase of the number of Common shares available for grant pursuant to the Plan by an additional 500,000 shares.

In November 2005, the Company's Board of Directors approved a new Incentive Stock Option Plan ("the Special Plan"). The number of Common shares available for grants pursuant to the Special Plan was set at 2,000,000 shares. The Special Plan is intended to be used solely to attract or retain senior management and/or Board members. Options granted pursuant to the Special Plan will have an exercise price of $ 3.00, will be locked for up to five years, and will be contingent upon the optionee providing services to the Company throughout the entire five year period. In the event of a change of control of the Company, the vesting of such options will be accelerated.


F -

A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits is as follows:

�� December 31, 
  2010  2011 
       
Balance at the beginning of the year $300  $400 
Uncertain tax position acquired during the year  100   - 
Increase in tax position due to the acquisition of FIS      925 
Increase in tax position  -   241 
Interest for unrecognized tax liabilities from prior years  -   66 
         
Balance at the end of the year $400  $1,632 

Unrecognized tax benefits included $ 808 of tax benefits, which if recognized, would affect the company's income tax provision and the effective tax rate.

As of December 31,


2011, most of the Company's Israeli subsidiaries are subject to Israeli income tax audits for the tax years 2007 through 2011, to U.S. federal income tax audits for the tax years of 2008 through 2011 and to other income tax audits for the tax years of 2006 through 2011.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except(except share and per share data)


NOTE 12:11:EQUITY (Cont.)

a.The common shares of the Company are traded on the Tel-Aviv Stock Exchange and on the NASDAQ.

Common shares confer upon their holders voting rights, the right to receive cash dividends and the right to share in excess assets upon liquidation of the Company.

b.Stock option plans:

In April 2009, the Company'sBoard of Directorsapproved a re-pricing of some of the Company's stock options held by Company's management. management.As a result of the re-pricing, 1,985,650 stock options at an exercise price range of $ 1.74 to $ 5.30 were re-priced to 1,554,627 stock options at an exercise price of $ 1.50 per share (925,870 stock options fromout of the 1,554,627 are at market conditions (a kick-in feature of $ 2.10 market price)). The Company accounted for the re-pricing of the options above in accordance with ASC 718, as a modification. The Company used the Black-Scholes valuation model to calculate the incremental fair value for the re-priced options, except for the options with market conditions, for which a Binominal model was used.used. In addition, the expected term of the options before the re-pricing was calculated using the Binomial model. Since there was no incremental value as a result of the modification, no additional expense was recorded in respect of the re-pricing of the respective options.


In 2011, in connection with the acquisition of IDIT and FIS, the Company's board of directors approved its 2011 Share Incentive Plan (the “2011 Plan”) pursuant to which the Company's employees, directors, officers, consultants, advisors, suppliers, business partner, customer and any other person or entity whose services are considered valuable are eligible to receive awards of share options, restricted shares, restricted share units and other share-based awards. The number of Common Shares available under the 2011 Plan was set at 4,000,000. Upon the approval of the 2011 Plan, the board of directors determined that no further awards would be issued under the Company's previously existing share incentive plans.

Pursuant to the terms of the acquisitions of IDIT and FIS, the Company replaced unvested options with Sapiens options, based on the agreed exchange ratio applicable to the purchase of the outstanding shares of IDIT and FIS, respectively. Each replaced option is subject to the same terms and conditions, including vesting and timing of exercisability, as applied to any such option immediately prior to the acquisition.

As of December 31, 2009, 1,365,204 options to Common2011 1,581,927 common shares of the Company arewere available for future grant.grant under the 2011 Plan. Any options,option granted under the 2011 Plan which are forfeited or cancelled before expiration, will become available for future grant under the 2011 Plan.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 11:EQUITY (Cont.)

A summary of the stock optionsoption activities in 20092011 is as follows:


  Year ended December 31, 2009 
  Amount of options  
Weighted
average
exercise
price
  Weighted average remaining contractual life  Aggregate intrinsic value 
     $  Years  $ 
             
Outstanding at beginning of year  2,698,350   3.45   6.37    
Granted  286,012   1.24   5.42    
Expired and forfeited  677,399   4.24   5.14    
                
Outstanding at end of year  2,306,963   2.16   5.23   224,728 
                 
Vested and expected to vest at end of year  2,276,720   2.17   5.23   218,852 
                 
Exercisable options at end of year  1,702,103   2.44   5.21   107,208 

The aggregate intrinsic value is

  Year ended December 31, 2011 
  Amount of options  Weighted
average
exercise
price
  Weighted average remaining contractual life (in years)  Aggregate intrinsic value 
             
Outstanding at January 1, 2011  2,945,772  $1.65   4.70  $2,026 
Granted with respect to IDIT and FIS acquisition (Note 1)  1,938,844   2.09         
Granted  491,000   3.29         
Exercised  (135,796)  1.69         
Expired and forfeited  (52,674)  1.54         
                 
Outstanding at December 31, 2011  5,187,146   1.97   4.56   19,609 
                 
Exercisable at December 31, 2011  3,688,079   1.81   4.22   7,307 

In 2009, 2010 and 2011, the difference between the Company's closingCompany granted 292,012, 789,000 and 2,429,844 stock price on the last trading day of the fiscal year 2009options to employees and the exercise price, multiplied by the number of in-the-money options that would have been received by the option holders had all option holders exercised their options on December 31, 2009. This aggregate intrinsic value changes based on the fair market value of the Company's shares.


directors, respectively.

The weighted average grant date fair values of the options granted during the years ended December 31, 2007, 20082009, 2010 and 20092011 were $ 1.38,0.59,0.641.08 and $ 0.59,2.25, respectively.

The total intrinsic value of options exercised during the years ended December 31, 2007, 20082010 and 20092011 was $ 18, $ 9716 and $ 0,253, respectively. Compensation expense recognized amounted to $ 115, $ 165 and $ 259 forNo options were exercise during 2009.

The options outstanding under the years endedCompany's stock option plans as of December 31, 2007, 20082011 have been separated into ranges of exercise price as follows:

               Weighted 
   Options  Weighted     Options  Average 
   outstanding  average  Weighted  Exercisable  Exercise 
   as of  remaining  average  as of  price of 
Ranges of December 31,  contractual  exercise  December 31,  Options 
exercise price 2011  Term  price  2011  Exercisable 
      (Years)  $     $ 
                      
$0.38  25,922   0.25   0.38   25,922   0.38 
$0.83  220,710   4.38   0.83   220,710   0.83 
$1-1.5  1,957,357   3.56   1.46   1,798,671   1.48 
$1.55-1.68  451,830   3.45   1.61   208,080   1.63 
$1.74-1.91  782,287   5.03   1.80   664,579   1.81 
$2.00-2.25  471,750   4.19   2.20   134,250   2.20 
$2.31-2.63  517,387   8.69   2.53   366,964   2.52 
$3.00-3.75  676,487   5.11   3.38   185,487   3.63 
$4.06-4.84  67,016   4.39   4.22   67,016   4.22 
$5.00-5.30  16,400   0.17   5.28   16,400   5.28 
                      
    5,187,146   4.56   1.97   3,688,079   1.81 

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and 2009, respectively.


per share data)

NOTE 11:EQUITY (Cont.)

c.The total stock-based compensation expenses related to all of the Company's equity-based awards recognized for the years ended December 31, 2009, 2010 and 2011 was, $ 259, $ 412 and $ 336, respectively. The total stock-based compensation expenses were recorded as Selling, marketing, general and administration expenses.

d.See Note 1d regarding shares and related put options issued to Harcase's former shareholders.

As of December 31, 2009,2011, there was $477$ 2,000 of total unrecognized compensation cost related to non-vested options granted under the Plan and the Special Plan, which is expected to be recognized over a period of up to four years.


Upon exercise

e.Warrants:

The following table summarizes information regarding outstanding warrants to purchase Common shares of options by employees, the Company satisfies the requirements by issuing newly issued shares.


F - 32

as of December 31, 2011:

Warrants to Common shares Weighted average exercise price per share  Warrants
exercisable
  Exercisable through
           
1,000,000 $3.82   1,000,000  August 2014
11,000 $2.00   11,000  May 2015
17,000 $2.24   17,000  February 2015
           
1,028,000 $3.77   1,028,000   

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except(except share and per share data)

NOTE 12:-EQUITY (Cont.)BASIC AND DILUTED NET EARNINGS PER SHARE

d.
Warrants:
In 2005, warrants were granted to advisory board members. As of December 31, 2009, warrants are outstanding as follows:
Warrants to Common shares Weighted average exercise price per share 
Warrants
exercisable
 Exercisable through
       
 11,000 $2.00  11,000 May 2015
 17,000 $2.24  17,000 February 2015
          
 28,000 $2.15  28,000  

These warrants were measured at fair value (according to the Black-Scholes option pricing model) with the following assumptions: Risk free rate of 3.5%, dividend yields of 0%, expected volatility of 80% and contractual life of ten years. Total compensation expense amounted to $ 25, of which $ 3, $ 0 and $ 0 were recorded in 2007, 2008 and 2009, respectively.
e.The total stock-based compensation expenses related to all of the Company's equity-based awards recognized for the years ended December 31, 2007, 2008 and 2009 was $ 118, $ 165 and $ 259, respectively. The total stock-based compensation expenses were recorded as general and administrative expenses.

  Year ended December 31, 
  2009  2010  2011 
          
Numerator:            
             
Net income attributed to Sapiens shareholders $4,201  $6,152  $5,897 
             
Denominator:            
             
Denominator for basic earnings per share - weighted average number of common shares, net of treasury stock  21,573   21,583   28,460 
Shares and related put options issued in Harcase acquisition (See Note 1d)  -   10   298 
Stock options and warrants  1   588   2,006 
             
Denominator for diluted net earnings per share - adjusted weighted average number of shares $21,574  $22,181  $30,764 

The weighted average number of shares related to outstanding anti-dilutive options and warrants excluded from the calculations of diluted net earnings per share was 2,763,298 and 834,844 and 1,308,212 for the years 2009, 2010 and 2011, respectively.

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 13:GEOGRAPHIC INFORMATION

a.The Company operates in a single reportable segment as a provider of software solutions. See Note 1 for a brief description of the Company's business. The data below is presented in accordance with ASC 280, "Segment Reporting".

b.
Geographic information:
The following is a summary of operations within geographic markets.
    Year ended December 31, 
    2007  2008  2009 
1. Revenues:         
            
  U.K. $13,417  $11,612  $12,323 
  North America  10,061   7,846   7,759 
  Israel  13,824   16,141   14,922 
  Japan  4,071   6,375   9,950 
  Europe  1,022   1,560   741 
               
    $42,395  $43,534  $45,695 


F - 33

The following is a summary of operations within geographic markets.

   Year ended December 31, 
   2009  2010  2011 
1.Revenues:            
              
 Israel $14,922  $19,554  $21,470 
 North America  7,759   8,991   20,889 
 United Kingdom  12,323   11,995   14,672 
 Asia  9,950   11,080   8,026 
 Europe  741   615   4,870 
              
   $45,695  $52,235  $69,927 

   December 31, 
   2010  2011 
2.Long-lived assets:        
          
 Israel $14,584  $32,676 
 North America  1,672   1,293 
 Rest of the world  272   578 
          
   $16,528  $34,547 

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


U.S. dollars in thousands (except(except share and per share data)

NOTE 13:GEOGRAPHIC INFORMATION (Cont.)

    December 31, 
    2008  2009 
2. Long-lived assets:      
         
  Netherlands Antilles $8,862  $8,621 
  Israel  16,078   15,319 
  Rest of the world  715   716 
           
    $25,655  $24,656 

NOTE 14:SELECTED STATEMENTS OF OPERATIONS DATA

a.Research and developmentFinancial expenses, net:
  Year ended December 31, 
  2007  2008  2009 
          
Total costs $6,635  $7,380  $6,427 
             
Less - capitalized software development costs  (3,133)  (3,496)  (3,692)
             
Research and development expenses, net $3,502  $3,884  $2,735 

  Year ended December 31, 
  2009  2010  2011 
          
Total costs $6,427  $8,680  $9,743 
Less - capitalized software development costs  (3,692)  (5,387)  (4,735)
             
Research and development expenses, net $2,735  $3,293  $5,008 

b.Financial expenses,income (expenses), net:
  Year ended December 31, 
  2007  2008 2009 
Financial income:         
Interest $300  $242  $109 
Re-evaluation of warrants (series 1) which are classified as liabilities  71   -   - 
Foreign currency transaction differences  250   183   106 
Income on sale of marketable securities, bonds and other  29   -   - 
Income on put option transactions  158   106   135 
             
   808   531   244 
Financial expenses:            
Interest *)  1,924   867   416 
Foreign currency transaction differences  913   519   150 
Bank charges and others  109   388   204 
Amortization of issuance expenses and discount on convertible notes
  551   679   458 
Loss on repurchase of convertible debentures  109   314   2 
             
   3,606   2,767   1,124 
             
Financial expenses, net $2,798  $2,236  $880 

Financial income:            
Interest $109  $87  $160 
Foreign currency translation  241   39   530 
             
   350   126   690 
Financial expenses:            
Interest  416   105   189 
Foreign currency translation  313   249   341 
Bank charges and others  43   30   56 
Re-measurement of earn-out payment  -   106   - 
Amortization of issuance expenses and discount on convertible notes  458   -   - 
             
   (1,230)  (490)  (586)
             
Financial income (expenses), net $(880) $(364) $104 

- - - - - - - -

*)For capitalization of interest expenses, see Note 6a.F-41


F - 34

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

U.S. dollars in thousands (except share and per share data)

NOTE 15:SUBSEQUENT EVENT

On April 27, 2010, the Company entered into Share Purchase Agreement ("SPA") with Harcase Software Ltd. ("Harcase"), a company that develops, implements and promotes software solutions and provides related professional services for property and casualty insurance carriers, for the acquisition of all of the outstanding shares of Harcase from its selling shareholders.

Under the terms of the SPA, the Company will pay consideration in the amount of approximately $4,000, of which approximately $3,000 will be paid in cash and the remaining balance will be paid by issuance of 454,546  of Company's Common shares. In addition, the Company is obligated to pay additional consideration to the selling shareholders of Harcase contingent upon achievement of certain performance targets as well as partially contingent upon continued employment of the selling shareholders.

Due to the fact that the acquisition occurred on April 27, 2010, the Company is currently evaluating the accounting treatment of the above acquisition on the Company's financial statements.

F - 35